MIME-Version: 1.0
Content-Type: multipart/related; boundary="----=_NextPart_01D74CBE.98D67E10"

This document is a Single File Web Page, also known as a Web Archive file.  If you are seeing this message, your browser or editor doesn't support Web Archive files.  Please download a browser that supports Web Archive.

------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:dt=3D"uuid:C2F41010-65B3-11d1-A29F-00AA00C14882"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link rel=3DFile-List href=3D"Kalydeco_clean_files/filelist.xml">
<title>Kalydeco II-86-PI-clean</title>
<!--[if gte mso 9]><xml>
 <o:DocumentProperties>
  <o:Subject>EPAR</o:Subject>
  <o:Author>CHMP</o:Author>
  <o:Keywords>Kalydeco, INN-ivacaftor</o:Keywords>
  <o:Template>Normal</o:Template>
  <o:LastAuthor>P Reshma Sagar</o:LastAuthor>
  <o:Revision>2</o:Revision>
  <o:TotalTime>0</o:TotalTime>
  <o:LastPrinted>2020-07-18T01:48:00Z</o:LastPrinted>
  <o:Created>2021-05-19T09:22:00Z</o:Created>
  <o:LastSaved>2021-05-19T09:22:00Z</o:LastSaved>
  <o:Pages>1</o:Pages>
  <o:Words>26035</o:Words>
  <o:Characters>148406</o:Characters>
  <o:Company>Hewlett-Packard Company</o:Company>
  <o:Lines>1236</o:Lines>
  <o:Paragraphs>348</o:Paragraphs>
  <o:CharactersWithSpaces>174093</o:CharactersWithSpaces>
  <o:Version>16.00</o:Version>
 </o:DocumentProperties>
 <o:CustomDocumentProperties>
  <o:Classification dt:dt=3D"string">Internal All EMA Staff and Contractors=
</o:Classification>
  <o:ContentTypeId dt:dt=3D"string">0x010100726F91DD1AE57B44B1BCEB7F1056F5D=
0</o:ContentTypeId>
  <o:DM_Author dt:dt=3D"string"></o:DM_Author>
  <o:DM_Authors dt:dt=3D"string"></o:DM_Authors>
  <o:DM_Category dt:dt=3D"string">Product Information</o:DM_Category>
  <o:DM_Creation_Date dt:dt=3D"string">25/09/2020 09:00:01</o:DM_Creation_D=
ate>
  <o:DM_Creator_Name dt:dt=3D"string">De Chiara Denisa</o:DM_Creator_Name>
  <o:DM_DocRefId dt:dt=3D"string">EMA/497493/2020</o:DM_DocRefId>
  <o:DM_emea_bcc dt:dt=3D"string"></o:DM_emea_bcc>
  <o:DM_emea_cc dt:dt=3D"string"></o:DM_emea_cc>
  <o:DM_emea_doc_category dt:dt=3D"string">General</o:DM_emea_doc_category>
  <o:DM_emea_doc_lang dt:dt=3D"string"></o:DM_emea_doc_lang>
  <o:DM_emea_doc_number dt:dt=3D"string">423415</o:DM_emea_doc_number>
  <o:DM_emea_doc_ref_id dt:dt=3D"string">EMA/497493/2020</o:DM_emea_doc_ref=
_id>
  <o:DM_emea_from dt:dt=3D"string"></o:DM_emea_from>
  <o:DM_emea_internal_label dt:dt=3D"string">EMA</o:DM_emea_internal_label>
  <o:DM_emea_legal_date dt:dt=3D"string">nulldate</o:DM_emea_legal_date>
  <o:DM_emea_meeting_action dt:dt=3D"string"></o:DM_emea_meeting_action>
  <o:DM_emea_meeting_flags dt:dt=3D"string"></o:DM_emea_meeting_flags>
  <o:DM_emea_meeting_hyperlink dt:dt=3D"string"></o:DM_emea_meeting_hyperli=
nk>
  <o:DM_emea_meeting_ref dt:dt=3D"string"></o:DM_emea_meeting_ref>
  <o:DM_emea_meeting_status dt:dt=3D"string"></o:DM_emea_meeting_status>
  <o:DM_emea_meeting_title dt:dt=3D"string"></o:DM_emea_meeting_title>
  <o:DM_emea_message_subject dt:dt=3D"string"></o:DM_emea_message_subject>
  <o:DM_emea_received_date dt:dt=3D"string">nulldate</o:DM_emea_received_da=
te>
  <o:DM_emea_resp_body dt:dt=3D"string"></o:DM_emea_resp_body>
  <o:DM_emea_revision_label dt:dt=3D"string"></o:DM_emea_revision_label>
  <o:DM_emea_sent_date dt:dt=3D"string">nulldate</o:DM_emea_sent_date>
  <o:DM_emea_to dt:dt=3D"string"></o:DM_emea_to>
  <o:DM_emea_year dt:dt=3D"string">2010</o:DM_emea_year>
  <o:DM_Keywords dt:dt=3D"string"></o:DM_Keywords>
  <o:DM_Language dt:dt=3D"string"></o:DM_Language>
  <o:DM_Modifer_Name dt:dt=3D"string">De Chiara Denisa</o:DM_Modifer_Name>
  <o:DM_Modified_Date dt:dt=3D"string">25/09/2020 09:07:01</o:DM_Modified_D=
ate>
  <o:DM_Modifier_Name dt:dt=3D"string">De Chiara Denisa</o:DM_Modifier_Name>
  <o:DM_Modify_Date dt:dt=3D"string">25/09/2020 09:07:01</o:DM_Modify_Date>
  <o:DM_Name dt:dt=3D"string">Kalydeco II-86-PI-clean</o:DM_Name>
  <o:DM_Owner dt:dt=3D"string">Espinasse Claire</o:DM_Owner>
  <o:DM_Path dt:dt=3D"string">/01. Evaluation of Medicines/H-C/J-L/Kalydeco=
 (Ivacaftor Vertex Pharmaceuticals)- 002494/05 Post Authorisation/Post Acti=
vities/2020-xx-xx-2494-II-0086-(EoI)-I-IIIB/03. Opinion</o:DM_Path>
  <o:DM_Status dt:dt=3D"string"></o:DM_Status>
  <o:DM_Subject dt:dt=3D"string"></o:DM_Subject>
  <o:DM_Title dt:dt=3D"string"></o:DM_Title>
  <o:DM_Type dt:dt=3D"string">emea_document</o:DM_Type>
  <o:DM_Version dt:dt=3D"string">1.1,CURRENT</o:DM_Version>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_ActionId dt:dt=3D"stri=
ng">79b4a345-51e7-46f2-ab67-69f89ed7e5a1</o:MSIP_Label_0eea11ca-d417-4147-8=
0ed-01a58412c458_ActionId>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Application dt:dt=3D"s=
tring">Microsoft Azure Information Protection</o:MSIP_Label_0eea11ca-d417-4=
147-80ed-01a58412c458_Application>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled dt:dt=3D"strin=
g">True</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Enabled>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Extended_MSFT_Method
   dt:dt=3D"string">Automatic</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a5841=
2c458_Extended_MSFT_Method>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Name dt:dt=3D"string">=
All EMA Staff and Contractors</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a5841=
2c458_Name>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Owner dt:dt=3D"string"=
>suina.maamar@ema.europa.eu</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c=
458_Owner>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_Parent dt:dt=3D"string=
">afe1b31d-cec0-4074-b4bd-f07689e43d84</o:MSIP_Label_0eea11ca-d417-4147-80e=
d-01a58412c458_Parent>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SetDate dt:dt=3D"strin=
g">2020-07-16T09:45:29.1153437Z</o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58=
412c458_SetDate>
  <o:MSIP_Label_0eea11ca-d417-4147-80ed-01a58412c458_SiteId dt:dt=3D"string=
">bc9dc15c-61bc-4f03-b60b-e5b6d8922839</o:MSIP_Label_0eea11ca-d417-4147-80e=
d-01a58412c458_SiteId>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_ActionId dt:dt=3D"stri=
ng">79b4a345-51e7-46f2-ab67-69f89ed7e5a1</o:MSIP_Label_afe1b31d-cec0-4074-b=
4bd-f07689e43d84_ActionId>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Application dt:dt=3D"s=
tring">Microsoft Azure Information Protection</o:MSIP_Label_afe1b31d-cec0-4=
074-b4bd-f07689e43d84_Application>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Enabled dt:dt=3D"strin=
g">True</o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Enabled>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Extended_MSFT_Method
   dt:dt=3D"string">Automatic</o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e=
43d84_Extended_MSFT_Method>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Name dt:dt=3D"string">=
Internal</o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Name>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_Owner dt:dt=3D"string"=
>suina.maamar@ema.europa.eu</o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43=
d84_Owner>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_SetDate dt:dt=3D"strin=
g">2020-07-16T09:45:29.1153437Z</o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f0768=
9e43d84_SetDate>
  <o:MSIP_Label_afe1b31d-cec0-4074-b4bd-f07689e43d84_SiteId dt:dt=3D"string=
">bc9dc15c-61bc-4f03-b60b-e5b6d8922839</o:MSIP_Label_afe1b31d-cec0-4074-b4b=
d-f07689e43d84_SiteId>
 </o:CustomDocumentProperties>
 <o:OfficeDocumentSettings>
  <o:RelyOnVML/>
  <o:AllowPNG/>
 </o:OfficeDocumentSettings>
</xml><![endif]-->
<link rel=3DdataStoreItem href=3D"Kalydeco_clean_files/item0001.xml"
target=3D"Kalydeco_clean_files/props002.xml">
<link rel=3DdataStoreItem href=3D"Kalydeco_clean_files/item0003.xml"
target=3D"Kalydeco_clean_files/props004.xml">
<link rel=3DdataStoreItem href=3D"Kalydeco_clean_files/item0005.xml"
target=3D"Kalydeco_clean_files/props006.xml">
<link rel=3DdataStoreItem href=3D"Kalydeco_clean_files/item0007.xml"
target=3D"Kalydeco_clean_files/props008.xml">
<link rel=3DdataStoreItem href=3D"Kalydeco_clean_files/item0009.xml"
target=3D"Kalydeco_clean_files/props010.xml">
<link rel=3DdataStoreItem href=3D"Kalydeco_clean_files/item0011.xml"
target=3D"Kalydeco_clean_files/props012.xml">
<link rel=3DdataStoreItem href=3D"Kalydeco_clean_files/item0013.xml"
target=3D"Kalydeco_clean_files/props014.xml">
<link rel=3DthemeData href=3D"Kalydeco_clean_files/themedata.thmx">
<link rel=3DcolorSchemeMapping href=3D"Kalydeco_clean_files/colorschememapp=
ing.xml">
<!--[if gte mso 9]><xml>
 <w:WordDocument>
  <w:TrackMoves/>
  <w:TrackFormatting/>
  <w:HyphenationZone>21</w:HyphenationZone>
  <w:DisplayHorizontalDrawingGridEvery>0</w:DisplayHorizontalDrawingGridEve=
ry>
  <w:DisplayVerticalDrawingGridEvery>0</w:DisplayVerticalDrawingGridEvery>
  <w:UseMarginsForDrawingGridOrigin/>
  <w:ValidateAgainstSchemas/>
  <w:SaveIfXMLInvalid>false</w:SaveIfXMLInvalid>
  <w:IgnoreMixedContent>false</w:IgnoreMixedContent>
  <w:AlwaysShowPlaceholderText>false</w:AlwaysShowPlaceholderText>
  <w:DoNotPromoteQF/>
  <w:LidThemeOther>ES</w:LidThemeOther>
  <w:LidThemeAsian>X-NONE</w:LidThemeAsian>
  <w:LidThemeComplexScript>AR-SA</w:LidThemeComplexScript>
  <w:Compatibility>
   <w:DoNotUseHTMLParagraphAutoSpacing/>
   <w:BreakWrappedTables/>
   <w:SnapToGridInCell/>
   <w:WrapTextWithPunct/>
   <w:UseAsianBreakRules/>
   <w:DontGrowAutofit/>
   <w:SplitPgBreakAndParaMark/>
   <w:EnableOpenTypeKerning/>
   <w:DontFlipMirrorIndents/>
   <w:OverrideTableStyleHps/>
   <w:UseFELayout/>
  </w:Compatibility>
  <w:DocumentVariables>
   <w:Registered>-1</w:Registered>
   <w:Version>0</w:Version>
  </w:DocumentVariables>
  <w:DoNotOptimizeForBrowser/>
  <m:mathPr>
   <m:mathFont m:val=3D"Cambria Math"/>
   <m:brkBin m:val=3D"before"/>
   <m:brkBinSub m:val=3D"&#45;-"/>
   <m:smallFrac m:val=3D"off"/>
   <m:dispDef/>
   <m:lMargin m:val=3D"0"/>
   <m:rMargin m:val=3D"0"/>
   <m:defJc m:val=3D"centerGroup"/>
   <m:wrapRight/>
   <m:intLim m:val=3D"subSup"/>
   <m:naryLim m:val=3D"undOvr"/>
  </m:mathPr></w:WordDocument>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <w:LatentStyles DefLockedState=3D"false" DefUnhideWhenUsed=3D"false"
  DefSemiHidden=3D"false" DefQFormat=3D"false" DefPriority=3D"99"
  LatentStyleCount=3D"376">
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
Normal"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
heading 1"/>
  <w:LsdException Locked=3D"false" QFormat=3D"true" Name=3D"heading 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"9" QFormat=3D"true" Name=3D"=
heading 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index 9"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 7"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 8"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"toc 9"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   QFormat=3D"true" Name=3D"annotation text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"header"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footer"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"index heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
caption"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of figures"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"envelope return"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"footnote reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"line number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"page number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote reference"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"endnote text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"table of authorities"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"macro"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"toa heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Bullet 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Number 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"10" QFormat=3D"true" Name=3D=
"Title"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Closing"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Signature"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Default Paragraph Font"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"List Continue 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Message Header"/>
  <w:LsdException Locked=3D"false" Priority=3D"11" QFormat=3D"true" Name=3D=
"Subtitle"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Salutation"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Date"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text First Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Note Heading"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Body Text Indent 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Block Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Hyperlink"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"FollowedHyperlink"/>
  <w:LsdException Locked=3D"false" Priority=3D"22" QFormat=3D"true" Name=3D=
"Strong"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" QFormat=3D"true" Name=3D"=
Emphasis"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Document Map"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Plain Text"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"E-mail Signature"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Top of Form"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Bottom of Form"/>
  <w:LsdException Locked=3D"false" Priority=3D"0" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Normal (Web)"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Acronym"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Address"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Cite"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Code"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Definition"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Keyboard"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Preformatted"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Sample"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Typewriter"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"HTML Variable"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Normal Table"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"annotation subject"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"No List"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Outline List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Simple 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Classic 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Colorful 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Columns 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Grid 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 4"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 5"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 6"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 7"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table List 8"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table 3D effects 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Contemporary"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Elegant"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Professional"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Subtle 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 2"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Web 3"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Balloon Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" Name=3D"Table Grid"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" UnhideWhenUsed=3D"tr=
ue"
   Name=3D"Table Theme"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" Name=3D"Placeholder =
Text"/>
  <w:LsdException Locked=3D"false" Priority=3D"1" QFormat=3D"true" Name=3D"=
No Spacing"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" SemiHidden=3D"true" Name=3D"Revision"/>
  <w:LsdException Locked=3D"false" Priority=3D"34" QFormat=3D"true"
   Name=3D"List Paragraph"/>
  <w:LsdException Locked=3D"false" Priority=3D"29" QFormat=3D"true" Name=3D=
"Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"30" QFormat=3D"true"
   Name=3D"Intense Quote"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"60" Name=3D"Light Shading Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"61" Name=3D"Light List Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"62" Name=3D"Light Grid Accen=
t 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"63" Name=3D"Medium Shading 1=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"64" Name=3D"Medium Shading 2=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"65" Name=3D"Medium List 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"66" Name=3D"Medium List 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"67" Name=3D"Medium Grid 1 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"68" Name=3D"Medium Grid 2 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"69" Name=3D"Medium Grid 3 Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"70" Name=3D"Dark List Accent=
 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"71" Name=3D"Colorful Shading=
 Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"72" Name=3D"Colorful List Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"73" Name=3D"Colorful Grid Ac=
cent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"19" QFormat=3D"true"
   Name=3D"Subtle Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"21" QFormat=3D"true"
   Name=3D"Intense Emphasis"/>
  <w:LsdException Locked=3D"false" Priority=3D"31" QFormat=3D"true"
   Name=3D"Subtle Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"32" QFormat=3D"true"
   Name=3D"Intense Reference"/>
  <w:LsdException Locked=3D"false" Priority=3D"33" QFormat=3D"true" Name=3D=
"Book Title"/>
  <w:LsdException Locked=3D"false" Priority=3D"37" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" Name=3D"Bibliography"/>
  <w:LsdException Locked=3D"false" Priority=3D"39" SemiHidden=3D"true"
   UnhideWhenUsed=3D"true" QFormat=3D"true" Name=3D"TOC Heading"/>
  <w:LsdException Locked=3D"false" Priority=3D"41" Name=3D"Plain Table 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"42" Name=3D"Plain Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"43" Name=3D"Plain Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"44" Name=3D"Plain Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"45" Name=3D"Plain Table 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"40" Name=3D"Grid Table Light=
"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"Grid Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"Grid Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"Grid Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"Grid Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"Grid Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"Grid Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"Grid Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"Grid Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"Grid Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"Grid Table 7 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"46" Name=3D"List Table 1 Lig=
ht"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k"/>
  <w:LsdException Locked=3D"false" Priority=3D"51" Name=3D"List Table 6 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"52" Name=3D"List Table 7 Col=
orful"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 1"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 2"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 3"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 4"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 5"/>
  <w:LsdException Locked=3D"false" Priority=3D"46"
   Name=3D"List Table 1 Light Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"47" Name=3D"List Table 2 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"48" Name=3D"List Table 3 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"49" Name=3D"List Table 4 Acc=
ent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"50" Name=3D"List Table 5 Dar=
k Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"51"
   Name=3D"List Table 6 Colorful Accent 6"/>
  <w:LsdException Locked=3D"false" Priority=3D"52"
   Name=3D"List Table 7 Colorful Accent 6"/>
 </w:LatentStyles>
</xml><![endif]-->
<style>
<!--
 /* Font Definitions */
 @font-face
	{font-family:Helvetica;
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Courier;
	panose-1:2 7 4 9 2 2 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-format:other;
	mso-font-pitch:fixed;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Tms Rmn";
	panose-1:2 2 6 3 4 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Helv;
	panose-1:2 11 6 4 2 2 2 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"New York";
	panose-1:2 4 5 3 6 5 6 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:System;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Wingdings;
	panose-1:5 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-alt:"MS Mincho";
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:Batang;
	panose-1:2 3 6 0 0 1 1 1 1 1;
	mso-font-alt:\BC14\D0D5;
	mso-font-charset:129;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:SimSun;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\5B8B\4F53;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:PMingLiU;
	panose-1:2 1 6 1 0 1 1 1 1 1;
	mso-font-alt:\65B0\7D30\660E\9AD4;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611969 684719354 22 0 1048577 0;}
@font-face
	{font-family:"MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;
	mso-font-alt:"\FF2D\FF33 \30B4\30B7\30C3\30AF";
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:Dotum;
	panose-1:2 11 6 0 0 1 1 1 1 1;
	mso-font-alt:\B3CB\C6C0;
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:SimHei;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\9ED1\4F53;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-2147482945 953122042 22 0 262145 0;}
@font-face
	{font-family:MingLiU;
	panose-1:2 1 6 9 0 1 1 1 1 1;
	mso-font-alt:\7D30\660E\9AD4;
	mso-font-charset:136;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-1610611969 684719354 22 0 1048577 0;}
@font-face
	{font-family:Mincho;
	panose-1:2 2 6 9 4 3 5 8 3 5;
	mso-font-alt:\660E\671D;
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:fixed;
	mso-font-signature:1 134676480 16 0 131072 0;}
@font-face
	{font-family:Gulim;
	panose-1:2 11 6 0 0 1 1 1 1 1;
	mso-font-alt:\AD74\B9BC;
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:Century;
	panose-1:2 4 6 4 5 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Angsana New";
	panose-1:2 2 6 3 5 4 5 2 3 4;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:"Cordia New";
	panose-1:2 11 3 4 2 2 2 2 2 4;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Mangal;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:32771 0 0 0 1 0;}
@font-face
	{font-family:Latha;
	panose-1:2 0 4 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1048579 0 0 0 1 0;}
@font-face
	{font-family:Sylfaen;
	panose-1:1 10 5 2 5 3 6 3 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:67110535 0 0 0 159 0;}
@font-face
	{font-family:Vrinda;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:65539 0 0 0 1 0;}
@font-face
	{font-family:Raavi;
	panose-1:2 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:131075 0 0 0 1 0;}
@font-face
	{font-family:Shruti;
	panose-1:2 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:262147 0 0 0 1 0;}
@font-face
	{font-family:Sendnya;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:Gautami;
	panose-1:2 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:2097155 0 0 0 1 0;}
@font-face
	{font-family:Tunga;
	panose-1:0 0 4 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:4194307 0 0 0 1 0;}
@font-face
	{font-family:"Estrangelo Edessa";
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:1;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 0 0 0 0 0;}
@font-face
	{font-family:"Cambria Math";
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:"Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;
	mso-font-alt:\6E38\30B4\30B7\30C3\30AF;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:DengXian;
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-alt:\7B49\7EBF;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612033 953122042 22 0 262159 0;}
@font-face
	{font-family:Calibri;
	panose-1:2 15 5 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:"Calibri Light";
	panose-1:2 15 3 2 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073732485 9 0 511 0;}
@font-face
	{font-family:"Palatino Linotype";
	panose-1:2 4 5 2 5 5 5 3 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870265 1073741843 0 0 415 0;}
@font-face
	{font-family:Verdana;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610610945 1073750107 16 0 415 0;}
@font-face
	{font-family:"Arial Unicode MS";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Segoe UI Emoji";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 33554432 0 0 1 0;}
@font-face
	{font-family:Cambria;
	panose-1:2 4 5 3 5 4 6 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536869121 1107305727 33554432 0 415 0;}
@font-face
	{font-family:Tahoma;
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-520081665 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"Times New Roman Bold";
	panose-1:2 2 8 3 7 5 5 2 3 4;
	mso-font-alt:"Times New Roman";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 -1073711039 9 0 511 0;}
@font-face
	{font-family:TimesNewRoman;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"Yu Gothic";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:0 134676480 16 0 131073 0;}
@font-face
	{font-family:TimesNewRomanPSMT;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-alt:"MS Gothic";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:auto;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Adobe Devanagari";
	panose-1:2 4 5 3 5 2 1 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:32771 0 0 0 1 0;}
@font-face
	{font-family:"Adobe Arabic";
	panose-1:2 4 5 3 5 2 1 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-format:other;
	mso-font-pitch:variable;
	mso-font-signature:8195 0 8 0 65 0;}
@font-face
	{font-family:Marlett;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Arial Black";
	panose-1:2 11 10 4 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612049 1073772795 0 0 159 0;}
@font-face
	{font-family:"Bahnschrift Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiLight";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:Bahnschrift;
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiBold";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift Light SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiLight SemiConde";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiCondensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiBold SemiConden";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift Light Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiLight Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Bahnschrift SemiBold Condensed";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:Candara;
	panose-1:2 14 5 2 3 3 3 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073783883 0 0 415 0;}
@font-face
	{font-family:"Candara Light";
	panose-1:2 14 5 2 3 3 3 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611969 2 0 0 415 0;}
@font-face
	{font-family:"Comic Sans MS";
	panose-1:3 15 7 2 3 3 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:647 19 0 0 159 0;}
@font-face
	{font-family:Consolas;
	panose-1:2 11 6 9 2 2 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536869121 64767 1 0 415 0;}
@font-face
	{font-family:Constantia;
	panose-1:2 3 6 2 5 3 6 3 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:Corbel;
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073783883 0 0 415 0;}
@font-face
	{font-family:"Corbel Light";
	panose-1:2 11 3 3 2 2 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073783883 0 0 415 0;}
@font-face
	{font-family:Ebrima;
	panose-1:2 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612641 33554497 2048 0 147 0;}
@font-face
	{font-family:"Franklin Gothic Medium";
	panose-1:2 11 6 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Gabriola;
	panose-1:4 4 6 5 5 16 2 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:-536870161 1342185547 0 0 159 0;}
@font-face
	{font-family:Gadugi;
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 33554432 12288 0 1 0;}
@font-face
	{font-family:Georgia;
	panose-1:2 4 5 2 5 4 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Impact;
	panose-1:2 11 8 6 3 9 2 5 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Ink Free";
	panose-1:3 8 4 2 0 5 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:"Javanese Text";
	panose-1:2 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 8192 0 0 1 0;}
@font-face
	{font-family:"Leelawadee UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1560281085 0 65536 0 65793 0;}
@font-face
	{font-family:"Leelawadee UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1560281085 0 65536 0 65793 0;}
@font-face
	{font-family:"Lucida Console";
	panose-1:2 11 6 9 4 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-2147482993 6144 0 0 31 0;}
@font-face
	{font-family:"Lucida Sans Unicode";
	panose-1:2 11 6 2 3 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147480833 14699 0 0 191 0;}
@font-face
	{font-family:"Malgun Gothic";
	panose-1:2 11 5 3 2 0 0 2 0 4;
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1879048145 701988091 18 0 524289 0;}
@font-face
	{font-family:"\@Malgun Gothic";
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1879048145 701988091 18 0 524289 0;}
@font-face
	{font-family:"Malgun Gothic Semilight";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1342174545 165641467 18 0 4063677 0;}
@font-face
	{font-family:"\@Malgun Gothic Semilight";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1342174545 165641467 18 0 4063677 0;}
@font-face
	{font-family:"Microsoft Himalaya";
	panose-1:1 1 1 0 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 65536 64 0 1 0;}
@font-face
	{font-family:"Microsoft JhengHei";
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei";
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft JhengHei UI";
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei UI";
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:679 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft JhengHei Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei Light";
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft JhengHei UI Light";
	panose-1:2 11 3 4 3 5 4 4 2 4;
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"\@Microsoft JhengHei UI Light";
	mso-font-charset:136;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482969 684672000 22 0 1048585 0;}
@font-face
	{font-family:"Microsoft New Tai Lue";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 -2147483648 0 1 0;}
@font-face
	{font-family:"Microsoft PhagsPa";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 134217728 0 1 0;}
@font-face
	{font-family:"Microsoft Sans Serif";
	panose-1:2 11 6 4 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-452972801 -1073717157 41 0 66047 0;}
@font-face
	{font-family:"Microsoft Tai Le";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 1073741824 0 1 0;}
@font-face
	{font-family:"Microsoft YaHei";
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"\@Microsoft YaHei";
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"Microsoft YaHei UI";
	panose-1:2 11 5 3 2 2 4 2 2 4;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"\@Microsoft YaHei UI";
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718224464 22 0 262175 0;}
@font-face
	{font-family:"Microsoft YaHei Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"\@Microsoft YaHei Light";
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"Microsoft YaHei UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"\@Microsoft YaHei UI Light";
	mso-font-charset:134;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 718209040 22 0 262175 0;}
@font-face
	{font-family:"Microsoft Yi Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 66562 524290 0 1 0;}
@font-face
	{font-family:MingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"\@MingLiU-ExtB";
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:PMingLiU-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"\@PMingLiU-ExtB";
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:MingLiU_HKSCS-ExtB;
	panose-1:2 2 5 0 0 0 0 0 0 0;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"\@MingLiU_HKSCS-ExtB";
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 168296456 16 0 1048577 0;}
@font-face
	{font-family:"Mongolian Baiti";
	panose-1:3 0 5 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483613 0 131072 0 1 0;}
@font-face
	{font-family:"\@MS Gothic";
	panose-1:2 11 6 9 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"MS UI Gothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"\@MS UI Gothic";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"MS PGothic";
	panose-1:2 11 6 0 7 2 5 8 2 4;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"\@MS PGothic";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:"MV Boli";
	panose-1:2 0 5 0 3 2 0 9 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 0 256 0 1 0;}
@font-face
	{font-family:"Myanmar Text";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 1024 0 1 0;}
@font-face
	{font-family:"Nirmala UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130739165 74 512 0 1 0;}
@font-face
	{font-family:"Nirmala UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130739165 74 512 0 1 0;}
@font-face
	{font-family:"Segoe MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 268435456 0 0 1 0;}
@font-face
	{font-family:"Segoe Print";
	panose-1:2 0 6 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:655 0 0 0 159 0;}
@font-face
	{font-family:"Segoe Script";
	panose-1:3 11 5 4 2 0 0 0 0 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:655 0 0 0 159 0;}
@font-face
	{font-family:"Segoe UI";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Segoe UI Black";
	panose-1:2 11 10 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1073800319 33 0 415 0;}
@font-face
	{font-family:"Segoe UI Historic";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483153 33554434 6340736 0 1 0;}
@font-face
	{font-family:"Segoe UI Light";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Segoe UI Semibold";
	panose-1:2 11 7 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Segoe UI Semilight";
	panose-1:2 11 4 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-469750017 -1073683329 9 0 511 0;}
@font-face
	{font-family:"Segoe UI Symbol";
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483165 302055407 262144 0 1 0;}
@font-face
	{font-family:"\@SimSun";
	panose-1:2 1 6 0 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 680460288 22 0 262145 0;}
@font-face
	{font-family:NSimSun;
	panose-1:2 1 6 9 3 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:643 680460288 22 0 262145 0;}
@font-face
	{font-family:"\@NSimSun";
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:643 680460288 22 0 262145 0;}
@font-face
	{font-family:SimSun-ExtB;
	panose-1:2 1 6 9 6 1 1 1 1 1;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:3 168689664 16 0 262145 0;}
@font-face
	{font-family:"\@SimSun-ExtB";
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:3 168689664 16 0 262145 0;}
@font-face
	{font-family:"Sitka Small";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Text";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Subheading";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Heading";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Display";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Banner";
	panose-1:2 0 5 5 0 0 0 2 0 4;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Trebuchet MS";
	panose-1:2 11 6 3 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1671 0 0 0 159 0;}
@font-face
	{font-family:Webdings;
	panose-1:5 3 1 2 1 5 9 6 7 3;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"\@Yu Gothic";
	panose-1:2 11 4 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI";
	panose-1:2 11 5 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI Semibold";
	panose-1:2 11 7 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semibold";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic Light";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI Light";
	panose-1:2 11 3 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI Light";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic Medium";
	panose-1:2 11 5 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic Medium";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"Yu Gothic UI Semilight";
	panose-1:2 11 4 0 0 0 0 0 0 0;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"\@Yu Gothic UI Semilight";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717749759 22 0 131231 0;}
@font-face
	{font-family:"HoloLens MDL2 Assets";
	panose-1:5 10 1 2 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 268435456 0 0 1 0;}
@font-face
	{font-family:"Agency FB";
	panose-1:2 11 5 3 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Algerian;
	panose-1:4 2 7 5 4 10 2 6 7 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Book Antiqua";
	panose-1:2 4 6 2 5 3 5 3 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Arial Narrow";
	panose-1:2 11 6 6 2 2 2 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 2048 0 0 159 0;}
@font-face
	{font-family:"Arial Rounded MT Bold";
	panose-1:2 15 7 4 3 5 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Baskerville Old Face";
	panose-1:2 2 6 2 8 5 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bauhaus 93";
	panose-1:4 3 9 5 2 11 2 2 12 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bell MT";
	panose-1:2 2 5 3 6 3 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bernard MT Condensed";
	panose-1:2 5 8 6 6 9 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bodoni MT";
	panose-1:2 7 6 3 8 6 6 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bodoni MT Black";
	panose-1:2 7 10 3 8 6 6 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bodoni MT Condensed";
	panose-1:2 7 6 6 8 6 6 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bodoni MT Poster Compressed";
	panose-1:2 7 7 6 8 6 1 5 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 17 0;}
@font-face
	{font-family:"Bookman Old Style";
	panose-1:2 5 6 4 5 5 5 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Bradley Hand ITC";
	panose-1:3 7 4 2 5 3 2 3 2 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Britannic Bold";
	panose-1:2 11 9 3 6 7 3 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Berlin Sans FB";
	panose-1:2 14 6 2 2 5 2 2 3 6;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Berlin Sans FB Demi";
	panose-1:2 14 8 2 2 5 2 2 3 6;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Broadway;
	panose-1:4 4 9 5 8 11 2 2 5 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Brush Script MT";
	panose-1:3 6 8 2 4 4 6 7 3 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Bookshelf Symbol 7";
	panose-1:5 1 1 1 1 1 1 1 1 1;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Californian FB";
	panose-1:2 7 4 3 6 8 11 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Calisto MT";
	panose-1:2 4 6 3 5 5 5 3 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Castellar;
	panose-1:2 10 4 2 6 4 6 1 3 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Century Schoolbook";
	panose-1:2 4 6 4 5 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Centaur;
	panose-1:2 3 5 4 5 2 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Chiller;
	panose-1:4 2 4 4 3 16 7 2 6 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Colonna MT";
	panose-1:4 2 8 5 6 2 2 3 2 3;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Cooper Black";
	panose-1:2 8 9 4 4 3 11 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Copperplate Gothic Bold";
	panose-1:2 14 7 5 2 2 6 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Copperplate Gothic Light";
	panose-1:2 14 5 7 2 2 6 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Curlz MT";
	panose-1:4 4 4 4 5 7 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Dubai;
	panose-1:2 11 5 3 3 4 3 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147475353 -2147483648 8 0 65 0;}
@font-face
	{font-family:"Dubai Light";
	panose-1:2 11 3 3 3 4 3 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147475353 -2147483648 8 0 65 0;}
@font-face
	{font-family:"Dubai Medium";
	panose-1:2 11 6 3 3 4 3 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147475353 -2147483648 8 0 65 0;}
@font-face
	{font-family:Elephant;
	panose-1:2 2 9 4 9 5 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Engravers MT";
	panose-1:2 9 7 7 8 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Bold ITC";
	panose-1:2 11 9 7 3 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Demi ITC";
	panose-1:2 11 8 5 3 5 4 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Light ITC";
	panose-1:2 11 4 2 3 5 4 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Eras Medium ITC";
	panose-1:2 11 6 2 3 5 4 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Felix Titling";
	panose-1:4 6 5 5 6 2 2 2 10 4;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Forte;
	panose-1:3 6 9 2 4 5 2 7 2 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Franklin Gothic Book";
	panose-1:2 11 5 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Demi";
	panose-1:2 11 7 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Demi Cond";
	panose-1:2 11 7 6 3 4 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Heavy";
	panose-1:2 11 9 3 2 1 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Franklin Gothic Medium Cond";
	panose-1:2 11 6 6 3 4 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Freestyle Script";
	panose-1:3 8 4 2 3 2 5 11 4 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"French Script MT";
	panose-1:3 2 4 2 4 6 7 4 6 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Footlight MT Light";
	panose-1:2 4 6 2 6 3 10 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Garamond;
	panose-1:2 2 4 4 3 3 1 1 8 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:Gigi;
	panose-1:4 4 5 4 6 16 7 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Gill Sans MT";
	panose-1:2 11 5 2 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gill Sans MT Condensed";
	panose-1:2 11 5 6 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gill Sans Ultra Bold Condensed";
	panose-1:2 11 10 6 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gill Sans Ultra Bold";
	panose-1:2 11 10 2 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Gloucester MT Extra Condensed";
	panose-1:2 3 8 8 2 6 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Gill Sans MT Ext Condensed Bold";
	panose-1:2 11 9 2 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Century Gothic";
	panose-1:2 11 5 2 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Goudy Old Style";
	panose-1:2 2 5 2 5 3 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Goudy Stout";
	panose-1:2 2 9 4 7 3 11 2 4 1;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Harlow Solid Italic";
	panose-1:4 3 6 4 2 15 2 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Harrington;
	panose-1:4 4 5 5 5 10 2 2 7 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Haettenschweiler;
	panose-1:2 11 7 6 4 9 2 6 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"High Tower Text";
	panose-1:2 4 5 2 5 5 6 3 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Imprint MT Shadow";
	panose-1:4 2 6 5 6 3 3 3 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Informal Roman";
	panose-1:3 6 4 2 3 4 6 11 2 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Blackadder ITC";
	panose-1:4 2 5 5 5 16 7 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Edwardian Script ITC";
	panose-1:3 3 3 2 4 7 7 13 8 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Kristen ITC";
	panose-1:3 5 5 2 4 2 2 3 2 2;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Jokerman;
	panose-1:4 9 6 5 6 13 6 2 7 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Juice ITC";
	panose-1:4 4 4 3 4 10 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Kunstler Script";
	panose-1:3 3 4 2 2 6 7 13 13 6;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Wide Latin";
	panose-1:2 10 10 7 5 5 5 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Bright";
	panose-1:2 4 6 2 5 5 5 2 3 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Calligraphy";
	panose-1:3 1 1 1 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Leelawadee;
	panose-1:2 11 5 2 4 2 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:16777219 0 0 0 65537 0;}
@font-face
	{font-family:"Lucida Fax";
	panose-1:2 6 6 2 5 5 5 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Handwriting";
	panose-1:3 1 1 1 1 1 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Sans";
	panose-1:2 11 6 2 3 5 4 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Lucida Sans Typewriter";
	panose-1:2 11 5 9 3 5 4 3 2 4;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Magneto;
	panose-1:4 3 8 5 5 8 2 2 13 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Maiandra GD";
	panose-1:2 14 5 2 3 3 8 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Matura MT Script Capitals";
	panose-1:3 2 8 2 6 6 2 7 2 2;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Mistral;
	panose-1:3 9 7 2 3 4 7 2 4 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"Modern No\. 20";
	panose-1:2 7 7 4 7 5 5 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Microsoft Uighur";
	panose-1:2 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147475421 -2147483646 8 0 65 0;}
@font-face
	{font-family:"Monotype Corsiva";
	panose-1:3 1 1 1 1 2 1 1 1 1;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:647 0 0 0 159 0;}
@font-face
	{font-family:"MT Extra";
	panose-1:5 5 1 2 1 2 5 2 2 2;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Niagara Engraved";
	panose-1:4 2 5 2 7 7 3 3 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Niagara Solid";
	panose-1:4 2 5 2 7 7 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"OCR A Extended";
	panose-1:2 1 5 9 2 1 2 1 3 3;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Old English Text MT";
	panose-1:3 4 9 2 4 5 8 3 8 6;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Onyx;
	panose-1:4 5 6 2 8 7 2 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"MS Outlook";
	panose-1:5 1 1 0 1 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Palace Script MT";
	panose-1:3 3 3 2 2 6 7 12 11 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Papyrus;
	panose-1:3 7 5 2 6 5 2 3 2 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Parchment;
	panose-1:3 4 6 2 4 7 8 4 8 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Perpetua;
	panose-1:2 2 5 2 6 4 1 2 3 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Perpetua Titling MT";
	panose-1:2 2 5 2 6 5 5 2 8 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Playbill;
	panose-1:4 5 6 3 10 6 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Poor Richard";
	panose-1:2 8 5 2 5 5 5 2 7 2;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Pristina;
	panose-1:3 6 4 2 4 4 6 8 2 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Rage Italic";
	panose-1:3 7 5 2 4 5 7 7 3 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Ravie;
	panose-1:4 4 8 5 5 8 9 2 6 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"MS Reference Sans Serif";
	panose-1:2 11 6 4 3 5 4 4 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:536871559 0 0 0 415 0;}
@font-face
	{font-family:"MS Reference Specialty";
	panose-1:5 0 5 0 0 0 0 0 0 0;
	mso-font-charset:2;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Rockwell Condensed";
	panose-1:2 6 6 3 5 4 5 2 1 4;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Rockwell;
	panose-1:2 6 6 3 2 2 5 2 4 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Rockwell Extra Bold";
	panose-1:2 6 9 3 4 5 5 2 4 3;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Script MT Bold";
	panose-1:3 4 6 2 4 6 7 8 9 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Showcard Gothic";
	panose-1:4 2 9 4 2 1 2 2 6 4;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Snap ITC";
	panose-1:4 4 10 7 6 10 2 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Stencil;
	panose-1:4 4 9 5 13 8 2 2 4 4;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Tw Cen MT";
	panose-1:2 11 6 2 2 1 4 2 6 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Tw Cen MT Condensed";
	panose-1:2 11 6 6 2 1 4 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Tw Cen MT Condensed Extra Bold";
	panose-1:2 11 8 3 2 2 2 2 2 4;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 3 0;}
@font-face
	{font-family:"Tempus Sans ITC";
	panose-1:4 2 4 4 3 13 7 2 2 2;
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Viner Hand ITC";
	panose-1:3 7 5 2 3 5 2 2 2 3;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Vivaldi;
	panose-1:3 2 6 2 5 5 6 9 8 4;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Vladimir Script";
	panose-1:3 5 4 2 4 4 7 7 3 5;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Wingdings 2";
	panose-1:5 2 1 2 1 5 7 7 7 7;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:"Wingdings 3";
	panose-1:5 4 1 2 1 8 7 7 7 7;
	mso-font-charset:2;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:0 268435456 0 0 -2147483648 0;}
@font-face
	{font-family:ZWAdobeF;
	panose-1:0 0 0 0 0 0 0 0 0 0;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:536881799 0 0 0 511 0;}
@font-face
	{font-family:Abadi;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:"Abadi Extra Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:Aharoni;
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:Aldhabi;
	mso-font-charset:178;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147475449 -2147483648 8 0 65 0;}
@font-face
	{font-family:Alef;
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741824 0 0 179 0;}
@font-face
	{font-family:"Amasis MT Pro";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610612561 1073750107 0 0 147 0;}
@font-face
	{font-family:"Amasis MT Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610612561 1073750107 0 0 147 0;}
@font-face
	{font-family:"Amasis MT Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610612561 1073750107 0 0 147 0;}
@font-face
	{font-family:"Amasis MT Pro Medium";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610612561 1073750107 0 0 147 0;}
@font-face
	{font-family:"Amatic SC";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:536873487 1073741826 0 0 439 0;}
@font-face
	{font-family:AngsanaUPC;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Aparajita;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:32771 0 0 0 1 0;}
@font-face
	{font-family:"Arabic Typesetting";
	mso-font-charset:178;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147475449 -2147483648 8 0 211 0;}
@font-face
	{font-family:"Aref Ruqaa";
	mso-font-charset:178;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147475345 -2147483573 0 0 65 0;}
@font-face
	{font-family:"Arial Nova";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:655 2 0 0 415 0;}
@font-face
	{font-family:"Arial Nova Cond";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:655 2 0 0 415 0;}
@font-face
	{font-family:"Arial Nova Cond Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:655 2 0 0 415 0;}
@font-face
	{font-family:"Arial Nova Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:655 2 0 0 415 0;}
@font-face
	{font-family:Assistant;
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610433 1073750091 0 0 33 0;}
@font-face
	{font-family:"Assistant ExtraBold";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610433 1073750091 0 0 33 0;}
@font-face
	{font-family:"Assistant ExtraLight";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610433 1073750091 0 0 33 0;}
@font-face
	{font-family:"Assistant Light";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610433 1073750091 0 0 33 0;}
@font-face
	{font-family:"Assistant SemiBold";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610433 1073750091 0 0 33 0;}
@font-face
	{font-family:Athiti;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Athiti ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Athiti Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Athiti Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Athiti SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Avenir Next LT Pro";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483409 1342185546 0 0 147 0;}
@font-face
	{font-family:"Avenir Next LT Pro Demi";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483409 1342185546 0 0 147 0;}
@font-face
	{font-family:"Avenir Next LT Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612497 1342185547 0 0 147 0;}
@font-face
	{font-family:BatangChe;
	mso-font-charset:129;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:Bembo;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:Bierstadt;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Bierstadt Display";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:Biome;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -2147483638 65536 0 415 0;}
@font-face
	{font-family:"Biome Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -2147483638 65536 0 415 0;}
@font-face
	{font-family:"Browallia New";
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:BrowalliaUPC;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Cavolini;
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -2147483638 65536 0 415 0;}
@font-face
	{font-family:Charmonman;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:Chonburi;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:CordiaUPC;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Dante;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:DaunPenh;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 65536 0 1 0;}
@font-face
	{font-family:David;
	mso-font-charset:177;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:Daytona;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482897 10 0 0 415 0;}
@font-face
	{font-family:"Daytona Condensed";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Daytona Condensed Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Daytona Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"DengXian Light";
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612033 953122042 22 0 262159 0;}
@font-face
	{font-family:DilleniaUPC;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:DokChampa;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2097151997 0 0 0 65537 0;}
@font-face
	{font-family:DotumChe;
	mso-font-charset:129;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:"EB Garamond";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 33555475 0 0 415 0;}
@font-face
	{font-family:"EB Garamond ExtraBold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 33555475 0 0 415 0;}
@font-face
	{font-family:"EB Garamond Medium";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 33555475 0 0 415 0;}
@font-face
	{font-family:"EB Garamond SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 33555475 0 0 415 0;}
@font-face
	{font-family:"Elephant Pro";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:536871559 2 0 0 415 0;}
@font-face
	{font-family:EucrosiaUPC;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Euphemia;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483537 74 8192 0 1 0;}
@font-face
	{font-family:Fahkwang;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Fahkwang ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Fahkwang Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Fahkwang Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Fahkwang SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:FangSong;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-2147482945 953122042 22 0 262145 0;}
@font-face
	{font-family:"Frank Ruhl Libre";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741825 0 0 163 0;}
@font-face
	{font-family:"Frank Ruhl Libre Black";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741825 0 0 163 0;}
@font-face
	{font-family:"Frank Ruhl Libre Light";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741825 0 0 163 0;}
@font-face
	{font-family:"Frank Ruhl Libre Medium";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741825 0 0 163 0;}
@font-face
	{font-family:FrankRuehl;
	mso-font-charset:177;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:FreesiaUPC;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:"Georgia Pro";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Cond";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Cond Black";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Cond Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Cond Semibold";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Georgia Pro Semibold";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Cond";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Cond Lt";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Cond Ultra Bold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Cond XBd";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Gill Sans Nova Ultra Bold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:Gisha;
	mso-font-charset:177;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147481593 1073741890 0 0 33 0;}
@font-face
	{font-family:"Goudy Type";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:7 1 0 0 147 0;}
@font-face
	{font-family:Grandview;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:"Grandview Display";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610612025 2 0 0 415 0;}
@font-face
	{font-family:Grotesque;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:"Grotesque Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 0 0 1 0;}
@font-face
	{font-family:GulimChe;
	mso-font-charset:129;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:Gungsuh;
	mso-font-charset:129;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:GungsuhChe;
	mso-font-charset:129;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-1342176593 1775729915 48 0 524447 0;}
@font-face
	{font-family:"Hadassah Friedlaender";
	mso-font-charset:177;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:Heebo;
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:"Heebo Black";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:"Heebo ExtraBold";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:"Heebo Light";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:"Heebo Medium";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:"Heebo Thin";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610610457 1073741891 0 0 33 0;}
@font-face
	{font-family:HGGothicE;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGMaruGothicMPRO;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGMinchoE;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGPGothicE;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGPMinchoE;
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGPSoeiKakugothicUB;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGSGothicE;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGSMinchoE;
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGSoeiKakugothicUB;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:HGSSoeiKakugothicUB;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 717745662 18 0 131073 0;}
@font-face
	{font-family:IrisUPC;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:"Iskoola Pota";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 512 0 1 0;}
@font-face
	{font-family:JasmineUPC;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:KaiTi;
	mso-font-charset:134;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-2147482945 953122042 22 0 262145 0;}
@font-face
	{font-family:Kalinga;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:524291 0 0 0 1 0;}
@font-face
	{font-family:Kartika;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:8388611 0 0 0 1 0;}
@font-face
	{font-family:"Khmer UI";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 65536 0 1 0;}
@font-face
	{font-family:Kigelia;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1609226497 -1040187317 67584 0 415 0;}
@font-face
	{font-family:"Kigelia Arabic";
	mso-font-charset:178;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610603905 -2147483645 8 0 471 0;}
@font-face
	{font-family:"Kigelia Arabic Light";
	mso-font-charset:178;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1610603905 -2147483645 8 0 471 0;}
@font-face
	{font-family:"Kigelia Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1609226497 -1040187317 67584 0 415 0;}
@font-face
	{font-family:KodchiangUPC;
	mso-font-charset:222;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:Kokila;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:32771 0 0 0 1 0;}
@font-face
	{font-family:Krub;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Krub ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Krub Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Krub Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Krub SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:Lalezar;
	mso-font-charset:178;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:536879111 0 8 0 467 0;}
@font-face
	{font-family:"Lao UI";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2113929213 0 0 0 1 0;}
@font-face
	{font-family:"Levenim MT";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:LilyUPC;
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2130706429 0 0 0 65537 0;}
@font-face
	{font-family:"Mangal Pro";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:Meiryo;
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791492095 134217746 0 131231 0;}
@font-face
	{font-family:"Meiryo UI";
	mso-font-charset:128;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791492095 134217746 0 131231 0;}
@font-face
	{font-family:"Microsoft GothicNeo";
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482945 701998203 16 0 2687135 0;}
@font-face
	{font-family:"Microsoft GothicNeo Light";
	mso-font-charset:129;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147482945 701998203 16 0 2687135 0;}
@font-face
	{font-family:MingLiU_HKSCS;
	mso-font-charset:136;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610611969 684719354 22 0 1048577 0;}
@font-face
	{font-family:Miriam;
	mso-font-charset:177;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:"Miriam Fixed";
	mso-font-charset:177;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:"Miriam Libre";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741824 0 0 179 0;}
@font-face
	{font-family:Mitr;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Mitr ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Mitr Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Mitr Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Mitr SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Modern Love";
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Modern Love Caps";
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Modern Love Grunge";
	mso-font-charset:0;
	mso-generic-font-family:decorative;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:MoolBoran;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 0 65536 0 1 0;}
@font-face
	{font-family:"MS PMincho";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
@font-face
	{font-family:Narkisim;
	mso-font-charset:177;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:"Neue Haas Grotesk Text Pro";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 147 0;}
@font-face
	{font-family:"News Gothic MT";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Nyala;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610612625 0 2048 0 147 0;}
@font-face
	{font-family:OCRB;
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:"Open Sans";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870161 1073750107 40 0 415 0;}
@font-face
	{font-family:"Open Sans ExtraBold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870161 1073750107 40 0 415 0;}
@font-face
	{font-family:"Open Sans Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870161 1073750107 40 0 415 0;}
@font-face
	{font-family:"Open Sans SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-536870161 1073750107 40 0 415 0;}
@font-face
	{font-family:"Plantagenet Cherokee";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:3 0 4096 0 1 0;}
@font-face
	{font-family:Posterama;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -805298101 65536 0 415 0;}
@font-face
	{font-family:Pridi;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Pridi ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Pridi Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Pridi Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Pridi SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:Prompt;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt Black";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt ExtraBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Prompt Thin";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Quire Sans";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -2147483638 65536 0 415 0;}
@font-face
	{font-family:"Quire Sans Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Quire Sans Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Reem Kufi";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:3 0 0 0 1 0;}
@font-face
	{font-family:Roboto;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Black";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Condensed";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Condensed Light";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Condensed Medium";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Light";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Medium";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Roboto Thin";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-536870145 1342185563 32 0 415 0;}
@font-face
	{font-family:"Rockwell Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 0 0 0 15 0;}
@font-face
	{font-family:"Rockwell Nova";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Rockwell Nova Cond";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Rockwell Nova Cond Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Rockwell Nova Extra Bold";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:"Rockwell Nova Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 2 0 0 159 0;}
@font-face
	{font-family:Rod;
	mso-font-charset:177;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:2051 0 0 0 33 0;}
@font-face
	{font-family:"Sabon Next LT";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1592449281 -805306357 65536 0 415 0;}
@font-face
	{font-family:"Sagona Book";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Sagona ExtraLight";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Sakkal Majalla";
	mso-font-charset:178;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147475449 -2147483648 8 0 211 0;}
@font-face
	{font-family:"Sanskrit Text";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-1610579897 0 0 0 1 0;}
@font-face
	{font-family:Seaford;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Seaford Display";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Secular One";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741824 0 0 179 0;}
@font-face
	{font-family:Selawik;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 147 0;}
@font-face
	{font-family:"Selawik Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 147 0;}
@font-face
	{font-family:"Selawik Semibold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:7 0 0 0 147 0;}
@font-face
	{font-family:"Shonar Bangla";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:65539 0 0 0 1 0;}
@font-face
	{font-family:"Simplified Arabic";
	mso-font-charset:178;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:8195 -2147483648 8 0 65 0;}
@font-face
	{font-family:"Simplified Arabic Fixed";
	mso-font-charset:178;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:8195 0 8 0 65 0;}
@font-face
	{font-family:"Sitka Banner Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Display Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Heading Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Small Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Subheading Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:"Sitka Text Semibold";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-1610611985 1073750091 0 0 415 0;}
@font-face
	{font-family:Skeena;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Skeena Display";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Source Code Pro";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Code Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Code Pro ExtraLight";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Code Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Code Pro Medium";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Code Pro Semibold";
	mso-font-charset:0;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:536871671 33568771 0 0 415 0;}
@font-face
	{font-family:"Source Sans Pro";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1610613495 33554433 0 0 415 0;}
@font-face
	{font-family:"Source Sans Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1610613495 33554433 0 0 415 0;}
@font-face
	{font-family:"Source Sans Pro ExtraLight";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1610613495 33554433 0 0 415 0;}
@font-face
	{font-family:"Source Sans Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1610613495 33554433 0 0 415 0;}
@font-face
	{font-family:"Source Sans Pro SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:1610613495 33554433 0 0 415 0;}
@font-face
	{font-family:"Source Serif Pro";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:536871559 33554435 0 0 415 0;}
@font-face
	{font-family:"Source Serif Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:536871559 33554435 0 0 415 0;}
@font-face
	{font-family:"Source Serif Pro ExtraLight";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:536871559 33554435 0 0 415 0;}
@font-face
	{font-family:"Source Serif Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:536871559 33554435 0 0 415 0;}
@font-face
	{font-family:"Source Serif Pro SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:536871559 33554435 0 0 415 0;}
@font-face
	{font-family:"Speak Pro";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Speak Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:STCaiyun;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 953090296 22 0 262145 0;}
@font-face
	{font-family:STFangsong;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:647 135200768 16 0 262303 0;}
@font-face
	{font-family:STHupo;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 135200768 16 0 262144 0;}
@font-face
	{font-family:STKaiti;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:647 135200768 16 0 262303 0;}
@font-face
	{font-family:STXihei;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:647 135200768 16 0 262303 0;}
@font-face
	{font-family:STXingkai;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 135200768 16 0 262144 0;}
@font-face
	{font-family:STXinwei;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:1 135200768 16 0 262144 0;}
@font-face
	{font-family:STZhongsong;
	mso-font-charset:134;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:647 135200768 16 0 262303 0;}
@font-face
	{font-family:"Suez One";
	mso-font-charset:177;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:2055 1073741824 0 0 179 0;}
@font-face
	{font-family:Tenorite;
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"Tenorite Display";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147483645 1 0 0 1 0;}
@font-face
	{font-family:"TH SarabunPSK";
	mso-font-charset:222;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:16777219 0 0 0 65809 0;}
@font-face
	{font-family:"The Hand";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Hand Black";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Hand Extrablack";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Hand Light";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Serif Hand";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Serif Hand Black";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Serif Hand Extrablack";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"The Serif Hand Light";
	mso-font-charset:0;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Tisa Offc Serif Pro";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147482905 2 0 0 415 0;}
@font-face
	{font-family:"Tisa Offc Serif Pro Thin";
	mso-font-charset:0;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:-2147482905 2 0 0 415 0;}
@font-face
	{font-family:"Trade Gothic Next";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Trade Gothic Next Cond";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Trade Gothic Next Cond Hv";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Trade Gothic Next Heavy";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Trade Gothic Next Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Traditional Arabic";
	mso-font-charset:178;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:8195 -2147483648 8 0 65 0;}
@font-face
	{font-family:Trirong;
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong Black";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong ExtraBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong ExtraLight";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong Light";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong Medium";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong SemiBold";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"Trirong Thin";
	mso-font-charset:222;
	mso-generic-font-family:auto;
	mso-font-pitch:variable;
	mso-font-signature:553648135 1 0 0 65939 0;}
@font-face
	{font-family:"UD Digi Kyokasho N-B";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:"UD Digi Kyokasho N-R";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:"UD Digi Kyokasho NK-B";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:"UD Digi Kyokasho NK-R";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:"UD Digi Kyokasho NP-B";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:"UD Digi Kyokasho NP-R";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482973 717745402 16 0 131072 0;}
@font-face
	{font-family:Univers;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 0 0 0 15 0;}
@font-face
	{font-family:"Univers Condensed";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 0 0 0 15 0;}
@font-face
	{font-family:"Univers Condensed Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 0 0 0 15 0;}
@font-face
	{font-family:"Univers Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 0 0 0 15 0;}
@font-face
	{font-family:"Urdu Typesetting";
	mso-font-charset:178;
	mso-generic-font-family:script;
	mso-font-pitch:variable;
	mso-font-signature:8195 -2147483648 8 0 65 0;}
@font-face
	{font-family:Utsaah;
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:32771 0 0 0 1 0;}
@font-face
	{font-family:Vani;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:2097155 0 0 0 1 0;}
@font-face
	{font-family:"Verdana Pro";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Black";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Cond";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Cond Black";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Cond Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Cond SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro Light";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:"Verdana Pro SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:swiss;
	mso-font-pitch:variable;
	mso-font-signature:-2147483001 67 0 0 159 0;}
@font-face
	{font-family:Vijaya;
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:1048579 0 0 0 1 0;}
@font-face
	{font-family:"Walbaum Display";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Walbaum Display Heavy";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Walbaum Display Light";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Walbaum Display SemiBold";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Walbaum Heading";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Walbaum Text";
	mso-font-charset:0;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147483601 10 0 0 1 0;}
@font-face
	{font-family:"Yu Mincho";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482905 717749503 18 0 131231 0;}
@font-face
	{font-family:"Yu Mincho Demibold";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482905 717749503 18 0 131231 0;}
@font-face
	{font-family:"Yu Mincho Light";
	mso-font-charset:128;
	mso-generic-font-family:roman;
	mso-font-pitch:variable;
	mso-font-signature:-2147482905 717749503 18 0 131231 0;}
@font-face
	{font-family:"\@MS Mincho";
	panose-1:2 2 6 9 4 2 5 8 3 4;
	mso-font-charset:128;
	mso-generic-font-family:modern;
	mso-font-pitch:fixed;
	mso-font-signature:-536870145 1791491579 134217746 0 131231 0;}
 /* Style Definitions */
 p.MsoNormal, li.MsoNormal, div.MsoNormal
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
h1
	{mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	tab-stops:28.35pt;
	font-size:16.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-font-kerning:16.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
h2
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 2 Char1";
	mso-style-next:"Normal Indent";
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:2;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
h3
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 3 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	tab-stops:28.35pt;
	font-size:13.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
h4
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 4 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:4;
	tab-stops:28.35pt;
	font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
h5
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 5 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-outline-level:5;
	tab-stops:28.35pt;
	font-size:13.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	font-style:italic;}
h6
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 6 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-outline-level:6;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.MsoHeading7, li.MsoHeading7, div.MsoHeading7
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 7 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-outline-level:7;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoHeading8, li.MsoHeading8, div.MsoHeading8
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 8 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-outline-level:8;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.MsoHeading9, li.MsoHeading9, div.MsoHeading9
	{mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Heading 9 Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-outline-level:9;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoIndex1, li.MsoIndex1, div.MsoIndex1
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoIndex2, li.MsoIndex2, div.MsoIndex2
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:22.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoIndex3, li.MsoIndex3, div.MsoIndex3
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:33.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoIndex4, li.MsoIndex4, div.MsoIndex4
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:44.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoIndex5, li.MsoIndex5, div.MsoIndex5
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:55.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoIndex6, li.MsoIndex6, div.MsoIndex6
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:66.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoIndex7, li.MsoIndex7, div.MsoIndex7
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:77.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoIndex8, li.MsoIndex8, div.MsoIndex8
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:88.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoIndex9, li.MsoIndex9, div.MsoIndex9
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:99.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoToc1, li.MsoToc1, div.MsoToc1
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-next:Normal;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoToc2, li.MsoToc2, div.MsoToc2
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoToc3, li.MsoToc3, div.MsoToc3
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:22.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoToc4, li.MsoToc4, div.MsoToc4
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:33.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoToc5, li.MsoToc5, div.MsoToc5
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:44.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoToc6, li.MsoToc6, div.MsoToc6
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:55.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoToc7, li.MsoToc7, div.MsoToc7
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:66.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoToc8, li.MsoToc8, div.MsoToc8
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:77.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoToc9, li.MsoToc9, div.MsoToc9
	{mso-style-update:auto;
	mso-style-noshow:yes;
	mso-style-priority:39;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:88.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoNormalIndent, li.MsoNormalIndent, div.MsoNormalIndent
	{mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:.5in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.MsoFootnoteText, li.MsoFootnoteText, div.MsoFootnoteText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Footnote Text Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoCommentText, li.MsoCommentText, div.MsoCommentText
	{mso-style-name:"Comment Text\, Car17\, Car17 Car\, Char Char Char\, Char =
Char1\,Annotationtext\,Car17\,Car17 Car\,Char\,Char Char Char\,Char Char1\,=
Comment Text Char Char\,Comment Text Char Char Char\,Comment Text Char Char=
1 Char\,Comment Text Char1 Char\,Comment Text Char2 Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Comment Text Char1\, Car17 Char\, Car17 Car Char\, Char Ch=
ar Char Char\, Char Char1 Char\,Annotationtext Char\,Car17 Char\,Car17 Car =
Char\,Char Char\,Char Char Char Char\,Char Char1 Char\,Comment Text Char Ch=
ar Char1\,Comment Text Char Char Char Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoHeader, li.MsoHeader, div.MsoHeader
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Header Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt center 207.65pt right 415.3pt;
	font-size:10.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoFooter, li.MsoFooter, div.MsoFooter
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Footer Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt center 3.15in right 415.3pt;
	font-size:8.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoIndexHeading, li.MsoIndexHeading, div.MsoIndexHeading
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:"Index 1";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.MsoCaption, li.MsoCaption, div.MsoCaption
	{mso-style-name:"Caption\,Caption 3\,appendix\,c";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	mso-style-link:"Caption Char\,Caption 3 Char\,appendix Char\,c Char";
	mso-style-next:Normal;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:1.0in;
	text-indent:-1.0in;
	mso-pagination:none;
	page-break-after:avoid;
	font-size:12.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:"Times New Roman Bold";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:EN-US;
	layout-grid-mode:line;
	font-weight:bold;}
p.MsoTof, li.MsoTof, div.MsoTof
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoEnvelopeAddress, li.MsoEnvelopeAddress, div.MsoEnvelopeAddress
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:2.0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	mso-element:frame;
	mso-element-frame-width:5.5in;
	mso-element-frame-height:99.0pt;
	mso-element-frame-hspace:9.0pt;
	mso-element-wrap:auto;
	mso-element-anchor-horizontal:page;
	mso-element-left:center;
	mso-element-top:bottom;
	mso-height-rule:exactly;
	font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoEnvelopeReturn, li.MsoEnvelopeReturn, div.MsoEnvelopeReturn
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.MsoCommentReference
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;}
p.MsoEndnoteText, li.MsoEndnoteText, div.MsoEndnoteText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Endnote Text Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoToa, li.MsoToa, div.MsoToa
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:11.0pt;
	text-indent:-11.0pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoMacroText, li.MsoMacroText, div.MsoMacroText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-style-link:"Macro Text Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:24.0pt 48.0pt 1.0in 96.0pt 120.0pt 2.0in 168.0pt 192.0pt 3.0in;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoToaHeading, li.MsoToaHeading, div.MsoToaHeading
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-next:Normal;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.MsoList, li.MsoList, div.MsoList
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListCxSpFirst, li.MsoListCxSpFirst, div.MsoListCxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListCxSpMiddle, li.MsoListCxSpMiddle, div.MsoListCxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListCxSpLast, li.MsoListCxSpLast, div.MsoListCxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet, li.MsoListBullet, div.MsoListBullet
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo21;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBulletCxSpFirst, li.MsoListBulletCxSpFirst, div.MsoListBulletCxSpF=
irst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo21;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBulletCxSpMiddle, li.MsoListBulletCxSpMiddle, div.MsoListBulletCxS=
pMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo21;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBulletCxSpLast, li.MsoListBulletCxSpLast, div.MsoListBulletCxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l9 level1 lfo21;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber, li.MsoListNumber, div.MsoListNumber
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo26;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumberCxSpFirst, li.MsoListNumberCxSpFirst, div.MsoListNumberCxSpF=
irst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo26;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumberCxSpMiddle, li.MsoListNumberCxSpMiddle, div.MsoListNumberCxS=
pMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo26;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumberCxSpLast, li.MsoListNumberCxSpLast, div.MsoListNumberCxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.25in;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l8 level1 lfo26;
	tab-stops:list .25in left 28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList2, li.MsoList2, div.MsoList2
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList2CxSpFirst, li.MsoList2CxSpFirst, div.MsoList2CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList2CxSpMiddle, li.MsoList2CxSpMiddle, div.MsoList2CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList2CxSpLast, li.MsoList2CxSpLast, div.MsoList2CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList3, li.MsoList3, div.MsoList3
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList3CxSpFirst, li.MsoList3CxSpFirst, div.MsoList3CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList3CxSpMiddle, li.MsoList3CxSpMiddle, div.MsoList3CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList3CxSpLast, li.MsoList3CxSpLast, div.MsoList3CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList4, li.MsoList4, div.MsoList4
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList4CxSpFirst, li.MsoList4CxSpFirst, div.MsoList4CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList4CxSpMiddle, li.MsoList4CxSpMiddle, div.MsoList4CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList4CxSpLast, li.MsoList4CxSpLast, div.MsoList4CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList5, li.MsoList5, div.MsoList5
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList5CxSpFirst, li.MsoList5CxSpFirst, div.MsoList5CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList5CxSpMiddle, li.MsoList5CxSpMiddle, div.MsoList5CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoList5CxSpLast, li.MsoList5CxSpLast, div.MsoList5CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	mso-add-space:auto;
	text-indent:-14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet2, li.MsoListBullet2, div.MsoListBullet2
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo22;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet2CxSpFirst, li.MsoListBullet2CxSpFirst, div.MsoListBullet2Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo22;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet2CxSpMiddle, li.MsoListBullet2CxSpMiddle, div.MsoListBullet2=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo22;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet2CxSpLast, li.MsoListBullet2CxSpLast, div.MsoListBullet2CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l7 level1 lfo22;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet3, li.MsoListBullet3, div.MsoListBullet3
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo23;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet3CxSpFirst, li.MsoListBullet3CxSpFirst, div.MsoListBullet3Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo23;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet3CxSpMiddle, li.MsoListBullet3CxSpMiddle, div.MsoListBullet3=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo23;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet3CxSpLast, li.MsoListBullet3CxSpLast, div.MsoListBullet3CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l6 level1 lfo23;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet4, li.MsoListBullet4, div.MsoListBullet4
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo24;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet4CxSpFirst, li.MsoListBullet4CxSpFirst, div.MsoListBullet4Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo24;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet4CxSpMiddle, li.MsoListBullet4CxSpMiddle, div.MsoListBullet4=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo24;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet4CxSpLast, li.MsoListBullet4CxSpLast, div.MsoListBullet4CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l5 level1 lfo24;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet5, li.MsoListBullet5, div.MsoListBullet5
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo25;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet5CxSpFirst, li.MsoListBullet5CxSpFirst, div.MsoListBullet5Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo25;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet5CxSpMiddle, li.MsoListBullet5CxSpMiddle, div.MsoListBullet5=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo25;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListBullet5CxSpLast, li.MsoListBullet5CxSpLast, div.MsoListBullet5CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l4 level1 lfo25;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber2, li.MsoListNumber2, div.MsoListNumber2
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo27;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber2CxSpFirst, li.MsoListNumber2CxSpFirst, div.MsoListNumber2Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo27;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber2CxSpMiddle, li.MsoListNumber2CxSpMiddle, div.MsoListNumber2=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo27;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber2CxSpLast, li.MsoListNumber2CxSpLast, div.MsoListNumber2CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:32.15pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l3 level1 lfo27;
	tab-stops:28.35pt list 32.15pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber3, li.MsoListNumber3, div.MsoListNumber3
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo28;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber3CxSpFirst, li.MsoListNumber3CxSpFirst, div.MsoListNumber3Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo28;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber3CxSpMiddle, li.MsoListNumber3CxSpMiddle, div.MsoListNumber3=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo28;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber3CxSpLast, li.MsoListNumber3CxSpLast, div.MsoListNumber3CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:46.3pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l2 level1 lfo28;
	tab-stops:28.35pt list 46.3pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber4, li.MsoListNumber4, div.MsoListNumber4
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo29;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber4CxSpFirst, li.MsoListNumber4CxSpFirst, div.MsoListNumber4Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo29;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber4CxSpMiddle, li.MsoListNumber4CxSpMiddle, div.MsoListNumber4=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo29;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber4CxSpLast, li.MsoListNumber4CxSpLast, div.MsoListNumber4CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:60.45pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l1 level1 lfo29;
	tab-stops:28.35pt list 60.45pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber5, li.MsoListNumber5, div.MsoListNumber5
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo30;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber5CxSpFirst, li.MsoListNumber5CxSpFirst, div.MsoListNumber5Cx=
SpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo30;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber5CxSpMiddle, li.MsoListNumber5CxSpMiddle, div.MsoListNumber5=
CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo30;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListNumber5CxSpLast, li.MsoListNumber5CxSpLast, div.MsoListNumber5CxSp=
Last
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:74.6pt;
	mso-add-space:auto;
	text-indent:-.25in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-list:l0 level1 lfo30;
	tab-stops:28.35pt list 74.6pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoTitle, li.MsoTitle, div.MsoTitle
	{mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Title Char";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	text-align:center;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-outline-level:1;
	tab-stops:28.35pt;
	font-size:16.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.MsoClosing, li.MsoClosing, div.MsoClosing
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Closing Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:212.6pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoSignature, li.MsoSignature, div.MsoSignature
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Signature Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:212.6pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoBodyText, li.MsoBodyText, div.MsoBodyText
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Body Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	color:green;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.MsoBodyTextIndent, li.MsoBodyTextIndent, div.MsoBodyTextIndent
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Body Text Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue, li.MsoListContinue, div.MsoListContinue
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinueCxSpFirst, li.MsoListContinueCxSpFirst, div.MsoListContinu=
eCxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinueCxSpMiddle, li.MsoListContinueCxSpMiddle, div.MsoListConti=
nueCxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:14.15pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinueCxSpLast, li.MsoListContinueCxSpLast, div.MsoListContinueC=
xSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue2, li.MsoListContinue2, div.MsoListContinue2
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:28.3pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue2CxSpFirst, li.MsoListContinue2CxSpFirst, div.MsoListConti=
nue2CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue2CxSpMiddle, li.MsoListContinue2CxSpMiddle, div.MsoListCon=
tinue2CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.3pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue2CxSpLast, li.MsoListContinue2CxSpLast, div.MsoListContinu=
e2CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:28.3pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue3, li.MsoListContinue3, div.MsoListContinue3
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:42.45pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue3CxSpFirst, li.MsoListContinue3CxSpFirst, div.MsoListConti=
nue3CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue3CxSpMiddle, li.MsoListContinue3CxSpMiddle, div.MsoListCon=
tinue3CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:42.45pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue3CxSpLast, li.MsoListContinue3CxSpLast, div.MsoListContinu=
e3CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:42.45pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue4, li.MsoListContinue4, div.MsoListContinue4
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:56.6pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue4CxSpFirst, li.MsoListContinue4CxSpFirst, div.MsoListConti=
nue4CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue4CxSpMiddle, li.MsoListContinue4CxSpMiddle, div.MsoListCon=
tinue4CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.6pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue4CxSpLast, li.MsoListContinue4CxSpLast, div.MsoListContinu=
e4CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:56.6pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue5, li.MsoListContinue5, div.MsoListContinue5
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:70.75pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue5CxSpFirst, li.MsoListContinue5CxSpFirst, div.MsoListConti=
nue5CxSpFirst
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue5CxSpMiddle, li.MsoListContinue5CxSpMiddle, div.MsoListCon=
tinue5CxSpMiddle
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.75pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListContinue5CxSpLast, li.MsoListContinue5CxSpLast, div.MsoListContinu=
e5CxSpLast
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:70.75pt;
	mso-add-space:auto;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoMessageHeader, li.MsoMessageHeader, div.MsoMessageHeader
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Message Header Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:56.7pt;
	text-indent:-56.7pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	background:#CCCCCC;
	mso-shading:windowtext;
	mso-pattern:gray-20 auto;
	border:none;
	mso-border-alt:solid windowtext .75pt;
	padding:0in;
	mso-padding-alt:1.0pt 1.0pt 1.0pt 1.0pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoSubtitle, li.MsoSubtitle, div.MsoSubtitle
	{mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Subtitle Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	text-align:center;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	mso-outline-level:2;
	tab-stops:28.35pt;
	font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoSalutation, li.MsoSalutation, div.MsoSalutation
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Salutation Char";
	mso-style-next:Normal;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoDate, li.MsoDate, div.MsoDate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Date Char";
	mso-style-next:Normal;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoBodyTextFirstIndent, li.MsoBodyTextFirstIndent, div.MsoBodyTextFirstIn=
dent
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"Body Text";
	mso-style-link:"Body Text First Indent Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-indent:10.5pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoBodyTextFirstIndent2, li.MsoBodyTextFirstIndent2, div.MsoBodyTextFirst=
Indent2
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"Body Text Indent";
	mso-style-link:"Body Text First Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	text-indent:10.5pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoNoteHeading, li.MsoNoteHeading, div.MsoNoteHeading
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Note Heading Char";
	mso-style-next:Normal;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoBodyText2, li.MsoBodyText2, div.MsoBodyText2
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Body Text 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:200%;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.MsoBodyText3, li.MsoBodyText3, div.MsoBodyText3
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Body Text 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoBodyTextIndent2, li.MsoBodyTextIndent2, div.MsoBodyTextIndent2
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Body Text Indent 2 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:200%;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoBodyTextIndent3, li.MsoBodyTextIndent3, div.MsoBodyTextIndent3
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Body Text Indent 3 Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:14.15pt;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoBlockText, li.MsoBlockText, div.MsoBlockText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	margin-top:0in;
	margin-right:1.0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
a:link, span.MsoHyperlink
	{mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	color:blue;
	text-decoration:underline;
	text-underline:single;}
a:visited, span.MsoHyperlinkFollowed
	{mso-style-unhide:no;
	mso-style-parent:"";
	color:purple;
	text-decoration:underline;
	text-underline:single;}
p.MsoDocumentMap, li.MsoDocumentMap, div.MsoDocumentMap
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Document Map Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoPlainText, li.MsoPlainText, div.MsoPlainText
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"Plain Text Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoAutoSig, li.MsoAutoSig, div.MsoAutoSig
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"E-mail Signature Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p
	{mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-language:JA;}
address
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"HTML Address Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
pre
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-link:"HTML Preformatted Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoCommentSubject, li.MsoCommentSubject, div.MsoCommentSubject
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"Comment Text\, Car17\, Car17 Car\, Char Char Char\, Char=
 Char1\,Annotationtext\,Car17\,Car17 Car\,Char\,Char Char Char\,Char Char1\=
,Comment Text Char Char\,Comment Text Char Char Char\,Comment Text Char Cha=
r1 Char\,Comment Text Char1 Char\,Comment Text Char2 Char";
	mso-style-link:"Comment Subject Char";
	mso-style-next:"Comment Text\, Car17\, Car17 Car\, Char Char Char\, Char C=
har1\,Annotationtext\,Car17\,Car17 Car\,Char\,Char Char Char\,Char Char1\,C=
omment Text Char Char\,Comment Text Char Char Char\,Comment Text Char Char1=
 Char\,Comment Text Char1 Char\,Comment Text Char2 Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.MsoAcetate, li.MsoAcetate, div.MsoAcetate
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Balloon Text Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoNoSpacing, li.MsoNoSpacing, div.MsoNoSpacing
	{mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoRMPane, li.MsoRMPane, div.MsoRMPane
	{mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoListParagraph, li.MsoListParagraph, div.MsoListParagraph
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpFirst, li.MsoListParagraphCxSpFirst, div.MsoListParag=
raphCxSpFirst
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpMiddle, li.MsoListParagraphCxSpMiddle, div.MsoListPar=
agraphCxSpMiddle
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
p.MsoListParagraphCxSpLast, li.MsoListParagraphCxSpLast, div.MsoListParagra=
phCxSpLast
	{mso-style-priority:34;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-type:export-only;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:.5in;
	mso-add-space:auto;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
p.MsoQuote, li.MsoQuote, div.MsoQuote
	{mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Quote Char";
	mso-style-next:Normal;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	color:black;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.MsoIntenseQuote, li.MsoIntenseQuote, div.MsoIntenseQuote
	{mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-link:"Intense Quote Char";
	mso-style-next:Normal;
	margin-top:10.0pt;
	margin-right:.65in;
	margin-bottom:14.0pt;
	margin-left:.65in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	border:none;
	mso-border-bottom-alt:solid #4F81BD .5pt;
	padding:0in;
	mso-padding-alt:0in 0in 4.0pt 0in;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	color:#4F81BD;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	font-style:italic;}
p.MsoBibliography, li.MsoBibliography, div.MsoBibliography
	{mso-style-noshow:yes;
	mso-style-priority:37;
	mso-style-next:Normal;
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MsoTocHeading, li.MsoTocHeading, div.MsoTocHeading
	{mso-style-priority:39;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Heading 1";
	mso-style-next:Normal;
	margin-top:12.0pt;
	margin-right:0in;
	margin-bottom:3.0pt;
	margin-left:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	tab-stops:28.35pt;
	font-size:16.0pt;
	font-family:"Cambria",serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:16.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
span.Heading2Char
	{mso-style-name:"Heading 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;
	font-style:italic;}
span.FooterChar
	{mso-style-name:"Footer Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Footer;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.HeaderChar
	{mso-style-name:"Header Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Header;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.MemoHeaderStyle, li.MemoHeaderStyle, div.MemoHeaderStyle
	{mso-style-name:MemoHeaderStyle;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:70.9pt;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-line-height-alt:6.0pt;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Arial",sans-serif;
	mso-fareast-font-family:SimSun;
	font-variant:small-caps;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
span.BodyTextChar
	{mso-style-name:"Body Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.CommentTextChar
	{mso-style-name:"Comment Text Char";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.EMEAEnBodyText, li.EMEAEnBodyText, div.EMEAEnBodyText
	{mso-style-name:"EMEA En Body Text";
	mso-style-priority:99;
	mso-style-unhide:no;
	margin-top:6.0pt;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	text-align:justify;
	text-justify:inter-ideograph;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-language:EN-US;}
span.BalloonTextChar
	{mso-style-name:"Balloon Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Balloon Text";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.BodytextAgency, li.BodytextAgency, div.BodytextAgency
	{mso-style-name:"Body text \(Agency\)";
	mso-style-unhide:no;
	mso-style-link:"Body text \(Agency\) Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
span.BodytextAgencyChar
	{mso-style-name:"Body text \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body text \(Agency\)";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.DraftingNotesAgency, li.DraftingNotesAgency, div.DraftingNotesAgency
	{mso-style-name:"Drafting Notes \(Agency\)";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Drafting Notes \(Agency\) Char";
	mso-style-next:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	color:#339966;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-style:italic;}
span.DraftingNotesAgencyChar
	{mso-style-name:"Drafting Notes \(Agency\) Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Drafting Notes \(Agency\)";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:"Courier New";
	mso-bidi-font-family:"Courier New";
	color:#339966;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-style:italic;}
p.NormalAgency, li.NormalAgency, div.NormalAgency
	{mso-style-name:"Normal \(Agency\)";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"Normal \(Agency\) Char";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
p.TableheadingrowsAgency, li.TableheadingrowsAgency, div.TableheadingrowsAg=
ency
	{mso-style-name:"Table heading rows \(Agency\)";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"Body text \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:7.0pt;
	margin-left:0in;
	line-height:14.0pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.TabletextrowsAgency, li.TabletextrowsAgency, div.TabletextrowsAgency
	{mso-style-name:"Table text rows \(Agency\)";
	mso-style-priority:99;
	mso-style-unhide:no;
	margin:0in;
	line-height:14.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:SimSun;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:ZH-CN;}
span.NormalAgencyChar
	{mso-style-name:"Normal \(Agency\) Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Normal \(Agency\)";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	mso-bidi-language:AR-SA;}
p.labeltext, li.labeltext, div.labeltext
	{mso-style-name:"label text";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"label text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-language:EN-US;}
span.labeltextChar
	{mso-style-name:"label text Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"label text";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;
	mso-bidi-language:AR-SA;}
p.labeltextheading, li.labeltextheading, div.labeltextheading
	{mso-style-name:"label text heading";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"label text";
	margin:0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-language:EN-US;
	font-style:italic;}
p.documenttext, li.documenttext, div.documenttext
	{mso-style-name:"document text";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"document text Char1";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-language:EN-US;}
span.documenttextChar1
	{mso-style-name:"document text Char1";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"document text";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;
	mso-bidi-language:AR-SA;}
span.CommentTextChar1
	{mso-style-name:"Comment Text Char1\, Car17 Char\, Car17 Car Char\, Char C=
har Char Char\, Char Char1 Char\,Annotationtext Char\,Car17 Char\,Car17 Car=
 Char\,Char Char\,Char Char Char Char\,Char Char1 Char\,Comment Text Char C=
har Char1\,Comment Text Char Char Char Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Comment Text\, Car17\, Car17 Car\, Char Char Char\, Char C=
har1\,Annotationtext\,Car17\,Car17 Car\,Char\,Char Char Char\,Char Char1\,C=
omment Text Char Char\,Comment Text Char Char Char\,Comment Text Char Char1=
 Char\,Comment Text Char1 Char\,Comment Text Char2 Char";
	mso-ansi-language:EN-GB;}
p.TableTitle, li.TableTitle, div.TableTitle
	{mso-style-name:"Table Title";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"Table Title Char";
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:6.0pt;
	margin-left:1.0in;
	text-indent:-1.0in;
	mso-pagination:widow-orphan lines-together;
	page-break-after:avoid;
	tab-stops:list 0in left 1.0in;
	font-size:12.0pt;
	font-family:"Times New Roman Bold";
	mso-fareast-font-family:SimSun;
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.tabletextleftjustified, li.tabletextleftjustified, div.tabletextleftjusti=
fied
	{mso-style-name:"table text left justified";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"table text left justified Char";
	margin-top:1.0pt;
	margin-right:0in;
	margin-bottom:1.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-language:EN-US;}
span.tabletextleftjustifiedChar
	{mso-style-name:"table text left justified Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"table text left justified";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;
	mso-bidi-language:AR-SA;}
p.tablefootnote, li.tablefootnote, div.tablefootnote
	{mso-style-name:"table footnote";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"table footnote Char";
	margin:0in;
	mso-pagination:widow-orphan;
	tab-stops:.2in;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-language:EN-US;}
span.tablefootnoteChar
	{mso-style-name:"table footnote Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"table footnote";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;
	mso-bidi-language:AR-SA;}
span.TableTitleChar
	{mso-style-name:"Table Title Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Table Title";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Times New Roman Bold";
	mso-ascii-font-family:"Times New Roman Bold";
	mso-hansi-font-family:"Times New Roman Bold";
	mso-bidi-font-family:"Times New Roman Bold";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;
	mso-bidi-language:AR-SA;
	font-weight:bold;}
span.hilighti1
	{mso-style-name:hilighti1;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	color:red;
	font-weight:bold;
	text-decoration:underline;
	text-underline:single;}
span.hilightu
	{mso-style-name:hilightu;
	mso-style-priority:99;
	mso-style-unhide:no;}
span.Heading2Char1
	{mso-style-name:"Heading 2 Char1";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 2";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
span.DocumentTextChar
	{mso-style-name:"Document Text Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Document Text";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"MS Mincho";
	mso-fareast-font-family:"MS Mincho";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	mso-bidi-language:AR-SA;
	text-decoration:underline;
	text-underline:single;}
p.DocumentText0, li.DocumentText0, div.DocumentText0
	{mso-style-name:"Document Text";
	mso-style-update:auto;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"Document Text Char";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	text-decoration:underline;
	text-underline:single;}
span.BodyText2Char
	{mso-style-name:"Body Text 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text 2";
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.tablefootnotelast, li.tablefootnotelast, div.tablefootnotelast
	{mso-style-name:"table footnote last";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"table footnote";
	mso-style-link:"table footnote last Char";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:12.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	tab-stops:.2in;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-language:EN-US;}
span.tablefootnotelastChar
	{mso-style-name:"table footnote last Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"table footnote last";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;}
p.tabletextcenterjustified, li.tabletextcenterjustified, div.tabletextcente=
rjustified
	{mso-style-name:"table text center justified";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-style-link:"table text center justified Char";
	margin-top:1.0pt;
	margin-right:0in;
	margin-bottom:1.0pt;
	margin-left:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-language:EN-US;}
span.tabletextcenterjustifiedChar
	{mso-style-name:"table text center justified Char";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"table text center justified";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;
	mso-bidi-language:AR-SA;}
p.Default, li.Default, div.Default
	{mso-style-name:Default;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	mso-layout-grid-align:none;
	text-autospace:none;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	color:black;
	mso-fareast-language:EN-US;}
span.CommentSubjectChar
	{mso-style-name:"Comment Subject Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Comment Subject";
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.Revisin1, li.Revisin1, div.Revisin1
	{mso-style-name:Revisin1;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.aalonsog
	{mso-style-name:aalonsog;
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	color:navy;
	font-weight:normal;
	font-style:normal;
	text-decoration:none;
	text-underline:none;
	text-decoration:none;
	text-line-through:none;}
span.NormalAgencyCar
	{mso-style-name:"Normal \(Agency\) Car";
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:9.0pt;
	mso-bidi-font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	mso-bidi-language:AR-SA;}
span.CaptionChar
	{mso-style-name:"Caption Char\,Caption 3 Char\,appendix Char\,c Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Caption\,Caption 3\,appendix\,c";
	mso-ansi-font-size:12.0pt;
	font-family:"Times New Roman Bold";
	mso-ascii-font-family:"Times New Roman Bold";
	mso-hansi-font-family:"Times New Roman Bold";
	mso-ansi-language:EN-US;
	mso-fareast-language:EN-US;
	mso-bidi-language:AR-SA;
	layout-grid-mode:both;
	font-weight:bold;}
p.normal-p, li.normal-p, div.normal-p
	{mso-style-name:normal-p;
	mso-style-unhide:no;
	margin:0in;
	line-height:13.0pt;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:"MS Mincho";
	mso-fareast-language:JA;}
span.normal-h1
	{mso-style-name:normal-h1;
	mso-style-unhide:no;
	mso-style-parent:"";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-ascii-font-family:"Times New Roman";
	mso-hansi-font-family:"Times New Roman";
	mso-bidi-font-family:"Times New Roman";}
span.hilightd1
	{mso-style-name:hilightd1;
	mso-style-unhide:no;
	mso-style-parent:"";
	color:red;
	text-decoration:line-through;}
p.FooterAgency, li.FooterAgency, div.FooterAgency
	{mso-style-name:"Footer \(Agency\)";
	mso-style-unhide:no;
	mso-style-link:"Footer \(Agency\) Char Char";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#6D6F71;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
span.FooterAgencyCharChar
	{mso-style-name:"Footer \(Agency\) Char Char";
	mso-style-noshow:yes;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Footer \(Agency\)";
	mso-ansi-font-size:7.0pt;
	mso-bidi-font-size:7.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	color:#6D6F71;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	mso-bidi-language:AR-SA;}
p.No-numheading3Agency, li.No-numheading3Agency, div.No-numheading3Agency
	{mso-style-name:"No-num heading 3 \(Agency\)";
	mso-style-unhide:no;
	mso-style-link:"No-num heading 3 \(Agency\) Char";
	mso-style-next:"Body text \(Agency\)";
	margin-top:14.0pt;
	margin-right:0in;
	margin-bottom:11.0pt;
	margin-left:0in;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-font-kerning:16.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
span.No-numheading3AgencyChar
	{mso-style-name:"No-num heading 3 \(Agency\) Char";
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"No-num heading 3 \(Agency\)";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Verdana",sans-serif;
	mso-ascii-font-family:Verdana;
	mso-fareast-font-family:Verdana;
	mso-hansi-font-family:Verdana;
	mso-bidi-font-family:Arial;
	mso-font-kerning:16.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	mso-bidi-language:AR-SA;
	font-weight:bold;}
p.TitleA, li.TitleA, div.TitleA
	{mso-style-name:"Title A";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"Heading 1";
	margin:0in;
	text-align:center;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:1;
	tab-stops:28.35pt;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-font-kerning:16.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;
	font-weight:bold;}
p.TitleB, li.TitleB, div.TitleB
	{mso-style-name:"Title B";
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"No-num heading 3 \(Agency\)";
	margin-top:0in;
	margin-right:0in;
	margin-bottom:0in;
	margin-left:28.35pt;
	text-indent:-28.35pt;
	mso-pagination:widow-orphan;
	page-break-after:avoid;
	mso-outline-level:3;
	font-size:11.0pt;
	font-family:"Times New Roman Bold";
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:"Times New Roman";
	text-transform:uppercase;
	mso-font-kerning:16.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;
	font-weight:bold;}
p.DocsubtitleAgency, li.DocsubtitleAgency, div.DocsubtitleAgency
	{mso-style-name:"Doc subtitle \(Agency\)";
	mso-style-unhide:no;
	mso-style-next:Normal;
	margin-top:0in;
	margin-right:0in;
	margin-bottom:32.0pt;
	margin-left:0in;
	line-height:18.0pt;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Verdana",sans-serif;
	mso-fareast-font-family:Verdana;
	mso-bidi-font-family:Verdana;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-GB;}
span.PlainTextChar
	{mso-style-name:"Plain Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Plain Text";
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-hansi-font-family:"Courier New";
	mso-bidi-font-family:"Courier New";
	mso-ansi-language:EN-GB;}
span.s10
	{mso-style-name:s10;
	mso-style-unhide:no;
	mso-style-parent:"";}
p.s15, li.s15, div.s15
	{mso-style-name:s15;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-margin-top-alt:auto;
	margin-right:0in;
	mso-margin-bottom-alt:auto;
	margin-left:0in;
	mso-pagination:widow-orphan;
	font-size:12.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-fareast-language:EN-US;}
span.BodyText3Char
	{mso-style-name:"Body Text 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text 3";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	mso-ansi-language:EN-GB;}
span.BodyTextFirstIndentChar
	{mso-style-name:"Body Text First Indent Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text First Indent";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.BodyTextIndentChar
	{mso-style-name:"Body Text Indent Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text Indent";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-GB;}
span.BodyTextFirstIndent2Char
	{mso-style-name:"Body Text First Indent 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"Body Text Indent Char";
	mso-style-link:"Body Text First Indent 2";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-GB;}
span.BodyTextIndent2Char
	{mso-style-name:"Body Text Indent 2 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text Indent 2";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-GB;}
span.BodyTextIndent3Char
	{mso-style-name:"Body Text Indent 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Body Text Indent 3";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	mso-ansi-language:EN-GB;}
span.ClosingChar
	{mso-style-name:"Closing Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Closing;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-GB;}
span.DateChar
	{mso-style-name:"Date Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Date;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-GB;}
span.DocumentMapChar
	{mso-style-name:"Document Map Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Document Map";
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Tahoma",sans-serif;
	mso-ascii-font-family:Tahoma;
	mso-hansi-font-family:Tahoma;
	mso-bidi-font-family:Tahoma;
	mso-ansi-language:EN-GB;}
span.E-mailSignatureChar
	{mso-style-name:"E-mail Signature Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"E-mail Signature";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-GB;}
span.EndnoteTextChar
	{mso-style-name:"Endnote Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Endnote Text";
	mso-ansi-language:EN-GB;}
span.FootnoteTextChar
	{mso-style-name:"Footnote Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Footnote Text";
	mso-ansi-language:EN-GB;}
span.Heading3Char
	{mso-style-name:"Heading 3 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 3";
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;}
span.Heading4Char
	{mso-style-name:"Heading 4 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 4";
	mso-ansi-font-size:14.0pt;
	mso-bidi-font-size:14.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;}
span.Heading5Char
	{mso-style-name:"Heading 5 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 5";
	mso-ansi-font-size:13.0pt;
	mso-bidi-font-size:13.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;
	font-style:italic;}
span.Heading6Char
	{mso-style-name:"Heading 6 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 6";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-weight:bold;}
span.Heading7Char
	{mso-style-name:"Heading 7 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 7";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
span.Heading8Char
	{mso-style-name:"Heading 8 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 8";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;
	font-style:italic;}
span.Heading9Char
	{mso-style-name:"Heading 9 Char";
	mso-style-noshow:yes;
	mso-style-priority:9;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Heading 9";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
span.HTMLAddressChar
	{mso-style-name:"HTML Address Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"HTML Address";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-GB;
	font-style:italic;}
span.HTMLPreformattedChar
	{mso-style-name:"HTML Preformatted Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"HTML Preformatted";
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-hansi-font-family:"Courier New";
	mso-bidi-font-family:"Courier New";
	mso-ansi-language:EN-GB;}
span.IntenseQuoteChar
	{mso-style-name:"Intense Quote Char";
	mso-style-priority:30;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Intense Quote";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	color:#4F81BD;
	mso-ansi-language:EN-GB;
	font-weight:bold;
	font-style:italic;}
span.MacroTextChar
	{mso-style-name:"Macro Text Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Macro Text";
	font-family:"Courier New";
	mso-ascii-font-family:"Courier New";
	mso-hansi-font-family:"Courier New";
	mso-bidi-font-family:"Courier New";
	mso-ansi-language:EN-GB;}
span.MessageHeaderChar
	{mso-style-name:"Message Header Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Message Header";
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	background:#CCCCCC;
	mso-shading:windowtext;
	mso-pattern:gray-20 auto;
	mso-ansi-language:EN-GB;}
span.NoteHeadingChar
	{mso-style-name:"Note Heading Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:"Note Heading";
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-GB;}
span.QuoteChar
	{mso-style-name:"Quote Char";
	mso-style-priority:29;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Quote;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	color:black;
	mso-ansi-language:EN-GB;
	font-style:italic;}
span.SalutationChar
	{mso-style-name:"Salutation Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Salutation;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-GB;}
span.SignatureChar
	{mso-style-name:"Signature Char";
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Signature;
	mso-ansi-font-size:11.0pt;
	mso-bidi-font-size:11.0pt;
	mso-ansi-language:EN-GB;}
span.SubtitleChar
	{mso-style-name:"Subtitle Char";
	mso-style-priority:11;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Subtitle;
	mso-ansi-font-size:12.0pt;
	mso-bidi-font-size:12.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	mso-ansi-language:EN-GB;}
span.TitleChar
	{mso-style-name:"Title Char";
	mso-style-priority:10;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:Title;
	mso-ansi-font-size:16.0pt;
	mso-bidi-font-size:16.0pt;
	font-family:"Cambria",serif;
	mso-ascii-font-family:Cambria;
	mso-fareast-font-family:"Times New Roman";
	mso-hansi-font-family:Cambria;
	mso-bidi-font-family:"Times New Roman";
	mso-font-kerning:14.0pt;
	mso-ansi-language:EN-GB;
	font-weight:bold;}
p.2, li.2, div.2
	{mso-style-name:2;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-link:"Texto comentario Car";
	mso-style-next:"Comment Text\, Car17\, Car17 Car\, Char Char Char\, Char C=
har1\,Annotationtext\,Car17\,Car17 Car\,Char\,Char Char Char\,Char Char1\,C=
omment Text Char Char\,Comment Text Char Char Char\,Comment Text Char Char1=
 Char\,Comment Text Char1 Char\,Comment Text Char2 Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.TextocomentarioCar
	{mso-style-name:"Texto comentario Car";
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-locked:yes;
	mso-style-parent:"";
	mso-style-link:2;
	mso-ansi-language:EN-GB;}
p.1, li.1, div.1
	{mso-style-name:1;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-next:"Comment Text\, Car17\, Car17 Car\, Char Char Char\, Char C=
har1\,Annotationtext\,Car17\,Car17 Car\,Char\,Char Char Char\,Char Char1\,C=
omment Text Char Char\,Comment Text Char Char Char\,Comment Text Char Char1=
 Char\,Comment Text Char1 Char\,Comment Text Char2 Char";
	margin:0in;
	line-height:13.0pt;
	mso-line-height-rule:exactly;
	mso-pagination:widow-orphan;
	tab-stops:28.35pt;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
p.Nessunaspaziatura, li.Nessunaspaziatura, div.Nessunaspaziatura
	{mso-style-name:"Nessuna spaziatura";
	mso-style-priority:1;
	mso-style-unhide:no;
	mso-style-qformat:yes;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-fareast-font-family:Calibri;
	mso-bidi-font-family:"Times New Roman";
	mso-fareast-language:EN-US;}
p.Revisin, li.Revisin, div.Revisin
	{mso-style-name:Revisin;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-style-parent:"";
	margin:0in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-language:EN-GB;
	mso-fareast-language:EN-US;}
span.msoIns
	{mso-style-type:export-only;
	mso-style-name:"";
	text-decoration:underline;
	text-underline:single;
	color:teal;}
span.msoDel
	{mso-style-type:export-only;
	mso-style-name:"";
	text-decoration:line-through;
	color:red;}
span.msoChangeProp
	{mso-style-type:export-only;
	mso-style-name:"";}
.MsoChpDefault
	{mso-style-type:export-only;
	mso-default-props:yes;
	font-size:10.0pt;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	mso-fareast-font-family:SimSun;}
 /* Page Definitions */
 @page
	{mso-footnote-separator:url("Kalydeco_clean_files/header.htm") fs;
	mso-footnote-continuation-separator:url("Kalydeco_clean_files/header.htm")=
 fcs;
	mso-endnote-separator:url("Kalydeco_clean_files/header.htm") es;
	mso-endnote-continuation-separator:url("Kalydeco_clean_files/header.htm") =
ecs;
	mso-endnote-numbering-style:arabic;}
@page WordSection1
	{size:595.35pt 842.0pt;
	margin:56.9pt 70.55pt 56.9pt 70.55pt;
	mso-header-margin:36.7pt;
	mso-footer-margin:36.7pt;
	mso-title-page:yes;
	mso-footer:url("Kalydeco_clean_files/header.htm") f1;
	mso-first-footer:url("Kalydeco_clean_files/header.htm") ff1;
	mso-paper-source:0;}
div.WordSection1
	{page:WordSection1;
	mso-endnote-numbering-style:arabic;}
 /* List Definitions */
 @list l0
	{mso-list-id:-132;
	mso-list-type:simple;
	mso-list-template-ids:-2047724144;}
@list l0:level1
	{mso-level-style-link:"List Number 5";
	mso-level-tab-stop:74.6pt;
	mso-level-number-position:left;
	margin-left:74.6pt;
	text-indent:-.25in;}
@list l1
	{mso-list-id:-131;
	mso-list-type:simple;
	mso-list-template-ids:1810138998;}
@list l1:level1
	{mso-level-style-link:"List Number 4";
	mso-level-tab-stop:60.45pt;
	mso-level-number-position:left;
	margin-left:60.45pt;
	text-indent:-.25in;}
@list l2
	{mso-list-id:-130;
	mso-list-type:simple;
	mso-list-template-ids:795111130;}
@list l2:level1
	{mso-level-style-link:"List Number 3";
	mso-level-tab-stop:46.3pt;
	mso-level-number-position:left;
	margin-left:46.3pt;
	text-indent:-.25in;}
@list l3
	{mso-list-id:-129;
	mso-list-type:simple;
	mso-list-template-ids:-741072954;}
@list l3:level1
	{mso-level-style-link:"List Number 2";
	mso-level-tab-stop:32.15pt;
	mso-level-number-position:left;
	margin-left:32.15pt;
	text-indent:-.25in;}
@list l4
	{mso-list-id:-128;
	mso-list-type:simple;
	mso-list-template-ids:-2047195250;}
@list l4:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 5";
	mso-level-text:\F0B7;
	mso-level-tab-stop:74.6pt;
	mso-level-number-position:left;
	margin-left:74.6pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l5
	{mso-list-id:-127;
	mso-list-type:simple;
	mso-list-template-ids:1610633634;}
@list l5:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 4";
	mso-level-text:\F0B7;
	mso-level-tab-stop:60.45pt;
	mso-level-number-position:left;
	margin-left:60.45pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l6
	{mso-list-id:-126;
	mso-list-type:simple;
	mso-list-template-ids:-670935640;}
@list l6:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 3";
	mso-level-text:\F0B7;
	mso-level-tab-stop:46.3pt;
	mso-level-number-position:left;
	margin-left:46.3pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l7
	{mso-list-id:-125;
	mso-list-type:simple;
	mso-list-template-ids:1108097228;}
@list l7:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet 2";
	mso-level-text:\F0B7;
	mso-level-tab-stop:32.15pt;
	mso-level-number-position:left;
	margin-left:32.15pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l8
	{mso-list-id:-120;
	mso-list-type:simple;
	mso-list-template-ids:-1001641838;}
@list l8:level1
	{mso-level-style-link:"List Number";
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;}
@list l9
	{mso-list-id:-119;
	mso-list-type:simple;
	mso-list-template-ids:-125296172;}
@list l9:level1
	{mso-level-number-format:bullet;
	mso-level-style-link:"List Bullet";
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l10
	{mso-list-id:47924435;
	mso-list-type:hybrid;
	mso-list-template-ids:279314584 -1767453926 676618662 -1691828192 35301592=
8 -919314110 -1364265126 59526604 205834990 -1880998420;}
@list l10:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l10:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l10:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l10:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l10:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l10:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l10:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l10:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l10:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l11
	{mso-list-id:69231354;
	mso-list-type:hybrid;
	mso-list-template-ids:-1520917520 1105091100 1706059922 833269620 17372289=
08 654579764 -171405146 -1256190376 -883937466 -362413252;}
@list l11:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l11:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l11:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l11:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l11:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l11:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l11:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l12
	{mso-list-id:146284027;
	mso-list-type:hybrid;
	mso-list-template-ids:-1452917138 -1883703788 -518465730 -572340782 -11806=
49844 -1218947974 1640779080 1226353380 -1832498116 -35250052;}
@list l12:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:46.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l12:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:82.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l12:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:118.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l12:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:154.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l12:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:190.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l12:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:226.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l12:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:262.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l12:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:298.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l12:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:334.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13
	{mso-list-id:163054000;
	mso-list-type:hybrid;
	mso-list-template-ids:-631762902 -1445682390 -101783806 -1246089678 -14704=
31458 -1253409772 -1394956384 441348434 -332903744 -27632976;}
@list l13:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:46.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:82.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l13:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:118.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:154.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:190.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l13:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:226.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l13:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:262.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l13:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:298.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l13:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:334.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14
	{mso-list-id:163859649;
	mso-list-type:hybrid;
	mso-list-template-ids:2146616686 1523746748 -949463004 -1242939608 1489675=
788 -2077092314 12737664 -256344718 499010188 1305906896;}
@list l14:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l14:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l14:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l14:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l14:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l14:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l14:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l14:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15
	{mso-list-id:170997346;
	mso-list-type:hybrid;
	mso-list-template-ids:601238014 -1200614766 -418466600 1061450194 -2745554=
48 -1581593770 541498976 1836641926 940883568 1123827552;}
@list l15:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l15:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l15:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l15:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16
	{mso-list-id:197746816;
	mso-list-type:hybrid;
	mso-list-template-ids:-858734130 -1119057124 1025535606 346073314 17059252=
02 1599080798 -983823734 -1908607232 1750096854 -2064229230;}
@list l16:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:38.8pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:74.8pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:110.8pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:146.8pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:182.8pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:218.8pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l16:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:254.8pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l16:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:290.8pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l16:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:326.8pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l17
	{mso-list-id:202061725;
	mso-list-type:hybrid;
	mso-list-template-ids:1657727586 1997452552 -1927930634 1339823816 1896791=
112 -1503251416 1554668034 -1963935390 1646017292 -958390374;}
@list l17:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l17:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l17:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l17:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l17:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l17:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l17:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l17:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l17:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l18
	{mso-list-id:207957826;
	mso-list-type:hybrid;
	mso-list-template-ids:1374196098 1469482540 -1367734234 -408522354 -951153=
046 -48202604 -707858492 -1148185330 -111502988 -2134855192;}
@list l18:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l18:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l18:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l18:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l18:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l18:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l18:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l18:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:"Courier New";
	mso-bidi-font-family:"Times New Roman";}
@list l18:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.75in;
	mso-level-number-position:left;
	margin-left:4.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l19
	{mso-list-id:220335159;
	mso-list-type:hybrid;
	mso-list-template-ids:-1550676638 -1171468134 1344053828 -2014668756 17461=
51458 -64478286 -1096229104 57301998 576726198 -478523432;}
@list l19:level1
	{mso-level-start-at:12;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:20.5pt;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;}
@list l19:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:56.5pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l19:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:92.5pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l19:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:128.5pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l19:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:164.5pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l19:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:200.5pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l19:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:236.5pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l19:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:272.5pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l19:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:308.5pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l20
	{mso-list-id:250167365;
	mso-list-type:hybrid;
	mso-list-template-ids:-328430496 1784079646 1693105256 1616799966 -1772746=
432 1596983072 -735931684 -1499411348 -113356794 1229593678;}
@list l20:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-fareast-font-family:SimSun;
	mso-bidi-font-family:"Times New Roman";}
@list l20:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l20:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l20:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l20:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l20:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l20:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l20:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l20:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21
	{mso-list-id:284698048;
	mso-list-type:hybrid;
	mso-list-template-ids:866265638 2122492662 302968330 -1887940642 152137609=
2 730363316 526688002 -2095142172 -1881384830 -248189918;}
@list l21:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l21:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l21:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l21:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l21:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l22
	{mso-list-id:318505084;
	mso-list-template-ids:2052353280;}
@list l22:level1
	{mso-level-start-at:4;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l22:level2
	{mso-level-start-at:5;
	mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l22:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l22:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l22:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l22:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l22:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l22:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l22:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l23
	{mso-list-id:341857630;
	mso-list-type:hybrid;
	mso-list-template-ids:-1124047966 -1886327840 -1381367326 -1890005170 -169=
5514218 -1207397804 820544266 -1102401936 1804125086 222870844;}
@list l23:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;}
@list l23:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l23:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l23:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l23:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l23:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l23:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l23:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l23:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l24
	{mso-list-id:373501306;
	mso-list-type:hybrid;
	mso-list-template-ids:285403570 1015291418 390250792 -852717256 -209083019=
2 -613803878 386539460 10121640 -1399578706 -1030079034;}
@list l24:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-fareast-font-family:SimSun;
	mso-bidi-font-family:"Times New Roman";}
@list l24:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l24:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l24:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l24:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l24:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l24:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l24:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l24:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l25
	{mso-list-id:481042321;
	mso-list-type:hybrid;
	mso-list-template-ids:509258728 -785252264 -1917391500 155733216 -20461249=
30 159666598 -948382046 -1255111430 -4048766 1636698008;}
@list l25:level1
	{mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l25:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l25:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:right;
	margin-left:1.25in;
	text-indent:-9.0pt;}
@list l25:level4
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;}
@list l25:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;}
@list l25:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:right;
	margin-left:2.75in;
	text-indent:-9.0pt;}
@list l25:level7
	{mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;}
@list l25:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;}
@list l25:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:right;
	margin-left:4.25in;
	text-indent:-9.0pt;}
@list l26
	{mso-list-id:550118558;
	mso-list-type:hybrid;
	mso-list-template-ids:-450607420 -1189593140 -98018146 -1840360290 -207810=
6852 833505116 537718872 333731852 1317691408 -1282629912;}
@list l26:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:46.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l26:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:82.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l26:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:118.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l26:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:154.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l26:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:190.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l26:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:226.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l26:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:262.35pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l26:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:298.35pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l26:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:334.35pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l27
	{mso-list-id:594826960;
	mso-list-template-ids:-1993992828;}
@list l27:level1
	{mso-level-start-at:4;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l27:level2
	{mso-level-start-at:5;
	mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l27:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l27:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l27:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l27:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l27:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l27:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l27:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l28
	{mso-list-id:610169957;
	mso-list-type:hybrid;
	mso-list-template-ids:1426613728 291509688 -1188813736 -1693521704 1537100=
346 533334106 -454552526 32172364 -2017294400 988064796;}
@list l28:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l28:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l28:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l28:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l28:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l28:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l28:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l28:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l28:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l29
	{mso-list-id:652369963;
	mso-list-type:hybrid;
	mso-list-template-ids:1420223108 -1762125046 -1138566918 -2004324054 -1274=
924424 -1514890214 151431562 -1077109864 -1399575308 -364358420;}
@list l29:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l29:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l29:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l29:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l29:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l29:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l29:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l29:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l29:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l30
	{mso-list-id:714281188;
	mso-list-type:hybrid;
	mso-list-template-ids:1486133698 -999551248 -1878073176 278924296 -4106032=
40 1453367912 -389394858 -1377523100 1433326722 591286954;}
@list l30:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l30:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l30:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l30:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l30:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l30:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l30:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l31
	{mso-list-id:717314799;
	mso-list-template-ids:-1693814426;}
@list l31:level1
	{mso-level-start-at:5;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l31:level2
	{mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l31:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l31:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l31:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l31:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l31:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l31:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l31:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l32
	{mso-list-id:777262601;
	mso-list-type:hybrid;
	mso-list-template-ids:509258728 -1570334110 695119662 465867680 -933874004=
 -585749878 1984595764 1828345060 96927554 568095412;}
@list l32:level1
	{mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l32:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;}
@list l32:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.25in;
	mso-level-number-position:right;
	margin-left:1.25in;
	text-indent:-9.0pt;}
@list l32:level4
	{mso-level-tab-stop:1.75in;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;}
@list l32:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.25in;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;}
@list l32:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:2.75in;
	mso-level-number-position:right;
	margin-left:2.75in;
	text-indent:-9.0pt;}
@list l32:level7
	{mso-level-tab-stop:3.25in;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;}
@list l32:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:3.75in;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;}
@list l32:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.25in;
	mso-level-number-position:right;
	margin-left:4.25in;
	text-indent:-9.0pt;}
@list l33
	{mso-list-id:827097071;
	mso-list-template-ids:73719496;}
@list l33:level1
	{mso-level-start-at:5;
	mso-level-text:%1;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l33:level2
	{mso-level-text:"%1\.%2";
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l33:level3
	{mso-level-text:"%1\.%2\.%3";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l33:level4
	{mso-level-text:"%1\.%2\.%3\.%4";
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	margin-left:.5in;
	text-indent:-.5in;}
@list l33:level5
	{mso-level-text:"%1\.%2\.%3\.%4\.%5";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l33:level6
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6";
	mso-level-tab-stop:.75in;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.75in;}
@list l33:level7
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l33:level8
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l33:level9
	{mso-level-text:"%1\.%2\.%3\.%4\.%5\.%6\.%7\.%8\.%9";
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-1.0in;}
@list l34
	{mso-list-id:878590864;
	mso-list-type:hybrid;
	mso-list-template-ids:1748008200 530381372 1402253228 -2187752 -1998175888=
 -1081051470 717492778 813990268 -711954004 1218185024;}
@list l34:level1
	{mso-level-number-format:image;
	list-style-image:url("Kalydeco_clean_files/image001.png");
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l34:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l34:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l34:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l34:level5
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l34:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l34:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l34:level8
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l34:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l35
	{mso-list-id:900169158;
	mso-list-type:hybrid;
	mso-list-template-ids:-666226346 569704406 2127044416 1509868310 -10464389=
06 -101011376 1527534552 235600330 1953681784 1959930448;}
@list l35:level1
	{mso-level-start-at:3;
	mso-level-tab-stop:33.0pt;
	mso-level-number-position:left;
	margin-left:33.0pt;
	text-indent:-28.5pt;}
@list l35:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l35:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l35:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l35:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l35:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l35:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l35:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l35:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l36
	{mso-list-id:1008678622;
	mso-list-type:hybrid;
	mso-list-template-ids:1817759728 -122226996 -1805759540 751174394 18183951=
92 36330644 -47049958 1049363636 -947219770 477506158;}
@list l36:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l36:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l36:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l36:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l36:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l36:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l36:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l36:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l36:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l37
	{mso-list-id:1027946162;
	mso-list-type:hybrid;
	mso-list-template-ids:-1041729866 1731263568 678705892 -1851858628 1306666=
736 1352940202 -325413004 -1336509060 1797428572 -1856871536;}
@list l37:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F02D;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l37:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l37:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l37:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l37:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l37:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l37:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l37:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l37:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l38
	{mso-list-id:1060442958;
	mso-list-type:hybrid;
	mso-list-template-ids:2057499986 -667530856 -1222583146 -439830948 1513128=
028 -616035854 245694374 166369258 2137005726 162675478;}
@list l38:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l38:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l38:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l38:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l38:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l38:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l38:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l38:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l38:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l39
	{mso-list-id:1097671427;
	mso-list-type:hybrid;
	mso-list-template-ids:-1449376804 -393564846 -1195356794 -1660676050 35276=
7970 -1640855442 1308363372 590519728 405825422 552897764;}
@list l39:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l39:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:8.0pt;
	mso-bidi-font-size:8.0pt;
	font-family:"Courier New";}
@list l39:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l39:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l39:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l39:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l39:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l39:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l39:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l40
	{mso-list-id:1124539092;
	mso-list-type:hybrid;
	mso-list-template-ids:-887865494 -1008050342 1595826176 1237989482 -154388=
1066 1436028284 -1045128528 -99312684 -1224582688 1275131862;}
@list l40:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l40:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l40:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l40:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l40:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l40:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l40:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l40:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l40:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l41
	{mso-list-id:1135372372;
	mso-list-type:hybrid;
	mso-list-template-ids:1788624624 21141480 114579594 869182796 -1030868088 =
1598690694 -216505936 692982016 1801208184 -492635306;}
@list l41:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l41:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l41:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l41:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l41:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l41:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l41:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l41:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l41:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l42
	{mso-list-id:1165895830;
	mso-list-type:hybrid;
	mso-list-template-ids:1431235632 1823397526 -836439456 -606179412 -1581495=
010 -341147696 -729672364 -1450538200 644011734 1260713772;}
@list l42:level1
	{mso-level-start-at:2;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;}
@list l42:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l42:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l42:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l42:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l42:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l42:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l43
	{mso-list-id:1191802819;
	mso-list-type:hybrid;
	mso-list-template-ids:-510749826 -198537276 -135470546 -2117807848 4920162=
2 -872129582 186273600 -1560140608 1478809454 1002474902;}
@list l43:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l43:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l43:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l43:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l44
	{mso-list-id:1210456527;
	mso-list-type:hybrid;
	mso-list-template-ids:528389542 -266982712 -1440826414 -293970536 50149388=
0 -495257152 -187672648 -1356407280 -1964710948 610713384;}
@list l44:level1
	{mso-level-start-at:7;
	mso-level-number-format:bullet;
	mso-level-text:*;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:17.1pt;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;
	mso-ansi-font-weight:normal;}
@list l44:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:53.1pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l44:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:89.1pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l44:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:125.1pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l44:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:161.1pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l44:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:197.1pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l44:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:233.1pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l44:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:269.1pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l44:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:305.1pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l45
	{mso-list-id:1225873328;
	mso-list-type:hybrid;
	mso-list-template-ids:1700056102 507796420 -412062736 1760100268 -25387930=
0 436354618 -1567076608 342529400 -1407284302 -942749574;}
@list l45:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l45:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l45:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l45:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l45:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l45:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l45:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l45:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l45:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l46
	{mso-list-id:1239485659;
	mso-list-type:hybrid;
	mso-list-template-ids:866562984 1801494314 -1766192640 -306002108 12483558=
2 1671220196 1929390986 -889935392 1641858548 -1257497594;}
@list l46:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l46:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l46:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l46:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l46:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l46:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l46:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l46:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l46:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l47
	{mso-list-id:1257514403;
	mso-list-type:hybrid;
	mso-list-template-ids:189038368 -2088357616 -1980202320 737844514 -1028464=
282 -1012208178 -1550135368 -2106558650 766041418 -234599240;}
@list l47:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l47:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l47:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l47:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l47:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l47:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l47:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l47:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l47:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l48
	{mso-list-id:1283072063;
	mso-list-type:hybrid;
	mso-list-template-ids:1981288162 -826268372 1504723766 -739612592 10464957=
56 695127886 -1591987802 -145039946 788948706 1484816802;}
@list l48:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l48:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l48:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l48:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l48:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l48:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l48:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l48:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l48:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l49
	{mso-list-id:1317495257;
	mso-list-type:hybrid;
	mso-list-template-ids:560077598 -1975359282 359557038 470181194 1249940716=
 -1755943514 88214000 -1307913578 1997159240 -1712173388;}
@list l49:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l49:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l49:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l49:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l49:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l49:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l49:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l49:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l49:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l50
	{mso-list-id:1346781612;
	mso-list-type:hybrid;
	mso-list-template-ids:1865038876 1141002264 -149888306 -1638095976 -139442=
1048 -749799332 2063759128 1909883584 -1713863952 -1322107428;}
@list l50:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l50:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l50:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l50:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l50:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l50:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l50:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l50:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l50:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l51
	{mso-list-id:1542133478;
	mso-list-type:hybrid;
	mso-list-template-ids:-47816744 218642654 52299390 -2112334824 -1788946784=
 1908185586 1830947816 20604440 793955146 -1837058396;}
@list l51:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-fareast-font-family:SimSun;
	mso-bidi-font-family:"Times New Roman";}
@list l51:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l51:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l51:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l51:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l51:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l51:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l51:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l51:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l52
	{mso-list-id:1550460473;
	mso-list-type:hybrid;
	mso-list-template-ids:-2120206364 1567539248 1768592840 -1944133298 772509=
66 1187567390 643326694 -1664843480 1014658976 -742247218;}
@list l52:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	margin-left:1.0in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l52:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l52:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l52:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l52:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l52:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l52:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l52:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l52:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l53
	{mso-list-id:1591115670;
	mso-list-type:hybrid;
	mso-list-template-ids:-243005798 -947904266 -172089902 1768354758 -1707167=
298 1601852126 -1953302670 -2060299950 983888548 799285178;}
@list l53:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l53:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l53:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l53:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l53:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l53:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l53:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l53:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l53:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l54
	{mso-list-id:1662388512;
	mso-list-type:hybrid;
	mso-list-template-ids:1970412984 1140868866 2055899230 684249550 187713295=
6 68550950 1695965580 -1281619114 1486280782 -1031005500;}
@list l54:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l54:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l54:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l54:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l54:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l54:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l54:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l54:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l54:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l55
	{mso-list-id:1663269461;
	mso-list-type:hybrid;
	mso-list-template-ids:-1615959544 -1944441204 164685236 -1190120006 -14108=
33816 -1959857744 -1635775730 -1844832756 685811780 -1256188246;}
@list l55:level1
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l55:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l55:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l55:level4
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l55:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l55:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l55:level7
	{mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l55:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l55:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:none;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l56
	{mso-list-id:1776900692;
	mso-list-type:hybrid;
	mso-list-template-ids:1008267184 1081118624 1703834008 1662965618 -6795769=
06 -25926508 -507744142 1444430968 422764902 -1279474350;}
@list l56:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:19.85pt;
	mso-level-number-position:left;
	margin-left:19.85pt;
	text-indent:-19.85pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l56:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l56:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l56:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l56:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l56:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l56:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l57
	{mso-list-id:1791315688;
	mso-list-type:hybrid;
	mso-list-template-ids:-853097060 395332646 -1095620976 -794657250 -7128755=
98 -2093209106 277930210 -932809938 1071694920 -1907592494;}
@list l57:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l57:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l57:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l57:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l57:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l57:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l57:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l57:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l57:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l58
	{mso-list-id:1850635158;
	mso-list-type:hybrid;
	mso-list-template-ids:1946969082 788793350 1385753588 -1683960476 10779820=
2 -20935042 -144794492 253259716 1252314620 -456387328;}
@list l58:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:Calibri;}
@list l58:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l58:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l58:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l58:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l58:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l58:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l58:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l58:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l59
	{mso-list-id:1871919056;
	mso-list-type:hybrid;
	mso-list-template-ids:773608056 -1247631416 1092748482 -907760128 -1006966=
990 -323961514 201913798 1995316814 -360576826 -635554094;}
@list l59:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l59:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l59:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l59:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l59:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l59:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l59:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l59:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l59:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l60
	{mso-list-id:1885870421;
	mso-list-type:hybrid;
	mso-list-template-ids:323110438 -2111167964 1335150 1409057562 260350766 -=
1132159346 899425986 1407350854 -1928942028 2008563128;}
@list l60:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l60:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l60:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l60:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l60:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l60:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l60:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l60:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l60:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l61
	{mso-list-id:1891645135;
	mso-list-type:hybrid;
	mso-list-template-ids:-1752550930 1944585796 -983135736 -282802130 2685982=
54 -434103282 -1999235166 -74429196 -1483989282 1966788604;}
@list l61:level1
	{mso-level-start-at:2;
	mso-level-tab-stop:28.5pt;
	mso-level-number-position:left;
	margin-left:28.5pt;
	text-indent:-28.5pt;
	mso-ansi-font-weight:bold;}
@list l61:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l61:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l61:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l61:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l61:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l61:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l62
	{mso-list-id:1901210608;
	mso-list-type:hybrid;
	mso-list-template-ids:1877757464 837827248 -288725544 -1349476120 17503953=
48 567457296 624449368 641872740 175157196 -1407139022;}
@list l62:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l62:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l62:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l62:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l62:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l62:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l62:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l62:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l62:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l63
	{mso-list-id:1932810485;
	mso-list-type:hybrid;
	mso-list-template-ids:-181118140 -73881820 -2092285142 926169502 -58667280=
4 -383091604 -1270828708 -973284122 166520556 -2126891252;}
@list l63:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l63:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l63:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l63:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l63:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l63:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l63:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l63:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l63:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l64
	{mso-list-id:1940748310;
	mso-list-type:hybrid;
	mso-list-template-ids:1538553002 1957841308 2073167546 1946726704 35941772=
0 1495012950 1274154008 1030538448 -281480608 43179812;}
@list l64:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l64:level2
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l64:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l64:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:1.75in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l64:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.25in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l64:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:2.75in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l64:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.25in;
	text-indent:-.25in;
	font-family:Symbol;}
@list l64:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:3.75in;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l64:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:4.25in;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l65
	{mso-list-id:1945455339;
	mso-list-type:hybrid;
	mso-list-template-ids:-318861952 935342504 1592976026 -1392486628 56847693=
2 595604242 -1577650348 -40055602 -1802982212 1106004434;}
@list l65:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-fareast-font-family:SimSun;
	mso-bidi-font-family:"Times New Roman";}
@list l65:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l65:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l65:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l65:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l65:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l65:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l65:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l65:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l66
	{mso-list-id:1947349100;
	mso-list-type:hybrid;
	mso-list-template-ids:-1566553878 -1986519492 1194202746 -2015435248 21356=
99338 660273340 -19225094 -212410102 -1197540260 -504974326;}
@list l66:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.25in;
	mso-level-number-position:left;
	margin-left:.25in;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l66:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l66:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l66:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l66:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l66:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l66:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l66:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l66:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l67
	{mso-list-id:1947931152;
	mso-list-type:hybrid;
	mso-list-template-ids:589210898 283014566 -14669762 583035056 -1480683464 =
418538468 -1060702120 -166931722 -889798832 318790694;}
@list l67:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l67:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l67:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l67:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l67:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l67:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l67:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;}
@list l67:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l67:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l68
	{mso-list-id:1972517185;
	mso-list-type:hybrid;
	mso-list-template-ids:35321422 1113339472 -465949820 -975286416 -37198632 =
1373124890 -53982704 -1469955554 -453709170 -1057605990;}
@list l68:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	mso-ansi-font-size:10.0pt;
	mso-bidi-font-size:10.0pt;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;
	color:windowtext;}
@list l68:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l68:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l68:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:2.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l68:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l68:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l68:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:3.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Symbol;
	mso-bidi-font-family:Symbol;}
@list l68:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l68:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:left;
	text-indent:-.25in;
	font-family:Wingdings;
	mso-bidi-font-family:Wingdings;}
@list l69
	{mso-list-id:1979455724;
	mso-list-type:hybrid;
	mso-list-template-ids:-1810601774 -908135822 -1574803382 2011722036 131522=
0564 -1402424122 -996391692 -1382149374 1917513396 -255281992;}
@list l69:level1
	{mso-level-start-at:0;
	mso-level-number-format:bullet;
	mso-level-text:-;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:20.5pt;
	text-indent:-.25in;
	font-family:"Times New Roman",serif;
	mso-fareast-font-family:SimSun;}
@list l69:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:56.5pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l69:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:92.5pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l69:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:128.5pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l69:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:164.5pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l69:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:200.5pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l69:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:236.5pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l69:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:272.5pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l69:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:308.5pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l70
	{mso-list-id:2020156757;
	mso-list-type:hybrid;
	mso-list-template-ids:-2070405370 -1605327296 2025754168 2055501696 -56986=
7106 13810648 -773682120 -486999164 -1090213428 -1399662914;}
@list l70:level1
	{mso-level-start-at:5;
	mso-level-tab-stop:.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l70:level2
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:1.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l70:level3
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:1.5in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l70:level5
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:2.5in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l70:level6
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:3.0in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l70:level8
	{mso-level-number-format:alpha-lower;
	mso-level-tab-stop:4.0in;
	mso-level-number-position:left;
	text-indent:-.25in;}
@list l70:level9
	{mso-level-number-format:roman-lower;
	mso-level-tab-stop:4.5in;
	mso-level-number-position:right;
	text-indent:-9.0pt;}
@list l71
	{mso-list-id:2089375535;
	mso-list-type:hybrid;
	mso-list-template-ids:-616516800 871515358 1724563400 180105816 -537107174=
 818939250 509495604 -1035940496 -844302864 -1286714156;}
@list l71:level1
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:39.0pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l71:level2
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:75.0pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l71:level3
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:111.0pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l71:level4
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:147.0pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l71:level5
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:183.0pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l71:level6
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:219.0pt;
	text-indent:-.25in;
	font-family:Wingdings;}
@list l71:level7
	{mso-level-number-format:bullet;
	mso-level-text:\F0B7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:255.0pt;
	text-indent:-.25in;
	font-family:Symbol;}
@list l71:level8
	{mso-level-number-format:bullet;
	mso-level-text:o;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:291.0pt;
	text-indent:-.25in;
	font-family:"Courier New";}
@list l71:level9
	{mso-level-number-format:bullet;
	mso-level-text:\F0A7;
	mso-level-tab-stop:none;
	mso-level-number-position:left;
	margin-left:327.0pt;
	text-indent:-.25in;
	font-family:Wingdings;}
ol
	{margin-bottom:0in;}
ul
	{margin-bottom:0in;}
-->
</style>
<!--[if gte mso 10]>
<style>
 /* Style Definitions */
 table.MsoNormalTable
	{mso-style-name:"Table Normal";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-parent:"";
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
table.MsoTableGrid
	{mso-style-name:"Table Grid";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:39;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:10.0pt;
	font-family:"Times New Roman",serif;}
table.TablegridAgencyblack
	{mso-style-name:"Table grid \(Agency\) black";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.75pt solid windowtext;
	mso-border-insidev:.75pt solid windowtext;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:9.0pt;
	font-family:"Verdana",sans-serif;
	mso-bidi-font-family:Verdana;}
table.TablegridAgencyblackFirstRow
	{mso-style-name:"Table grid \(Agency\) black";
	mso-table-condition:first-row;
	mso-style-noshow:yes;
	mso-style-priority:99;
	mso-style-unhide:no;
	mso-tstyle-border-top:.5pt solid windowtext;
	mso-tstyle-border-left:.5pt solid windowtext;
	mso-tstyle-border-bottom:.5pt solid windowtext;
	mso-tstyle-border-right:.5pt solid windowtext;
	mso-tstyle-diagonal-down:cell-none;
	mso-tstyle-diagonal-up:cell-none;
	mso-tstyle-border-insideh:.75pt solid windowtext;
	mso-tstyle-border-insidev:.75pt solid windowtext;}
table.TableGrid1
	{mso-style-name:"Table Grid1";
	mso-tstyle-rowband-size:0;
	mso-tstyle-colband-size:0;
	mso-style-priority:59;
	mso-style-unhide:no;
	border:solid windowtext 1.0pt;
	mso-border-alt:solid windowtext .5pt;
	mso-padding-alt:0in 5.4pt 0in 5.4pt;
	mso-border-insideh:.5pt solid windowtext;
	mso-border-insidev:.5pt solid windowtext;
	mso-para-margin:0in;
	mso-pagination:widow-orphan;
	font-size:11.0pt;
	font-family:"Calibri",sans-serif;
	mso-ascii-font-family:Calibri;
	mso-ascii-theme-font:minor-latin;
	mso-fareast-font-family:Calibri;
	mso-fareast-theme-font:minor-latin;
	mso-hansi-font-family:Calibri;
	mso-hansi-theme-font:minor-latin;
	mso-bidi-font-family:Arial;
	mso-bidi-theme-font:minor-bidi;}
</style>
<![endif]--><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2049"/>
</xml><![endif]--><!--[if gte mso 9]><xml>
 <o:shapelayout v:ext=3D"edit">
  <o:idmap v:ext=3D"edit" data=3D"1"/>
 </o:shapelayout></xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3Dpurple style=3D'tab-interval:.5in;wo=
rd-wrap:
break-word'>

<div class=3DWordSection1>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:-1.0in -.5in 28.35pt'=
><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:-1.0in -.5in 28.35pt'=
><b><span
lang=3DEN-GB>ANNEX I</span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:-1.0in -.5in 28.35pt'=
><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleA style=3D'mso-outline-level:body-text'><span lang=3DEN-GB>=
SUMMARY OF
PRODUCT CHARACTERISTICS</span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:-1.0in -.5in 28.35pt'=
><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:-1.0in -.5in 28.35pt'><i style=3D'mso-bidi-font-style:normal'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
i></p>

<b><span lang=3DEN-GB style=3D'font-size:16.0pt;font-family:"Arial",sans-se=
rif;
mso-fareast-font-family:SimSun;mso-font-kerning:16.0pt;mso-ansi-language:EN=
-GB;
mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'page-break-before:always'>
</span></b>

<h1 style=3D'margin:0in'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-b=
idi-font-size:
16.0pt;font-family:"Times New Roman",serif;mso-bidi-font-family:Arial'>1.<s=
pan
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT<o:p><=
/o:p></span></h1>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;page-break-after:avoid;tab-stops:28.35pt 103.5pt;mso-lay=
out-grid-align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB>Kalydeco 150&nbsp;mg film&#8209;coated tablets</s=
pan></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;tab-stops:28.35pt 103.5pt;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;tab-stops:28.35pt 103.5pt;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;font-family:"Times New Roman",serif;mso-bidi-font-family:Arial;
color:black'>2.<span style=3D'mso-tab-count:1'> </span>QUALITATIVE AND
QUANTITATIVE COMPOSITION</span><span lang=3DEN-GB style=3D'font-size:11.0pt;
color:black'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB>Each film&#8209;coated tablet contains 150&nbsp;m=
g of
ivacaftor.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><u><span lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbs=
p;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><u><span lang=3DEN-GB>Excipient with known effect<o:p></o:p></span><=
/u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB>Each film&#8209;coated tablet contains 167.2&nbsp=
;mg of
lactose monohydrate.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB>For the full list of excipients, see section&nbsp=
;6.1.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;tab-stops:28.35pt 103.5pt;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;font-family:"Times New Roman",serif;mso-bidi-font-family:Arial'>3.<s=
pan
style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL FORM</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;text-transform:uppercase'><o:p></o:p=
></span></h1>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;page-break-after:avoid;tab-stops:28.35pt 103.5pt;mso-lay=
out-grid-align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;page-break-after:avoid;tab-stops:28.35pt 103.5pt;mso-lay=
out-grid-align:
none;text-autospace:none'><span lang=3DEN-GB>Film&#8209;coated tablet (tabl=
et)</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Light =
blue,
capsule&#8209;shaped film&#8209;coated tablets, printed with V&nbsp;150 in
black ink on one side and plain on the other</span><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>
(16.5&nbsp;mm x 8.4&nbsp;mm in modified tablet shape).</span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;tab-stops:28.35pt 103.5pt;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;tab-stops:28.35pt 103.5pt;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;font-family:"Times New Roman",serif;mso-bidi-font-family:Arial;
text-transform:uppercase'>4.<span style=3D'mso-tab-count:1'> </span><=
/span><span
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>CLINICAL PARTICULARS</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;text-transform:uppercase'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;page-break-after:avoid;tab-stops:28.35pt 103.5pt;mso-lay=
out-grid-align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2'><b><span lang=3DEN-GB>4.1<span style=3D'mso-tab-count:=
1'> </span>Therapeutic
indications</span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;page-break-after:avoid;tab-stops:28.35pt 103.5pt;mso-lay=
out-grid-align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Kalydeco tablets are ind=
icated:
<o:p></o:p></span></p>

<p class=3Dlabeltext style=3D'margin-left:28.35pt;text-indent:-.25in;mso-li=
st:l71 level1 lfo67'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>As monotherapy for the treatment of adults,
adolescents, and children aged 6&nbsp;years and older and weighing 25&nbsp;=
kg
or more with cystic fibrosis (CF) who have an <i>R117H CFTR</i> mutation or=
 one
of the following gating (class III) mutations in the cystic fibrosis
transmembrane conductance regulator (<i>CFTR)</i> gene: <i style=3D'mso-bid=
i-font-style:
normal'>G551D</i>, <i style=3D'mso-bidi-font-style:normal'>G1244E</i>, <i
style=3D'mso-bidi-font-style:normal'>G1349D</i>, <i style=3D'mso-bidi-font-=
style:
normal'>G178R</i>, <i style=3D'mso-bidi-font-style:normal'>G551S</i>, <i
style=3D'mso-bidi-font-style:normal'>S1251N</i>, <i style=3D'mso-bidi-font-=
style:
normal'>S1255P</i>, <i style=3D'mso-bidi-font-style:normal'>S549N</i> <span
style=3D'mso-bidi-font-style:italic'>or</span> <i style=3D'mso-bidi-font-st=
yle:
normal'>S549R</i> (see sections&nbsp;4.4 and 5.1).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-align:justify;text-j=
ustify:
inter-ideograph;line-height:normal;tab-stops:28.35pt 103.5pt;mso-layout-gri=
d-align:
none;text-autospace:none'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-.25in;mso-list:l71 level1 lfo67;tab-stops:103.5pt;mso-layout-g=
rid-align:
none;text-autospace:none'><![if !supportLists]><span style=3D'font-family:S=
ymbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In a combination regimen with tezacaftor
100&nbsp;mg/ivacaftor 150&nbsp;mg tablets for the treatment of adults and
adolescents aged 12&nbsp;years and older with cystic fibrosis (CF) who are
homozygous for the <i style=3D'mso-bidi-font-style:normal'>F508del </i>muta=
tion
or who are heterozygous for the <i style=3D'mso-bidi-font-style:normal'>F50=
8del</i>
mutation and have one of the following mutations in the <i>CFTR</i> gene: <i
style=3D'mso-bidi-font-style:normal'>P67L, R117C, L206W, R352Q, A455E, D579=
G,
711+3A&#8594;G, S945L, S977F, R1070W, D1152H, 2789+5G&#8594;A, 3272&#8209;2=
6A&#8594;G,
</i>and<i style=3D'mso-bidi-font-style:normal'> 3849+10kbC&#8594;T</i>.</p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-st=
ops:
28.35pt 103.5pt;mso-layout-grid-align:none;text-autospace:none'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoListParagraphCxSpFirst style=3D'margin-left:28.35pt;mso-add-s=
pace:
auto;text-indent:-.25in;mso-list:l71 level1 lfo67;tab-stops:103.5pt;mso-lay=
out-grid-align:
none;text-autospace:none'><a name=3D"_Hlk36013910"><![if !supportLists]><sp=
an
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In a combination regimen with ivacaftor&nbsp=
;75&nbsp;mg/tezacaftor&nbsp;50&nbsp;mg/elexacaftor&nbsp;100&nbsp;mg
tablets for the treatment of adults and adolescents aged 12&nbsp;years and
older with cystic fibrosis (CF) who are homozygous for the <i>F508del</i>
mutation in the <i>CFTR</i> gene or heterozygous for <i>F508del</i> in the =
<i>CFTR</i>
gene with a minimal function (MF) mutation (see section 5.1).</a></p>

<p class=3DMsoListParagraphCxSpLast><span style=3D'mso-bookmark:_Hlk3601391=
0'><o:p>&nbsp;</o:p></span></p>

<span style=3D'mso-bookmark:_Hlk36013910'></span>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:2'><b><span lang=3DEN-GB>4.2<span
style=3D'mso-tab-count:1'> </span>Posology and method of administration=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;page-break-after:avoid;tab-stops:28.35pt 103.5pt;mso-lay=
out-grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:=
bold;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
28.35pt 103.5pt;mso-layout-grid-align:none;text-autospace:none'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'=
>Kalydeco
should only be prescribed by physicians with experience in the treatment of
cystic fibrosis. If the patient's genotype is unknown, an accurate and
validated genotyping method should be performed before starting treatment to
confirm the presence of an indicated mutation in the <i>CFTR</i> gene (see
section 4.1). The phase of the poly&#8209;T variant identified with the <i>=
R117H</i>
mutation should be determined in accordance with local clinical
recommendations.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;tab-stops:28.35pt 103.5pt;mso-layout-grid-align:none;
text-autospace:none'><a name=3Dparagraph00000061></a><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together no-line-numbers;
page-break-after:avoid'><u><span lang=3DEN-GB>Posology<o:p></o:p></span></u=
></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><u><span lang=3DEN-GB style=3D'mso-bidi-font-style:=
italic'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span style=3D'font-size:11.0pt;mso-bidi-font-style=
:italic'>Adults</span><span
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt'>, adolescents and chil=
dren
aged 6&nbsp;years and older </span><span style=3D'font-size:11.0pt;mso-bidi=
-font-style:
italic'>should be dosed according to Table&nbsp;1. </span></p>

<p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'margin-bottom:6.0pt;mso-pagination:widow-orph=
an lines-together;
page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
style=3D'font-size:11.0pt'>Table 1: Dosing recommendations<o:p></o:p></span=
></b></p>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0 widt=
h=3D626
 style=3D'margin-left:-.25pt;border-collapse:collapse;mso-table-layout-alt:=
fixed;
 border:none;mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:1184;
 mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:16.25pt'>
  <td width=3D151 style=3D'width:113.4pt;border:solid windowtext 1.0pt;mso-=
border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:16.25pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><b><span style=3D'f=
ont-size:
  11.0pt;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D312 style=3D'width:233.9pt;border:solid windowtext 1.0pt;bord=
er-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windo=
wtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.25pt'>
  <p class=3Dlabeltext align=3Dcenter style=3D'text-align:center;page-break=
-after:
  avoid'><b><span style=3D'font-size:11.0pt;mso-bidi-font-style:italic'>Mor=
ning<o:p></o:p></span></b></p>
  </td>
  <td width=3D163 style=3D'width:122.3pt;border:solid windowtext 1.0pt;bord=
er-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windo=
wtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.25pt'>
  <p class=3Dlabeltext align=3Dcenter style=3D'text-align:center;page-break=
-after:
  avoid'><b><span style=3D'font-size:11.0pt;mso-bidi-font-style:italic'>Eve=
ning<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;height:15.3pt'>
  <td width=3D626 colspan=3D3 style=3D'width:469.6pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.3pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><b><span style=3D'f=
ont-size:
  11.0pt;mso-bidi-font-style:italic'>Ivacaftor as monotherapy<o:p></o:p></s=
pan></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:16.25pt'>
  <td width=3D151 style=3D'width:113.4pt;border:solid windowtext 1.0pt;bord=
er-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.25pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt;mso-bidi-font-style:italic'>6&nbsp;years and older, &#8805;25&nbsp=
;kg<o:p></o:p></span></p>
  </td>
  <td width=3D312 style=3D'width:233.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
6.25pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt;mso-bidi-font-style:italic'>One ivacaftor&nbsp;150 mg&nbsp;tablet<=
o:p></o:p></span></p>
  </td>
  <td width=3D163 style=3D'width:122.3pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
6.25pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt;mso-bidi-font-style:italic'>One ivacaftor&nbsp;150&nbsp;mg tablet<=
o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:15.3pt'>
  <td width=3D626 colspan=3D3 style=3D'width:469.6pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.3pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><b><span style=3D'f=
ont-size:
  11.0pt;mso-bidi-font-style:italic'>Ivacaftor in combination with
  tezacaftor/ivacaftor<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:15.3pt'>
  <td width=3D151 style=3D'width:113.4pt;border:solid windowtext 1.0pt;bord=
er-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.3pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt'>12&nbsp;years and older<span style=3D'mso-bidi-font-style:italic'=
><o:p></o:p></span></span></p>
  </td>
  <td width=3D312 style=3D'width:233.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.3pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt;mso-bidi-font-style:italic'>One tezacaftor&nbsp;100&nbsp;mg/ivacaf=
tor&nbsp;150&nbsp;mg
  tablet<o:p></o:p></span></p>
  </td>
  <td width=3D163 style=3D'width:122.3pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.3pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt;mso-bidi-font-style:italic'>One ivacaftor&nbsp;150&nbsp;mg tablet<=
o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;height:15.3pt'>
  <td width=3D626 colspan=3D3 style=3D'width:469.6pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.3pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><b><span style=3D'f=
ont-size:
  11.0pt'>Ivacaftor in combination with ivacaftor/tezacaftor/elexacaftor<sp=
an
  style=3D'mso-bidi-font-style:italic'><o:p></o:p></span></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;mso-yfti-lastrow:yes;height:15.3pt'>
  <td width=3D151 style=3D'width:113.4pt;border:solid windowtext 1.0pt;bord=
er-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.3pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt'>12&nbsp;years and older<o:p></o:p></span></p>
  </td>
  <td width=3D312 style=3D'width:233.9pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.3pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt;mso-bidi-font-style:italic'>Two ivacaftor&nbsp;75&nbsp;mg/tezacaft=
or&nbsp;50&nbsp;mg/elexacaftor&nbsp;100&nbsp;mg
  tablets<o:p></o:p></span></p>
  </td>
  <td width=3D163 style=3D'width:122.3pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.3pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt;mso-bidi-font-style:italic'>One ivacaftor&nbsp;150&nbsp;mg tablet<=
o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt'><span
style=3D'mso-spacerun:yes'></span></span><o:p></o:p></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'>The <span style=3D'fo=
nt-size:
11.0pt;mso-bidi-font-style:italic'>morning and evening dose should be taken
approximately 12 hours apart with fat-containing food (see Method of
administration).<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span style=3D'font-size:11.0pt'>Missed dose<o:p></o:p></span></i><=
/p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'>If
6&nbsp;hours or less have passed since the missed morning or evening dose, =
the
patient should take it as soon as possible and continue on the original sch=
edule.
If more than 6&nbsp;hours have passed since the time the dose is usually ta=
ken,
the patient should be told to wait until the next scheduled dose.<o:p></o:p=
></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'>Patients receiving iv=
acaftor in
a combination regimen should not take more than one dose of either medicine=
 at
the same time.</span><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB=
'><o:p></o:p></span></i></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-G=
B'>Concomitant
use of CYP3A inhibitors<o:p></o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-G=
B'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>When co-administered wit=
h moderate
or strong inhibitors of CYP3A, either as monotherapy or</span> in a combina=
tion
regimen with tezacaftor/ivacaftor<span lang=3DEN-GB style=3D'font-size:11.0=
pt;
mso-ansi-language:EN-GB'> or ivacaftor/tezacaftor/elexacaftor</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-l=
anguage:
EN-GB'>, the dose </span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-a=
nsi-language:
EN-GB'>should be reduced (see Table 2 for the recommended dose). Dosing
intervals</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-=
size:
10.0pt;mso-ansi-language:EN-GB'> should be </span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>modified</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-l=
anguage:
EN-GB'> according to </span><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>clinical response and tolerability (see sections</=
span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-l=
anguage:
EN-GB'>&nbsp;4.4 and 4.5).</span></p>

<p class=3Dlabeltext><o:p>&nbsp;</o:p></p>

<p class=3Dlabeltext style=3D'margin-bottom:6.0pt;page-break-after:avoid'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:11.0pt'>Tabl=
e&nbsp;2:
Dosing recommendations for concomitant use with moderate or strong CYP3A
inhibitors<o:p></o:p></span></b></p>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'border-collapse:collapse;border:none;mso-border-alt:solid windowt=
ext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <thead>
  <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
   <td width=3D54 valign=3Dtop style=3D'width:40.25pt;border:solid windowte=
xt 1.0pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
   <p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
   style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></p>
   </td>
   <td width=3D288 valign=3Dtop style=3D'width:215.75pt;border:solid window=
text 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;page-brea=
k-after:
   avoid'><b><span lang=3DEN-GB style=3D'font-size:10.0pt'>Moderate CYP3A i=
nhibitors<o:p></o:p></span></b></p>
   </td>
   <td width=3D264 valign=3Dtop style=3D'width:197.75pt;border:solid window=
text 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;page-brea=
k-after:
   avoid'><b><span lang=3DEN-GB style=3D'font-size:10.0pt'>Strong CYP3A inh=
ibitors<o:p></o:p></span></b></p>
   </td>
  </tr>
 </thead>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D605 colspan=3D3 valign=3Dtop style=3D'width:453.75pt;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><b><span lang=3DEN-GB style=3D'font-size:10.0pt'>Iva=
caftor as
  monotherapy<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D54 valign=3Dtop style=3D'width:40.25pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>6&nbsp=
;years and
  older,<br>
  &#8805;25 kg<o:p></o:p></span></p>
  </td>
  <td width=3D288 valign=3Dtop style=3D'width:215.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>One mo=
rning tablet
  of ivacaftor 150&nbsp;mg once daily. <o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'><o:p>&=
nbsp;</o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>No eve=
ning dose.<o:p></o:p></span></p>
  </td>
  <td width=3D264 valign=3Dtop style=3D'width:197.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>One mo=
rning tablet
  of ivacaftor 150&nbsp;mg twice a week, approximately 3 to 4 days apart.<o=
:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'><o:p>&=
nbsp;</o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>No eve=
ning dose.<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D605 colspan=3D3 valign=3Dtop style=3D'width:453.75pt;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><b><span lang=3DEN-GB style=3D'font-size:10.0pt'>Iva=
caftor in a
  combination regimen with tezacaftor/ivacaftor<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4'>
  <td width=3D54 valign=3Dtop style=3D'width:40.25pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>12&nbs=
p;years
  and older<o:p></o:p></span></p>
  </td>
  <td width=3D288 valign=3Dtop style=3D'width:215.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>Altern=
ate each morning:<o:p></o:p></span></p>
  <p class=3DMsoListParagraphCxSpFirst style=3D'margin-left:20.5pt;mso-add-=
space:
  auto;text-indent:-.25in;mso-list:l19 level1 lfo65'><![if !supportLists]><=
span
  style=3D'font-size:10.0pt'><span style=3D'mso-list:Ignore'>-<span
  style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;
  </span></span></span><![endif]><span style=3D'font-size:10.0pt'>one table=
t of
  tezacaftor&nbsp;100&nbsp;mg/ivacaftor&nbsp;150&nbsp;mg on the first day<o=
:p></o:p></span></p>
  <p class=3DMsoListParagraphCxSpLast style=3D'margin-left:20.5pt;mso-add-s=
pace:
  auto;text-indent:-.25in;mso-list:l19 level1 lfo65'><![if !supportLists]><=
span
  style=3D'font-size:10.0pt'><span style=3D'mso-list:Ignore'>-<span
  style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;
  </span></span></span><![endif]><span style=3D'font-size:10.0pt'>one table=
t of ivacaftor&nbsp;150&nbsp;mg
  on the next day<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-left:2.5pt'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>Continue alternating tablets each day.<o:p></o=
:p></span></p>
  <p class=3DMsoNormal style=3D'margin-left:2.5pt'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-left:2.5pt'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>No evening dose.<o:p></o:p></span></p>
  </td>
  <td width=3D264 valign=3Dtop style=3D'width:197.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>One mo=
rning tablet
  of tezacaftor 100&nbsp;mg/ivacaftor 150&nbsp;mg<span style=3D'mso-bidi-fo=
nt-weight:
  bold'> twice a week, </span>approximately 3 to 4 days apart.<o:p></o:p></=
span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'><o:p>&=
nbsp;</o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>No eve=
ning dose.<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5'>
  <td width=3D605 colspan=3D3 valign=3Dtop style=3D'width:453.75pt;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><b><span lang=3DEN-GB style=3D'font-size:10.0pt'>Iva=
caftor in
  a combination regimen with ivacaftor/tezacaftor/elexacaftor<o:p></o:p></s=
pan></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;mso-yfti-lastrow:yes'>
  <td width=3D54 valign=3Dtop style=3D'width:40.25pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>12&nbs=
p;years
  and older<o:p></o:p></span></p>
  </td>
  <td width=3D288 valign=3Dtop style=3D'width:215.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>Altern=
ate each morning:
  <o:p></o:p></span></p>
  <p class=3DMsoListParagraphCxSpFirst style=3D'margin-left:20.5pt;mso-add-=
space:
  auto;text-indent:-.25in;mso-list:l19 level1 lfo65'><![if !supportLists]><=
span
  style=3D'font-size:10.0pt'><span style=3D'mso-list:Ignore'>-<span
  style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;
  </span></span></span><![endif]><span style=3D'font-size:10.0pt'>two table=
ts of ivacaftor&nbsp;75&nbsp;mg/tezacaftor&nbsp;50&nbsp;mg/elexacaftor&nbsp=
;100&nbsp;mg
  on the first day <o:p></o:p></span></p>
  <p class=3DMsoListParagraphCxSpLast style=3D'margin-left:20.5pt;mso-add-s=
pace:
  auto;text-indent:-.25in;mso-list:l19 level1 lfo65'><![if !supportLists]><=
span
  style=3D'font-size:10.0pt'><span style=3D'mso-list:Ignore'>-<span
  style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;
  </span></span></span><![endif]><span style=3D'font-size:10.0pt'>one table=
t of ivacaftor&nbsp;150&nbsp;mg
  on the next day <o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-left:2.5pt'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>Continue alternating tablets each day.<o:p></o=
:p></span></p>
  <p class=3DMsoNormal style=3D'margin-left:2.5pt'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-left:2.5pt'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>No evening dose.<o:p></o:p></span></p>
  </td>
  <td width=3D264 valign=3Dtop style=3D'width:197.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>Two mo=
rning dose
  tablets of ivacaftor&nbsp;75&nbsp;mg/tezacaftor&nbsp;50&nbsp;mg/elexacaft=
or&nbsp;100&nbsp;mg<span
  style=3D'mso-bidi-font-weight:bold'> twice a week, </span>approximately 3=
 to 4
  days apart.<o:p></o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'><o:p>&=
nbsp;</o:p></span></p>
  <p class=3DMsoNormal><span lang=3DEN-GB style=3D'font-size:10.0pt'>No eve=
ning dose.<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3Dlabeltext><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB=
'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Special populations<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><i><span
style=3D'mso-ansi-language:EN-US'>Elderly<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><i><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US'>Very limited data are available for elder=
ly
patients treated with ivacaftor (administered as monotherapy or in a
combination regimen). No dose adjustment specific to this patient populatio=
n is
required (see section 5.2).<u><o:p></o:p></u></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i=
><span
lang=3DEN-GB>Renal impairment<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i=
><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>No dose adjustment is necessary for patients with mild to mode=
rate
renal impairment. Caution is recommended in patients with severe renal
impairment (creatinine clearance less than or equal to 30&nbsp;mL/min) or e=
nd&#8209;stage
renal disease (see sections&nbsp;4.4 and 5.2).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3Dlabeltextheading style=3D'mso-pagination:none'><a name=3D"_Hlk46=
222749"></a><a
name=3D"_Hlk45278269"><span style=3D'mso-bookmark:_Hlk46222749'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Hepatic impairment<o:p><=
/o:p></span></span></a></p>

<p class=3Dlabeltextheading style=3D'mso-pagination:none'><span style=3D'ms=
o-bookmark:
_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</span></span></p>

<p class=3Dlabeltextheading style=3D'mso-pagination:none'><span style=3D'ms=
o-bookmark:
_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;font-style:normal;mso-bid=
i-font-style:
italic'>No dose adjustment is necessary for ivacaftor as monotherapy or in a
combination regimen in patients with mild hepatic impairment (Child&#8209;P=
ugh
Class A). <o:p></o:p></span></span></span></p>

<p class=3Dlabeltextheading style=3D'mso-pagination:none'><span style=3D'ms=
o-bookmark:
_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;font-style:normal;mso-bid=
i-font-style:
italic'><o:p>&nbsp;</o:p></span></span></span></p>

<p class=3Dlabeltextheading style=3D'mso-pagination:none'><span style=3D'ms=
o-bookmark:
_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;font-style:normal;mso-bid=
i-font-style:
italic'>For patients with moderate hepatic impairment (Child&#8209;Pugh Cla=
ss
B) </span></span></span><span style=3D'mso-bookmark:_Hlk45278269'><span
style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB style=3D'font-size:1=
1.0pt;
mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB;font-style:normal;mso-bid=
i-font-style:
italic'>the dose </span></span></span><span style=3D'mso-bookmark:_Hlk45278=
269'><span
style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB style=3D'font-size:1=
1.0pt;
mso-ansi-language:EN-GB;font-style:normal;mso-bidi-font-style:italic'>of
ivacaftor as monotherapy </span></span></span><span style=3D'mso-bookmark:_=
Hlk45278269'><span
style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB style=3D'font-size:1=
1.0pt;
mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB;font-style:normal;mso-bid=
i-font-style:
italic'>should be reduced </span></span></span><span style=3D'mso-bookmark:=
_Hlk45278269'><span
style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB style=3D'font-size:1=
1.0pt;
mso-ansi-language:EN-GB;font-style:normal;mso-bidi-font-style:italic'>to
150&nbsp;mg once daily. <o:p></o:p></span></span></span></p>

<p class=3Dlabeltextheading style=3D'mso-pagination:none'><span style=3D'ms=
o-bookmark:
_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;font-style:normal;mso-bid=
i-font-style:
italic'><o:p>&nbsp;</o:p></span></span></span></p>

<p class=3Dlabeltextheading style=3D'mso-pagination:none'><span style=3D'ms=
o-bookmark:
_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;font-style:normal;mso-bid=
i-font-style:
italic'>For patients with severe hepatic impairment (Child-Pugh Class C), t=
he
dose of ivacaftor as monotherapy should be reduced to 150&nbsp;mg every oth=
er
day or less frequently. <o:p></o:p></span></span></span></p>

<p class=3Dlabeltextheading style=3D'mso-pagination:none'><span style=3D'ms=
o-bookmark:
_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB;
font-style:normal;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></spa=
n></span></p>

<p class=3Dlabeltextheading style=3D'mso-pagination:none'><span style=3D'ms=
o-bookmark:
_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;font-style:normal;mso-bid=
i-font-style:
italic'>For use as an evening dose in a combination regimen with
tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexacaftor see Table&nbsp;3 f=
or
dosing regimen</span></span></span><span style=3D'mso-bookmark:_Hlk45278269=
'><span
style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB style=3D'font-size:1=
1.0pt;
mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB;font-style:normal;mso-bid=
i-font-style:
italic'> recommendations</span></span></span><span style=3D'mso-bookmark:_H=
lk45278269'><span
style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB style=3D'font-size:1=
1.0pt;
mso-ansi-language:EN-GB;font-style:normal;mso-bidi-font-style:italic'>. <o:=
p></o:p></span></span></span></p>

<p class=3Dlabeltextheading style=3D'mso-pagination:none;page-break-after:a=
uto'><span
style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk4622274=
9'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;=
</o:p></span></span></span></p>

<p class=3Dlabeltext style=3D'margin-bottom:6.0pt;mso-pagination:none;page-=
break-after:
avoid'><span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmar=
k:_Hlk46222749'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:11.0pt;color=
:black;
mso-themecolor:text1'>Table&nbsp;3: Recommendations for patients with moder=
ate
or severe hepatic impairment <o:p></o:p></span></b></span></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"104%"
 style=3D'width:104.54%;border-collapse:collapse;border:none;mso-border-alt=
:solid windowtext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-insid=
eh:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;mso-yfti-lastrow:yes'>
  <td width=3D"13%" valign=3Dtop style=3D'width:13.42%;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'></span></span>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk45278269'><span
  style=3D'mso-bookmark:_Hlk46222749'><b style=3D'mso-bidi-font-weight:norm=
al'><span
  lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
  <td width=3D"49%" valign=3Dtop style=3D'width:49.26%;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Moderate (Child-=
Pugh Class
  B)<o:p></o:p></span></b></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
  <td width=3D"37%" valign=3Dtop style=3D'width:37.32%;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Severe (Child-Pu=
gh Class
  C)<o:p></o:p></span></b></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
 </tr>
</table>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0 widt=
h=3D633
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:
 0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D633 colspan=3D3 valign=3Dtop style=3D'width:474.65pt;border:s=
olid windowtext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><b><span lang=3DE=
N-GB
  style=3D'font-size:10.0pt'>Ivacaftor as monotherapy<o:p></o:p></span></b>=
</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D83 valign=3Dtop style=3D'width:62.0pt;border:solid windowtext=
 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>6&nbsp;years and older,<br>
  &#8805;25&nbsp;kg<o:p></o:p></span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
  <td width=3D314 valign=3Dtop style=3D'width:235.45pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>One morning tablet of ivacaftor&nbsp;150&nbsp;=
mg
  once daily. <o:p></o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>No evening dose.<o:p></o:p></span></span></spa=
n></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
  <td width=3D236 valign=3Dtop style=3D'width:177.2pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>Use is not recommended unless the benefits are
  expected to outweigh the risks. <o:p></o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>In such cases, take one morning tablet of ivac=
aftor&nbsp;150&nbsp;mg
  every other day or less frequently. <o:p></o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>Dosing interval should be modified according to
  clinical response and tolerability. <o:p></o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>No evening dose.<o:p></o:p></span></span></spa=
n></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D633 colspan=3D3 valign=3Dtop style=3D'width:474.65pt;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><b><span
  lang=3DEN-GB style=3D'font-size:10.0pt'>Ivacaftor in a combination regime=
n with
  tezacaftor/ivacaftor<o:p></o:p></span></b></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D83 valign=3Dtop style=3D'width:62.0pt;border:solid windowtext=
 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><span
  lang=3DEN-GB style=3D'font-size:10.0pt'>12&nbsp;years and older<o:p></o:p=
></span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
  <td width=3D314 valign=3Dtop style=3D'width:235.45pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><span
  lang=3DEN-GB style=3D'font-size:10.0pt'>One morning tablet of tezacaftor&=
nbsp;100&nbsp;mg/ivacaftor&nbsp;150&nbsp;mg
  once daily.<o:p></o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><span
  lang=3DEN-GB style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></=
span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><span
  lang=3DEN-GB style=3D'font-size:10.0pt'>No evening dose.<o:p></o:p></span=
></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
  <td width=3D236 valign=3Dtop style=3D'width:177.2pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><span
  lang=3DEN-GB style=3D'font-size:10.0pt'>Use is not recommended unless the
  benefits are expected to outweigh the risks. <o:p></o:p></span></span></s=
pan></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><span
  lang=3DEN-GB style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></=
span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><span
  lang=3DEN-GB style=3D'font-size:10.0pt'>In such cases, take one morning t=
ablet of
  tezacaftor&nbsp;100&nbsp;mg/ivacaftor&nbsp;150&nbsp;mg<span style=3D'mso-=
bidi-font-weight:
  bold'> </span>once daily or less frequently. <o:p></o:p></span></span></s=
pan></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><span
  lang=3DEN-GB style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></=
span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><span
  lang=3DEN-GB style=3D'font-size:10.0pt'>Dosing interval should be modified
  according to clinical response and tolerability. <o:p></o:p></span></span=
></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><span
  lang=3DEN-GB style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></=
span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'=
><span
  style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222=
749'><span
  lang=3DEN-GB style=3D'font-size:10.0pt'>No evening dose.<o:p></o:p></span=
></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:4'>
  <td width=3D633 colspan=3D3 valign=3Dtop style=3D'width:474.65pt;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><b><span lang=3DE=
N-GB
  style=3D'font-size:10.0pt'>Ivacaftor in a combination regimen with ivacaf=
tor/tezacaftor/elexacaftor
  <o:p></o:p></span></b></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:5;mso-yfti-lastrow:yes'>
  <td width=3D83 valign=3Dtop style=3D'width:62.0pt;border:solid windowtext=
 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>12&nbsp;years and older<o:p></o:p></span></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
  <td width=3D314 valign=3Dtop style=3D'width:235.45pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>Use not recommended.<o:p></o:p></span></span><=
/span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>Use should only be considered when there is a =
clear
  medical need and the benefits are expected to outweigh the risks.<o:p></o=
:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>If used: alternate each day between two
  ivacaftor&nbsp;75&nbsp;mg/tezacaftor&nbsp;50&nbsp;mg/elexacaftor&nbsp;100=
&nbsp;mg
  tablets and one
  ivacaftor&nbsp;75&nbsp;mg/tezacaftor&nbsp;50&nbsp;mg/elexacaftor&nbsp;100=
&nbsp;mg
  tablet.<o:p></o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>No evening dose.<o:p></o:p></span></span></spa=
n></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
  <td width=3D236 valign=3Dtop style=3D'width:177.2pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>Should not be used.<o:p></o:p></span></span></=
span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>No morning ivacaftor 75&nbsp;mg/tezacaftor
  50&nbsp;mg/elexacaftor 100&nbsp;mg dose.<o:p></o:p></span></span></span><=
/p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></span></span></p>
  <p class=3DMsoNormal style=3D'mso-pagination:none'><span style=3D'mso-boo=
kmark:
  _Hlk45278269'><span style=3D'mso-bookmark:_Hlk46222749'><span lang=3DEN-GB
  style=3D'font-size:10.0pt'>No evening dose.<o:p></o:p></span></span></spa=
n></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk45278269'><span style=3D'mso-bookmark:_Hl=
k46222749'></span></span>
 </tr>
</table>

<span style=3D'mso-bookmark:_Hlk45278269'></span>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span style=3D'mso-bookmark:_Hlk46222749'><span
lang=3DEN-GB style=3D'font-size:8.0pt;mso-bidi-font-size:11.0pt'><o:p>&nbsp=
;</o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk46222749'></span>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'=
>Paediatric
population<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><u><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'=
><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>The safety and efficacy of ivacaftor monotherapy in children a=
ged
less than 4&nbsp;months have not been established. No data are available.</=
span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US'>An appropriate dose for children under
6&nbsp;years of age and weighing less than 25&nbsp;kg cannot be achieved wi=
th ivacaftor
tablets.<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>Limited data are available in patients less than 6&nbsp;years of age
with an <i>R117H </i>mutation in the <i>CFTR </i>gene. Available data in
patients aged </span><span style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt'>6&nbsp;years</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> and older =
are described
in sections 4.8, 5.1, and 5.2.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><u><span style=3D'mso-ansi-language:EN-US'><o:p><=
span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>The safety and efficacy of ivacaftor in a combination regimen with
tezacaftor/ivacaftor and ivacaftor/tezacaftor/elexacaftor in children aged =
less
than 12&nbsp;years have not been established. No data are available.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><u><span style=3D'mso-ansi-language:EN-US'><o:p><=
span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><u><span lang=3DEN-GB>Method of administration<o:p>=
</o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><u><span lang=3DEN-GB><o:p><span style=3D'text-deco=
ration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB>For=
 oral
use. </span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span lang=3DEN-GB>Patients should be instructed =
to
swallow the tablets whole. The tablets should not be chewed, crushed, or br=
oken
before swallowing because there are no clinical data currently available to
support other methods of administration.</span><span lang=3DEN-GB
style=3D'mso-fareast-font-family:TimesNewRoman;mso-fareast-language:JA'><o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-fareast-font-fami=
ly:TimesNewRoman;
mso-fareast-language:JA'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-fareast-font-fami=
ly:TimesNewRoman;
mso-fareast-language:JA'>Ivacaftor tablets should be taken with fat&#8209;c=
ontaining
food.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-fareast-font-fami=
ly:TimesNewRoman;
mso-fareast-language:JA'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DEN-GB style=3D'mso-fareast-font-family:Ti=
mesNewRoman;
mso-fareast-language:JA'>Food or drink containing grapefruit should be avoi=
ded
during treatment (see section&nbsp;4.5).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DEN-GB style=3D'mso-fareast-font-family:"M=
S Mincho";
mso-fareast-language:JA'><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin:0in'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-b=
idi-font-size:
12.0pt'>4.3<span style=3D'mso-tab-count:1'> </span>Contraindications<=
/span></h2>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB><o:=
p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><span
lang=3DEN-GB>Hypersensitivity to the active substance or to any of the exci=
pients
listed in section 6.1.</span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt;
mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin:0in'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-b=
idi-font-size:
12.0pt'>4.4<span style=3D'mso-tab-count:1'> </span>Special warnings a=
nd
precautions for use</span></h2>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt;
mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Only patients with CF who =
had a <i
style=3D'mso-bidi-font-style:normal'>G551D</i>, <i style=3D'mso-bidi-font-s=
tyle:
normal'>G1244E</i>, <i style=3D'mso-bidi-font-style:normal'>G1349D</i>, <i
style=3D'mso-bidi-font-style:normal'>G178R</i>, <i style=3D'mso-bidi-font-s=
tyle:
normal'>G551S</i>, <i style=3D'mso-bidi-font-style:normal'>S1251N</i>, <i
style=3D'mso-bidi-font-style:normal'>S1255P</i>, <i style=3D'mso-bidi-font-=
style:
normal'>S549N</i>, <i style=3D'mso-bidi-font-style:normal'>S549R</i> gating=
 (class
III), <i style=3D'mso-bidi-font-style:normal'>G970R</i> </span><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>or <i>R117H </i=
></span><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>mutation in at least one a=
llele of
the <i style=3D'mso-bidi-font-style:normal'>CFTR</i> gene were included in
studies 1, 2, 5 and 6 (see section&nbsp;5.1).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB style=3D=
'mso-bidi-font-weight:
bold'>In study&nbsp;5, four patients with the <i style=3D'mso-bidi-font-sty=
le:
normal'>G970R</i> mutation were included. In three of four patients the cha=
nge
in the sweat chloride test was &lt;&nbsp;5&nbsp;mmol/L and this group did n=
ot
demonstrate a clinically relevant improvement in FEV<sub>1</sub> after 8&nb=
sp;weeks
of treatment. Clinical efficacy in patients with the <i style=3D'mso-bidi-f=
ont-style:
normal'>G970R</i> mutation of the <i style=3D'mso-bidi-font-style:normal'>C=
FTR</i>
gene could not be established (see section 5.1).<o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB><o:p>&nb=
sp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB style=3D=
'mso-bidi-font-weight:
bold'>Efficacy results from a phase 2 study in patients with CF who are
homozygous for the <i style=3D'mso-bidi-font-style:normal'>F508del </i>muta=
tion
in the <i style=3D'mso-bidi-font-style:normal'>CFTR</i> gene showed no
statistically significant difference in FEV<sub>1</sub> over 16&nbsp;weeks =
of
ivacaftor treatment compared to placebo (see section&nbsp;5.1). Therefore, =
use
of ivacaftor as monotherapy in these patients is not recommended.<o:p></o:p=
></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB style=3D=
'mso-bidi-font-style:
italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold'>Less evidence of a positive effect of
ivacaftor has been shown for patients with an <i style=3D'mso-bidi-font-sty=
le:
normal'>R117H&#8209;7T</i> mutation associated with less severe disease in
study&nbsp;6 (see section&nbsp;5.1). <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span style=3D'mso-ans=
i-language:
EN-US'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span>=
</u></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt;mso-bidi-font-weight:b=
old'>Ivacaftor
in a combination regimen with tezacaftor/ivacaftor should not be prescribed=
 in
patients with CF </span><span style=3D'font-size:11.0pt'>who are heterozygo=
us for
the <i style=3D'mso-bidi-font-style:normal'>F508del</i> mutation and have a
second <i style=3D'mso-bidi-font-style:normal'>CFTR</i> mutation not listed=
 in
section&nbsp;4.1.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span style=3D'mso-far=
east-font-family:
"Times New Roman";mso-ansi-language:EN-US;mso-fareast-language:ES;mso-bidi-=
font-weight:
bold'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span><=
/u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman";mso-fareast=
-language:
ES;mso-bidi-font-weight:bold'>Effect on liver function tests<o:p></o:p></sp=
an></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman";mso-fareast=
-language:
ES;mso-bidi-font-weight:bold'><o:p><span style=3D'text-decoration:none'>&nb=
sp;</span></o:p></span></u></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman";mso-fareast=
-language:
ES'>Moderate transaminase (alanine transaminase [ALT] or aspartate transami=
nase
[AST]) elevations are common in subjects with CF. Transaminase elevations h=
ave been
observed in some patients treated with ivacaftor as monotherapy and in
combination regimens with tezacaftor/ivacaftor or ivacaftor/tezacaftor/elex=
acaftor.
Therefore, liver function tests are recommended for all patients prior to
initiating ivacaftor, every 3&nbsp;months during the first year of treatment
and annually thereafter. For all patients with a history of transaminase el=
evations,
more frequent monitoring of liver function tests should be considered. In t=
he
event of significant elevations of transaminases (e.g., patients with ALT or
AST &gt;&nbsp;5 x the upper limit of normal (ULN), or ALT or AST &gt;&nbsp;=
3 x
ULN with bilirubin &gt;&nbsp;2 x ULN), dosing should be interrupted, and
laboratory tests closely followed until the abnormalities resolve. Following
resolution of transaminase elevations, the benefits and risks of resuming
treatment should be considered (see section 4.8).<o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><a
name=3D"_Hlk45278421"><u><span lang=3DEN-GB>Hepatic impairment<o:p></o:p></=
span></u></a></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk45278421'><u><span lang=3DEN-GB><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk45278421'><span
lang=3DEN-GB>Use of ivacaftor, either as monotherapy or in a combination re=
gimen
with tezacaftor/ivacaftor, is not recommended in patients with severe hepat=
ic
impairment unless the benefits are expected to outweigh the risks. Patients
with severe hepatic impairment should not be treated with ivacaftor in a
combination regimen with ivacaftor/tezacaftor/elexacaftor. (See Table 3 and
sections 4.2 and 5.2). </span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk45278421'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk45278421'><span
lang=3DEN-GB>For patients with moderate hepatic impairment, use of ivacafto=
r in a
combination regimen with ivacaftor/tezacaftor/elexacaftor is not recommende=
d.
Treatment should only be considered when there is a clear medical need and =
the
benefits are expected to outweigh the risks. If used, it should be used with
caution at a reduced dose (see Table 3 and sections 4.2 and 5.2).</span></s=
pan></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk45278421'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk45278421'></span>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'>Renal impairment<o:p></o:=
p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p><span style=3D'text-=
decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Caution is recommended w=
hile
using ivacaftor, </span><span style=3D'font-size:11.0pt'>either as monother=
apy or
in a combination regimen with tezacaftor/ivacaftor or ivacaftor/tezacaftor/=
elexacaftor,</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'> in patient=
s with
severe renal impairment or end&#8209;stage renal disease (see sections 4.2 =
and
5.2).</span><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB=
'><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Patients after organ transplantation<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Ivacaftor, either as monotherapy or in a combination regimen w=
ith
tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexacaftor, has not been stud=
ied
in patients with CF who have undergone organ transplantation. Therefore, us=
e in
transplanted patients is not recommended. See section 4.5 for interactions =
with
ciclosporin or tacrolimus.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in'><u><span lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp=
;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in'><u><span lang=3DEN-GB>Rash events <o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in'><span lang=3DEN-GB>The incidence of rash events with ivacaftor in a
combination regimen with ivacaftor/tezacaftor/elexacaftor was higher in fem=
ales
than in males</span><span style=3D'mso-ansi-language:EN-US'>, particularly =
in
females taking hormonal contraceptives</span><span lang=3DEN-GB>. A role for
hormonal contraceptives in the occurrence of rash cannot be excluded. For p=
atients
taking hormonal contraceptives who develop rash, interrupting treatment with
ivacaftor in a combination regimen with ivacaftor/tezacaftor/elexacaftor and
hormonal contraceptives should be considered. Following the resolution of r=
ash,
it should be considered if resuming ivacaftor in a combination regimen with
ivacaftor/tezacaftor/elexacaftor without hormonal contraceptives is
appropriate. If rash does not recur, resumption of hormonal contraceptives =
can
be considered (see section 4.8).<i style=3D'mso-bidi-font-style:normal'> <o=
:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Interactions with medicinal products<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>CYP3A inducers<o:p>=
</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Exposure to ivacaftor is significantly decreased and exposures=
 to
elexacaftor and tezacaftor are expected to decrease by the concomitant use =
of
CYP3A inducers, potentially resulting in the loss of ivacaftor efficacy; th=
erefore,
co-administration of ivacaftor (as monotherapy or in a combination regimen =
with
tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexacaftor) with strong CYP3A
inducers is not recommended (see section&nbsp;4.5). </span></p>

<p class=3Dlabeltext><o:p>&nbsp;</o:p></p>

<p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span
style=3D'font-size:11.0pt'>CYP3A inhibitors<o:p></o:p></span></i></p>

<p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span style=3D'font-size:11.0pt'>Exposure to ivacaf=
tor,
tezacaftor and elexacaftor are increased when co-administered with strong or
moderate CYP3A inhibitors. The dose of ivacaftor (as monotherapy or in a co=
mbination
regimen with tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexacaftor) must=
 be
adjusted when used concomitantly with strong or moderate CYP3A inhibitors (=
see Table&nbsp;2
and sections&nbsp;4.2 and 4.5).</span><span style=3D'font-size:11.0pt;mso-b=
idi-font-size:
10.0pt'><o:p></o:p></span></p>

<p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Paediatric population<o:p>=
</o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'=
>Cases
of non&#8209;congenital lens opacities/cataracts without impact on vision h=
ave
been reported in paediatric patients treated with ivacaftor and ivacaftor-c=
ontaining
regimens. Although other risk factors were present in some cases (such as
corticosteroid use and exposure to radiation), a possible risk attributable=
 to treatment
with ivacaftor cannot be excluded. Baseline and follow&#8209;up
ophthalmological examinations are recommended in paediatric patients initia=
ting
ivacaftor treatment</span><span lang=3DEN-GB>, either as monotherapy or in =
a combination
regimen with tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexacaftor <span
style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>(see section=
&nbsp;5.3).</span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Lactose content<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Kalydeco contains lactose. Patients with rare hereditary probl=
ems of
galactose intolerance, total lactase deficiency or glucose&#8209;galactose
malabsorption should not take this medicine.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Sodium content<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>This medicine contains less than 1&nbsp;mmol sodium (23&nbsp;m=
g) per
dose, that is to say essentially sodium&#8209;free.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.1pt;text-indent:-28.1pt;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2;mso-list:l27 level2 lfo9;tab-stops:list 28.5pt'><![if !=
supportLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'><span
style=3D'mso-list:Ignore'>4.5<span style=3D'font:7.0pt "Times New Roman"'>&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>Interaction with o=
ther
medicinal products and other forms of interaction<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Ivacaftor is a substrate of CYP3A4 =
and
CYP3A5. It is a weak inhibitor of CYP3A and P&#8209;gp and a potential
inhibitor of CYP2C9. <i style=3D'mso-bidi-font-style:normal'>In vitro</i> s=
tudies
showed that ivacaftor is not a substrate for P&#8209;gp. </span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-fareast-language:JA'><o:p></o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";mso-fareast-l=
anguage:
JA'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB=
'>Medicinal
products affecting the pharmacokinetics of ivacaftor, tezacaftor and/or
elexacaftor</span></u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi=
-font-size:
10.0pt;mso-ansi-language:EN-GB'><o:p></o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-bidi-font-size:10.0pt'>CYP3A inducers<o:p></o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-bidi-font-size:10.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Co&#8209;administration of ivacafto=
r with
rifampicin, a strong CYP3A inducer, decreased ivacaftor exposure (AUC) <span
style=3D'mso-font-kerning:14.0pt'>by 89% and decreased hydroxymethyl ivacaf=
tor (M1)
to a lesser extent than ivacaftor. Co&#8209;administration of ivacaftor (as
monotherapy or in a combination regimen with tezacaftor/</span></span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt'>ivacaftor=
</span><span
lang=3DEN-GB style=3D'font-size:11.0pt'> or ivacaftor/tezacaftor/elexacafto=
r</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt'>)</span><=
span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-font-kerning:14.0pt'> with stron=
g </span><span
lang=3DEN-GB style=3D'font-size:11.0pt'>CYP3A inducers, such as rifampicin,
rifabutin, phenobarbital, carbamazepine, phenytoin and St. Johns wort (<i
style=3D'mso-bidi-font-style:normal'>Hypericum perforatum</i>), is not
recommended (see section&nbsp;4.4).<o:p></o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt'>No dose adjustment is recommended when ivacaftor=
 (as
monotherapy or in a combination regimen with tezacaftor/ivacaftor or ivacaf=
tor/tezacaftor/elexacaftor)
is used with moderate or weak CYP3A inducers. <o:p></o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'>CYP3A inhibitors<o:p></o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Ivacaftor is a sensitive=
 CYP3A
substrate. Co-administration with ketoconazole, a strong CYP3A inhibitor,
increased ivacaftor exposure (measured as area under the curve [AUC]) by 8.=
5&#8209;fold
and increased M1 to a lesser extent than ivacaftor. A reduction of the ivac=
aftor
dose (as monotherapy or in a combination regimen with tezacaftor/ivacaftor =
or ivacaftor/tezacaftor/elexacaftor)
is recommended for co&#8209;administration with strong CYP3A inhibitors, su=
ch
as ketoconazole, itraconazole, posaconazole, voriconazole, telithromycin and
clarithromycin (see sections&nbsp;4.2 and 4.4).<o:p></o:p></span></p>

<p class=3Dlabeltext><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-an=
si-language:
EN-GB'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span>=
</u></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>Co&#8209;administration with fluconazole, a moderate inhibitor of CY=
P3A,
increased ivacaftor exposure by 3&#8209;fold and increased M1 to a lesser
extent than ivacaftor. A reduction of the ivacaftor dose (as monotherapy or=
 in
a combination regimen with tezacaftor/ivacaftor or ivacaftor/tezacaftor/ele=
xacaftor)
is recommended for patients taking concomitant moderate CYP3A inhibitors, s=
uch
as fluconazole, erythromycin, and verapamil (see sections&nbsp;4.2 and 4.4)=
.<o:p></o:p></span></p>

<p class=3Dlabeltext><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bi=
di-font-size:
10.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text-decoration:none'>&=
nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>Co&#8209;administration of ivacaftor with grapefruit juice, which
contains one or more components that moderately inhibit CYP3A, may increase
exposure to ivacaftor. Food or drink containing grapefruit should be avoided
during treatment with ivacaftor (as monotherapy or in a combination regimen
with tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexacaftor, see
section&nbsp;4.2).<o:p></o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-bidi-font-size:10.0pt'>Potential for ivacaftor to interact with
transporters<o:p></o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-fareast-language:JA'><o:p><span style=3D'text-decoration:none'>&nbsp;</=
span></o:p></span></u></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>In vitro</span=
></i><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-fareast-language:JA'> studies showed that ivacaftor is not a substrate =
for
OATP1B1 or OATP1B3. Ivacaftor and its metabolites are substrates of BCRP <i
style=3D'mso-bidi-font-style:normal'>in vitro</i>. Due to its high intrinsic
permeability and low likelihood of being excreted intact, co-administration=
 of
BCRP inhibitors is not expected to alter exposure of ivacaftor and M1&#8209=
;IVA,
while any potential changes in M6&#8209;IVA exposures are not expected to be
clinically relevant. <o:p></o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal;mso-pagination:widow-=
orphan lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt'><o:p>&nbsp;</o:p></spa=
n></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;mso-pagination:widow-=
orphan lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt'>Ciprofloxacin<o:p></o:=
p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;mso-pagination:widow-=
orphan lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;mso-pagination:widow-=
orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt'>Co&#8=
209;administration
of ciprofloxacin with ivacaftor did not affect the exposure of ivacaftor. No
dose adjustment is required when ivacaftor (as monotherapy or in a combinat=
ion
regimen with tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexacaftor) is c=
o&#8209;administered
with ciprofloxacin.<o:p></o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB=
'>Medicinal
products affected by ivacaftor, tezacaftor and/or elexacaftor<o:p></o:p></s=
pan></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB=
'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Administration of ivacaftor may inc=
rease
systemic exposure of medicinal products that are sensitive substrates of CY=
P2C9,
and/or P&#8209;gp, and/or CYP3A which may increase or prolong their therape=
utic
effect and adverse reactions.<o:p></o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>CYP2C9 substrates<o=
:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Ivacaftor may inhibit CYP2C9. There=
fore,
monitoring of the international normalised ratio (INR) is recommended durin=
g co&#8209;administration
of warfarin with ivacaftor (as monotherapy or in a combination regimen with=
 tezacaftor/ivacaftor
or ivacaftor/tezacaftor/elexacaftor). Other medicinal products for which
exposure may be increased include glimepiride and glipizide; these medicinal
products should be used with caution.<i style=3D'mso-bidi-font-style:normal=
'><span
style=3D'border:solid windowtext 1.0pt;mso-border-alt:solid windowtext .5pt;
padding:0in'><o:p></o:p></span></i></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB>Digoxin and other P&#8209;gp substrates<o:p></o:=
p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Co&#8209;administration with digoxi=
n, a
sensitive P&#8209;gp substrate, increased digoxin exposure by 1.3&#8209;fol=
d,
consistent with weak inhibition of P&#8209;gp by ivacaftor. Administration =
of ivacaftor
(as monotherapy or in a combination regimen with tezacaftor/ivacaftor or
ivacaftor/tezacaftor/elexacaftor) may increase systemic exposure of medicin=
al
products that are sensitive substrates of P&#8209;gp, which may increase or
prolong their therapeutic effect and adverse reactions. When used concomita=
ntly</span><span
style=3D'font-size:11.0pt;mso-ansi-language:EN-US'> with</span><span lang=
=3DEN-GB
style=3D'font-size:11.0pt'> digoxin or other substrates of P&#8209;gp with =
a narrow
therapeutic index, such as ciclosporin, everolimus, sirolimus or tacrolimus=
, caution
and appropriate monitoring should be used.<o:p></o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-bidi-font-size:10.0pt'>CYP3A substrates <o:p></o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-bidi-font-size:10.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Co&#8209;administration with (oral)
midazolam, a sensitive CYP3A substrate, increased midazolam exposure 1.5&#8=
209;fold,
consistent with weak inhibition of CYP3A by ivacaftor. No dose adjustment of
CYP3A substrates, such as midazolam, alprazolam, diazepam or triazolam, is
required when these are co&#8209;administered with ivacaftor (as monotherap=
y or
in a combination regimen with tezacaftor/ivacaftor or ivacaftor/tezacaftor/=
elexacaftor).
<o:p></o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB>Hormonal
contraceptives<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><u><span lang=3DEN-GB><o:p><span style=3D'text-deco=
ration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Ivacaftor (as monotherapy or in a
combination regimen with tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexa=
caftor)
has been studied with an oestrogen/progesterone oral contraceptive and was
found to have no significant effect on the exposures of the oral contracept=
ive.
Therefore, no dose adjustment of oral contraceptives is necessary.<o:p></o:=
p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB><=
o:p>&nbsp;</o:p></span></p>

<p style=3D'margin:0in;page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Paediatric population<o:=
p></o:p></span></u></p>

<p style=3D'margin:0in;page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p style=3D'margin:0in;page-break-after:avoid'><span lang=3DEN-GB style=3D'=
font-size:
11.0pt;mso-ansi-language:EN-GB'>Interaction studies have only been performe=
d in
adults.<o:p></o:p></span></p>

<p style=3D'margin:0in;page-break-after:avoid'><i style=3D'mso-bidi-font-st=
yle:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:12.=
0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:28.1pt;text-indent:-28.1pt;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2'><b><span lang=3DEN-GB>4.6<span style=3D'mso-tab-count:=
1'> </span>Fertility,
pregnancy and lactation</span></b></p>

<p style=3D'margin:0in;page-break-after:avoid'><span style=3D'font-size:11.=
0pt;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'margin-left:28.1pt;text-indent:-28.1pt;mso-pa=
gination:
widow-orphan no-line-numbers;page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Pregnancy<o:p></o:p></sp=
an></u></p>

<p class=3Dlabeltext style=3D'margin-left:28.1pt;text-indent:-28.1pt;mso-pa=
gination:
widow-orphan no-line-numbers;page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>There are no or limited =
amount
of data (less than 300 pregnancy outcomes) from the use of ivacaftor in
pregnant women. Animals studies do not indicate direct or indirect harmful
effects with respect to reproductive toxicity (see section 5.3). As a
precautionary measure, it is preferable to avoid the use of ivacaftor during
pregnancy.<o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;tab-stops:0in'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Breast&#8209;feeding<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>It is unknown whether
ivacaftor and/or its metabolites are excreted in human milk. Available
pharmacokinetic data in animals have shown excretion of ivacaftor into the =
milk
of lactating female rats. As such, a risk to the newborns/infants cannot be
excluded. A decision must be made whether to discontinue breast&#8209;feedi=
ng
or to discontinue/abstain from ivacaftor therapy taking into account the
benefit of breast&#8209;feeding for the child and the benefit of therapy for
the woman.<o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;tab-stops:0in'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;mso-pagination:widow-orphan =
lines-together;
page-break-after:avoid;tab-stops:0in'><u><span lang=3DEN-GB>Fertility<o:p><=
/o:p></span></u></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;mso-pagination:widow-orphan =
lines-together;
page-break-after:avoid;tab-stops:0in'><u><span lang=3DEN-GB><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-fareast-font-family=
:"MS Mincho";
mso-fareast-language:JA'>There are no data available on the effect of ivaca=
ftor
on fertility in humans. Ivacaftor had an effect on fertility in rats (see
section 5.3).<o:p></o:p></span></p>

<p style=3D'margin:0in'><span style=3D'font-size:11.0pt;mso-bidi-font-weigh=
t:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:2'><b><span lang=3DEN-GB>4.7<span
style=3D'mso-tab-count:1'> </span>Effects on ability to drive and use
machines</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Ivacaftor has minor influe=
nce on
the ability to drive or use machines. Ivacaftor may cause dizziness (see
section&nbsp;4.8) and, therefore,</span><span lang=3DEN-GB> <span
style=3D'mso-bidi-font-weight:bold'>patients experiencing dizziness should =
be
advised not to drive or use machines until symptoms abate.<o:p></o:p></span=
></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:2'><b><span lang=3DEN-GB>4.8<span
style=3D'mso-tab-count:1'> </span><a name=3D"_Hlk36070162">Undesirable =
effects<o:p></o:p></a></span></b></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
_Hlk36070162'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-lang=
uage:
EN-GB'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span>=
</u></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
_Hlk36070162'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-lang=
uage:
EN-GB'>Summary of the safety profile<o:p></o:p></span></u></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
_Hlk36070162'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-lang=
uage:
EN-GB'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span>=
</u></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
_Hlk36070162'><span style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt'>Th=
e most
common adverse reactions experienced by patients aged 6&nbsp;years and older
who received ivacaftor are headache (23.9%), oropharyngeal pain (22.0%), up=
per
respiratory tract infection (22.0%), nasal congestion (20.2%), abdominal pa=
in
(15.6%), nasopharyngitis (14.7%), diarrhoea (12.8%), </span></span><span
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB style=3D'font-size:1=
1.0pt;
mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB'>dizziness (9.2%), </span=
></span><span
style=3D'mso-bookmark:_Hlk36070162'><span style=3D'font-size:11.0pt;mso-bid=
i-font-size:
10.0pt'>rash (12.8%</span></span><span style=3D'mso-bookmark:_Hlk36070162'>=
<span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-l=
anguage:
EN-GB'>) and </span></span><span style=3D'mso-bookmark:_Hlk36070162'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>bacteria</s=
pan></span><span
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB style=3D'font-size:1=
1.0pt;
mso-fareast-font-family:"Times New Roman"'> </span></span><span
style=3D'mso-bookmark:_Hlk36070162'><span style=3D'font-size:11.0pt;mso-far=
east-font-family:
"Times New Roman"'>in </span></span><span style=3D'mso-bookmark:_Hlk3607016=
2'><span
style=3D'font-size:11.0pt'>sputum (12.8%).</span></span><span style=3D'mso-=
bookmark:
_Hlk36070162'><span style=3D'font-size:11.0pt;mso-fareast-font-family:"Time=
s New Roman";
mso-ansi-language:EN-GB'> </span></span><span style=3D'mso-bookmark:_Hlk360=
70162'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Transaminase
elevations occurred in 12.8% of ivacaftor-treated patients versus 11.5% of
placebo&#8209;treated patients.</span></span></p>

<p class=3Dlabeltext><span style=3D'mso-bookmark:_Hlk36070162'><u><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></u></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'>In patient=
s aged 2
to less than 6&nbsp;years the most common adverse reactions were nasal
congestion (26.5%), upper respiratory tract infection (23.5%), transaminase
elevations (14.7%), rash (11.8%), and bacteria in sputum (11.8%).<o:p></o:p=
></span></span></p>

<p class=3Dlabeltext><span style=3D'mso-bookmark:_Hlk36070162'><u><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></u></span></p>

<p class=3Dlabeltext><span style=3D'mso-bookmark:_Hlk36070162'><span
style=3D'font-size:11.0pt'>Serious adverse reactions in patients who receiv=
ed
ivacaftor included abdominal pain and transaminase elevations (see section&=
nbsp;4.4).<o:p></o:p></span></span></p>

<p class=3Dlabeltext><span style=3D'mso-bookmark:_Hlk36070162'><u><span lan=
g=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
_Hlk36070162'><a name=3D"_Hlk45279317"><u><span lang=3DEN-GB style=3D'font-=
size:11.0pt;
mso-ansi-language:EN-GB'>Tabulated list of adverse reactions<o:p></o:p></sp=
an></u></a></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk4527931=
7'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk4527931=
7'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>Table&nbsp;4 re=
flects
the adverse reactions observed with ivacaftor monotherapy in clinical trials
(placebo-controlled and uncontrolled studies) in which the length of exposu=
re
to ivacaftor ranged from 16&nbsp;weeks to 144&nbsp;weeks. </span></span></s=
pan><span
style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk4527931=
7'><span
style=3D'mso-ansi-language:EN-US'>Additional adverse reactions observed with
ivacaftor in <span style=3D'mso-bidi-font-weight:bold'>a </span>combination=
 <span
style=3D'mso-bidi-font-weight:bold'>regimen </span>with tezacaftor/ivacafto=
r <span
style=3D'mso-bidi-font-weight:bold'>and/or in a combination regimen with
ivacaftor/tezacaftor/elexacaftor </span>are also provided in Table<span
style=3D'mso-bidi-font-weight:bold'> 4</span>. <span style=3D'mso-bidi-font=
-weight:
bold'>The frequency of adverse reactions is defined as follows: very common=
 (&#8805;&nbsp;1/10);
common (&#8805;&nbsp;1/100 to &lt;&nbsp;1/10); uncommon (&#8805;&nbsp;1/1,0=
00
to &lt;&nbsp;1/100); rare (&#8805;&nbsp;1/10,000 to &lt;&nbsp;1/1,000); very
rare (&lt;&nbsp;1/10,000); not known (cannot be estimated from the available
data). </span></span><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'=
>Within
each frequency grouping, adverse reactions are presented in order of decrea=
sing
seriousness.</span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-weight:
bold'><o:p>&nbsp;</o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:6.0pt;
margin-left:40.3pt;text-indent:-40.3pt;line-height:normal;mso-pagination:wi=
dow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk3607=
0162'><span
style=3D'mso-bookmark:_Hlk45279317'><b><span lang=3DEN-GB>Table&nbsp;4: Adv=
erse
reactions in patients treated with ivacaftor monotherapy and/or in a
combination regimen</span></b><span lang=3DEN-GB style=3D'mso-bidi-font-wei=
ght:
bold'><o:p></o:p></span></span></span></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"99%"
 style=3D'width:99.18%;margin-left:-.25pt;border-collapse:collapse;border:n=
one;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <thead>
  <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoi=
d;
   height:15.5pt'>
   <td width=3D"34%" valign=3Dtop style=3D'width:34.06%;border:solid window=
text 1.0pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   15.5pt'>
   <p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-or=
phan lines-together;
   page-break-after:avoid'><span style=3D'mso-bookmark:_Hlk36070162'><span
   style=3D'mso-bookmark:_Hlk45279317'><b><span lang=3DEN-GB>System organ c=
lass</span></b></span></span></p>
   </td>
   <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_H=
lk45279317'></span></span>
   <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border:solid window=
text 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:15.5pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   mso-pagination:widow-orphan lines-together;page-break-after:avoid'><span
   style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk4527=
9317'><b><span
   lang=3DEN-GB>Adverse reactions<o:p></o:p></span></b></span></span></p>
   </td>
   <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_H=
lk45279317'></span></span>
   <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border:solid windowt=
ext 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:15.5pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   mso-pagination:widow-orphan lines-together;page-break-after:avoid'><span
   style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk4527=
9317'><b><span
   lang=3DEN-GB>Frequency<o:p></o:p></span></b></span></span></p>
   </td>
   <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_H=
lk45279317'></span></span>
  </tr>
 </thead>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid;height:.2in'>
  <td width=3D"34%" rowspan=3D4 valign=3Dtop style=3D'width:34.06%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Infections and infestations</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Upper respiratory tract infection</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>very common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Nasopharyngitis</s=
pan></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>very common</span>=
</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Influenza </span><=
/span></span><span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><sup><span
  lang=3DEN-GB style=3D'font-family:"Arial",sans-serif'></span></sup></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common </span></sp=
an></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Rhinitis</span></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common</span></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid;height:.2in'>
  <td width=3D"34%" valign=3Dtop style=3D'width:34.06%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Metabolism and nutrition disorders</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Hypoglycaemia </span></span></span><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><sup><span lang=3DEN-GB style=3D'font=
-family:
  "Arial",sans-serif'></span></sup><span lang=3DEN-GB> </span></span></spa=
n></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>common </span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid;height:.2in'>
  <td width=3D"34%" rowspan=3D2 valign=3Dtop style=3D'width:34.06%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Nervous system disorders</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Headache</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>very common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Dizziness</span></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>very common</span>=
</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid;height:.2in'>
  <td width=3D"34%" rowspan=3D6 valign=3Dtop style=3D'width:34.06%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Ear and labyrinth disorders</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Ear pain</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Ear discomfort</sp=
an></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common</span></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:10;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Tinnitus</span></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common</span></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:11;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Tympanic membrane
  hyperaemia</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common</span></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:12;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Vestibular disorde=
r</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common</span></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:13;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Ear congestion</sp=
an></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>uncommon</span></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:14;page-break-inside:avoid;height:.2in'>
  <td width=3D"34%" rowspan=3D7 valign=3Dtop style=3D'width:34.06%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Respiratory, thoracic and mediastinal disorders</span></span=
></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Oropharyngeal pain</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>very common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:15;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Nasal congestion</=
span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>very common</span>=
</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:16;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Abnormal breathing=
 </span></span></span><span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><sup><span
  lang=3DEN-GB style=3D'font-family:"Arial",sans-serif'></span></sup></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common </span></sp=
an></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:17;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Rhinorrhoea </span=
></span></span><span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><sup><span
  lang=3DEN-GB style=3D'font-family:"Arial",sans-serif'></span></sup></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common </span></sp=
an></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:18;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Sinus congestion</=
span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common</span></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:19;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Pharyngeal erythem=
a</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common</span></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:20;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Wheezing </span></=
span></span><span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><sup><span
  lang=3DEN-GB style=3D'font-family:"Arial",sans-serif'></span></sup></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>uncommon</span></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:21;page-break-inside:avoid;height:.2in'>
  <td width=3D"34%" rowspan=3D5 valign=3Dtop style=3D'width:34.06%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Gastrointestinal disorders</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Abdominal pain</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>very common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:22;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Diarrhoea</span></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>very common</span>=
</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:23;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Abdominal pain upp=
er </span></span></span><span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><sup><span
  lang=3DEN-GB style=3D'font-family:"Arial",sans-serif'></span></sup></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common</span></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:24;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Flatulence </span>=
</span></span><span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><sup><span
  lang=3DEN-GB style=3D'font-family:"Arial",sans-serif'></span></sup></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common </span></sp=
an></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:25;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Nausea <sup>*</sup=
></span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>common</span></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:26;page-break-inside:avoid;height:.2in'>
  <td width=3D"34%" rowspan=3D3 valign=3Dtop style=3D'width:34.06%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DDA style=3D'mso-ansi-language:DA'>Hepatobiliary disorders</span></=
span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Transaminase elevations</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>very common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:27;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Alanine aminotransferase increased </span></span></span><span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><sup><span
  lang=3DEN-GB style=3D'font-family:"Arial",sans-serif'></span></sup></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:28;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Aspartate aminotransferase increased </span></span></span><s=
pan
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><sup><span
  lang=3DEN-GB style=3D'font-family:"Arial",sans-serif'></span></sup></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>common </span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:29;page-break-inside:avoid;height:.2in'>
  <td width=3D"34%" rowspan=3D3 valign=3Dtop style=3D'width:34.06%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Skin and subcutaneous tissue disorders</span></span></span><=
/p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Rash</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>very common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:30;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Acne </span></span></span><span style=3D'mso-bookmark:_Hlk36=
070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><sup><span lang=3DEN-GB style=3D'font=
-family:
  "Arial",sans-serif'></span></sup></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:31;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Pruritus </span></span></span><span style=3D'mso-bookmark:_H=
lk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><sup><span lang=3DEN-GB style=3D'font=
-family:
  "Arial",sans-serif'></span></sup></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>common </span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:32;page-break-inside:avoid;height:.2in'>
  <td width=3D"34%" rowspan=3D5 valign=3Dtop style=3D'width:34.06%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Reproductive system and breast disorders</span></span></span=
></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:28.35pt right 1.95in'><span style=3D'mso-bookmark:_Hlk36070162'=
><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Breast mass</span>=
</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:33;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:8.95pt 28.35pt=
'><span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Breast inflammation</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>uncommon</span></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:34;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Gynaecomastia</spa=
n></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>uncommon</span></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:35;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Nipple disorder</s=
pan></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>uncommon</span></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:36;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>Nipple pain</span>=
</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-book=
mark:_Hlk36070162'><span
  style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB>uncommon</span></s=
pan></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:37;page-break-inside:avoid;height:.2in'>
  <td width=3D"34%" rowspan=3D3 valign=3Dtop style=3D'width:34.06%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:.2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Investigations</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Bacteria in sputum</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>very common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:38;page-break-inside:avoid;height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Blood creatine phosphokinase increased </span></span></span>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><sup><span
  lang=3DEN-GB style=3D'font-family:"Arial",sans-serif'></span></sup></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>common</span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
 <tr style=3D'mso-yfti-irow:39;mso-yfti-lastrow:yes;page-break-inside:avoid;
  height:.2in'>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"35%" valign=3Dtop style=3D'width:35.94%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>Blood pressure increased </span></span></span><span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><sup><span
  lang=3DEN-GB style=3D'font-family:"Arial",sans-serif'></span></sup></spa=
n></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
  <td width=3D"30%" valign=3Dtop style=3D'width:30.0%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:.=
2in'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279=
317'><span
  lang=3DEN-GB>uncommon </span></span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hl=
k45279317'></span></span>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid'><span style=3D'mso-bookmark:_Hlk36070162'><span
style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB style=3D'font-size:9=
.0pt;
mso-bidi-font-size:11.0pt'>*</span></span></span><span style=3D'mso-bookmar=
k:
_Hlk36070162'><span style=3D'mso-bookmark:_Hlk45279317'><span lang=3DEN-GB
style=3D'font-size:9.0pt'> Adverse reaction and frequency reported from cli=
nical
studies with ivacaftor in combination with tezacaftor/ivacaftor</span></spa=
n></span><span
style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk4527931=
7'><span
lang=3DEN-GB style=3D'font-size:9.0pt;mso-bidi-font-size:11.0pt'><o:p></o:p=
></span></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid'><span style=3D'mso-bookmark:_Hlk36070162'><span
style=3D'mso-bookmark:_Hlk45279317'><sup><span lang=3DEN-GB style=3D'font-s=
ize:9.0pt;
font-family:"Arial",sans-serif'></span></sup></span></span><span
style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-bookmark:_Hlk4527931=
7'><span
lang=3DEN-GB style=3D'font-size:9.0pt'> Adverse reaction and frequency repo=
rted from
clinical studies with ivacaftor in combination with
ivacaftor/tezacaftor/elexacaftor<o:p></o:p></span></span></span></p>

<span style=3D'mso-bookmark:_Hlk45279317'></span>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><u><span lang=3DEN-GB><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><u><span lang=3DEN-GB>Description of se=
lected
adverse reactions<o:p></o:p></span></u></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DEN-GB>Transaminase elevations <o:p></o:p></span></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB><o:p>&nbsp;</o:p></s=
pan></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>During the 48-week p=
lacebo&#8209;controlled
studies 1 and 2 of ivacaftor as monotherapy in patients aged 6&nbsp;years a=
nd
older, the incidence of maximum transaminase (ALT or AST) &gt;&nbsp;8, &gt;=
&nbsp;5
or &gt;&nbsp;3&nbsp;x ULN was 3.7%, 3.7% and 8.3% in ivacaftor&#8209;treated
patients and 1.0%, 1.9% and 8.7% in placebo&#8209;treated patients,
respectively. Two patients, one on placebo and one on ivacaftor permanently
discontinued treatment for elevated transaminases, each &gt;&nbsp;8&nbsp;x =
ULN.
No ivacaftor&#8209;treated patients experienced a transaminase elevation &g=
t;&nbsp;3&nbsp;x
ULN associated with elevated total bilirubin &gt;&nbsp;1.5&nbsp;x ULN. In
ivacaftor&#8209;treated patients, most transaminase elevations up to 5&nbsp=
;x ULN
resolved without treatment interruption. Ivacaftor dosing was interrupted in
most patients with transaminase elevations &gt;&nbsp;5&nbsp;x ULN. In all
instances where dosing was interrupted for elevated transaminases</span></s=
pan><span
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB style=3D'mso-fareast=
-font-family:
"Times New Roman"'> </span><span lang=3DEN-GB>and subsequently resumed, iva=
caftor
dosing was able to be resumed successfully (see section&nbsp;4.4).</span></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB><o:p>&nbsp;</o:p></s=
pan></span></p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk36070162'><span lang=
=3DEN-GB>During
the placebo controlled phase 3 studies (up to 24 weeks) of
tezacaftor/ivacaftor, the incidence of maximum transaminase (ALT or AST) &g=
t;
8, &gt; 5, or &gt; 3 x ULN were 0.2%, 1.0%, and 3.4% in tezacaftor/ivacaftor
treated patients, and 0.4%, 1.0%, and 3.4% in placebo-treated patients. One
patient (0.2%) on therapy and 2 patients (0.4%) on placebo permanently
discontinued treatment for elevated transaminases. No patients treated with
tezacaftor/ivacaftor experienced a transaminase elevation &gt;3 x ULN assoc=
iated
with elevated total bilirubin &gt;2 x ULN. </span></span><span
style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-ansi-language:EN-US'=
><o:p></o:p></span></span></p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk36070162'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk36070162'><span lang=
=3DEN-GB>During
the 24-week, placebo-controlled, phase 3 study of
ivacaftor/tezacaftor/elexacaftor, these figures were 1.5%, 2.5%, and 7.9% in
ivacaftor/tezacaftor/elexacaftor-treated patients and 1.0%, 1.5%, and 5.5% =
in placebo-treated
patients. The incidence of adverse reactions of transaminase elevations was
10.9% in ivacaftor in a combination regimen with
ivacaftor/tezacaftor/elexacaftor treated patients and 4.0% in placebo-treat=
ed
patients.</span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Rash events<o:p></o:p></sp=
an></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>R<span style=3D'mso-=
bidi-font-weight:
bold'>ash events, generally mild to moderate in severity, have been observed
with the use of ivacaftor in a combination regimen with
ivacaftor/tezacaftor/elexacaftor and occurred more frequently in female-tre=
ated
patients (16.3%) and in those taking hormonal contraceptives (20.5%). See
section 4.4.<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DEN-GB>Increased creatine phosphokinase <o:p></o:p></span></i></span>=
</p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>Generally transient =
and
asymptomatic increases in </span></span><span style=3D'mso-bookmark:_Hlk360=
70162'><span
lang=3DEN-CA style=3D'mso-ansi-language:EN-CA'>creatine phosphokinase were =
observed
in patients treated with ivacaftor in a combination regimen with ivacaftor/=
tezacaftor/elexacaftor,
which did not lead to treatment discontinuation.<o:p></o:p></span></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DEN-GB>Increased blood pressure<o:p></o:p></span></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>An <span style=3D'ms=
o-bidi-font-weight:
bold'>increase from baseline in mean systolic and diastolic blood pressure =
of 3.5&nbsp;mmHg
and&nbsp;1.9 mmHg, respectively was observed in patients treated with ivaca=
ftor
in a combination regimen with ivacaftor/tezacaftor/elexacaftor. <o:p></o:p>=
</span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><u><span lang=3DEN-GB>Paediatric popula=
tion<o:p></o:p></span></u></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB style=3D'mso-fareast=
-language:
JA'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB style=3D'mso-fareast=
-language:
JA;mso-bidi-font-style:italic'>The safety data of ivacaftor as monotherapy =
were
evaluated in 6 patients between 4 months to less than 6 months of age, 11
patients between 6&nbsp;months to less than 12&nbsp;months of age, </span><=
/span><span
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-size:
8.0pt;mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>19&nbsp;=
patients
between 12&nbsp;months to less than 24&nbsp;months of age, </span></span><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB style=3D'mso-fareast=
-font-family:
"MS Mincho";mso-fareast-language:JA'>34&nbsp;patients between 2 to less tha=
n 6&nbsp;years
of age,</span><span lang=3DEN-GB> </span></span><span style=3D'mso-bookmark=
:_Hlk36070162'><span
lang=3DEN-GB style=3D'mso-fareast-language:JA;mso-bidi-font-style:italic'>6=
1&nbsp;patients
between 6 to less than 12&nbsp;years of age and 94&nbsp;patients between 12=
 to
less than 18&nbsp;years of age. <o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
lang=3DEN-GB style=3D'mso-fareast-language:JA;mso-bidi-font-style:italic'>T=
he
safety profile of ivacaftor (as monotherapy or in a combination regimen) is
generally consistent among paediatric patients and is also consistent with =
adult
patients.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
lang=3DEN-GB style=3D'mso-fareast-language:JA;mso-bidi-font-style:italic'><=
o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
lang=3DEN-GB style=3D'mso-fareast-language:JA;mso-bidi-font-weight:bold;mso=
-bidi-font-style:
italic'>The incidence of transaminase elevations (ALT or AST) observed in
studies 2, 5 and 6 (patients aged 6&nbsp;to less than 12&nbsp;years), study=
&nbsp;7
(patients aged 2 to less than 6&nbsp;years), and study&nbsp;8 (patients </s=
pan><span
lang=3DEN-GB>aged 6 to less than </span></span><span style=3D'mso-bookmark:=
_Hlk36070162'><span
lang=3DEN-GB style=3D'mso-fareast-language:JA;mso-bidi-font-weight:bold;mso=
-bidi-font-style:
italic'>24&nbsp;months) are described in Table&nbsp;5. In the placebo
controlled studies</span><span lang=3DEN-GB>, the incidence of transaminase
elevations </span></span><span style=3D'mso-bookmark:_Hlk36070162'><span
lang=3DEN-GB style=3D'mso-fareast-language:JA;mso-bidi-font-weight:bold;mso=
-bidi-font-style:
italic'>were similar between treatment with ivacaftor (15.0%)</span><span
lang=3DEN-GB> and </span></span><span style=3D'mso-bookmark:_Hlk36070162'><=
span
lang=3DEN-GB style=3D'mso-fareast-language:JA;mso-bidi-font-weight:bold;mso=
-bidi-font-style:
italic'>placebo (14.6%). Across all populations, </span></span><span
style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-ansi-language:EN-US;
mso-fareast-language:JA;mso-bidi-font-weight:bold;mso-bidi-font-style:itali=
c'>peak
LFT elevations </span></span><span style=3D'mso-bookmark:_Hlk36070162'><span
lang=3DEN-GB style=3D'mso-fareast-language:JA;mso-bidi-font-weight:bold;mso=
-bidi-font-style:
italic'>returned to baseline levels following interruption, and </span></sp=
an><span
style=3D'mso-bookmark:_Hlk36070162'><span style=3D'mso-ansi-language:EN-US;
mso-fareast-language:JA;mso-bidi-font-weight:bold;mso-bidi-font-style:itali=
c'>in
almost all instances where dosing was interrupted for elevated transaminases
and subsequently resumed, ivacaftor dosing was able to be resumed successfu=
lly </span></span><span
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB style=3D'mso-fareast=
-language:
JA;mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>(see
section&nbsp;4.4). </span></span><span style=3D'mso-bookmark:_Hlk36070162'>=
<span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>Cases suggestiv=
e of
positive rechallenge were observed</span><span lang=3DEN-GB style=3D'mso-bi=
di-font-weight:
bold'>. In study&nbsp;7 </span></span><span style=3D'mso-bookmark:_Hlk36070=
162'><span
lang=3DEN-GB style=3D'mso-fareast-language:JA;mso-bidi-font-weight:bold;mso=
-bidi-font-style:
italic'>ivacaftor was permanently discontinued in one patient. </span><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>In study&nbsp;8 </span><sp=
an
lang=3DEN-GB>no patients had elevations in total bilirubin or discontinued
ivacaftor treatment due to transaminase elevations in either cohort (see
section&nbsp;4.4 for management of elevated transaminases).</span></span></=
p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk36070162'><b><span lan=
g=3DEN-GB><o:p>&nbsp;</o:p></span></b></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:12.0pt'><span style=3D'mso-book=
mark:_Hlk36070162'><b><span
lang=3DEN-GB>Table&nbsp;5: Transaminase elevations in patients 4&nbsp;month=
s to
&lt; 12&nbsp;years treated with ivacaftor as monotherapy<o:p></o:p></span><=
/b></span></p>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'margin-left:6.85pt;border-collapse:collapse;border:none;mso-borde=
r-alt:
 solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in =
5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:28.95pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:2=
8.95pt'><span
  style=3D'mso-bookmark:_Hlk36070162'></span>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk36070162'><b><span
  lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:28.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><b><span lang=3DEN-GB>n<o:p></o:p></s=
pan></b></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:28.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><b><span lang=3DEN-GB>% of Patients &=
gt; 3 x ULN
  <o:p></o:p></span></b></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:28.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><b><span lang=3DEN-GB>% of Patients &=
gt;5 x
  ULN<o:p></o:p></span></b></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:28.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><b><span lang=3DEN-GB>% of Patients &=
gt; 8 x ULN<o:p></o:p></span></b></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:1;height:14.35pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.35pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk36070162'><span lang=
=3DEN-GB>6
  to &lt;12 years</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>40</span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>15.0% (6)</span></=
span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>2.5% (1)</span></s=
pan></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>2.5% (1)</span></s=
pan></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:14.35pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.35pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk36070162'><span lang=
=3DEN-GB>2
  to &lt;6 years</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>34</span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>14.7% (5)</span></=
span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>14.7% (5)</span></=
span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>14.7% (5)</span></=
span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:14.35pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.35pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk36070162'><span lang=
=3DEN-GB>12
  to &lt;24 months</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>18</span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>27.8% (5)</span></=
span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>11.1% (2)</span></=
span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>11.1% (2)</span></=
span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:13.7pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.7pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk36070162'><span lang=
=3DEN-GB>6
  to &lt;12 months</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>11</span></span></=
p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>9.1% (1)</span></s=
pan></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>0.0% (0)</span></s=
pan></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>0.0% (0)</span></s=
pan></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
 </tr>
 <tr style=3D'mso-yfti-irow:5;mso-yfti-lastrow:yes;height:13.7pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.7pt'>
  <p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk36070162'><span lang=
=3DEN-GB>4
  to &lt;6 months</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>6</span></span></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>0.0% (0)</span></s=
pan></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>0.0% (0)</span></s=
pan></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span
  style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>0.0% (0)</span></s=
pan></p>
  </td>
  <span style=3D'mso-bookmark:_Hlk36070162'></span>
 </tr>
</table>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
_Hlk36070162'><u><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o=
:p></u></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><u><span lang=3DEN-GB>Reporting of susp=
ected
adverse reactions<o:p></o:p></span></u></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><u><span lang=3DEN-GB><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB>Reporting suspected =
adverse
reactions after authorisation of the medicinal product is important. It all=
ows
continued monitoring of the benefit/risk balance of the medicinal product.
Healthcare professionals are asked to report any suspected adverse reactions
via <span style=3D'background:lightgrey;mso-highlight:lightgrey'>the nation=
al
reporting system listed in </span></span></span><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB style=3D'color:windo=
wtext;
background:lightgrey;mso-highlight:lightgrey'>Appendix V</span></span><span
style=3D'mso-bookmark:_Hlk36070162'></span></a><span style=3D'mso-bookmark:=
_Hlk36070162'><span
lang=3DEN-GB>.</span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk36070162'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<h2 style=3D'margin:0in'><span style=3D'mso-bookmark:_Hlk36070162'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:12.0pt'>4.9<span
style=3D'mso-tab-count:1'> </span>Overdose</span></span></h2>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip'><span style=3D'mso-bookmark:_Hlk36070162'><span lang=3DEN-GB><o:p>&nb=
sp;</o:p></span></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
_Hlk36070162'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-languag=
e:EN-GB'>No
specific antidote is available for overdose with ivacaftor. Treatment of
overdose consists of general supportive measures including monitoring of vi=
tal
signs, liver function tests and observation of the clinical status of the
patient.<o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk36070162'></span>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span><=
/p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>5.<span style=3D'mso-tab-count:1'> </span=
>PHARMACOLOGICAL
PROPERTIES</span></h1>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.5pt;text-indent:-28.5pt;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2;mso-list:l31 level2 lfo8;tab-stops:list 28.5pt'><![if !=
supportLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'><span
style=3D'mso-list:Ignore'>5.1<span style=3D'font:7.0pt "Times New Roman"'>&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>Pharmacodynamic
properties<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Pharmacotherapeutic group: Other respiratory system products, =
ATC
code: </span><span lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho=
";
mso-fareast-language:JA;mso-bidi-font-weight:bold'>R07AX02</span><i><span
lang=3DEN-GB><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip'><u><span lang=3DEN-GB>Mechanism of action<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip'><u><span lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp=
;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Ivacaftor is a potentiator=
 of the
CFTR protein, i.e., <i style=3D'mso-bidi-font-style:normal'>in&nbsp;vitro</=
i>
ivacaftor increases CFTR channel gating to enhance chloride transport in
specified gating mutations (as listed in section&nbsp;4.1) with reduced cha=
nnel&#8209;open
probability <span style=3D'mso-bidi-font-style:italic'>compared to normal C=
FTR.
Ivacaftor also potentiated the channel&#8209;open probability of R117H&#820=
9;CFTR,
which has both low channel&#8209;open probability (gating) and reduced chan=
nel
current amplitude (conductance)</span>. The <i style=3D'mso-bidi-font-style=
:normal'>G970R
</i>mutation causes a splicing defect resulting in little-to-no CFTR protei=
n at
the cell surface which may explain the results observed in subjects with th=
is
mutation in study&nbsp;5 (see Pharmacodynamic effects and Clinical efficacy
data).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>In&nbsp;vitr=
o</span></i><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'> responses seen in single =
channel
patch clamp experiments using membrane patches from rodent cells expressing
mutant CFTR forms do not necessarily correspond to <i style=3D'mso-bidi-fon=
t-style:
normal'>in&nbsp;vivo </i>pharmacodynamic response (e.g., sweat chloride) or
clinical benefit. </span><span lang=3DEN-GB>The exact mechanism leading iva=
caftor
to potentiate the gating activity of normal and some mutant CFTR forms in t=
his
system has not been completely elucidated.<span style=3D'mso-bidi-font-weig=
ht:
bold'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Pharmacodynamic effects<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
style=3D'mso-ansi-language:EN-US'><o:p><span style=3D'text-decoration:none'=
>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'>Ivacaftor as monotherapy<o:p></o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>In studies 1 and 2 in pa=
tients
with the <i style=3D'mso-bidi-font-style:normal'>G551D </i>mutation in one =
allele
of the <i style=3D'mso-bidi-font-style:normal'>CFTR</i> gene, ivacaftor led=
 to
rapid (15 days), substantial (the mean change in sweat chloride from baseli=
ne
through week&nbsp;24 was &#8209;48&nbsp;mmol/L [95% CI &#8209;51, &#8209;45]
and &#8209;54 mmol/L [95% CI &#8209;62, &#8209;47], respectively) and susta=
ined
(through 48 weeks) reductions in sweat chloride concentration.<o:p></o:p></=
span></p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>In study&nbsp;5, part 1 =
in
patients who had a non&#8209;<i style=3D'mso-bidi-font-style:normal'>G551D<=
/i>
gating mutation in the <i style=3D'mso-bidi-font-style:normal'>CFTR</i> gen=
e,
treatment with ivacaftor led to a rapid (15 days) and substantial mean chan=
ge
from baseline in sweat chloride of &#8209;49&nbsp;mmol/L (95%&nbsp;CI &#820=
9;57,
&#8209;41) through 8 weeks of treatment. However, in patients with the <i
style=3D'mso-bidi-font-style:normal'>G970R</i>&#8209;<i style=3D'mso-bidi-f=
ont-style:
normal'>CFTR</i> mutation, the mean (SD) absolute change in sweat chloride =
at week&nbsp;8
was &#8209;6.25 (6.55)&nbsp;mmol/L. Similar results to part 1 were seen in =
part
2 of the study. </span><span style=3D'font-size:11.0pt'>At the 4&#8209;week
follow&#8209;up visit (4&nbsp;weeks after dosing with ivacaftor ended), mean
sweat chloride values for each group were trending to pre&#8209;treatment
levels.</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-languag=
e:EN-GB'><o:p></o:p></span></p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>In study&nbsp;6 in patie=
nts
aged 6&nbsp;years or older with CF who had an <i style=3D'mso-bidi-font-sty=
le:
normal'>R117H</i> mutation in the <i style=3D'mso-bidi-font-style:normal'>C=
FTR</i>
gene, the treatment difference in mean change in sweat chloride from baseli=
ne
through 24&nbsp;weeks of treatment was &#8209;24&nbsp;mmol/L (95%&nbsp;CI &=
#8209;28,
&#8209;20). In subgroup analyses by age, the treatment difference was -21.87
mmol/L (95% CI: -26.46, -17.28) in patients aged 18&nbsp;years or older, and
-27.63 mmol/L (95% CI: -37.16, -18.10) in patients aged 6-11&nbsp;years. </=
span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:12.0pt;mso-ansi-l=
anguage:
EN-GB'>Two patients 12 to 17</span><span lang=3DEN-GB style=3D'font-size:11=
.0pt;
mso-ansi-language:EN-GB'>&nbsp;</span><span lang=3DEN-GB style=3D'font-size=
:11.0pt;
mso-bidi-font-size:12.0pt;mso-ansi-language:EN-GB'>years of age were enroll=
ed
in this study.<o:p></o:p></span></p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Ivacaftor in a comb=
ination
regimen with tezacaftor/ivacaftor<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><br>
</span></i><span lang=3DEN-GB>In patients homozygous for the <i>F508del </i=
>mutation,
the treatment difference between ivacaftor in combination with
tezacaftor/ivacaftor and placebo in mean absolute change from baseline in s=
weat
chloride through week 24, was &#8209;10.1&nbsp;mmol/L (95%&nbsp;CI: &#8209;=
11.4,
&#8209;8.8<span style=3D'color:black'>).<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>In pat=
ients
heterozygous for the <i>F508del </i>mutation and a second mutation associat=
ed
with residual <span style=3D'mso-bidi-font-style:italic'>CFTR<i> </i></span=
>activity,
the treatment difference in mean absolute change from baseline in sweat
chloride through week&nbsp;8 was &#8209;9.5&nbsp;mmol/L (95%&nbsp;CI: &#820=
9;11.7,
&#8209;7.3) between tezacaftor/ivacaftor and placebo, and &#8209;4.5&nbsp;m=
mol/L
(95%&nbsp;CI: &#8209;6.7, &#8209;2.3) between ivacaftor and placebo.</span>=
</p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in;page-break-after:avoid'>=
<i><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Ivacaftor i=
n a
combination regimen with ivacaftor/tezacaftor/elexacaftor<o:p></o:p></span>=
</i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in'><i><span lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri'><o:p>=
&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in'><span lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri'>In patie=
nts with
an <i style=3D'mso-bidi-font-style:normal'>F508del</i> mutation on one alle=
le and
a mutation on the second allele that results in either no CFTR protein or a
CFTR protein that is not responsive to ivacaftor and tezacaftor/ivacaftor, =
the
treatment difference between ivacaftor/tezacaftor/elexacaftor and placebo f=
or
mean absolute change in sweat chloride from baseline through week 24 was &#=
8209;41.8
mmol/L (95%&nbsp;CI: -44.4, -39.3).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;mso-layout-grid-align:none;tex=
t-autospace:
none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'tab-stops:.5in;mso-layout-grid-align:none;tex=
t-autospace:
none'><span lang=3DEN-GB>In patients homozygous for the <i style=3D'mso-bid=
i-font-style:
normal'>F508del </i>mutation, the treatment difference between ivacaftor/te=
zacaftor/elexacaftor
and tezacaftor/ivacaftor for mean absolute change in sweat chloride from
baseline at week 4 was &#8209;45.1 mmol/L (95% CI: -50.1, -40.1).</span></p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in;page-break-after:avoid'>=
<u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Clinical ef=
ficacy
and safety<o:p></o:p></span></u></p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in;page-break-after:avoid'>=
<i
style=3D'mso-bidi-font-style:normal'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></i></p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in;page-break-after:avoid'>=
<i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-ansi-language:EN-GB'>Ivacaftor as monotherapy<o:p></o:p></span></i></p>

<p class=3Ddocumenttext style=3D'margin-bottom:0in;page-break-after:avoid'>=
<i
style=3D'mso-bidi-font-style:normal'><span style=3D'font-size:11.0pt'><o:p>=
&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB>Study&nbsp;1 and=
 2:
studies in patients with CF with G551D gating mutations<o:p></o:p></span></=
u></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3Dlabeltext style=3D'margin-right:-1.85pt;page-break-after:avoid'>=
<span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>The efficac=
y of ivacaftor
has been evaluated in two phase&nbsp;3 randomised, double&#8209;blind, plac=
ebo&#8209;controlled,
multi&#8209;centre studies of clinically stable patients with CF who had th=
e <i>G551D</i>
mutation in the <i style=3D'mso-bidi-font-style:normal'>CFTR</i> gene on at=
 least
1&nbsp;allele and had FEV<sub>1</sub> &#8805;&nbsp;40% predicted.<o:p></o:p=
></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>Patients in both studies were randomised 1:1 to receive either
150&nbsp;mg of ivacaftor or placebo every 12&nbsp;hours with food containing
fat for 48&nbsp;weeks in addition to their prescribed CF therapies (e.g.,
tobramycin, dornase alfa). The use of inhaled hypertonic sodium chloride was
not permitted.<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>Study&nbsp;1 evaluated 161&nbsp;patients who were 12&nbsp;years of a=
ge
or older; 122 (75.8%) patients had the <i style=3D'mso-bidi-font-style:norm=
al'>F508del</i>
mutation in the second allele. At the start of the study, patients in the
placebo group used some medicinal products at a higher frequency than the
ivacaftor group. These medications included dornase alfa (73.1% versus 65.1=
%),
salbutamol (53.8% versus 42.2%), tobramycin (44.9% versus 33.7%) and
salmeterol/fluticasone (41.0% versus 27.7%). At baseline, mean predicted FE=
V<sub>1</sub>
was 63.6% (range: 31.6% to 98.2%) and mean age was 26&nbsp;years (range:
12&nbsp;to 53&nbsp;years).<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>Study&nbsp;2 evaluated 52&nbsp;patients who were 6&nbsp;to 11&nbsp;y=
ears
of age at screening; mean (SD) body weight was 30.9 (8.63) kg; 42 (80.8%)
patients had the <i style=3D'mso-bidi-font-style:normal'>F508del</i> mutati=
on in
the second allele. At baseline, mean predicted FEV<sub>1</sub> was 84.2%
(range: 44.0% to 133.8%) and mean age was 9&nbsp;years (range: 6 to 12&nbsp=
;years);
8&nbsp;(30.8%) patients in the placebo group and 4&nbsp;(15.4%) patients in=
 the
ivacaftor group had an FEV<sub>1</sub> less than 70% predicted at baseline.=
<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>The primary efficacy endpoint in both studies was the mean absolute
change from baseline in percent predicted FEV<sub>1</sub> through 24&nbsp;w=
eeks
of treatment.<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>The treatment difference between ivacaftor and placebo for the mean
absolute change (95% CI) in percent predicted FEV<sub>1</sub> from baseline
through week&nbsp;24 was 10.6&nbsp;percentage points (8.6, 12.6) in study 1=
 and
12.5&nbsp;percentage points (6.6, 18.3) in study&nbsp;2. The treatment
difference between ivacaftor and placebo for the mean relative change (95% =
CI)
in percent predicted FEV<sub>1</sub> from baseline through week&nbsp;24 was
17.1% (13.9, 20.2) in study&nbsp;1 and 15.8% (8.4, 23.2) in study&nbsp;2. T=
he
mean change from baseline through week&nbsp;24 in FEV<sub>1</sub> (L) was
0.37&nbsp;L in the ivacaftor group and 0.01&nbsp;L in the placebo group in =
study&nbsp;1
and 0.30&nbsp;L in the ivacaftor group and 0.07&nbsp;L in the placebo group=
 in study&nbsp;2.
In both studies, improvements in FEV<sub>1</sub> were rapid in onset (day&n=
bsp;15)
and durable through 48&nbsp;weeks.<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>The treatment difference between ivacaftor and placebo for the mean
absolute change (95% CI) in percent predicted FEV<sub>1</sub> from baseline
through week&nbsp;24 in patients 12 to 17&nbsp;years of age in study&nbsp;1=
 was
11.9 percentage points (5.9, 17.9). The treatment difference between ivacaf=
tor
and placebo for the mean absolute change (95% CI) in percent predicted FEV<=
sub>1</sub>
from baseline through week&nbsp;24 in patients with baseline predicted FEV<=
sub>1
</sub>greater than 90% in study&nbsp;2 was 6.9&nbsp;percentage points (&#82=
09;3.8,
17.6).<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>The results for clinically relevant secondary endpoints are shown in
Table&nbsp;6.<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-=
font-size:
10.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'margin-bottom:6.0pt;page-break-after:avoid'><=
b><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Table&nbsp;=
6:
Effect of ivacaftor on other efficacy endpoints in studies 1 and 2<o:p></o:=
p></span></b></p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"98%"
 style=3D'width:98.82%;margin-left:5.45pt;border-collapse:collapse;mso-yfti=
-tbllook:
 480;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <thead>
  <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:10.5pt'>
   <td width=3D"27%" rowspan=3D2 valign=3Dbottom style=3D'width:27.12%;bord=
er:solid windowtext 1.0pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   10.5pt'>
   <p class=3DMsoNormal style=3D'margin-left:55.0pt;line-height:normal;page=
-break-after:
   avoid;tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso-fareast-languag=
e:EN-GB'>Endpoint<o:p></o:p></span></b></p>
   </td>
   <td width=3D"34%" colspan=3D2 valign=3Dtop style=3D'width:34.82%;border:=
solid windowtext 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:10.5pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   page-break-after:avoid;tab-stops:.5in'><b><span lang=3DEN-GB>Study&nbsp;=
1</span></b><b><span
   lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></b>=
</p>
   </td>
   <td width=3D"38%" colspan=3D2 valign=3Dtop style=3D'width:38.06%;border:=
solid windowtext 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:10.5pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   page-break-after:avoid;tab-stops:.5in'><b><span lang=3DEN-GB>Study&nbsp;=
2</span></b><b><span
   lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></b>=
</p>
   </td>
  </tr>
  <tr style=3D'mso-yfti-irow:1;height:28.25pt'>
   <td width=3D"20%" valign=3Dbottom style=3D'width:20.18%;border-top:none;
   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid=
 windowtext 1.0pt;
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windo=
wtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   28.25pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso-fareast-language:EN-G=
B'>Treatment
   difference<sup>a</sup><o:p></o:p></span></b></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso-fareast-language:EN-G=
B'>(95%&nbsp;CI)<o:p></o:p></span></b></p>
   </td>
   <td width=3D"14%" valign=3Dbottom style=3D'width:14.64%;border:solid win=
dowtext 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:28.25pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   tab-stops:.5in'><b><i><span lang=3DEN-GB>P </span></i><span lang=3DEN-GB
   style=3D'mso-bidi-font-style:italic'>value</span></b><b><span lang=3DEN-=
GB
   style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></b></p>
   </td>
   <td width=3D"20%" valign=3Dbottom style=3D'width:20.18%;border-top:none;
   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid=
 windowtext 1.0pt;
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windo=
wtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   28.25pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso-fareast-language:EN-G=
B'>Treatment
   difference<sup>a</sup><o:p></o:p></span></b></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso-fareast-language:EN-G=
B'>(95%&nbsp;CI)<o:p></o:p></span></b></p>
   </td>
   <td width=3D"17%" valign=3Dbottom style=3D'width:17.88%;border-top:none;
   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid=
 windowtext 1.0pt;
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windo=
wtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   28.25pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   page-break-after:avoid;tab-stops:.5in'><b><i><span lang=3DEN-GB>P </span=
></i><span
   lang=3DEN-GB style=3D'mso-bidi-font-style:italic'>value</span></b><b><sp=
an
   lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></b>=
</p>
   </td>
  </tr>
 </thead>
 <tr style=3D'mso-yfti-irow:2;height:10.5pt'>
  <td width=3D"100%" colspan=3D5 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bott=
om-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:10.5pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b><span lang=3DEN-GB>Mean absolute change from baseline =
in
  CFQ-R</span></b><sup><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bol=
d'>b</span></sup><b><span
  lang=3DEN-GB> respiratory domain score (points)</span></b><sup><span
  lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>c</span></sup><b><i><span
  lang=3DEN-GB><o:p></o:p></span></i></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>Through week 24<o:p></o=
:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>8=
.1<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
4.7,
  11.4)<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>&=
lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>6=
.1<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
&#8209;1.4,
  13.5)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.1092<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:18.85pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>Through week 48</span><=
/p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>8.6</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>(5.3, 11.9)</span><span lang=3DEN-GB
  style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>&=
lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>5=
.1<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
&#8209;1.6,
  11.8)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.1354<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;height:9.95pt'>
  <td width=3D"100%" colspan=3D5 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:9.95pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b><span lang=3DEN-GB>Relative risk of pulmonary exacerba=
tion</span></b><b><span
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></b><=
/p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;height:10.5pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:10.5pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>T=
hrough week
  24<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.5pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB>0.40</span><sup=
><span
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>d</span></sup><span lan=
g=3DEN-GB
  style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.5pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB>0.0016</span><s=
pan
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.5pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>NA<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.5pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>NA<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;height:9.95pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:9.95pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>T=
hrough week
  48</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:9=
.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.46<sup>d</sup><o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:9=
.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0012<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:9=
.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>NA<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:9=
.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>NA<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;height:10.5pt'>
  <td width=3D"100%" colspan=3D5 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:10.5pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b><span lang=3DEN-GB>Mean absolute change from baseline =
in
  body weight (kg)</span></b><b><span lang=3DEN-GB style=3D'mso-fareast-lan=
guage:
  EN-GB'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;height:18.85pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB>At&nbsp;week 24</span><span lang=3DEN-GB style=3D'mso-fareas=
t-language:
  EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>2.8</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>(1.8, 3.7)</span><span lang=3DEN-GB
  style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>&lt;&nbsp;0.0001</span><span lang=3DEN=
-GB
  style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>1.9</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
0.9,
  2.9)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0004<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB>At&nbsp;week 48</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:35.75pt'><span lang=3DEN-GB>2.7</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>(1.3, 4.1)</span><span lang=3DEN-GB
  style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>0=
.0001<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:32.7pt'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'=
>2.8<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
1.3,
  4.2)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0002<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;height:15.5pt'>
  <td width=3D"100%" colspan=3D5 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bott=
om-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:15.5pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-=
GB
  style=3D'mso-fareast-language:EN-GB'>Mean absolute change from baseline i=
n BMI (kg/m<sup>2</sup>)<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB>At week 24</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:35.2pt'><span lang=3DEN-GB>0.94</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:34.05pt'><span lang=3DEN-GB>(0.62, 1.26)</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>&=
lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>0=
.81<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
0.34,
  1.28)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0008<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB>At week 48</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>0.93</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>(0.48, 1.38)</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>&=
lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>1=
.09<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
0.51,
  1.67)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0003<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;height:15.05pt'>
  <td width=3D"100%" colspan=3D5 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bott=
om-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:15.05pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-=
GB
  style=3D'mso-fareast-language:EN-GB'>Mean change from baseline in z&#8209=
;scores</span></b><span
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:15;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB>Weight&#8209;for&#8209;age z&#8209;score at week 48<sup>e</s=
up></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>0.33</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>(0.04, 0.62)</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>0=
.0260<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>0=
.39<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
0.24, 0.53)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>&lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:16;mso-yfti-lastrow:yes;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>BMI&#8209;for&#8209;age z&#8209;score =
at week
  48<sup>e</sup></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB>0.33</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB>(0.002, 0.65)</=
span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0490<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.45<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>(0.26, 0.65)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>&lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3Dtablefootnote style=3D'margin-top:6.0pt;page-break-after:avoid'>=
<span
lang=3DEN-GB style=3D'font-size:9.0pt;mso-ansi-language:EN-GB'>CI: confiden=
ce
interval; NA: not analysed due to low incidence of events<o:p></o:p></span>=
</p>

<p class=3Dtablefootnote style=3D'margin-left:.2in;text-indent:-.2in;page-b=
reak-after:
avoid'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt;mso-ansi-language:E=
N-GB'>a</span></sup><span
lang=3DEN-GB style=3D'font-size:9.0pt;mso-ansi-language:EN-GB'><span
style=3D'mso-tab-count:1'> </span>Treatment difference =3D effect of iv=
acaftor
 effect of placebo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt;
mso-fareast-language:JA'>b</span></sup><span lang=3DEN-GB style=3D'font-siz=
e:9.0pt;
mso-fareast-language:JA'><span style=3D'mso-tab-count:1'> </span>CFQ&#8=
209;R:
Cystic Fibrosis Questionnaire&#8209;Revised is a disease&#8209;specific, he=
alth&#8209;related
quality&#8209;of&#8209;life measure for CF.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt;
mso-fareast-language:JA'>c</span></sup><span lang=3DEN-GB style=3D'font-siz=
e:9.0pt;
mso-fareast-language:JA'><span style=3D'mso-tab-count:1'> </span>Study&=
nbsp;1
data were pooled from CFQ&#8209;R for adults/adolescents and CFQ&#8209;R for
children 12 to 13&nbsp;years of age; Study&nbsp;2 data were obtained from C=
FQ&#8209;R
for children 6 to 11&nbsp;years of age.<o:p></o:p></span></p>

<p class=3Dtabletextcenterjustified align=3Dleft style=3D'margin-top:0in;ma=
rgin-right:
0in;margin-bottom:0in;margin-left:.2in;text-align:left;text-indent:-.2in;
page-break-after:avoid'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt;
mso-ansi-language:EN-GB'>d</span></sup><span lang=3DEN-GB style=3D'font-siz=
e:9.0pt;
mso-ansi-language:EN-GB'><span style=3D'mso-tab-count:1'> </span>Hazard=
 ratio
for time to first pulmonary exacerbation<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid;tab-stops:.5in'><sup><span lang=3DEN-GB style=3D'fon=
t-size:
9.0pt'>e</span></sup><span lang=3DEN-GB style=3D'font-size:9.0pt'><span
style=3D'mso-tab-count:1'> </span>In subjects under 20&nbsp;years of ag=
e (CDC
growth charts)<u><o:p></o:p></u></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB>Study&nbsp;5: st=
udy in
patients with CF with non&#8209;G551D gating mutations<o:p></o:p></span></u=
></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Study&nbsp;5 was a phase&nbsp;3, two&#8209;part, randomised, d=
ouble&#8209;blind,
placebo&#8209;controlled, crossover study (part&nbsp;1) followed by a 16&#8=
209;week
open&#8209;label extension period (part&nbsp;2) to evaluate the efficacy and
safety of ivacaftor in patients with CF aged 6&nbsp;years and older who hav=
e a <i
style=3D'mso-bidi-font-style:normal'>G970R</i> or non&#8209;<i style=3D'mso=
-bidi-font-style:
normal'>G551D</i> gating mutation in the <i style=3D'mso-bidi-font-style:no=
rmal'>CFTR</i>
gene <span style=3D'mso-bidi-font-weight:bold'>(<i style=3D'mso-bidi-font-s=
tyle:
normal'>G178R</i>, <i style=3D'mso-bidi-font-style:normal'>S549N</i>, <i
style=3D'mso-bidi-font-style:normal'>S549R</i>, <i style=3D'mso-bidi-font-s=
tyle:
normal'>G551S</i>, <i style=3D'mso-bidi-font-style:normal'>G1244E</i>, <i
style=3D'mso-bidi-font-style:normal'>S1251N</i>, <i style=3D'mso-bidi-font-=
style:
normal'>S1255P</i> or <i style=3D'mso-bidi-font-style:normal'>G1349D</i>)</=
span>.<s><o:p></o:p></s></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>In part 1, patients were
randomised 1:1 to receive either 150&nbsp;mg of ivacaftor or placebo every
12&nbsp;hours with fat&#8209;containing food for 8&nbsp;weeks in addition t=
o their
prescribed CF therapies and crossed over to the other treatment for the sec=
ond
8&nbsp;weeks after a 4&#8209; to 8&#8209;week washout period. The use of
inhaled hypertonic saline was not permitted. In part 2, all patients receiv=
ed
ivacaftor as indicated in part 1 for 16 additional weeks. The duration of
continuous ivacaftor treatment was 24&nbsp;weeks for patients randomised to
part 1 placebo/ivacaftor treatment sequence and 16&nbsp;weeks for patients
randomised to part 1 ivacaftor/placebo treatment sequence.<o:p></o:p></span=
></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB;mso-bidi-font-weight:bold'>Thirty&#8209;nine patients (mean age 23&nb=
sp;years)
with baseline FEV<sub>1</sub></span><span lang=3DEN-GB style=3D'font-size:1=
1.0pt;
mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB'> </span><span lang=3DEN-=
GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-bidi-font-weight:bold=
'>&#8805;&nbsp;40%
predicted (mean FEV<sub>1</sub> 78% predicted [range: 43% to 119%]) were
enrolled. Sixty&#8209;two percent (24/39) of them carried the <i
style=3D'mso-bidi-font-style:normal'>F508del</i>&#8209;<i style=3D'mso-bidi=
-font-style:
normal'>CFTR</i> mutation in the second allele. </span><span style=3D'font-=
size:
11.0pt;mso-bidi-font-weight:bold'>A total of 36&nbsp;patients continued into
part 2 (18 per treatment sequence).<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold'>In part 1 of study&nbsp;5, the mean FEV=
<sub>1</sub>
percent predicted at baseline in placebo&#8209;treated patients was 79.3% w=
hile
in ivacaftor&#8209;treated patients this value was 76.4%. The mean overall =
post&#8209;baseline
value was 76.0% and 83.7%, respectively. <span style=3D'mso-bidi-font-style=
:italic'>The
mean absolute change from baseline through week</span></span><span lang=3DE=
N-GB>&nbsp;<span
style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>8 in percent
predicted FEV<sub>1</sub> (primary efficacy endpoint) was 7.5% in the ivaca=
ftor
period and &#8209;3.2% in the placebo period. The observed treatment differ=
ence
(95% CI) between ivacaftor and placebo was 10.7% (7.3, 14.1) </span>(P&nbsp=
;&lt;&nbsp;0.0001).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The ef=
fect of
ivacaftor in the overall population of study&nbsp;5 (including the secondary
endpoints absolute change in BMI<span style=3D'mso-bidi-font-style:italic'>=
 at 8&nbsp;weeks
of treatment and absolute change in the respiratory domain score of the CFQ=
&#8209;R
through 8&nbsp;weeks of treatment)</span> and by individual mutation (absol=
ute
change in sweat chloride and in percent predicted FEV<sub>1</sub> at week&n=
bsp;8)
is shown in Table&nbsp;7.<span style=3D'mso-bidi-font-style:italic'> </span=
>Based
on clinical (percent predicted FEV<sub>1</sub>) and pharmacodynamic (sweat
chloride) responses to ivacaftor, efficacy in patients with the <i
style=3D'mso-bidi-font-style:normal'>G970R</i> mutation could not be establ=
ished.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:6.0pt;
margin-left:40.5pt;text-indent:-40.5pt;line-height:normal;mso-pagination:wi=
dow-orphan lines-together;
page-break-after:avoid;tab-stops:.5in'><b style=3D'mso-bidi-font-weight:nor=
mal'><span
lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>Table&nbsp;7: Effect of iva=
caftor
for efficacy variables in the overall population and for specific <i
style=3D'mso-bidi-font-style:normal'>CFTR</i> mutations<o:p></o:p></span></=
b></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"98%"
 style=3D'width:98.84%;margin-left:5.35pt;border-collapse:collapse;border:n=
one;
 mso-border-alt:solid windowtext 1.0pt;mso-yfti-tbllook:1184;mso-padding-al=
t:
 0in 5.4pt 0in 5.4pt;mso-border-insideh:1.0pt solid windowtext;mso-border-i=
nsidev:
 1.0pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D"32%" colspan=3D2 valign=3Dtop style=3D'width:32.6%;border:so=
lid windowtext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  mso-pagination:widow-orphan lines-together;page-break-after:avoid'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  8.0pt'>Absolute change in percent predicted FEV<sub>1</sub></span></b></p>
  </td>
  <td width=3D"33%" colspan=3D2 valign=3Dtop style=3D'width:33.66%;border:s=
olid windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  mso-pagination:widow-orphan lines-together;page-break-after:avoid;mso-lay=
out-grid-align:
  none;text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>BMI<o:p></o:p></span></b>=
</p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  mso-pagination:widow-orphan lines-together;page-break-after:avoid;mso-lay=
out-grid-align:
  none;text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>(kg/m<sup>2</sup>)<o:p></=
o:p></span></b></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.66%;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  mso-pagination:widow-orphan lines-together;page-break-after:avoid'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  8.0pt'>CFQ-R respiratory domain score (points)</span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D"32%" colspan=3D2 valign=3Dtop style=3D'width:32.6%;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>Through week</span></b><s=
pan
  lang=3DEN-GB>&nbsp;</span><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>8</span></b></p>
  </td>
  <td width=3D"33%" colspan=3D2 valign=3Dtop style=3D'width:33.66%;border-t=
op:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>At week</span></b><span
  lang=3DEN-GB>&nbsp;</span><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>8</span></b></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.66%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>Through week</span></b><s=
pan
  lang=3DEN-GB>&nbsp;</span><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>8</span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D"99%" colspan=3D5 valign=3Dtop style=3D'width:99.92%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:8.0pt'>All patients (N&nbsp;=3D&nbsp;39)<o:p>=
</o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB
  style=3D'mso-bidi-font-size:8.0pt'>Results shown as mean (95% CI) change =
from
  baseline ivacaftor vs placebo&#8209;treated patients:<o:p></o:p></span></=
p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D"32%" colspan=3D2 valign=3Dtop style=3D'width:32.6%;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:8.=
0pt;
  mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>10.7 (7.3, 14.1)</s=
pan></p>
  </td>
  <td width=3D"33%" colspan=3D2 valign=3Dtop style=3D'width:33.66%;border-t=
op:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:8.=
0pt'>0.66
  (0.34, 0.99)</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.66%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-size:8.=
0pt'>9.6
  (4.5, 14.7)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:13.4pt'>
  <td width=3D"99%" colspan=3D5 valign=3Dtop style=3D'width:99.92%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  mso-layout-grid-align:none;text-autospace:none'><b><span lang=3DEN-GB>Pat=
ients
  grouped under mutation types (n)<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><span lang=3DEN-GB>Results shown as mean (minimum,
  maximum) change from baseline for ivacaftor&#8209;treated patients at wee=
k&nbsp;8<sup>*</sup>:</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;height:13.4pt'>
  <td width=3D"16%" rowspan=3D2 valign=3Dtop style=3D'width:16.04%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;mso-layout-grid-align:none;text-autospace:none'><b=
><span
  lang=3DEN-GB>Mutation (n)<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  mso-layout-grid-align:none;text-autospace:none'><b><span lang=3DEN-GB><o:=
p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D"41%" colspan=3D2 valign=3Dtop style=3D'width:41.9%;border-to=
p:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;mso-layout-grid-align:none;text-autospace:none'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Absolute change =
in sweat
  chloride (mmol/L)<o:p></o:p></span></b></p>
  </td>
  <td width=3D"41%" colspan=3D2 valign=3Dtop style=3D'width:41.98%;border-t=
op:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;mso-layout-grid-align:none;text-autospace:none'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Absolute change =
in
  percent predicted FEV<sub>1 </sub>(percentage points)<span style=3D'mso-b=
idi-font-weight:
  bold'><o:p></o:p></span></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;height:13.4pt'>
  <td width=3D"41%" colspan=3D2 valign=3Dtop style=3D'width:41.9%;border-to=
p:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;mso-layout-grid-align:none;text-autospace:none'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>At week</span></=
b><span
  lang=3DEN-GB>&nbsp;<b style=3D'mso-bidi-font-weight:normal'>8<o:p></o:p><=
/b></span></p>
  </td>
  <td width=3D"41%" colspan=3D2 valign=3Dtop style=3D'width:41.98%;border-t=
op:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;mso-layout-grid-align:none;text-autospace:none'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>At week</span></=
b><span
  lang=3DEN-GB>&nbsp;<b style=3D'mso-bidi-font-weight:normal'>8<span
  style=3D'mso-bidi-font-weight:bold'><o:p></o:p></span></b></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;mso-yfti-lastrow:yes;height:18.4pt'>
  <td width=3D"16%" valign=3Dtop style=3D'width:16.04%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;mso-layout-grid-align:none;text-autospace:none'><i
  style=3D'mso-bidi-font-style:normal'><span lang=3DPT style=3D'mso-ansi-la=
nguage:
  PT'>G1244E</span></i><span lang=3DPT style=3D'mso-ansi-language:PT'> (5)<=
o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DPT
  style=3D'mso-ansi-language:PT'>G1349D</span></i><span lang=3DPT style=3D'=
mso-ansi-language:
  PT'> (2)<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DPT
  style=3D'mso-ansi-language:PT'>G178R</span></i><span lang=3DPT style=3D'm=
so-ansi-language:
  PT'> (5)<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DPT
  style=3D'mso-ansi-language:PT'>G551S</span></i><span lang=3DPT style=3D'm=
so-ansi-language:
  PT'> (2)<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lan=
g=3DPT
  style=3D'mso-ansi-language:PT'>G970R<sup>#</sup></span></i><sup><span lan=
g=3DPT
  style=3D'mso-ansi-language:PT'> </span></sup><span lang=3DPT style=3D'mso=
-ansi-language:
  PT'>(4)<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><i><span lang=3DEN-GB>S1251N </span></i><span
  lang=3DEN-GB>(8)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><i><span lang=3DEN-GB>S1255P</span></i><span
  lang=3DEN-GB> (2)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><i><span lang=3DEN-GB>S549N</span></i><span lang=
=3DEN-GB>
  (6)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;mso-layout-grid-align:none;text-autospace:none'><i=
><span
  lang=3DEN-GB>S549R</span></i><span lang=3DEN-GB> (4)<b><o:p></o:p></b></s=
pan></p>
  </td>
  <td width=3D"41%" colspan=3D2 valign=3Dtop style=3D'width:41.9%;border-to=
p:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span style=3D'font-family:"MS Mincho";mso-bidi-f=
ont-family:
  "MS Mincho"'>&#8209;</span><span lang=3DEN-GB>55 (-75, -34)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>-80 (-82, -79)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>-53 (-65, -35)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>-68<sup><span style=3D'positio=
n:relative;
  top:-3.0pt;mso-text-raise:3.0pt'></span></sup></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>-6 (-16, -2)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>-54 (-84, -7)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>-78 (-82, -74)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>-74 (-93, -53)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>-61<sup><span style=3D'positio=
n:relative;
  top:-3.0pt;mso-text-raise:3.0pt'></span></sup><span
  style=3D'mso-spacerun:yes'></span>(-71, -54)</span></p>
  </td>
  <td width=3D"41%" colspan=3D2 valign=3Dtop style=3D'width:41.98%;border-t=
op:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>8 (-1, 18)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>20 (3, 36)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>8 (-1, 18)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>3<sup><span style=3D'position:=
relative;
  top:-3.0pt;mso-text-raise:3.0pt'></span></sup></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>3 (-1, 5)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>9 (-20, 21)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>3 (-1, 8)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>11 (-2, 20)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><span lang=3DEN-GB>5 (-3, 13)<b style=3D'mso-bidi=
-font-weight:
  normal'><o:p></o:p></b></span></p>
  </td>
 </tr>
 <![if !supportMisalignedColumns]>
 <tr height=3D0>
  <td width=3D112 style=3D'border:none'></td>
  <td width=3D116 style=3D'border:none'></td>
  <td width=3D177 style=3D'border:none'></td>
  <td width=3D58 style=3D'border:none'></td>
  <td width=3D235 style=3D'border:none'></td>
 </tr>
 <![endif]>
</table>

<p class=3DMsoNormal style=3D'margin-top:6.0pt;margin-right:0in;margin-bott=
om:0in;
margin-left:.2in;margin-bottom:.0001pt;text-indent:-.2in;line-height:normal;
page-break-after:avoid;tab-stops:.5in'><sup><span lang=3DEN-GB style=3D'fon=
t-size:
9.0pt;mso-bidi-font-weight:bold'>*</span></sup><span lang=3DEN-GB
style=3D'font-size:9.0pt;mso-bidi-font-weight:bold'><span style=3D'mso-tab-=
count:
1'> </span>Statistical testing was not performed due to small numbers f=
or
individual mutations.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid;tab-stops:.5in'><sup><span lang=3DEN-GB style=3D'fon=
t-size:
9.0pt;mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'></span>=
</sup><span
lang=3DEN-GB style=3D'font-size:9.0pt;mso-fareast-font-family:"MS Mincho";
mso-fareast-language:JA'><span style=3D'mso-tab-count:1'> </span>Reflec=
ts
results from the one patient with the <i>G551S</i> mutation with data at th=
e 8&#8209;week
time point.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid;tab-stops:.5in'><sup><span lang=3DEN-GB style=3D'fon=
t-size:
9.0pt;mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'></span=
></sup><span
lang=3DEN-GB style=3D'font-size:9.0pt;mso-fareast-font-family:"MS Mincho";
mso-fareast-language:JA'><span style=3D'mso-tab-count:1'> </span>n&nbsp;=
=3D&nbsp;3
for the analysis of absolute change in sweat chloride.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid;tab-stops:.5in'><sup><span lang=3DEN-GB style=3D'fon=
t-size:
9.0pt'>#</span></sup><span lang=3DEN-GB style=3D'font-size:9.0pt'><span
style=3D'mso-tab-count:1'> </span>Causes a splicing defect resulting in
little-to-no CFTR protein at the cell surface<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>In par=
t 2 of study&nbsp;5,
the mean (SD) absolute change in percent predicted FEV<sub>1</sub> followin=
g 16&nbsp;weeks
(patients randomised to the ivacaftor/placebo treatment sequence in part 1)=
 of
continuous ivacaftor treatment was 10.4% (13.2%). At the follow&#8209;up vi=
sit,
4&nbsp;weeks after ivacaftor dosing had ended, the mean (SD) absolute chang=
e in
percent predicted FEV<sub>1 </sub>from<sub> </sub>part 2 week 16 was &#8209=
;5.9%
(9.4%). For patients randomised to the placebo/ivacaftor treatment sequence=
 in
part 1 there was a further mean (SD) change of 3.3% (9.3%) in percent predi=
cted
FEV<sub>1</sub> after the additional 16&nbsp;weeks of treatment with ivacaf=
tor.
At the follow up visit, 4&nbsp;weeks after ivacaftor dosing had ended, the =
mean
(SD) absolute change in percent predicted FEV<sub>1</sub> from part 2 week =
16
was &#8209;7.4% (5.5%).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:=
10.0pt;
mso-ansi-language:EN-GB'>Study&nbsp;3: study in patients with CF with the
F508del mutation in the CFTR gene<o:p></o:p></span></u></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:=
10.0pt;
mso-ansi-language:EN-GB'><o:p><span style=3D'text-decoration:none'>&nbsp;</=
span></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Study&nbsp;3 (part A) was a 16&#8209;week, 4:1 randomised, dou=
ble&#8209;blind,
placebo&#8209;controlled, parallel&#8209;group phase&nbsp;2 study of ivacaf=
tor
(150&nbsp;mg every 12&nbsp;hours) in 140&nbsp;patients with CF age
12&nbsp;years and older who were homozygous for the <i>F508del</i> mutation=
 in
the <i>CFTR</i> gene and who had FEV<sub>1</sub>&nbsp;&#8805;&nbsp;40%
predicted.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The me=
an
absolute change from baseline through week&nbsp;16 in percent predicted FEV=
<sub>1</sub>
(primary efficacy endpoint) was 1.5&nbsp;percentage points in the ivacaftor
group and &#8209;0.2 percentage points in the placebo group. The estimated
treatment difference for ivacaftor versus placebo was 1.7&nbsp;percentage p=
oints
(95%&nbsp;CI&nbsp;&#8209;0.6, 4.1); this difference was not statistically
significant (P<span style=3D'mso-bidi-font-style:italic'>&nbsp;</span>=3D&n=
bsp;0.15).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho"'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB>Study&nbsp;4: op=
en&#8209;label
extension study<o:p></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-fareast-language:JA'>In study&nbsp;4 patients who
completed treatment in studies 1 and 2 with placebo were switched to ivacaf=
tor
while patients on ivacaftor continued to receive it for a minimum of 96&nbs=
p;weeks,
i.e., the length of treatment with ivacaftor was at least 96 weeks for pati=
ents
in the placebo/ivacaftor group and at least 144&nbsp;weeks for patients in =
the
ivacaftor/ivacaftor group.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>One h=
undred
and forty&#8209;four (144) patients from study&nbsp;1 were rolled over in s=
tudy&nbsp;4,
67 in the placebo/ivacaftor group and 77 in the ivacaftor/ivacaftor group.
Forty&#8209;eight (48) patients from study&nbsp;2 were rolled over in study=
&nbsp;4,
22 in the placebo/ivacaftor group and 26 in the ivacaftor/ivacaftor group.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Table&=
nbsp;8 shows
the results of the mean (SD) absolute change in percent predicted FEV<sub>1=
</sub>
for both groups of patients. For patients in the placebo/ivacaftor group
baseline percent predicted FEV<sub>1</sub> is that of study&nbsp;4 while for
patients in the ivacaftor/ivacaftor group the baseline value is that of stu=
dies
1 and 2.</span><span lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Minc=
ho";
mso-fareast-language:JA'><o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-farea=
st-font-family:
"MS Mincho";mso-ansi-language:EN-GB;mso-fareast-language:JA'><o:p>&nbsp;</o=
:p></span></p>

<p class=3Dlabeltext style=3D'margin-bottom:6.0pt;page-break-after:avoid'><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:11.0pt'>Tabl=
e&nbsp;8:
Effect of ivacaftor on percent predicted FEV</span></b><sub>1</sub><b
style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:11.0pt'> in =
study&nbsp;4<o:p></o:p></span></b></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'margin-left:.05in;border-collapse:collapse;border:none;mso-border=
-alt:
 solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in =
5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.94%;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Original study a=
nd
  treatment group</span></b><span lang=3DEN-GB style=3D'mso-fareast-font-fa=
mily:
  "MS Mincho";mso-fareast-language:JA'><o:p></o:p></span></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.62%;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>Duration of ivacaftor treatment (weeks)</span></b><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-lan=
guage:
  JA'><o:p></o:p></span></p>
  </td>
  <td width=3D"46%" colspan=3D2 valign=3Dtop style=3D'width:46.44%;border:s=
olid windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>Absolute change from baseline in percent predicted FEV<sub>1=
 </sub>(percentage
  points)</span></b><span lang=3DEN-GB style=3D'mso-fareast-font-family:"MS=
 Mincho";
  mso-fareast-language:JA'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.94%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.62%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p=
></span></b></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.84%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>N<o:p></o:p></sp=
an></b></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.6%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
  lang=3DEN-GB>Mean (SD)<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D"100%" colspan=3D4 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB>Study&nbsp;1<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.94%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Ivacaftor<o:p></=
o:p></span></b></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.62%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>48<sup>*</sup></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.84%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>77</span></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.6%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>9.4 (8.3)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.94%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.62%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>144</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.84%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>72</span></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.6%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>9.4 (10.8)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.94%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Placebo<o:p></o:=
p></span></b></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.62%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>0<sup>*</sup></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.84%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>67</span></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.6%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>&#8209;1.2 (7.8)<sup><span style=3D'po=
sition:
  relative;top:-3.0pt;mso-text-raise:3.0pt'></span></sup></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.94%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.62%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>96</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.84%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>55</span></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.6%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>9.5 (11.2)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7'>
  <td width=3D"100%" colspan=3D4 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB>Study&nbsp;2<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.94%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Ivacaftor<o:p></=
o:p></span></b></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.62%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>48<sup>*</sup></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.84%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>26</span></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.6%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>10.2 (15.7)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.94%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.62%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>144</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.84%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>25</span></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.6%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>10.3 (12.4)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.94%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Placebo<o:p></o:=
p></span></b></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.62%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>0<sup>*</sup></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.84%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>22</span></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.6%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>&#8209;0.6 (10.1)<sup><span
  style=3D'position:relative;top:-3.0pt;mso-text-raise:3.0pt'></span></sup=
></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;mso-yfti-lastrow:yes'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.94%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.62%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>96</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.84%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>21</span></p>
  </td>
  <td width=3D"31%" valign=3Dtop style=3D'width:31.6%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>10.5 (11.5)</span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid;tab-stops:.5in'><sup><span lang=3DEN-GB style=3D'fon=
t-size:
9.0pt'>*</span></sup><span lang=3DEN-GB style=3D'font-size:9.0pt'><span
style=3D'mso-tab-count:1'> </span>Treatment occurred during blinded,
controlled, 48&#8209;week phase&nbsp;3 study.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid;tab-stops:.5in'><sup><span lang=3DEN-GB style=3D'fon=
t-size:
9.0pt;position:relative;top:-3.0pt;mso-text-raise:3.0pt'></span></sup><span
lang=3DEN-GB style=3D'font-size:9.0pt;position:relative;top:-3.0pt;mso-text=
-raise:
3.0pt'><span style=3D'mso-tab-count:1'> </span></span><span lang=3DEN-GB
style=3D'font-size:9.0pt'>Change from prior study baseline after 48&nbsp;we=
eks of
placebo treatment.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'><o:p>=
&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-farea=
st-font-family:
"MS Mincho";mso-ansi-language:EN-GB;mso-fareast-language:JA'>When the mean =
(SD)
absolute change in percent predicted FEV<sub>1</sub> is compared from study=
&nbsp;4
baseline for patients in the ivacaftor/ivacaftor group (n&nbsp;=3D&nbsp;72)=
 who
rolled over from study&nbsp;1, the mean (SD) absolute change in percent
predicted FEV<sub>1</sub> was 0.0% (9.05), while for patients in the
ivacaftor/ivacaftor group (n&nbsp;=3D&nbsp;25) who rolled over from study&n=
bsp;2
this figure was 0.6% (9.1). This shows that patients in the ivacaftor/ivaca=
ftor
group maintained the improvement seen at week</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>&nbsp;</span><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";mso-ansi-lang=
uage:
EN-GB;mso-fareast-language:JA'>48 of the initial study&nbsp;(day</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>&nbsp;</spa=
n><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-ansi-language:EN-GB;mso-fareast-language:JA'>0 through week&nbsp;48) in
percent predicted FEV<sub>1</sub> through week&nbsp;144. There were no
additional improvements in study&nbsp;4 (week&nbsp;48 through week&nbsp;144=
).<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-farea=
st-font-family:
"MS Mincho";mso-ansi-language:EN-GB;mso-fareast-language:JA'><o:p>&nbsp;</o=
:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-farea=
st-font-family:
"MS Mincho";mso-ansi-language:EN-GB;mso-fareast-language:JA'>For patients in
the placebo/ivacaftor group from study&nbsp;1, the annualised rate of pulmo=
nary
exacerbations was higher in the initial study when patients were on placebo
(1.34&nbsp;events/year) than during the subsequent study&nbsp;4 when patien=
ts
rolled over to ivacaftor (0.48&nbsp;events/year across day</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>&nbsp;</spa=
n><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-ansi-language:EN-GB;mso-fareast-language:JA'>1 to week</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>&nbsp;</spa=
n><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-ansi-language:EN-GB;mso-fareast-language:JA'>48, and 0.67&nbsp;events/y=
ear
across weeks</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'>&nbsp;</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareas=
t-font-family:
"MS Mincho";mso-ansi-language:EN-GB;mso-fareast-language:JA'>48 to 96). For
patients in the ivacaftor/ivacaftor group from study&nbsp;1, the annualised
rate of pulmonary exacerbations was 0.57&nbsp;events/year across day&nbsp;1=
 to week&nbsp;48
when patients were on ivacaftor. When they rolled over into study&nbsp;4, t=
he
rate of annualised pulmonary exacerbations was 0.91&nbsp;events/year across=
 day</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>&nbsp;</spa=
n><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-ansi-language:EN-GB;mso-fareast-language:JA'>1 to week</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>&nbsp;</spa=
n><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-ansi-language:EN-GB;mso-fareast-language:JA'>48 and 0.77 events/year ac=
ross
weeks&nbsp;48 to 96.<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-farea=
st-font-family:
"MS Mincho";mso-ansi-language:EN-GB;mso-fareast-language:JA'><o:p>&nbsp;</o=
:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-farea=
st-font-family:
"MS Mincho";mso-ansi-language:EN-GB;mso-fareast-language:JA'>For patients w=
ho
rolled over from study&nbsp;2 the number of events was, overall, low.<o:p><=
/o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-farea=
st-font-family:
"MS Mincho";mso-ansi-language:EN-GB;mso-fareast-language:JA'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><u><span style=3D'mso-ansi-language:EN=
-US'>Study&nbsp;6:
study&nbsp;in patients with CF with an R117H mutation in the CFTR gene<o:p>=
</o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><u><span style=3D'mso-ansi-language:EN=
-US'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-ansi-language:EN-US'>Study&nbsp;6 evaluated 69&nbsp;patients w=
ho
were 6&nbsp;years of age or older; 53 (76.8%) patients had the <i
style=3D'mso-bidi-font-style:normal'>F508del</i> mutation in the second all=
ele.
The confirmed <i>R117H </i>poly&#8209;T variant was <i>5T </i><span
style=3D'mso-bidi-font-style:italic'>in 38 patients<i> </i></span>and <i>7T=
 </i><span
style=3D'mso-bidi-font-style:italic'>in 16&nbsp;patients</span>. At baselin=
e,
mean predicted FEV<sub>1</sub> was 73% (range: 32.5% to 105.5%) and mean age
was 31&nbsp;years (range: 6 to 68&nbsp;years). The mean absolute change from
baseline through week&nbsp;24 in percent predicted FEV<sub>1</sub> (primary
efficacy endpoint) was 2.57&nbsp;percentage points in the ivacaftor group a=
nd
0.46&nbsp;percentage points in the placebo group. The estimated treatment
difference for ivacaftor versus placebo was 2.1&nbsp;percentage points (95%=
 CI &#8209;1.1,
5.4).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US;mso-bidi-font-weight:bold'>A pre&#8209;planned subgroup analysis was
conducted in patients 18&nbsp;years and older (26&nbsp;patients on placebo =
and
24 on ivacaftor). Treatment with ivacaftor resulted in a mean absolute chan=
ge
in percent predicted FEV<sub>1</sub> through week&nbsp;24 of
4.5&nbsp;percentage points in the ivacaftor group versus &#8209;0.46&nbsp;p=
ercentage
points in the placebo group. The estimated treatment difference for ivacaft=
or
versus placebo was 5.0 percentage points (95%&nbsp;CI 1.1, 8.8).<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'>In a subgroup analysis in patients with a confirmed <i>R117H&#8209;5=
T </i><span
style=3D'mso-bidi-font-style:italic'>genetic variant, </span>the difference=
 in
the mean absolute change from baseline through week</span><span lang=3DEN-G=
B>&nbsp;</span><span
style=3D'mso-ansi-language:EN-US'>24 in percent predicted FEV<sub>1</sub> b=
etween
ivacaftor and placebo was 5.3% (95% CI 1.3, 9.3). In patients with a confir=
med <i>R117H&#8209;7T
</i><span style=3D'mso-bidi-font-style:italic'>genetic variant, </span>the
treatment difference between ivacaftor and placebo was 0.2% (95% CI &#8209;=
8.1,
8.5).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><a name=3D"_Hlk37921752">=
<span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>For secondary efficacy var=
iables,
no treatment differences were observed for ivacaftor versus placebo in abso=
lute
change from baseline in BMI at week 24&nbsp;or time to first pulmonary
exacerbation. Treatment differences were observed in absolute change in CFQ=
&#8209;R
respiratory domain score through week 24 (treatment difference of ivacaftor
versus placebo was 8.4 [95% CI&nbsp;2.2, 14.6] points) and for the mean cha=
nge
from baseline in sweat chloride (see Pharmacodynamic effects).<o:p></o:p></=
span></a></p>

<span style=3D'mso-bookmark:_Hlk37921752'></span>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Ivacaftor in a comb=
ination
regimen with tezacaftor/ivacaftor or with ivacaftor/tezacaftor/elexacaftor<=
o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>The efficacy and safety of=
 ivacaftor
in a combination regimen with tezacaftor/ivacaftor in patients with CF aged=
 12&nbsp;years
and older was assessed in two clinical studies; a 24&nbsp;week, randomised,
double&#8209;blind, placebo&#8209;controlled study with 504&nbsp;patients w=
ho
were homozygous for the <i style=3D'mso-bidi-font-style:normal'>F508del </i=
>mutation;
and a randomised, double&#8209;blind, placebo&#8209;controlled and
ivacaftor&nbsp;controlled, 2&nbsp;period, 3&nbsp;treatment, 8&#8209;week
crossover study with 244&nbsp;patients who were heterozygous for the <i
style=3D'mso-bidi-font-style:normal'>F508del</i> mutation and a second muta=
tion
associated with residual <i style=3D'mso-bidi-font-style:normal'>CFTR </i>a=
ctivity.
The long-term safety and efficacy of the combination regimen was also asses=
sed
in both patient populations in a 96-week open-label, rollover, long-term
extension study. Refer to the Summary of Product Characteristics of
tezacaftor/ivacaftor for additional data.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>The efficacy and safety of=
 ivacaftor
in a combination regimen with ivacaftor/tezacaftor/elexacaftor in patients =
aged
12&nbsp;years and older was demonstrated in two, phase 3 studies, randomise=
d,
double blind, placebo-controlled (heterozygous <i>F508del</i> patients, n=
=3D403)
and active-controlled (homozygous <i>F508del</i> patients, n=3D107) of 24 a=
nd 4&nbsp;weeks
of duration, respectively. Heterozygous <i>F508del</i> patients had a minim=
al
function mutation on the second allele defined as one that either leads to =
</span><span
lang=3DEN-GB>no CFTR protein being produced (e.g. Class I) or a CFTR protei=
n that
does not function to transport chloride and is unlikely to respond to other
CFTR modulators (tezacaftor, ivacaftor or the combination of both)<span
style=3D'mso-bidi-font-weight:bold'>. Homozygous <i>F508del</i> patients re=
ceived
tezacaftor/ivacaftor and ivacaftor regimen during a 4-week open-label run-in
period and were then randomised and dosed to receive ivacaftor in combinati=
on
with ivacaftor/tezacaftor/elexacaftor during a 4-week double-blind treatment
period. Patients from both studies were eligible to enter an open&#8209;lab=
el,
rollover, 96-week study. Refer to the Summary of Product Characteristics of=
 ivacaftor/tezacaftor/elexacaftor
for additional data.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Paediatric population<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The Eu=
ropean
Medicines Agency has deferred the obligation to submit the results of studi=
es
with Kalydeco in one or more subsets of the paediatric population in cystic
fibrosis (see section&nbsp;4.2 for information on paediatric use).</span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2'><b><span lang=3DEN-GB>5.2<span style=3D'mso-tab-count:=
1'> </span>Pharmacokinetic
properties<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</=
o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in'><span lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-f=
areast-language:
JA'>The pharmacokinetics of ivacaftor are similar between healthy adult
volunteers and patients with CF.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>After=
 oral
administration of a single 150&nbsp;mg dose to healthy volunteers in a fed
state, the mean (&nbsp;SD) for AUC and C<sub>max</sub> were 10600
(5260)&nbsp;ng*hr/mL and 768 (233)&nbsp;ng/mL, respectively. After every 12=
&#8209;hour
dosing, steady&#8209;state plasma concentrations of ivacaftor were reached =
by days</span><span
lang=3DEN-GB>&nbsp;</span><span lang=3DEN-GB style=3D'mso-fareast-font-fami=
ly:"MS Mincho";
mso-fareast-language:JA'>3 to 5, with an accumulation ratio ranging from 2.=
2 to
2.9.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltextheading><u><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB;font-style:normal'>Absorption<o:p></o:p></span></u>=
</p>

<p class=3Dlabeltextheading><u><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB;font-style:normal'><o:p><span style=3D'text-decorat=
ion:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Following multiple oral =
dose
administrations of ivacaftor, the exposure of ivacaftor generally increased
with dose from 25&nbsp;mg every 12&nbsp;hours to 450&nbsp;mg every 12&nbsp;=
hours.
When given with fat-containing food, the exposure of ivacaftor increased
approximately 2.5&#8209; to 4&#8209;fold. When co-administered with tezacaf=
tor and
elexacaftor, the increase in AUC was similar (approximately 3&#8209;fold an=
d 2.5-to
4-fold respectively). Therefore, ivacaftor, administered as monotherapy or =
in a
combination regimen with tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexa=
caftor,
should be administered with fat&#8209;containing food. The median (range) t=
<sub>max</sub>
is approximately 4.0&nbsp;(3.0; 6.0)&nbsp;hours in the fed state.<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>Ivacaftor gr=
anules
(2 x 75&nbsp;mg sachets) had similar bioavailability as the 150&nbsp;mg tab=
let
when given with fat-containing food to healthy adult subjects. The geometric
least squares mean ratio (90% CI) for the granules relative to tablets was
0.951 (0.839, 1.08) for AUC<sub>0&#8209;&#8734;</sub> and 0.918 (0.750, 1.1=
2)
for C<sub>max</sub>. The effect of food on ivacaftor absorption is similar =
for
both formulations, i.e., tablets and granules.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-pag=
ination:
widow-orphan no-line-numbers;page-break-after:avoid;mso-list:skip'><u><span
lang=3DEN-GB>Distribution<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-pag=
ination:
widow-orphan no-line-numbers;page-break-after:avoid;mso-list:skip'><u><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Ivacaftor is approximate=
ly 99%
bound to plasma proteins, primarily to alpha 1&#8209;acid glycoprotein and
albumin. Ivacaftor does not bind to human red blood cells. After oral
administration of ivacaftor150&nbsp;mg every 12&nbsp;hours for 7&nbsp;days =
in
healthy volunteers in a fed state, the mean (&nbsp;SD) apparent volume of
distribution was 353&nbsp;L (122)&nbsp;.<o:p></o:p></span></p>

<p class=3Dlabeltext><i style=3D'mso-bidi-font-style:normal'><span lang=3DE=
N-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB=
'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Biotransformation<o:p></=
o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><u><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:E=
N-GB'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Ivacaftor is extensively
metabolised in humans. <i style=3D'mso-bidi-font-style:normal'>In&nbsp;vitr=
o</i>
and <i style=3D'mso-bidi-font-style:normal'>in&nbsp;vivo</i> data indicate =
that
ivacaftor is primarily metabolised by CYP3A. M1 and M6 are the two major
metabolites of ivacaftor in humans. M1 has approximately one&#8209;sixth the
potency of ivacaftor and is considered pharmacologically active. M6 has less
than one&#8209;fiftieth the potency of ivacaftor and is not considered
pharmacologically active.<i><o:p></o:p></i></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'>The effect of the <sp=
an
style=3D'mso-bidi-font-style:italic'>CYP3A4*22</span> heterozygous genotype=
 on
tezacaftor, ivacaftor and elexacaftor exposure is consistent with the effec=
t of
co-administration of a weak CYP3A4 inhibitor, which is not clinically relev=
ant.
No dose-adjustment of tezacaftor, ivacaftor or elexacaftor is considered
necessary. The effect in <span style=3D'mso-bidi-font-style:italic'>CYP3A4*=
22</span>
homozygous genotype patients is expected to be stronger. However, no data a=
re
available for such patients.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-list:skip'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-list:skip'><u><span lang=3DEN-GB>Elimination<o:p=
></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-list:skip'><u><span lang=3DEN-GB><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Following oral administr=
ation
in healthy volunteers, the majority of ivacaftor (87.8%) was eliminated in =
the
faeces after metabolic conversion. The major metabolites M1 and M6 accounted
for approximately 65% of the total dose eliminated with 22% as M1 and 43% as
M6. There was negligible urinary excretion of ivacaftor as unchanged parent.
The apparent terminal half&#8209;life was approximately 12 hours following a
single dose in the fed state. The apparent clearance (CL/F) of ivacaftor was
similar for healthy subjects and patients with CF. The mean (&nbsp;SD) CL/F
for a single 150&nbsp;mg dose was 17.3 (8.4)&nbsp;L/hr in healthy subjects.=
<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Linearity/non&#8209;line=
arity<o:p></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>The pharmacokinetics of =
ivacaftor
are generally linear with respect to time or dose ranging from 25&nbsp;mg to
250&nbsp;mg.<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Special populations<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3Dlabeltextheading><a name=3D"_Hlk45278559"><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-language:EN-GB=
'>Hepatic
impairment<o:p></o:p></span></a></p>

<p class=3Dlabeltextheading><span style=3D'mso-bookmark:_Hlk45278559'><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-l=
anguage:
EN-GB'><o:p>&nbsp;</o:p></span></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
_Hlk45278559'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-languag=
e:EN-GB'>Following
a single dose of 150&nbsp;mg of ivacaftor, adult subjects with moderately
impaired hepatic function (Child&#8209;Pugh Class B, score 7 to 9) had simi=
lar
ivacaftor C<sub>max</sub> (mean [&nbsp;SD] of 735 [331]&nbsp;ng/mL) but an
approximately two&#8209;fold increase in ivacaftor AUC<sub>0-&#8734;</sub>
(mean [&nbsp;SD] of 16800 [6140]&nbsp;ng*hr/mL) compared with healthy subj=
ects
matched for demographics. Simulations for predicting the steady&#8209;state
exposure of ivacaftor showed that by reducing the dosage from 150&nbsp;mg&n=
bsp;q12h
to 150&nbsp;mg once daily, adults with moderate hepatic impairment would ha=
ve
comparable steady&#8209;state C<sub>min</sub> values as those obtained with=
 a
dose of 150&nbsp;mg&nbsp;q12h in adults without hepatic impairment. <o:p></=
o:p></span></span></p>

<p class=3Dlabeltext><span style=3D'mso-bookmark:_Hlk45278559'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span>=
</span></p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk45278559'><span
style=3D'mso-ansi-language:EN-US'>In subjects with moderately impaired hepa=
tic
function (Child Pugh Class B, score 7 to 9), ivacaftor AUC increased
approximately by 50% following multiple doses for 10 days of either tezacaf=
tor
and ivacaftor or of ivacaftor, tezacaftor and elexacaftor. <o:p></o:p></spa=
n></span></p>

<p class=3DMsoNormal><span style=3D'mso-bookmark:_Hlk45278559'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></span></p>

<p class=3Dlabeltext><span style=3D'mso-bookmark:_Hlk45278559'><span
style=3D'font-size:11.0pt'>The impact of severe hepatic impairment (Child P=
ugh
Class C, score 10 to15) on the pharmacokinetics of ivacaftor as monotherapy=
 or
in a combination regimen with tezacaftor/ivacaftor or
ivacaftor/tezacaftor/elexacaftor has not been studied. The magnitude of inc=
rease
in exposure in these patients is unknown but is expected to be higher than =
that
observed in patients with moderate hepatic impairment. <o:p></o:p></span></=
span></p>

<p class=3Dlabeltext><span style=3D'mso-bookmark:_Hlk45278559'><span
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></span></p>

<p class=3Dlabeltext><span style=3D'mso-bookmark:_Hlk45278559'><span
style=3D'font-size:11.0pt'>For guidance on appropriate use and dose modific=
ation
see Table 3 in section 4.2.<o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk45278559'></span>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'>Renal impairment<o:p></o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Pharmacokinetic studies =
have
not been performed with ivacaftor in patients with renal impairment, either=
 as
monotherapy or in a combination regimen with tezacaftor/ivacaftor </span>or=
 with
<span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>ivaca=
ftor/tezacaftor/elexacaftor.
In a human pharmacokinetic study with ivacaftor monotherapy, there was mini=
mal
elimination of ivacaftor and its metabolites in urine (only 6.6% of total
radioactivity was recovered in the urine). There was negligible urinary
excretion of ivacaftor as unchanged parent (less than 0.01% following a sin=
gle
oral dose of 500&nbsp;mg). <o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>No dose adjustments are recommended for mild and moderate renal
impairment. Caution is recommended when administering ivacaftor, either as
monotherapy or in a combination with tezacaftor/ivacaftor or with
ivacaftor/tezacaftor/elexacaftor, to patients with severe renal impairment
(creatinine clearance less than or equal to 30&nbsp;mL/min) or end&#8209;st=
age
renal disease (see sections 4.2 and 4.4).<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'>Race<o:p></o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-bidi-font-style:itali=
c'>Race
had no clinically meaningful effect on the PK of ivacaftor in white (n&nbsp=
;=3D&nbsp;379)
and non-white (n&nbsp;=3D&nbsp;29) patients based on a population PK analys=
is.<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'>Gender<o:p></o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-bidi-font-style:itali=
c'>The
pharmacokinetic parameters of ivacaftor, either as monotherapy or in
combination with tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexacaftor, =
are
similar in males and females.<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'>Elderly<o:p></o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt;
mso-ansi-language:EN-GB'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-bidi-font-style:itali=
c'>Clinical
studies of ivacaftor monotherapy did not include sufficient numbers of pati=
ents
aged 65&nbsp;years and older to determine whether pharmacokinetic parameters
are similar or not to those in younger adults.<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB>The pharmacokinetic parameters of ivacaftor in combination wit=
h tezacaftor
in the elderly patients (65&#8209;72&nbsp;years) are comparable to those in
younger adults. <span style=3D'mso-bidi-font-style:italic'>No patients aged=
 65
years and older were included in the clinical studies of </span>ivacaftor/t=
ezacaftor/elexacaftor
and therefore it cannot be </span><span style=3D'mso-ansi-language:EN-US'>d=
etermined
whether pharmacokinetic parameters are similar or not to those in younger a=
dults</span><span
lang=3DEN-GB>.</span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB;mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltextheading><u><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB;font-style:normal'>Paediatric population<o:p></o:p>=
</span></u></p>

<p class=3Dlabeltextheading><u><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB;font-style:normal'><o:p><span style=3D'text-decorat=
ion:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-ansi-language:EN-US'>Predicted ivacaftor exposure based on obs=
erved
ivacaftor concentrations in phase 2 and 3 studies as determined using
population PK analysis is presented by age group in Table&nbsp;9.<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:6.0pt;line-height:normal;page-b=
reak-after:
avoid'><b><span style=3D'mso-ansi-language:EN-US'>Table&nbsp;9: Mean (SD)
ivacaftor exposure by age group<o:p></o:p></span></b></p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"101%"
 style=3D'width:101.48%;margin-left:5.35pt;border-collapse:collapse;mso-yft=
i-tbllook:
 1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:23.9pt'>
  <td width=3D"55%" style=3D'width:55.74%;border:solid windowtext 1.0pt;mso=
-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:23.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:6.0pt;text-ali=
gn:center;
  line-height:normal;page-break-after:avoid'><b style=3D'mso-bidi-font-weig=
ht:
  normal'><span style=3D'mso-ansi-language:EN-US'>Age group<o:p></o:p></spa=
n></b></p>
  </td>
  <td width=3D"14%" style=3D'width:14.96%;border:solid windowtext 1.0pt;bor=
der-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windo=
wtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:23.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:6.0pt;text-ali=
gn:center;
  line-height:normal;page-break-after:avoid'><b style=3D'mso-bidi-font-weig=
ht:
  normal'><span style=3D'mso-ansi-language:EN-US'>Dose<o:p></o:p></span></b=
></p>
  </td>
  <td width=3D"13%" style=3D'width:13.1%;border:solid windowtext 1.0pt;bord=
er-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windo=
wtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:23.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:6.0pt;text-ali=
gn:center;
  line-height:normal;page-break-after:avoid'><b style=3D'mso-bidi-font-weig=
ht:
  normal'><span style=3D'mso-ansi-language:EN-US'>C<sub>min, ss</sub> (ng/m=
L)<o:p></o:p></span></b></p>
  </td>
  <td width=3D"16%" style=3D'width:16.2%;border:solid windowtext 1.0pt;bord=
er-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windo=
wtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:23.9pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'margin-bottom:6.0pt;text-ali=
gn:center;
  line-height:normal;page-break-after:avoid'><b style=3D'mso-bidi-font-weig=
ht:
  normal'><span lang=3DPT style=3D'mso-ansi-language:PT'>AUC</span><sub><sp=
an
  lang=3DEN-GB>&#964;</span></sub></b><b style=3D'mso-bidi-font-weight:norm=
al'><sub><span
  lang=3DPT style=3D'mso-ansi-language:PT'>, ss</span></sub></b><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DPT style=3D'mso-ansi-l=
anguage:
  PT'> (ng*h/mL)<sub><o:p></o:p></sub></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;height:19.0pt'>
  <td width=3D"55%" style=3D'width:55.74%;border:solid windowtext 1.0pt;bor=
der-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:19.0pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;mso-pagination:widow-or=
phan lines-together;
  page-break-after:avoid'><span style=3D'mso-ansi-language:EN-US'>6&nbsp;mo=
nths
  to less than 12 months (5&nbsp;kg to &lt;&nbsp;7&nbsp;kg)</span><span
  class=3DMsoCommentReference><span lang=3DEN-GB style=3D'font-size:8.0pt'>=
&nbsp;</span></span><sup><span
  style=3D'mso-ansi-language:EN-US'>*</span></sup><span style=3D'mso-ansi-l=
anguage:
  EN-US'><o:p></o:p></span></p>
  </td>
  <td width=3D"14%" style=3D'width:14.96%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;mso-pagination:widow-or=
phan lines-together;
  page-break-after:avoid'><span style=3D'mso-ansi-language:EN-US'>25&nbsp;m=
g q12h<o:p></o:p></span></p>
  </td>
  <td width=3D"13%" style=3D'width:13.1%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;mso-pagination:widow-or=
phan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB>336</span><span style=3D'mso-a=
nsi-language:
  EN-US'><o:p></o:p></span></p>
  </td>
  <td width=3D"16%" style=3D'width:16.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;mso-pagination:widow-or=
phan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB>5410</span><span style=3D'mso-=
ansi-language:
  EN-US'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:19.0pt'>
  <td width=3D"55%" style=3D'width:55.74%;border:solid windowtext 1.0pt;bor=
der-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:19.0pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;mso-pagination:widow-or=
phan lines-together;
  page-break-after:avoid'><span style=3D'mso-ansi-language:EN-US'>6&nbsp;mo=
nths
  to less than 12 months (7&nbsp;kg to &lt;&nbsp;14&nbsp;kg)<o:p></o:p></sp=
an></p>
  </td>
  <td width=3D"14%" style=3D'width:14.96%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;mso-pagination:widow-or=
phan lines-together;
  page-break-after:avoid'><span style=3D'mso-ansi-language:EN-US'>50&nbsp;m=
g q12h<o:p></o:p></span></p>
  </td>
  <td width=3D"13%" style=3D'width:13.1%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;mso-pagination:widow-or=
phan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB>508 (252)</span><span
  style=3D'mso-ansi-language:EN-US'><o:p></o:p></span></p>
  </td>
  <td width=3D"16%" style=3D'width:16.2%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'margin-bottom:6.0pt;mso-pagination:widow-or=
phan lines-together;
  page-break-after:avoid'><span lang=3DEN-GB>9140 (4200)</span><span
  style=3D'mso-ansi-language:EN-US'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:19.0pt'>
  <td width=3D"55%" valign=3Dtop style=3D'width:55.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:19.0pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt'>12&nbsp;months to less than 24&nbsp;months (7&nbsp;kg to
  &lt;&nbsp;14&nbsp;kg)<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.96%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt'>50&nbsp;mg&nbsp;q12h<o:p></o:p></span></p>
  </td>
  <td width=3D"13%" valign=3Dtop style=3D'width:13.1%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt'>440 (212)<o:p></o:p></span></p>
  </td>
  <td width=3D"16%" valign=3Dtop style=3D'width:16.2%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt'>9050 (3050)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:19.0pt'>
  <td width=3D"55%" valign=3Dtop style=3D'width:55.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:19.0pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt'>12&nbsp;months to less than 24&nbsp;months (</span><span
  style=3D'font-size:11.0pt;font-family:SimSun;mso-ascii-font-family:"Times=
 New Roman";
  mso-hansi-font-family:"Times New Roman"'>&#8805;</span><span
  style=3D'font-size:11.0pt'>&nbsp;14 kg to &lt;&nbsp;25 kg)<o:p></o:p></sp=
an></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.96%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt'>75&nbsp;mg&nbsp;q12h<o:p></o:p></span></p>
  </td>
  <td width=3D"13%" valign=3Dtop style=3D'width:13.1%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt'>451 (125)<o:p></o:p></span></p>
  </td>
  <td width=3D"16%" valign=3Dtop style=3D'width:16.2%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font=
-size:
  11.0pt'>9600 (1800)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;height:19.0pt'>
  <td width=3D"55%" valign=3Dtop style=3D'width:55.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:19.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-ansi-language:EN-US'>2&#8209; to 5&#8209;year-olds (&lt;&nbs=
p;14&nbsp;kg)<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.96%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-ansi-language:EN-US'>50&nbsp;mg&nbsp;q12h<o:p></o:p></span><=
/p>
  </td>
  <td width=3D"13%" valign=3Dtop style=3D'width:13.1%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-ansi-language:EN-US'>577 (317)<o:p></o:p></span></p>
  </td>
  <td width=3D"16%" valign=3Dtop style=3D'width:16.2%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-ansi-language:EN-US'>10500 (4260)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;height:19.0pt'>
  <td width=3D"55%" valign=3Dtop style=3D'width:55.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:19.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>2&#8209; to 5&#8209;year-olds (&#8805;&nbsp;14&nbsp;kg to &lt;&nbs=
p;25
  kg)<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.96%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>75&nbsp;mg&nbsp;q12h<o:p></o:p></span></p>
  </td>
  <td width=3D"13%" valign=3Dtop style=3D'width:13.1%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>629 (296)<o:p></o:p></span></p>
  </td>
  <td width=3D"16%" valign=3Dtop style=3D'width:16.2%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>11300 (3820)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;height:19.0pt'>
  <td width=3D"55%" valign=3Dtop style=3D'width:55.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:19.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>6&#8209; to 11&#8209;year-olds&nbsp;<sup></sup> (&#8805;&nbsp;14&=
nbsp;kg
  to &lt;&nbsp;25 kg)<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.96%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>75&nbsp;mg&nbsp;q12h<o:p></o:p></span></p>
  </td>
  <td width=3D"13%" valign=3Dtop style=3D'width:13.1%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>641 (329)<o:p></o:p></span></p>
  </td>
  <td width=3D"16%" valign=3Dtop style=3D'width:16.2%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>10760 (4470)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;height:19.0pt'>
  <td width=3D"55%" valign=3Dtop style=3D'width:55.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:19.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>6&#8209; to 11&#8209;year-olds&nbsp;<sup></sup> (&#8805;&nbsp;25 =
kg)<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.96%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>150&nbsp;mg&nbsp;q12h<o:p></o:p></span></p>
  </td>
  <td width=3D"13%" valign=3Dtop style=3D'width:13.1%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>958 (546)<o:p></o:p></span></p>
  </td>
  <td width=3D"16%" valign=3Dtop style=3D'width:16.2%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>15300 (7340)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;height:19.0pt'>
  <td width=3D"55%" valign=3Dtop style=3D'width:55.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:19.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>12&#8209; to 17&#8209;year-olds <o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.96%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>150&nbsp;mg&nbsp;q12h<o:p></o:p></span></p>
  </td>
  <td width=3D"13%" valign=3Dtop style=3D'width:13.1%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>564 (242)<o:p></o:p></span></p>
  </td>
  <td width=3D"16%" valign=3Dtop style=3D'width:16.2%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi=
-language:
  EN-US'>9240 (3420)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;mso-yfti-lastrow:yes;height:19.0pt'>
  <td width=3D"55%" valign=3Dtop style=3D'width:55.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:19.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-ansi-language:EN-US'>Adults (&#8805;&nbsp;18&nbsp;years old)=
 <o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.96%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-ansi-language:EN-US'>150&nbsp;mg&nbsp;q12h<o:p></o:p></span>=
</p>
  </td>
  <td width=3D"13%" valign=3Dtop style=3D'width:13.1%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-ansi-language:EN-US'>701 (317)<o:p></o:p></span></p>
  </td>
  <td width=3D"16%" valign=3Dtop style=3D'width:16.2%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
9.0pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  style=3D'mso-ansi-language:EN-US'>10700 (4100)<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-top:6.0pt;margin-right:0in;margin-bott=
om:0in;
margin-left:.2in;margin-bottom:.0001pt;text-indent:-.2in;line-height:normal;
page-break-after:avoid;tab-stops:.5in'><sup><span style=3D'font-size:9.0pt;
mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>*</span></sup><span
style=3D'font-size:9.0pt;mso-ansi-language:EN-US;mso-bidi-font-weight:bold'=
><span
style=3D'mso-tab-count:1'> </span>Values based on data from a single pa=
tient;
standard deviation not reported.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid;tab-stops:.5in'><sup><span lang=3DEN-GB style=3D'fon=
t-size:
9.0pt;position:relative;top:-3.0pt;mso-text-raise:3.0pt'></span></sup><span
style=3D'font-size:9.0pt;mso-ansi-language:EN-US;mso-bidi-font-weight:bold'=
><span
style=3D'mso-tab-count:1'> </span>Exposures in 6&#8209; to 11&#8209;yea=
r&#8209;olds
are predictions based on simulations from the population PK model using data
obtained for this age group.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The
pharmacokinetic parameters of ivacaftor in combination with tezacaftor and =
with
tezacaftor/elexacaftor in adolescent patients (12&nbsp;to 17-year-olds) are=
 similar
to that of adult patients (see Table&nbsp;10).</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:6.0pt;line-height:normal;page-b=
reak-after:
avoid;tab-stops:.5in'><b><span style=3D'mso-fareast-font-family:Calibri;
mso-ansi-language:EN-US;mso-fareast-language:NL'>Table&nbsp;10: Mean (SD) of
ivacaftor exposure when used in combination with tezacaftor and in combinat=
ion
with tezacaftor/elexacaftor, by age group<o:p></o:p></span></b></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D623
 style=3D'width:467.55pt;border-collapse:collapse;border:none;mso-border-al=
t:
 solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:0in 0in 0in 0i=
n;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:26.55pt'>
  <td width=3D"40%" style=3D'width:40.88%;border:solid windowtext 1.0pt;mso=
-border-alt:
  solid windowtext .5pt;padding:0in 0in 0in 0in;height:26.55pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso=
-fareast-font-family:
  Calibri;mso-fareast-language:NL'>Age group<o:p></o:p></span></b></p>
  </td>
  <td width=3D"27%" style=3D'width:27.28%;border:solid windowtext 1.0pt;bor=
der-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windo=
wtext .5pt;
  padding:0in 0in 0in 0in;height:26.55pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso=
-fareast-font-family:
  Calibri;mso-fareast-language:NL'>Dose<o:p></o:p></span></b></p>
  </td>
  <td width=3D"31%" style=3D'width:31.84%;border:solid windowtext 1.0pt;bor=
der-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windo=
wtext .5pt;
  padding:0in 0in 0in 0in;height:26.55pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso=
-fareast-font-family:
  Calibri;mso-fareast-language:NL'>Ivacaftor Mean (SD)<o:p></o:p></span></b=
></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso=
-fareast-font-family:
  Calibri;mso-fareast-language:NL'>AUC<sub>0-12h</sub>,ss (ng*h/mL)<o:p></o=
:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;height:13.0pt'>
  <td width=3D"40%" style=3D'width:40.88%;border:solid windowtext 1.0pt;bor=
der-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 0in 0in 0in;height:13.0pt'>
  <p class=3DMsoNormal style=3D'margin-left:4.5pt;line-height:normal;page-b=
reak-after:
  avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-font-family=
:Calibri;
  mso-fareast-language:NL'>Adolescent patients (12 to &lt;18 years) <o:p></=
o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-left:4.5pt;line-height:normal;page-b=
reak-after:
  avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-font-family=
:Calibri;
  mso-fareast-language:NL'>n&nbsp;=3D&nbsp;97<o:p></o:p></span></p>
  </td>
  <td width=3D"27%" rowspan=3D2 style=3D'width:27.28%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 0in 0in 0in;height:13.0p=
t'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DPT style=3D'mso-farea=
st-font-family:
  Calibri;mso-ansi-language:PT;mso-fareast-language:NL'>tezacaftor
  100&nbsp;mg&nbsp;qd/ <br>
  ivacaftor 150&nbsp;mg&nbsp;q12h<o:p></o:p></span></p>
  </td>
  <td width=3D"31%" style=3D'width:31.84%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 0in 0in 0in;height:13.0p=
t'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-font-family:
  Calibri;mso-fareast-language:NL'>11400 (5500)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:13.0pt'>
  <td width=3D"40%" style=3D'width:40.88%;border:solid windowtext 1.0pt;bor=
der-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 0in 0in 0in;height:13.0pt'>
  <p class=3DMsoNormal style=3D'margin-left:4.5pt;line-height:normal;page-b=
reak-after:
  avoid;tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>Adult patie=
nts
  (&#8805;&nbsp;18&nbsp;years)<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-left:4.5pt;line-height:normal;page-b=
reak-after:
  avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-font-family=
:Calibri;
  mso-fareast-language:NL'>n&nbsp;=3D&nbsp;389<o:p></o:p></span></p>
  </td>
  <td width=3D"31%" style=3D'width:31.84%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 0in 0in 0in;height:13.0p=
t'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-font-family:
  Calibri;mso-fareast-language:NL'>11400 (4140)<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:13.0pt'>
  <td width=3D"40%" style=3D'width:40.88%;border:solid windowtext 1.0pt;bor=
der-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 0in 0in 0in;height:13.0pt'>
  <p class=3DMsoNormal style=3D'margin-left:4.5pt;line-height:normal;page-b=
reak-after:
  avoid;tab-stops:.5in'><span style=3D'mso-fareast-font-family:Calibri;
  mso-ansi-language:EN-US'>Adolescent patients (12 to &lt;18&nbsp;years)<o:=
p></o:p></span></p>
  <p class=3DMsoNormal style=3D'margin-left:4.5pt;line-height:normal;page-b=
reak-after:
  avoid;tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>n =3D 69<o:=
p></o:p></span></p>
  </td>
  <td width=3D"27%" rowspan=3D2 style=3D'width:27.28%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 0in 0in 0in;height:13.0p=
t'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span style=3D'mso-fareast-font-fa=
mily:
  Calibri;mso-ansi-language:EN-US'>elexacaftor 200&nbsp;mg qd/<br>
  tezacaftor 100&nbsp;mg qd/<br>
  ivacaftor 150&nbsp;mg&nbsp;q12h</span><span lang=3DPT style=3D'mso-fareas=
t-font-family:
  Calibri;mso-ansi-language:PT;mso-fareast-language:NL'><o:p></o:p></span><=
/p>
  </td>
  <td width=3D"31%" style=3D'width:31.84%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 0in 0in 0in;height:13.0p=
t'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span style=3D'mso-ansi-language:E=
N-US;
  mso-bidi-font-weight:bold'>10600 (3350)</span><span lang=3DEN-GB
  style=3D'mso-fareast-font-family:Calibri;mso-fareast-language:NL'><o:p></=
o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;mso-yfti-lastrow:yes;height:13.0pt'>
  <td width=3D"40%" style=3D'width:40.88%;border:solid windowtext 1.0pt;bor=
der-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 0in 0in 0in;height:13.0pt'>
  <p class=3DMsoNormal style=3D'margin-left:4.5pt;line-height:normal;page-b=
reak-after:
  avoid;tab-stops:.5in'><span style=3D'mso-fareast-font-family:Calibri;
  mso-ansi-language:EN-US'>Adult patients (&#8805;18&nbsp;years)<o:p></o:p>=
</span></p>
  <p class=3DMsoNormal style=3D'margin-left:4.5pt;line-height:normal;page-b=
reak-after:
  avoid;tab-stops:.5in'><span style=3D'mso-fareast-font-family:Calibri;
  mso-ansi-language:EN-US'>n =3D 186</span><span style=3D'mso-ansi-language=
:EN-US'><o:p></o:p></span></p>
  </td>
  <td width=3D"31%" style=3D'width:31.84%;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 0in 0in 0in;height:13.0p=
t'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span style=3D'mso-ansi-language:E=
N-US;
  mso-bidi-font-weight:bold'>12100 (4170)</span><span lang=3DEN-GB
  style=3D'mso-fareast-font-family:Calibri;mso-fareast-language:NL'><o:p></=
o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together no-line-numbers;
page-break-after:avoid;mso-outline-level:2'><b><span lang=3DEN-GB>5.3<span
style=3D'mso-tab-count:1'> </span>Preclinical safety data</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB>Non-clinical data reveal no spec=
ial
hazard for humans based on conventional studies of safety pharmacology,
repeated dose toxicity, genotoxicity, and carcinogenic potential.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><u><span lang=3DEN-GB=
>Pregnancy
and fertility<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Iv=
acaftor
was associated with slight decreases of the seminal vesicle weights, a decr=
ease
of overall fertility index and number of pregnancies in females mated with
treated males and significant reductions in number of corpora lutea and
implantation sites with subsequent reductions in the average litter size and
average number of viable embryos per litter in treated females. The No&#820=
9;Observed&#8209;Adverse&#8209;Effect&#8209;Level
(NOAEL) for fertility findings provides an exposure level of approximately
4&nbsp;times the systemic exposure of ivacaftor and its metabolites when
administered as ivacaftor monotherapy in adult humans at the maximum
recommended human dose (MRHD). Placental transfer of ivacaftor was observed=
 in
pregnant rats and rabbits.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><u><span lang=3DEN-GB=
>Peri&#8209;
and post&#8209;natal development<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Iv=
acaftor
decreased survival and lactation indices and caused a reduction in pup body
weights. The NOAEL for viability and growth in the offspring provides an
exposure level of approximately 3&nbsp;times the systemic exposure of ivaca=
ftor
and its metabolites when administered as ivacaftor monotherapy in adult hum=
ans
at the MRHD. </span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><u><span lang=3DEN-GB=
>Juvenile
animal studies<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Fi=
ndings of
cataracts were observed in juvenile rats dosed from postnatal day&nbsp;7 th=
rough
35 at ivacaftor exposure levels of 0.22&nbsp;times the MRHD based on system=
ic
exposure of ivacaftor and its metabolites when administered as ivacaftor
monotherapy. This finding has not been observed in foetuses derived from rat
dams treated with ivacaftor on gestation days&nbsp;7 to 17, in rat pups exp=
osed
to ivacaftor through milk ingestion up to postnatal day&nbsp;20, in 7&#8209=
;week
old rats, nor in 3.5 to 5&#8209;month old dogs treated with ivacaftor. The
potential relevance of these findings in humans is unknown.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none'><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;font-family:"Times New Roman",serif;mso-bidi-font-family:Arial'>6.<s=
pan
style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL PARTICULARS</span><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;font-weight:normal;mso-bidi-font-wei=
ght:
bold'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2'><b><span lang=3DEN-GB>6.1<span style=3D'mso-tab-count:=
1'> </span>List
of excipients</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Tablet core<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p><span style=3D'text-=
decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>Cellulose, microcrystalline<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>Lactose monohydrate<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>Hypromellose acetate succinate<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DIT style=3D'mso-ansi-language:IT'>Croscarmellose sodium<o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DIT style=3D'mso-ansi-language:IT'>Sodium laurilsulfate (E487)<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DIT style=3D'mso-ansi-language:IT'>Silica, colloidal anhydrous<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DIT style=3D'mso-ansi-language:IT'>Magnesium stearate<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DIT style=3D'mso-ansi-language:IT'>Tablet film coat<o:p></o:p></span>=
</u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DIT style=3D'mso-ansi-language:IT'><o:p><span style=3D'text-decoratio=
n:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DIT style=3D'mso-ansi-language:IT'>Polyvinyl alcohol<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DIT style=3D'mso-ansi-language:IT'>Titanium dioxide (E171)<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DPT style=3D'mso-ansi-language:PT'>Macrogol (PEG 3350)<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DPT style=3D'mso-ansi-language:PT'>Talc<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DPT style=3D'mso-ansi-language:PT'>Indigo carmine aluminium lake (E13=
2)<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-ansi-language:EN-US'>Carnauba wax<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
style=3D'mso-ansi-language:EN-US'>Printing ink<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
style=3D'mso-ansi-language:EN-US'><o:p><span style=3D'text-decoration:none'=
>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-ansi-language:EN-US'>Shellac<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-ansi-language:EN-US'>Iron oxide black (E172)<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DIT style=3D'mso-ansi-language:IT'>Propylene glycol (E1520)<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-ansi-language:
IT'>Ammonia solution, concentrated<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DIT style=3D'=
mso-ansi-language:
IT'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:2'><b><span lang=3DEN-GB>6.2<span
style=3D'mso-tab-count:1'> </span>Incompatibilities</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Not applicable.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2'><b><span lang=3DEN-GB>6.3<span style=3D'mso-tab-count:=
1'> </span>Shelf
life</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB>4&nbsp;years.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2'><b><span lang=3DEN-GB>6.4<span style=3D'mso-tab-count:=
1'> </span>Special
precautions for storage<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
89.75pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>This medicinal product does not require any special storage
conditions.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:2'><b><span lang=3DEN-GB>6.5<span
style=3D'mso-tab-count:1'> </span>Nature and contents of container<o:p>=
</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>The film-coated tablets are packed in a thermoform (PolyChloro=
TriFluoroEthylene
[PCTFE]/foil) blister or a High-Density PolyEthylene (HDPE) bottle with </s=
pan><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>a polypropylene child-resistant closure, foil-lined induction seal and
molecular sieve</span><span lang=3DEN-GB> desiccant.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>The following pack sizes are available:</span></p>

<p class=3DMsoNormal style=3D'margin-left:13.5pt;text-indent:-13.5pt;line-h=
eight:
normal;page-break-after:avoid;mso-list:l37 level1 lfo3;tab-stops:.5in'><![i=
f !supportLists]><span
lang=3DEN-GB style=3D'font-size:8.0pt;font-family:Symbol;mso-fareast-font-f=
amily:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </spa=
n></span></span><![endif]><span
lang=3DEN-GB>Blister card pack containing 28 film&#8209;coated tablets</spa=
n></p>

<p class=3DMsoNormal style=3D'margin-left:13.5pt;text-indent:-13.5pt;line-h=
eight:
normal;page-break-after:avoid;mso-list:l37 level1 lfo3;tab-stops:.5in'><![i=
f !supportLists]><span
lang=3DEN-GB style=3D'font-size:8.0pt;font-family:Symbol;mso-fareast-font-f=
amily:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </spa=
n></span></span><![endif]><span
lang=3DEN-GB>Blister pack containing 56 film&#8209;coated tablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:13.5pt;text-indent:-13.5pt;line-h=
eight:
normal;mso-list:l37 level1 lfo3;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:8.0pt;font-family:Symbol;mso-fareast-font-f=
amily:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'>-<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </spa=
n></span></span><![endif]><span
lang=3DEN-GB>Bottle containing 56 film&#8209;coated tablets</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'>Not all pack sizes may be marketed<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.1pt;text-indent:-28.1pt;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2'><a name=3D"OLE_LINK1"><b><span lang=3DEN-GB>6.6<span
style=3D'mso-tab-count:1'> </span>Special precautions for disposal and o=
ther
handling</span></b></a></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
style:
italic'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:OLE_LINK1'><span lang=3DEN-GB style=3D'mso-bidi-font-=
style:
italic'>Any unused medicinal product or waste material should be disposed o=
f in
accordance with local requirements.<o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:OLE_LINK1'></span>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>7.<span style=3D'mso-tab-count:1'> </span=
>MARKETING
AUTHORISATION HOLDER</span><span lang=3DEN-GB style=3D'font-size:11.0pt;fon=
t-family:
"Times New Roman",serif'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Vertex Pharmaceuticals (Ireland) Limit=
ed<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>28-32 Pembroke Street Upper<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Dublin 2, D02 EK84<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'>Ireland</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>8.<span style=3D'mso-tab-count:1'> </span=
>MARKETING
AUTHORISATION NUMBER(S)</span><span lang=3DEN-GB style=3D'font-size:11.0pt;
font-family:"Times New Roman",serif;font-weight:normal;mso-bidi-font-weight:
bold'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB>EU/1/12/782/001</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB>EU/1/12/782/002</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>EU/1/12/782/005</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>9.<span style=3D'mso-tab-count:1'> </span=
>DATE
OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'><o:p></o:p><=
/span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB>Date of first authorisation: 23 =
July
2012</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB>Date of latest renewal: 28 April=
 2017</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>10.<span style=3D'mso-tab-count:1'> </span>=
DATE
OF REVISION OF THE TEXT</span><span lang=3DEN-GB style=3D'font-size:11.0pt;
font-family:"Times New Roman",serif;font-weight:normal;mso-bidi-font-weight:
bold'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Detailed information on this medicinal product is available on=
 the
website of the European Medicines Agency <u>http://www.ema.europa.eu</u>.</=
span></p>

<b><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roma=
n",serif;
mso-fareast-font-family:SimSun;mso-ansi-language:EN-GB;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span></b>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers'><b><span
lang=3DEN-GB>1.<span style=3D'mso-tab-count:1'> </span>NAME OF THE ME=
DICINAL
PRODUCT</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none'><span
lang=3DEN-GB>Kalydeco 25&nbsp;mg granules in sachet</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none'><span
lang=3DEN-GB>Kalydeco 50&nbsp;mg granules in sachet</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none'><span
lang=3DEN-GB>Kalydeco 75&nbsp;mg granules in sachet</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;font-family:"Times New Roman",serif;mso-bidi-font-family:Arial'>2.<s=
pan
style=3D'mso-tab-count:1'> </span>QUALITATIVE AND QUANTITATIVE COMPOS=
ITION</span><span
lang=3DEN-GB style=3D'font-size:11.0pt'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><u><span lang=3DEN-GB>Kalydeco 25&nbsp;mg granules in sachet<o:p></o=
:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB>Each sachet contains 25&nbsp;mg of ivacaftor.</sp=
an></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Excipient=
 with
known effect<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbs=
p;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB>Each sachet contains 36.6&nbsp;mg of lactose
monohydrate.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><u><span lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbs=
p;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><u><span lang=3DEN-GB>Kalydeco 50&nbsp;mg granules in sachet<o:p></o=
:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB>Each sachet contains 50&nbsp;mg of ivacaftor.</sp=
an></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><u><span lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbs=
p;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Excipient=
 with
known effect<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbs=
p;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB>Each sachet contains 73.2&nbsp;mg of lactose
monohydrate.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><u><span lang=3DEN-GB>Kalydeco 75&nbsp;mg granules in sachet<o:p></o=
:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><u><span lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbs=
p;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB>Each sachet contains 75&nbsp;mg of ivacaftor.</sp=
an></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><u><span lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbs=
p;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Excipient=
 with
known effect<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbs=
p;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB>Each sachet contains 109.8&nbsp;mg of lactose mon=
ohydrate.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid'><span lang=3DEN-GB>For the full list of excipients, see section&nbsp=
;6.1.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal;mso-pagination:none'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;mso-bidi-font=
-family:
Arial'>3.<span style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL FORM<=
/span><span
lang=3DEN-GB style=3D'font-size:11.0pt;text-transform:uppercase'><o:p></o:p=
></span></h1>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;mso-pagination:no-line-numbers;page-break-after:avoid;
tab-stops:269.4pt;mso-layout-grid-align:none;text-autospace:none'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'text-align:justify;text-justify:inter-ideogra=
ph;
line-height:normal;mso-pagination:none;page-break-after:avoid;tab-stops:28.=
35pt 103.5pt;
mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB>Granules=
 in
sachet</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none'><span
lang=3DEN-GB>White to off&#8209;white granules approximately 2&nbsp;mm in
diameter.</span><span lang=3DEN-GB style=3D'font-size:12.0pt'><o:p></o:p></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers'><span
lang=3DEN-GB style=3D'font-size:10.0pt;mso-bidi-font-size:11.0pt'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers'><span
lang=3DEN-GB style=3D'font-size:10.0pt;mso-bidi-font-size:11.0pt'><o:p>&nbs=
p;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal;mso-pagination:none'><span lang=
=3DEN-GB
style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;mso-bidi-font=
-family:
Arial;text-transform:uppercase'>4.<span style=3D'mso-tab-count:1'> </=
span></span><span
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>CLINICAL PARTICULARS</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;text-transform:uppercase'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:no-line-numbers;page-break-after:avoid;mso-outline-le=
vel:
2'><b><span lang=3DEN-GB>4.1<span style=3D'mso-tab-count:1'> </span>The=
rapeutic
indications</span></b></p>

<p class=3DMsoNormal style=3D'mso-pagination:none;page-break-after:avoid'><=
span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'mso-pagination:none;page-break-after:avoid'><=
span
style=3D'font-size:11.0pt'>Kalydeco granules are indicated for the treatmen=
t of infants
aged at least 4&nbsp;months, toddlers and children weighing 5&nbsp;kg to le=
ss
than 25&nbsp;kg with cystic fibrosis (CF) who have an <i>R117H CFTR</i>
mutation or one of the following gating (class III) mutations in the <i>CFT=
R</i>
gene: <i style=3D'mso-bidi-font-style:normal'>G551D, G1244E, G1349D, G178R,
G551S, S1251N, S1255P, S549N </i><span style=3D'mso-bidi-font-style:italic'=
>or</span><i
style=3D'mso-bidi-font-style:normal'> S549R</i> (see sections&nbsp;4.4 and =
5.1).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:none'><span lang=3DEN-GB><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers;
mso-outline-level:2'><b><span lang=3DEN-GB>4.2<span style=3D'mso-tab-count:=
1'> </span>Posology
and method of administration<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers'><span
lang=3DEN-GB>Kalydeco should only be prescribed by physicians with experien=
ce in
the treatment of cystic fibrosis. </span><span style=3D'mso-fareast-font-fa=
mily:
"MS Mincho";mso-ansi-language:EN-US;mso-fareast-language:JA'>If the patient=
's
genotype is unknown, an </span><span lang=3DEN-GB>accurate and validated
genotyping method should be performed before starting treatment to confirm =
the
presence of an indicated mutation in at least one allele of the <i
style=3D'mso-bidi-font-style:normal'>CFTR</i> gene (see section 4.1). The p=
hase
of the poly-T variant identified with the <i style=3D'mso-bidi-font-style:n=
ormal'>R117H
</i>mutation should be determined in accordance with local clinical
recommendation.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers'><u><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:no-line-num=
bers;
page-break-after:avoid'><u><span lang=3DEN-GB>Posology<o:p></o:p></span></u=
></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Infants aged at least 4&nbsp;months, toddlers, children, adole=
scents
and adults should be dosed according to Table&nbsp;1.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:6.0pt;line-height:normal;page-b=
reak-after:
avoid'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Table&nb=
sp;1:
Dosing recommendations for patients aged 4&nbsp;months and older<o:p></o:p>=
</span></b></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"99%"
 style=3D'width:99.0%;border-collapse:collapse;border:none;mso-border-alt:s=
olid windowtext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt;mso-border-insid=
eh:
 .5pt solid windowtext;mso-border-insidev:.5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:10.85pt'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.68%;border:solid windowt=
ext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-=
GB>Age<o:p></o:p></span></b></p>
  </td>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.68%;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:10.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-=
GB>Weight<o:p></o:p></span></b></p>
  </td>
  <td width=3D"36%" valign=3Dtop style=3D'width:36.18%;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:10.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-=
GB>Dose<o:p></o:p></span></b></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.46%;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:10.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-=
GB>Total
  daily dose<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;height:10.85pt'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.68%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:10.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>4 months to less than 6 months</span><=
/p>
  </td>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span style=3D'font-family:SimSun;mso-ascii-font-family:"=
Times New Roman";
  mso-hansi-font-family:"Times New Roman"'>&#8805;</span><span lang=3DEN-GB=
>5&nbsp;kg</span></p>
  </td>
  <td width=3D"36%" valign=3Dtop style=3D'width:36.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>25 mg granules taken orally every 12 h=
ours
  with fat-containing food</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.46%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>50 mg</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:10.85pt'>
  <td width=3D"21%" rowspan=3D4 style=3D'width:21.68%;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:10.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>6 months and older</span></p>
  </td>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span style=3D'font-family:SimSun;mso-ascii-font-family:"=
Times New Roman";
  mso-hansi-font-family:"Times New Roman"'>&#8805;</span><span lang=3DEN-GB=
>5&nbsp;kg
  to &lt;&nbsp;7&nbsp;kg</span></p>
  </td>
  <td width=3D"36%" valign=3Dtop style=3D'width:36.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>25&nbsp;mg granules taken orally every
  12&nbsp;hours with fat&#8209;containing food</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.46%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>50&nbsp;mg</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:10.85pt'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span style=3D'font-family:SimSun;mso-ascii-font-family:"=
Times New Roman";
  mso-hansi-font-family:"Times New Roman"'>&#8805;</span><span lang=3DEN-GB=
>&nbsp;7&nbsp;kg
  to &lt;&nbsp;14&nbsp;kg</span></p>
  </td>
  <td width=3D"36%" valign=3Dtop style=3D'width:36.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>50&nbsp;mg granules taken orally every
  12&nbsp;hours with fat&#8209;containing food</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.46%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>100&nbsp;mg</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:10.85pt'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span style=3D'font-family:SimSun;mso-ascii-font-family:"=
Times New Roman";
  mso-hansi-font-family:"Times New Roman"'>&#8805;</span><span lang=3DEN-GB=
>&nbsp;14&nbsp;kg
  to &lt;&nbsp;25&nbsp;kg</span></p>
  </td>
  <td width=3D"36%" valign=3Dtop style=3D'width:36.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>75&nbsp;mg granules taken orally every
  12&nbsp;hours with fat&#8209;containing food</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.46%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>150&nbsp;mg</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;mso-yfti-lastrow:yes;height:15.7pt'>
  <td width=3D"21%" valign=3Dtop style=3D'width:21.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.7pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  style=3D'font-family:SimSun;mso-ascii-font-family:"Times New Roman";mso-h=
ansi-font-family:
  "Times New Roman"'>&#8805;</span><span lang=3DEN-GB>&nbsp;25&nbsp;kg</spa=
n></p>
  </td>
  <td width=3D"56%" colspan=3D2 valign=3Dtop style=3D'width:56.64%;border-t=
op:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.7pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-lan=
guage:
  JA'>See Kalydeco tablets SmPC for further details.</span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span clas=
s=3Ds10><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
class=3Ds10><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Miss=
ed dose<o:p></o:p></span></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
class=3Ds10><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p=
>&nbsp;</o:p></span></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
class=3Ds10><span lang=3DEN-GB>If 6&nbsp;hours or less have passed since th=
e missed
morning or evening dose, the patient should take it as soon as possible and=
 continue
on the original schedule. If more than 6&nbsp;hours have passed since the t=
ime
the dose is usually taken, the patient should be told to wait until the next
scheduled dose.<o:p></o:p></span></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></sp=
an></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span style=3D'font-size:11.0pt'>Concomitant use of CYP3A inhibitor=
s<o:p></o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'>When
co-administered with strong inhibitors of CYP3A in patients aged 6 months a=
nd
older, the </span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-lan=
guage:
EN-GB;mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>ivacaftor dose
should be reduced to one sachet (ivacaftor 25&nbsp;mg for patients 5&nbsp;k=
g to
&lt;&nbsp;7&nbsp;kg; ivacaftor 50&nbsp;mg for patients 7&nbsp;kg to &lt;&nb=
sp;14&nbsp;kg;
ivacaftor 75&nbsp;mg for patients 14&nbsp;kg to &lt;&nbsp;25&nbsp;kg) twice=
 a
week </span><span style=3D'font-size:11.0pt'>(see sections&nbsp;4.4 and 4.5=
).<span
style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><o:p></o:p><=
/span></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt;mso-bidi-font-weight:b=
old;
mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'>When co-administered =
with
moderate inhibitors of CYP3A in patients aged 6 months and older,</span><sp=
an
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB;mso-bidi-fon=
t-weight:
bold;mso-bidi-font-style:italic'> the ivacaftor dose is as above recommended
but administered once daily </span><span style=3D'font-size:11.0pt'>(see
sections&nbsp;4.4 and 4.5).<span style=3D'mso-bidi-font-weight:bold;mso-bid=
i-font-style:
italic'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:13.5pt 28.35pt'>=
<span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:13.5pt 28.35pt'>=
<span
lang=3DEN-GB>Due to the variability in maturation of the cytochrome (CYP) e=
nzymes
involved in ivacaftor metabolism, treatment with ivacaftor is not recommend=
ed
when co-administered with moderate or strong inhibitors of CYP3A in patient=
s aged
4 months to less than 6 months, unless the benefits outweigh the risks. In =
such
cases, the recommended dose is one packet of 25 mg granules twice weekly or
less frequently (see sections 4.4 and 4.5). Dosing intervals should be modi=
fied
according to clinical response and tolerability (see sections 4.4 and 5.2)<=
/span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:13.5pt 28.35pt'>=
<span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:13.5pt 28.35pt'>=
<span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Special populations<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i=
><span
lang=3DEN-GB>Renal impairment<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i=
><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'>No
dose adjustment is necessary for patients with mild to moderate renal
impairment. Caution is recommended in patients with severe renal impairment
(creatinine clearance less than or equal to 30&nbsp;mL/min) or end&#8209;st=
age
renal disease (see sections&nbsp;4.4 and 5.2).<o:p></o:p></span></p>

<p class=3Dlabeltextheading><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o=
:p></span></p>

<p class=3Dlabeltextheading><span style=3D'font-size:11.0pt'>Hepatic impair=
ment<o:p></o:p></span></p>

<p class=3Dlabeltextheading><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o=
:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>No dose adjustment is
necessary for patients aged 6 months and older with mild hepatic impairment
(Child&#8209;Pugh Class A). <span style=3D'mso-bidi-font-weight:bold'>For
patients aged 6 months and older with moderate hepatic impairment (Child&#8=
209;Pugh
Class B), a </span></span><span style=3D'font-size:11.0pt'>reduced dose of =
one
sachet (ivacaftor 25&nbsp;mg for patients 5&nbsp;kg to &lt;&nbsp;7&nbsp;kg;
ivacaftor 50&nbsp;mg for patients 7&nbsp;kg to &lt;&nbsp;14&nbsp;kg; ivacaf=
tor
75&nbsp;mg for patients 14&nbsp;kg to &lt;&nbsp;25&nbsp;kg) once daily is
recommended. There is no experience of the use of ivacaftor in patients age=
d 6
months and older with severe hepatic impairment (Child-Pugh Class C); there=
fore,
its use is not recommended unless the benefits outweigh the risks. In such
cases, the starting dose should be as above recommended, administered </spa=
n><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>every other=
 day</span><span
style=3D'font-size:11.0pt'>. Dosing intervals should be modified according =
to
clinical response and tolerability (see sections&nbsp;4.4 and 5.2).<o:p></o=
:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'>Due to variability in
maturation of cytochrome (CYP) enzymes involved in ivacaftor metabolism,
treatment with ivacaftor is not recommended in patients aged 4 months to le=
ss
than 6 months with hepatic impairment, unless the benefits outweigh the ris=
ks.
In such cases, the recommended dose is one sachet (ivacaftor 25 mg) once da=
ily
or less frequently. Dosing intervals should be modified according to clinic=
al
response and tolerability (see sections 4.4 and 5.2).<o:p></o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><u><span lang=3DEN-GB>Paediatric population<o:p></o=
:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></b></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'>The
safety and efficacy of ivacaftor in children aged less than 4&nbsp;months h=
ave
not been established. No data are available.<o:p></o:p></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></sp=
an></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'>Limited data are avai=
lable in
patients less than 6&nbsp;years of age with an <i style=3D'mso-bidi-font-st=
yle:
normal'>R117H</i> mutation in the <i style=3D'mso-bidi-font-style:normal'>C=
FTR</i>
gene. Available data in patients aged 6&nbsp;years and older are described =
in
sections 4.8, 5.1 and 5.2.<o:p></o:p></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><u><span lang=3DEN-GB>Method of administration <o:p=
></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><u><span lang=3DEN-GB><o:p><span style=3D'text-deco=
ration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB>For=
 oral
use.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span lang=3DEN-GB>Each sachet is for single use =
only.</span><span
style=3D'mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-US;
mso-fareast-language:JA'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Each sachet of granules sh=
ould be
mixed with 5&nbsp;mL of age&#8209;appropriate soft food or liquid and</span=
><span
lang=3DEN-GB> <span style=3D'mso-bidi-font-weight:bold'>completely and imme=
diately
consumed. </span></span><span style=3D'mso-ansi-language:EN-US;mso-bidi-fon=
t-weight:
bold'>Food or liquid should be at room temperature or below. </span><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>If not immediately consume=
d, the
mixture has been shown to be stable for one hour and therefore should be
ingested during this period. A fat&#8209;containing meal or snack should be
consumed just before or just after dosing.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Food or drink containing grapefruit should be avoided during
treatment (see section&nbsp;4.5).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin:0in'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-b=
idi-font-size:
12.0pt'>4.3<span style=3D'mso-tab-count:1'> </span>Contraindications<=
/span></h2>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><span
lang=3DEN-GB>Hypersensitivity to the active substance or to any of the exci=
pients
listed in section&nbsp;6.1.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin:0in'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-b=
idi-font-size:
12.0pt'>4.4<span style=3D'mso-tab-count:1'> </span>Special warnings a=
nd
precautions for use</span><i style=3D'mso-bidi-font-style:normal'><span
lang=3DEN-GB><o:p></o:p></span></i></h2>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:0in'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Only =
patients
with CF who had a <i style=3D'mso-bidi-font-style:normal'>G551D, G1244E, G1=
349D,
G178R, G551S, S1251N, S1255P, S549N</i> or <i style=3D'mso-bidi-font-style:=
normal'>S549R</i>
gating (class III) or <i style=3D'mso-bidi-font-style:normal'>G970R</i> mut=
ation
in at least one allele of the <i style=3D'mso-bidi-font-style:normal'>CFTR<=
/i>
gene were included in studies&nbsp;1, 2, 5 and 7 (see section</span><span
lang=3DEN-GB>&nbsp;<span style=3D'mso-bidi-font-weight:bold'>5.1).<o:p></o:=
p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:0in'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:0in'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Less =
evidence
of a positive effect of ivacaftor has been shown for patients with an <i>R1=
17H-7T</i>
mutation associated with less severe disease in study&nbsp;6 (see section 5=
.1).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:0in'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>In study&nbsp;5, four pati=
ents
with the <i style=3D'mso-bidi-font-style:normal'>G970R</i> mutation were
included. In three of four patients the change in the sweat chloride test w=
as
&lt;&nbsp;5</span><span lang=3DEN-GB>&nbsp;<span style=3D'mso-bidi-font-wei=
ght:
bold'>mmol/L and this group did not demonstrate a clinically relevant
improvement in FEV<sub>1</sub> after 8&nbsp;weeks of treatment. Clinical
efficacy in patients with the <i style=3D'mso-bidi-font-style:normal'>G970R=
</i>
mutation of the <i style=3D'mso-bidi-font-style:normal'>CFTR</i> gene could=
 not
be established (see section&nbsp;5.1).<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Efficacy results from a ph=
ase&nbsp;2
study in patients with CF who are homozygous for the <i style=3D'mso-bidi-f=
ont-style:
normal'>F508del </i>mutation in the <i style=3D'mso-bidi-font-style:normal'=
>CFTR</i>
gene showed no statistically significant difference in FEV<sub>1</sub> over
16&nbsp;weeks of ivacaftor treatment compared to placebo (see
section&nbsp;5.1). Therefore, use of ivacaftor as monotherapy in these pati=
ents
is not recommended.<o:p></o:p></span></p>

<p class=3Dlabeltextheading><span lang=3DEN-GB style=3D'font-size:11.0pt;ms=
o-bidi-font-size:
10.0pt;mso-ansi-language:EN-GB;font-style:normal'><o:p>&nbsp;</o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in'><u><span lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Rom=
an";
mso-fareast-language:ES;mso-bidi-font-weight:bold'>Effect on liver function
tests<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in'><u><span lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Rom=
an";
mso-fareast-language:ES;mso-bidi-font-weight:bold'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt;
mso-fareast-font-family:"Times New Roman";mso-fareast-language:ES'>Moderate
transaminase (alanine transaminase [ALT] or aspartate transaminase [AST])
elevations are common in subjects with CF. Transaminase elevations have been
observed in some patients treated with ivacaftor monotherapy. Therefore, li=
ver
function tests are recommended for all patients prior to initiating ivacaft=
or,
every 3</span><span style=3D'font-size:11.0pt;mso-bidi-font-weight:bold'>&n=
bsp;</span><span
style=3D'font-size:11.0pt;mso-fareast-font-family:"Times New Roman";mso-far=
east-language:
ES'>months during the first year of treatment and annually thereafter. </sp=
an><span
style=3D'font-size:11.0pt'>For all patients with a history of transaminase
elevations, more frequent monitoring of liver function tests should be cons=
idered.
</span><span style=3D'font-size:11.0pt;mso-fareast-font-family:"Times New R=
oman";
mso-fareast-language:ES'>In the event of significant elevations of
transaminases (e.g., patients with ALT or AST &gt;&nbsp;5 x the upper limit=
 of
normal (ULN), or ALT or AST &gt;&nbsp;3 x ULN with bilirubin &gt;&nbsp;2 x
ULN), dosing should be interrupted, and laboratory tests closely followed u=
ntil
the abnormalities resolve. Following resolution of transaminase elevations,=
 the
benefits and risks of resuming treatment should be considered (see section
4.8).</span><span style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt'><o:p=
></o:p></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Hepatic impairment<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Use of ivacaftor is not recommended in patients with severe he=
patic
impairment unless the benefits are expected to outweigh the risks (see
sections&nbsp;4.2 and 5.2). No safety data are available in infants aged 4 =
to
less than 12&nbsp;months of age with moderate or severe hepatic impairment
treated with ivacaftor.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'>Renal impairment<o:p></o:=
p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p><span style=3D'text-=
decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'>Caution
is recommended while using ivacaftor in patients with severe renal impairme=
nt
or end&#8209;stage renal disease (see sections&nbsp;4.2 and 5.2).<o:p></o:p=
></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Patients after organ transplantation<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Ivacaftor has not been studied in patients with CF who have un=
dergone
organ transplantation. Therefore, use in transplanted patients is not
recommended. See section&nbsp;4.5 for interactions with ciclosporin or
tacrolimus.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span style=3D'fon=
t-size:
11.0pt'>Interactions with medicinal products<o:p></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span style=3D'fon=
t-size:
11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span=
></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span style=3D'font-size:11.0pt'>CYP3A inducers</span></i><span
style=3D'font-size:11.0pt'> <o:p></o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'>Exposure
to ivacaftor is significantly decreased by the concomitant use of CYP3A
inducers, potentially resulting in the loss of ivacaftor efficacy; therefor=
e, </span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>co-administ=
ration </span><span
style=3D'font-size:11.0pt'>of ivacaftor </span><span lang=3DEN-GB style=3D'=
font-size:
11.0pt;mso-ansi-language:EN-GB'>with strong CYP3A inducers is not recommend=
ed</span><span
style=3D'font-size:11.0pt'> (see section&nbsp;4.5).<o:p></o:p></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></sp=
an></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span style=3D'font-size:11.0pt'>CYP3A inhibitors <o:p></o:p></span=
></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'>Exposure
to ivacaftor is increased when co-administered with strong or moderate CYP3A
inhibitors. The dose of ivacaftor must be adjusted when used concomitantly =
with
strong or moderate CYP3A inhibitors (see sections&nbsp;4.2 and 4.5). No saf=
ety
data are available in infants aged 4 to less than 12&nbsp;months of age who=
 are
treated with ivacaftor and moderate or strong CYP3A inhibitors (see sections
4.2 and 4.5).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><u><span lang=3DEN-GB style=3D'mso-bidi-font-weight=
:bold'>Paediatric
population <o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><u><span lang=3DEN-GB style=3D'mso-bidi-font-weight=
:bold'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bo=
ld;
mso-bidi-font-style:italic'>Cases of non&#8209;congenital lens opacities/ca=
taracts
without impact on vision have been reported in paediatric patients treated =
with
ivacaftor. Although other risk factors were present in some cases (such as
corticosteroid use and exposure to radiation), a possible risk attributable=
 to treatment
with ivacaftor cannot be excluded. Baseline and follow&#8209;up
ophthalmological examinations are recommended in paediatric patients
initiating&nbsp;ivacaftor treatment.</span><u><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'><o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Lactose content<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Kalydeco contains lactose. Patients with rare hereditary probl=
ems of
galactose intolerance, total lactase deficiency or glucose&#8209;galactose
malabsorption should not take this medicine.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Sodium content<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>This medicine contains less than 1&nbsp;mmol sodium (23&nbsp;m=
g) per
dose, that is to say essentially sodium&#8209;free.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.5pt;text-indent:-28.5pt;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2;mso-list:l22 level2 lfo16;tab-stops:list 28.5pt'><![if =
!supportLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'><span
style=3D'mso-list:Ignore'>4.5<span style=3D'font:7.0pt "Times New Roman"'>&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>Interaction with o=
ther medicinal
products and other forms of interaction<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'=
>Ivacaftor
is a substrate of CYP3A4 and CYP3A5. It is a weak inhibitor of CYP3A and P&=
#8209;gp
and a potential inhibitor of CYP2C9. </span><i style=3D'mso-bidi-font-style=
:normal'><span
lang=3DEN-GB>In vitro</span></i><span lang=3DEN-GB> studies showed that iva=
caftor
is not a substrate for P&#8209;gp. <span style=3D'mso-bidi-font-weight:bold;
mso-bidi-font-style:italic'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Medicinal products affecting the pharmacokinetics of ivacaftor=
</span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-bidi-font-size:10.0pt'>CYP3A inducers<o:p></o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-bidi-font-size:10.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Co&#8209;administration of ivacafto=
r with
rifampicin, a strong CYP3A inducer, decreased ivacaftor exposure (AUC) <span
style=3D'mso-font-kerning:14.0pt'>by 89% and decreased hydroxymethyl ivacaf=
tor (M1)
to a lesser extent than ivacaftor. Co&#8209;administration of ivacaftor with
strong </span>CYP3A inducers, such as rifampicin, rifabutin, phenobarbital,
carbamazepine, phenytoin and St. Johns wort (<i style=3D'mso-bidi-font-sty=
le:
normal'>Hypericum perforatum</i>), is not recommended (see section&nbsp;4.4=
).<o:p></o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt'>No dose adjustment is recommended when ivacaftor=
 is
used with moderate or weak CYP3A inducers. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt'>CYP3A
inhibitors<o:p></o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt'><o:p>&nb=
sp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Ivacaftor is a sensitive=
 CYP3A
substrate. Co&#8209;administration with ketoconazole, a strong CYP3A inhibi=
tor,
increased ivacaftor exposure (measured as area under the curve [AUC]) by 8.=
5&#8209;fold
and increased M1 to a lesser extent than ivacaftor. A reduction of the </sp=
an><span
style=3D'font-size:11.0pt;mso-bidi-font-weight:bold;mso-bidi-font-style:ita=
lic'>ivacaftor
dose </span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:=
EN-GB'>is
recommended for co&#8209;administration with strong CYP3A inhibitors, such =
as
ketoconazole, itraconazole, posaconazole, voriconazole, telithromycin and
clarithromycin (see sections&nbsp;4.2 and 4.4).<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>Co&#8209;administration with fluconazole, a moderate inhibitor of CY=
P3A,
increased ivacaftor exposure by 3&#8209;fold and increased M1 to a lesser
extent than ivacaftor. A reduction of the </span><span style=3D'font-size:1=
1.0pt;
mso-bidi-font-weight:bold;mso-bidi-font-style:italic'>ivacaftor dose is
recommended </span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-la=
nguage:
EN-GB'>for patients taking concomitant moderate CYP3A inhibitors, such as
fluconazole, erythromycin, and verapamil (see sections&nbsp;4.2 and 4.4).<o=
:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'>Co-administration of ivacaftor with grapefruit juice, which contains=
 one
or more components that moderately inhibit CYP3A, may increase exposure to
ivacaftor. Food or drink containing grapefruit should be avoided during
treatment with ivacaftor (see section&nbsp;4.2).<o:p></o:p></span></p>

<p class=3Dlabeltext><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-=
language:
EN-GB'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-fareast-language:JA'>Potential for ivacaftor to interact with transport=
ers<o:p></o:p></span></u></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><u><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-fareast-language:JA'><o:p><span style=3D'text-decoration:none'>&nbsp;</=
span></o:p></span></u></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>In vitro</span=
></i><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";
mso-fareast-language:JA'> studies showed that ivacaftor is not a substrate =
for
OATP1B1 or OATP1B3. Ivacaftor and its metabolites are substrates of BCRP <i
style=3D'mso-bidi-font-style:normal'>in vitro</i>. Due to its high intrinsic
permeability and low likelihood of being excreted intact, co&#8209;administ=
ration
of BCRP inhibitors is not expected to alter exposure of ivacaftor and M1&#8=
209;IVA,
while any potential changes in M6&#8209;IVA exposures are not expected to be
clinically relevant. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB>Ciprofloxacin<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'>Co-administration
of ciprofloxacin with ivacaftor did not affect the exposure of ivacaftor. No
dose adjustment is required when ivacaftor is co&#8209;administered with
ciprofloxacin.<o:p></o:p></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt;mso-bidi-font-style:it=
alic'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:10.0pt'>Medicinal products affected by ivacaftor<=
o:p></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:10.0pt'><o:p><span style=3D'text-decoration:none'=
>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Administration of ivacaftor may inc=
rease
systemic exposure of medicinal products that are sensitive substrates of CY=
P2C9,
and/or P&#8209;gp, and/or CYP3A which may increase or prolong their therape=
utic
effect and adverse reactions.<o:p></o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB>CYP2C9
substrates<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;mso-pagination:widow-=
orphan lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt'>Ivaca=
ftor may
inhibit CYP2C9. Therefore, monitoring of the international normalised ratio
(INR) is recommended during co&#8209;administration of warfarin with ivacaf=
tor.
Other medicinal products for which exposure may be increased include
glimepiride and glipizide; these medicinal products should be used with
caution.<i style=3D'mso-bidi-font-style:normal'><span style=3D'border:solid=
 windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:0in'><o:p></o:p></span></i></s=
pan></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Digoxin and other P=
&#8209;gp
substrates<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Co&#8209;administration with digoxi=
n, a
sensitive P&#8209;gp substrate, increased digoxin exposure by 1.3&#8209;fol=
d,
consistent with weak inhibition of P&#8209;gp by ivacaftor. Administration =
of ivacaftor
may increase systemic exposure of medicinal products that are sensitive
substrates of P&#8209;gp, which may increase or prolong their therapeutic
effect and adverse reactions. When used concomitantly</span><span
style=3D'font-size:11.0pt;mso-ansi-language:EN-US'> with</span><span lang=
=3DEN-GB
style=3D'font-size:11.0pt'> digoxin or other substrates of P&#8209;gp with =
a narrow
therapeutic index, such as ciclosporin, everolimus, sirolimus or tacrolimus=
, caution
and appropriate monitoring should be used.<o:p></o:p></span></p>

<p class=3DMsoCommentText style=3D'line-height:normal'><i style=3D'mso-bidi=
-font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></sp=
an></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-bidi-font-size:10.0pt'>CYP3A substrates <o:p></o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'font-size:=
11.0pt;
mso-bidi-font-size:10.0pt'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Co&#8209;administration with (oral)
midazolam, a sensitive CYP3A substrate, increased midazolam exposure 1.5&#8=
209;fold,
consistent with weak inhibition of CYP3A by ivacaftor. No dose adjustment of
CYP3A substrates, such as midazolam, alprazolam, diazepam or triazolam, is
required when these are co-administered with ivacaftor. <o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB>Hormonal
contraceptives<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><u><span lang=3DEN-GB><o:p><span style=3D'text-deco=
ration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoCommentText style=3D'line-height:normal;page-break-after:avoi=
d'><span
lang=3DEN-GB style=3D'font-size:11.0pt'>Ivacaftor has been studied with an
oestrogen/progesterone oral contraceptive and was found to have no signific=
ant
effect on the exposures of the oral contraceptive.</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";mso-fareast-l=
anguage:
JA'> </span><span lang=3DEN-GB style=3D'font-size:11.0pt'>Therefore, no dose
adjustment of oral contraceptives is necessary.<o:p></o:p></span></p>

<p style=3D'margin:0in'><span style=3D'font-size:11.0pt;mso-bidi-font-size:=
12.0pt'><o:p>&nbsp;</o:p></span></p>

<p style=3D'margin:0in;page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Paediatric population<o:=
p></o:p></span></u></p>

<p style=3D'margin:0in;page-break-after:avoid'><u><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'><o:p><span style=3D'text=
-decoration:
 none'>&nbsp;</span></o:p></span></u></p>

<p style=3D'margin:0in;page-break-after:avoid'><span lang=3DEN-GB style=3D'=
font-size:
11.0pt;mso-ansi-language:EN-GB'>Interaction studies have only been performe=
d in
adults.<i style=3D'mso-bidi-font-style:normal'> </i></span><i style=3D'mso-=
bidi-font-style:
normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:12.=
0pt;
mso-ansi-language:EN-GB'><o:p></o:p></span></i></p>

<p style=3D'margin:0in'><b style=3D'mso-bidi-font-weight:normal'><span
style=3D'font-size:11.0pt;mso-bidi-font-size:12.0pt'><o:p>&nbsp;</o:p></spa=
n></b></p>

<h2 style=3D'margin:0in'><span lang=3DEN-GB style=3D'font-size:11.0pt'>4.6<=
span
style=3D'mso-tab-count:1'> </span>Fertility, pregnancy and lactation<=
o:p></o:p></span></h2>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-style:ita=
lic'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span style=3D'fon=
t-size:
11.0pt'>Pregnancy<o:p></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span style=3D'fon=
t-size:
11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span=
></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>There are no or limited =
amount
of data (less than 300&nbsp;pregnancy outcomes) from the use of ivacaftor in
pregnant women.</span><span lang=3DEN-GB style=3D'font-size:11.0pt'> </span=
><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Animals stu=
dies do
not indicate direct or indirect harmful effects with respect to reproductive
toxicity (see section 5.3). As a precautionary measure, it is preferable av=
oid
the use of ivacaftor during pregnancy.<o:p></o:p></span></p>

<p class=3Dlabeltext><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Breast&#8209;feeding<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'>It
is unknown whether ivacaftor and/or its metabolites are excreted in human m=
ilk.
</span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB=
'>Available
pharmacokinetic data in animals have shown excretion of </span><span
style=3D'font-size:11.0pt'>ivacaftor into the milk of lactating female rats=
. </span><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>As such, a =
risk to
the newborns/infants cannot be excluded. A decision must be made whether to
discontinue breast-feeding or to discontinue/abstain from ivacaftor therapy
taking into account the benefit of breast&#8209;feeding for the child and t=
he
benefit of therapy for the woman.<o:p></o:p></span></p>

<p class=3Dlabeltext><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid;tab-s=
tops:
0in'><u><span lang=3DEN-GB>Fertility<o:p></o:p></span></u></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid;tab-s=
tops:
0in'><u><span lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;=
</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>There are no data available on the effect of ivacaftor on fertility in
humans. Ivacaftor had an effect on fertility in rats (see section 5.3)</spa=
n><span
style=3D'mso-fareast-font-family:"MS Mincho";mso-ansi-language:EN-US;mso-fa=
reast-language:
JA'>.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:2'><b><span lang=3DEN-GB>4.7<span
style=3D'mso-tab-count:1'> </span>Effects on ability to drive and use
machines</span></b><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN=
-GB><o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Ivacaftor has minor influe=
nce on
the ability to drive or use machines. Ivacaftor may cause dizziness (see
section&nbsp;4.8) and, therefore, patients experiencing dizziness should be
advised not to drive or use machines until symptoms abate.<o:p></o:p></span=
></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together no-line-numbers;
page-break-after:avoid;mso-outline-level:2'><b><span lang=3DEN-GB>4.8<span
style=3D'mso-tab-count:1'> </span>Undesirable effects<o:p></o:p></span>=
</b></p>

<p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><u><span style=3D'font-size:11.0pt'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><u><span style=3D'font-size:11.0pt'>Summary of the =
safety
profile</span></u><u><span style=3D'font-size:11.0pt;mso-bidi-font-size:10.=
0pt'><o:p></o:p></span></u></p>

<p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p><=
/span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-fareast-font-family=
:"Times New Roman"'>The
most common adverse reactions experienced by patients aged 6&nbsp;years and
older are headache (23.9%), oropharyngeal pain (22.0%), upper respiratory t=
ract
infection (22.0%), nasal congestion (20.2%), abdominal pain (15.6%),
nasopharyngitis (14.7%), diarrhoea (12.8%), dizziness (9.2%), rash (12.8%) =
and
bacteria in sputum (12.8%).</span><span lang=3DEN-GB> </span><span lang=3DE=
N-GB
style=3D'mso-fareast-font-family:"Times New Roman"'>Transaminase elevations
occurred in 12.8% of ivacaftor&#8209;treated patients versus 11.5% of
placebo-treated patients.<o:p></o:p></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'><o:p>&nbsp;</o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"Times New Roman"'>In patients aged 2 to l=
ess
than 6&nbsp;years the most common adverse reactions were nasal congestion (=
26.5%),
upper respiratory tract infection (23.5%), transaminase elevations (14.7%),
rash (11.8%), and bacteria in sputum (11.8%).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"Times New Roman"'><o:p>&nbsp;</o:p></span=
></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"Times New Roman"'>Serious adverse reactio=
ns in
patients who received ivacaftor included abdominal pain and transaminase
elevations (see section 4.4).<o:p></o:p></span></p>

<p class=3Dlabeltext><u><span style=3D'font-size:11.0pt'><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span style=3D'fon=
t-size:
11.0pt'>Tabulated list of adverse reactions<o:p></o:p></span></u></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><u><span style=3D'fon=
t-size:
11.0pt'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span=
></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'>Table&nbsp=
;2
reflects the adverse reactions observed with ivacaftor in clinical trials
(placebo&#8209;controlled and uncontrolled studies) in which the length of
exposure to ivacaftor ranged from 16&nbsp;weeks to 144&nbsp;weeks. The freq=
uency
of adverse reactions is defined as follows: very common (&#8805;&nbsp;1/10);
common (&#8805;&nbsp;1/100 to &lt;&nbsp;1/10); uncommon (&#8805;&nbsp;1/1,0=
00
to &lt;&nbsp;1/100); rare (&#8805;&nbsp;1/10,000 to &lt;&nbsp;1/1,000); very
rare (&lt;&nbsp;1/10,000); not known (cannot be estimated from the available
data). </span><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Within=
 each
frequency grouping, adverse reactions are presented in order of decreasing
seriousness.</span><span lang=3DEN-GB style=3D'mso-fareast-font-family:"Tim=
es New Roman"'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:6.0pt;line-height:normal;page-b=
reak-after:
avoid'><b><span style=3D'mso-ansi-language:EN-US'>Table&nbsp;2: Adverse rea=
ctions
in ivacaftor&#8209;treated patients aged 4&nbsp;months and older<o:p></o:p>=
</span></b></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"95%"
 style=3D'width:95.28%;margin-left:5.45pt;border-collapse:collapse;border:n=
one;
 mso-border-alt:solid windowtext .5pt;mso-padding-alt:0in 5.4pt 0in 5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <thead>
  <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;page-break-inside:avoi=
d;
   height:12.55pt'>
   <td width=3D"32%" valign=3Dtop style=3D'width:32.52%;border:solid window=
text 1.0pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   12.55pt'>
   <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'=
><b><span
   lang=3DEN-GB>System organ class</span></b></p>
   </td>
   <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border:solid window=
text 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:12.55pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   page-break-after:avoid'><b><span style=3D'mso-ansi-language:EN-US'>Adver=
se
   reactions<o:p></o:p></span></b></p>
   </td>
   <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border:solid window=
text 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:12.55pt'>
   <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'=
><b><span
   lang=3DNL-BE style=3D'mso-ansi-language:NL-BE'>Frequency <o:p></o:p></sp=
an></b></p>
   </td>
  </tr>
 </thead>
 <tr style=3D'mso-yfti-irow:1;page-break-inside:avoid;height:6.4pt'>
  <td width=3D"32%" rowspan=3D3 valign=3Dtop style=3D'width:32.52%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:6.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Infe=
ctions and
  infestations</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:6=
.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Upper
  respiratory tract infection</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:6=
.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>very=
 common</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;page-break-inside:avoid;height:6.4pt'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:6=
.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Naso=
pharyngitis</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:6=
.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>very=
 common</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;page-break-inside:avoid;height:6.35pt'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:6=
.35pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Rhin=
itis </span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:6=
.35pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>comm=
on</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;page-break-inside:avoid'>
  <td width=3D"32%" rowspan=3D2 valign=3Dtop style=3D'width:32.52%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Nerv=
ous system
  disorders</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Head=
ache</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>very=
 common</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;page-break-inside:avoid'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Dizz=
iness</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>very=
 common</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;page-break-inside:avoid;height:13.15pt'>
  <td width=3D"32%" rowspan=3D6 valign=3Dtop style=3D'width:32.52%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Ear =
and
  labyrinth disorders</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Ear =
pain</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>comm=
on</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;page-break-inside:avoid;height:13.15pt'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Ear =
discomfort</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>comm=
on</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;page-break-inside:avoid;height:13.15pt'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Tinn=
itus</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>comm=
on</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;page-break-inside:avoid;height:13.15pt'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Tymp=
anic
  membrane hyperaemia</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>comm=
on</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;page-break-inside:avoid;height:13.15pt'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Vest=
ibular
  disorder</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>comm=
on</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;page-break-inside:avoid;height:13.15pt'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Ear =
congestion</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>unco=
mmon</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;page-break-inside:avoid;height:13.15pt'>
  <td width=3D"32%" rowspan=3D4 valign=3Dtop style=3D'width:32.52%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>Respiratory, thoracic and mediastinal disorders</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>Oropharyngeal pain</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.15pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>very common</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;page-break-inside:avoid;height:6.4pt'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:6=
.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>Nasal congestion</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:6=
.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>very common</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;page-break-inside:avoid;height:6.4pt'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:6=
.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>Sinus congestion </span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:6=
.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>common</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:15;page-break-inside:avoid;height:16.6pt'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
6.6pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Phar=
yngeal
  erythema</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
6.6pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>comm=
on</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:16;page-break-inside:avoid;height:18.75pt'>
  <td width=3D"32%" rowspan=3D2 valign=3Dtop style=3D'width:32.52%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.75pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Gast=
rointestinal
  disorders</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.75pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Abdo=
minal pain</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.75pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>very=
 common</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:17;page-break-inside:avoid;height:18.75pt'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.75pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Diar=
rhoea</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.75pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>very=
 common</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:18;page-break-inside:avoid;height:18.75pt'>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.52%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.75pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DDA style=
=3D'mso-ansi-language:
  DA'>Hepatobiliary disorders</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.75pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Tran=
saminase
  elevations</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.75pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>very=
 common</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:19;page-break-inside:avoid'>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.52%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Skin=
 and
  subcutaneous tissue disorders</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Rash=
</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>very=
 common</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:20;page-break-inside:avoid'>
  <td width=3D"32%" rowspan=3D5 valign=3Dtop style=3D'width:32.52%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Repr=
oductive
  system and breast disorders</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Brea=
st mass</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>comm=
on</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:21;page-break-inside:avoid'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Brea=
st
  inflammation</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>unco=
mmon</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:22;page-break-inside:avoid'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Gyna=
ecomastia</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>unco=
mmon</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:23;page-break-inside:avoid'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Nipp=
le
  disorder</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>unco=
mmon</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:24;page-break-inside:avoid'>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Nipp=
le pain</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>unco=
mmon</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:25;mso-yfti-lastrow:yes;page-break-inside:avoid;
  height:16.6pt'>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.52%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.6pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Inve=
stigations</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.76%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
6.6pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Bact=
eria in
  sputum</span></p>
  </td>
  <td width=3D"33%" valign=3Dtop style=3D'width:33.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
6.6pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>very=
 common</span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Description of selected adverse reactions<o:p></o:p></span></u=
></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i=
><span
lang=3DEN-GB>Transaminase elevations</span></i><i style=3D'mso-bidi-font-st=
yle:
normal'><span lang=3DEN-GB><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>During the 48&#8209;week placebo&#8209;controlled studies 1 an=
d 2 in
patients aged 6&nbsp;years and older, the incidence of maximum transaminase
(ALT or AST) &gt;&nbsp;8, &gt;&nbsp;5 or &gt;&nbsp;3&nbsp;x ULN was 3.7%, 3=
.7%
and 8.3% in ivacaftor-treated patients and 1.0%, 1.9% and 8.7% in
placebo-treated patients, respectively. Two patients, one on placebo and on=
e on
ivacaftor, permanently discontinued treatment for elevated transaminases, e=
ach
&gt;&nbsp;8&nbsp;x ULN. No ivacaftor&#8209;treated patients experienced a
transaminase elevation &gt;&nbsp;3&nbsp;x ULN associated with elevated total
bilirubin &gt;&nbsp;1.5&nbsp;x ULN. In ivacaftor-treated patients, most
transaminase elevations up to 5&nbsp;x ULN resolved without treatment
interruption. Ivacaftor dosing was interrupted in most patients with
transaminase elevations &gt;&nbsp;5<span style=3D'mso-bidi-font-weight:bold=
'>&nbsp;</span>x
ULN. In all instances where dosing was interrupted for elevated transaminas=
es
and </span><span lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New R=
oman"'>subsequently
resumed, ivacaftor</span><span lang=3DEN-GB> dosing was able to be resumed
successfully (see section&nbsp;4.4).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>During the placebo controlled phase=
 3
studies (up to 24 weeks) of tezacaftor/ivacaftor, the incidence of maximum
transaminase (ALT or AST) &gt; 8, &gt; 5, or &gt; 3 x ULN were 0.2%, 1.0%, =
and
3.4% in tezacaftor/ivacaftor treated patients, and 0.4%, 1.0%, and 3.4% in
placebo-treated patients. One patient (0.2%) on therapy and 2 patients (0.4=
%)
on placebo permanently discontinued treatment for elevated transaminases. No
patients treated with tezacaftor/ivacaftor experienced a transaminase eleva=
tion
&gt;3 x ULN associated with elevated total bilirubin &gt;2 x ULN. </span></=
p>

<p class=3DMsoNormal><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>During the 24-week, placebo-control=
led, phase
3 study of ivacaftor/tezacaftor/elexacaftor, these figures were 1.5%, 2.5%,=
 and
7.9% in ivacaftor/tezacaftor/elexacaftor-treated patients and 1.0%, 1.5%, a=
nd
5.5% in placebo-treated patients. The incidence of adverse reactions of
transaminase elevations was 10.9% in ivacaftor in a combination regimen with
ivacaftor/tezacaftor/elexacaftor treated patients and 4.0% in placebo-treat=
ed
patients.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt;mso-fareast-font-family:"MS =
Mincho";
mso-fareast-language:JA'>Paediatric population<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt;mso-fareast-font-family:"MS =
Mincho";
mso-fareast-language:JA'><o:p><span style=3D'text-decoration:none'>&nbsp;</=
span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt;mso-fareast-font-family:"MS =
Mincho";
mso-fareast-language:JA'>The safety data of ivacaftor were evaluated in 6
patients between 4 months to less than 6 months of age, 11&nbsp;patients
between 6&nbsp;months to less than 12&nbsp;months of age, 19&nbsp;patients
between 12&nbsp;months to less than 24&nbsp;months of age, 34&nbsp;patients
between 2 to less than 6&nbsp;years of age, 61&nbsp;patients between 6 to l=
ess
than 12&nbsp;years of age and 94&nbsp;patients between 12 to less than 18&n=
bsp;years
of age.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:8.0pt;mso-fareast-font-family:"MS Mincho";mso-f=
areast-language:
JA'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:8.0pt;mso-fareast-font-family:"MS Mincho";mso-f=
areast-language:
JA'>The safety profile is generally consistent among paediatric patients ag=
ed 4&nbsp;months
and older and is also consistent with adult patients.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-size:8.0pt;mso-fareast-font-family:"MS Mincho";mso-f=
areast-language:
JA'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt;m=
so-fareast-font-family:
"MS Mincho";mso-fareast-language:JA'>The incidence of transaminase elevatio=
ns
(ALT or AST) observed in studies 2, 5 and 6 (patients aged 6 to less than 12
years), study 7 (patients aged 2 to less than 6&nbsp;years), and study 8
(patients aged 6 to less than 24 months) are described in Table 3. </span><=
span
lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt;mso-bidi-font-weight:bold'>I=
n the
placebo controlled studies, the incidence of transaminase elevations were
similar between treatment with ivacaftor (15.0%) and placebo</span><span
style=3D'mso-bidi-font-size:8.0pt;mso-ansi-language:EN-US;mso-bidi-font-wei=
ght:
bold'>(14.6%)</span><span lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt;
mso-bidi-font-weight:bold'>Across all populations, </span><span
style=3D'mso-bidi-font-size:8.0pt;mso-ansi-language:EN-US;mso-bidi-font-wei=
ght:
bold'>peak LFT </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt;
mso-bidi-font-weight:bold'>elevations </span><span style=3D'mso-fareast-fon=
t-family:
"Times New Roman";mso-ansi-language:EN-US'>returned to baseline levels
following interruption, and </span><span style=3D'mso-bidi-font-size:8.0pt;
mso-ansi-language:EN-US;mso-bidi-font-weight:bold'>in almost all instances
where dosing was interrupted for elevated transaminases and subsequently
resumed, ivacaftor dosing was able to be resumed successfully (see
section&nbsp;4.4). Cases suggestive of positive rechallenge were observed. =
In
study 7 </span><span lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt;mso-bid=
i-font-weight:
bold'>ivacaftor was permanently discontinued in one patient. In study 8 </s=
pan><span
lang=3DEN-GB>no patients had elevations in total bilirubin or discontinued
ivacaftor treatment due to transaminase elevations in either cohort (see
section&nbsp;4.4 for management of elevated transaminases).</span></p>

<p class=3DMsoNormal><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-bottom:12.0pt'><b><span lang=3DEN-GB>T=
able&nbsp;3:
Transaminase elevations in patients 4&nbsp;months to &lt; 12&nbsp;years tre=
ated
with ivacaftor as monotherapy<o:p></o:p></span></b></p>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'margin-left:6.85pt;border-collapse:collapse;border:none;mso-borde=
r-alt:
 solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in =
5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:28.95pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:2=
8.95pt'>
  <p class=3DMsoNormal><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></=
p>
  </td>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:28.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b><span
  lang=3DEN-GB>n<o:p></o:p></span></b></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:28.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b><span
  lang=3DEN-GB>% of Patients &gt; 3 x ULN <o:p></o:p></span></b></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:28.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b><span
  lang=3DEN-GB>% of Patients &gt;5 x ULN<o:p></o:p></span></b></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border:solid windowtex=
t 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:28.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b><span
  lang=3DEN-GB>% of Patients &gt; 8 x ULN<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;height:14.35pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.35pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>6 to &lt;12 years</span></p>
  </td>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>40</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>15.0%
  (6)</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>2.5%
  (1)</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>2.5%
  (1)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:14.35pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.35pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>2 to &lt;6 years</span></p>
  </td>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>34</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>14.7%
  (5)</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>14.7%
  (5)</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>14.7%
  (5)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:14.35pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:14.35pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>12 to &lt;24 months</span></p>
  </td>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>18</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>27.8%
  (5)</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>11.1%
  (2)</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
4.35pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>11.1%
  (2)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:13.7pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.7pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>6 to &lt;12 months</span></p>
  </td>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>11</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>9.1%
  (1)</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>0.0%
  (0)</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>0.0%
  (0)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;mso-yfti-lastrow:yes;height:13.7pt'>
  <td width=3D161 valign=3Dtop style=3D'width:121.1pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.7pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>4 to &lt;6 months</span></p>
  </td>
  <td width=3D66 valign=3Dtop style=3D'width:49.65pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>6</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:80.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>0.0%
  (0)</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>0.0%
  (0)</span></p>
  </td>
  <td width=3D108 valign=3Dtop style=3D'width:81.0pt;border-top:none;border=
-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.7pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><span lan=
g=3DEN-GB>0.0%
  (0)</span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Reporting of suspected adverse reactions<o:p></o:p></span></u>=
</p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Reporting suspected adverse reactions after authorisation of t=
he
medicinal product is important. It allows continued monitoring of the
benefit/risk balance of the medicinal product. Healthcare professionals are
asked to report any suspected adverse reactions via <span style=3D'backgrou=
nd:
lightgrey;mso-highlight:lightgrey'>the national reporting system listed in =
</span><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
style=3D'color:windowtext;background:lightgrey;mso-highlight:lightgrey'>App=
endix
V</span></a>.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin:0in'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-b=
idi-font-size:
12.0pt'>4.9<span style=3D'mso-tab-count:1'> </span>Overdose</span></h=
2>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt'>No
specific antidote is available for overdose with ivacaftor. Treatment of
overdose consists of general supportive measures including monitoring of vi=
tal
signs, liver function tests and observation of the clinical status of the
patient.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in'><span lang=3DEN-GB style=3D'font-size:11.0pt;font-=
family:
"Times New Roman",serif;mso-bidi-font-family:Arial'>5.<span style=3D'mso-ta=
b-count:
1'> </span>PHARMACOLOGICAL PROPERTIES</span><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.5pt;text-indent:-28.5pt;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2;mso-list:l33 level2 lfo17;tab-stops:list 28.5pt'><![if =
!supportLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'><span
style=3D'mso-list:Ignore'>5.1<span style=3D'font:7.0pt "Times New Roman"'>&=
nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>Pharmacodynamic
properties<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:1'><i><span lang=3DEN-GB><o:p>&nbs=
p;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1'><span lang=3DEN-GB>Pharmacotherapeutic group: Other respiratory system
products, ATC code: </span><span style=3D'mso-fareast-font-family:"MS Minch=
o";
mso-ansi-language:EN-US;mso-fareast-language:JA;mso-bidi-font-weight:bold'>=
R07AX02</span><i><span
lang=3DEN-GB><o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><u><span lang=3DEN-GB><o:p><span style=3D'text-decorat=
ion:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><u><span lang=3DEN-GB>Mechanism of action<o:p></o:p></=
span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><u><span lang=3DEN-GB><o:p><span style=3D'text-decorat=
ion:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold'>Ivacaftor is a potentiator of the CFTR
protein, i.e., <i style=3D'mso-bidi-font-style:normal'>in&nbsp;vitro</i>
ivacaftor increases CFTR channel gating to enhance chloride transport in
specified gating mutations (as listed in section&nbsp;4.1) with reduced cha=
nnel&#8209;open
probability <span style=3D'mso-bidi-font-style:italic'>compared to normal C=
FTR</span>.
Ivacaftor also potentiated the channel-open probability of <span
style=3D'mso-bidi-font-style:italic'>R117H-CFTR</span>, which has both low
channel-open probability (gating) and reduced channel current amplitude
(conductance). The <i style=3D'mso-bidi-font-style:normal'>G970R </i>mutati=
on
causes a splicing defect resulting in little-to-no CFTR protein at the cell
surface which may explain the results observed in subjects with this mutati=
on
in study&nbsp;5 (see Pharmacodynamic effects and Clinical efficacy data). <=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>In&nbsp;vitr=
o</span></i><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'> responses seen in single =
channel
patch clamp experiments using membrane patches from rodent cells expressing
mutant CFTR forms do not necessarily correspond to <i style=3D'mso-bidi-fon=
t-style:
normal'>in&nbsp;vivo </i>pharmacodynamic response (e.g., sweat chloride) or
clinical benefit. </span><span lang=3DEN-GB>The exact mechanism leading iva=
caftor
to potentiate the gating activity of normal and some mutant CFTR forms in t=
his
system has not been completely elucidated.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Pharmacodynamic effects</span></u><i><span lang=3DEN-GB><o:p><=
/o:p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>In
studies&nbsp;1 and 2 in patients with the <i style=3D'mso-bidi-font-style:n=
ormal'>G551D
</i>mutation in one allele of the <i style=3D'mso-bidi-font-style:normal'>C=
FTR</i>
gene, ivacaftor led to rapid (15&nbsp;days), substantial (the mean change in
sweat chloride from baseline through week&nbsp;24 was &#8209;48&nbsp;mmol/L
[95% CI &#8209;51, &#8209;45] and &#8209;54&nbsp;mmol/L [95% CI &#8209;62, =
&#8209;47],
respectively) and sustained (through 48&nbsp;weeks) reductions in sweat
chloride concentration.</span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB><o:p><span style=3D'text-decorat=
ion:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal><span lang=3DEN-GB>In study&nbsp;5, part 1 in patients=
 who had
a non-<i style=3D'mso-bidi-font-style:normal'>G551D</i> gating mutation in =
the <i
style=3D'mso-bidi-font-style:normal'>CFTR</i> gene, treatment with ivacafto=
r led
to a rapid (15&nbsp;days) and substantial mean change from baseline in sweat
chloride of &#8209;49&nbsp;mmol/L (95%&nbsp;CI &#8209;57, &#8209;41) through
8&nbsp;weeks of treatment. However, in patients with the <i style=3D'mso-bi=
di-font-style:
normal'>G970R</i>&#8209;<i style=3D'mso-bidi-font-style:normal'>CFTR</i>
mutation, the mean (SD) absolute change in sweat chloride at week&nbsp;8 wa=
s &#8209;6.25
(6.55)&nbsp;mmol/L. Similar results to part 1 were seen in part 2 of the st=
udy.
At the 4&#8209;week follow&#8209;up visit (4 weeks after dosing with ivacaf=
tor
ended), mean sweat chloride values for each group were trending to pre&#820=
9;treatment
levels.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>In study&nbsp;6 in patients aged
6&nbsp;years or older with CF who had an <i style=3D'mso-bidi-font-style:no=
rmal'>R117H</i>
mutation in the <i style=3D'mso-bidi-font-style:normal'>CFTR</i> gene, the
treatment difference in mean change in sweat chloride from baseline through
24&nbsp;weeks of treatment was &#8209;24&nbsp;mmol/L (95%&nbsp;CI &#8209;28=
, &#8209;20).
In subgroup analyses by age, the treatment difference was &#8209;21.87 mmol=
/L
(95% CI: &#8209;26.46, &#8209;17.28) in patients aged 18&nbsp;years or olde=
r,
and &#8209;27.63 mmol/L (95% CI: &#8209;37.16, &#8209;18.10) in patients ag=
ed 6&#8209;11&nbsp;years.
Two&nbsp;patients 12 to 17<span style=3D'mso-bidi-font-weight:bold'>&nbsp;<=
/span>years
of age were enrolled in this study.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>In study&nbsp;7 in patients aged 2 =
to less
than 6&nbsp;years with a gating mutation on at least 1&nbsp;allele of the <i
style=3D'mso-bidi-font-style:normal'>CFTR</i> gene administered either 50&n=
bsp;mg
or 75&nbsp;mg of ivacaftor twice daily, the mean absolute change from basel=
ine
in sweat chloride was &#8209;47&nbsp;mmol/L (95% CI &#8209;58, &#8209;36) a=
t week&nbsp;24.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>In study&nbsp;8 in patients with CF=
 aged
less than 24&nbsp;months, the mean absolute change from baseline in sweat
chloride was -65.1&nbsp;mmol/L (95% CI &#8209;74.1, &#8209;56.0) at week&nb=
sp;24.
Results were consistent in the 12&nbsp;months to less than 24&nbsp;months,
6&nbsp;months to less than 12&nbsp;months, and 4 months to less than 6 mont=
hs
age cohorts.</span></p>

<p class=3DMsoNormal><u><span lang=3DEN-GB><o:p><span style=3D'text-decorat=
ion:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><u><span lang=3DEN-GB=
>Clinical
efficacy and safety<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><u><span lang=3DEN-GB=
><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB>Study 1 and 2: studies in patients with CF with =
G551D
gating mutations<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Th=
e efficacy
of ivacaftor has been evaluated in two phase&nbsp;3 randomised, double&#820=
9;blind,
placebo&#8209;controlled, multi&#8209;centre studies of clinically stable
patients with CF who had the <i style=3D'mso-bidi-font-style:normal'>G551D<=
/i>
mutation in the <i style=3D'mso-bidi-font-style:normal'>CFTR</i> gene on at=
 least
1&nbsp;allele and had FEV<sub>1</sub> </span><span style=3D'font-family:Sim=
Sun;
mso-ascii-font-family:"Times New Roman";mso-hansi-font-family:"Times New Ro=
man"'>&#8805;</span><span
lang=3DEN-GB>&nbsp;40% predicted.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>Patients in both studies were rando=
mised
1:1 to receive either 150&nbsp;mg of ivacaftor or placebo every 12&nbsp;hou=
rs
with food containing fat for 48&nbsp;weeks in addition to their prescribed =
CF
therapies (e.g., tobramycin, dornase alfa). The use of inhaled hypertonic s=
odium
chloride was not permitted.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>Study&nbsp;1 evaluated 161&nbsp;pat=
ients
who were 12&nbsp;years of age or older; 122 (75.8%) patients had the <i
style=3D'mso-bidi-font-style:normal'>F508del</i> mutation in the second all=
ele.
At the start of the study, patients in the placebo group used some medicinal
products at a higher frequency than the ivacaftor group. These medications
included dornase alfa (73.1% versus 65.1%), salbutamol (53.8% versus 42.2%),
tobramycin (44.9% versus 33.7%) and salmeterol/fluticasone (41.0% versus
27.7%). At baseline, mean predicted FEV<sub>1</sub> was 63.6% (range: 31.6%=
 to
98.2%) and mean age was 26&nbsp;years (range: 12 to 53&nbsp;years).</span><=
/p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>Study&nbsp;2 evaluated 52&nbsp;pati=
ents who
were 6&nbsp;to 11&nbsp;years of age at screening; mean (SD) body weight was
30.9 (8.63)&nbsp;kg; 42 (80.8%) patients had the <i style=3D'mso-bidi-font-=
style:
normal'>F508del</i> mutation in the second allele. At baseline, mean predic=
ted
FEV<sub>1</sub> was 84.2% (range: 44.0% to 133.8%) and mean age was
9&nbsp;years (range: 6 to 12&nbsp;years); 8&nbsp;(30.8%) patients in the
placebo group and 4 (15.4%) patients in the ivacaftor group had an FEV<sub>=
1</sub>
less than 70% predicted at baseline.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>The primary efficacy endpoint in bo=
th
studies was the mean absolute change from baseline in percent predicted FEV=
<sub>1</sub>
through 24&nbsp;weeks of treatment.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>The treatment difference between iv=
acaftor
and placebo for the mean absolute change (95% CI) in percent predicted FEV<=
sub>1</sub>
from baseline through week&nbsp;24 was 10.6&nbsp;percentage points (8.6, 12=
.6)
in study&nbsp;1 and 12.5&nbsp;percentage points (6.6, 18.3) in study&nbsp;2.
The treatment difference between ivacaftor and placebo for the mean relative
change (95% CI) in percent predicted FEV<sub>1</sub> from baseline through =
week&nbsp;24
was 17.1% (13.9, 20.2) in study&nbsp;1 and 15.8% (8.4, 23.2) in study&nbsp;=
2.
The mean change from baseline through week&nbsp;24 in FEV<sub>1</sub> (L) w=
as
0.37&nbsp;L in the ivacaftor group and 0.01&nbsp;L in the placebo group in
study&nbsp;1 and 0.30&nbsp;L in the ivacaftor group and 0.07&nbsp;L in the
placebo group in study&nbsp;2. In both studies, improvements in FEV<sub>1</=
sub>
were rapid in onset (day&nbsp;15) and durable through 48&nbsp;weeks.</span>=
</p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>The treatment difference between iv=
acaftor
and placebo for the mean absolute change (95% CI) in percent predicted FEV<=
sub>1</sub>
from baseline through week&nbsp;24 in patients 12 to 17&nbsp;years of age in
study&nbsp;1 was 11.9&nbsp;percentage points (5.9, 17.9). The treatment
difference between ivacaftor and placebo for the mean absolute change (95% =
CI)
in percent predicted FEV<sub>1</sub> from baseline through week&nbsp;24 in
patients with baseline predicted FEV<sub>1 </sub>greater than 90% in study&=
nbsp;2
was 6.9&nbsp;percentage points (&#8209;3.8, 17.6).</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The re=
sults for
clinically relevant secondary endpoints are shown in Table&nbsp;4.</span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><b=
><span
lang=3DEN-GB>Table&nbsp;4: Effect of ivacaftor on other efficacy endpoints =
in
studies 1 and 2<o:p></o:p></span></b></p>

<table class=3DMsoNormalTable border=3D0 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"98%"
 style=3D'width:98.82%;margin-left:5.45pt;border-collapse:collapse;mso-yfti=
-tbllook:
 480;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <thead>
  <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:10.5pt'>
   <td width=3D"27%" rowspan=3D2 valign=3Dbottom style=3D'width:27.12%;bord=
er:solid windowtext 1.0pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   10.5pt'>
   <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
   tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso-fareast-language:EN-G=
B'>Endpoint<o:p></o:p></span></b></p>
   </td>
   <td width=3D"34%" colspan=3D2 valign=3Dtop style=3D'width:34.82%;border:=
solid windowtext 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:10.5pt'>
   <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
   tab-stops:.5in'><b><span lang=3DEN-GB>Study&nbsp;1</span></b><b><span
   lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></b>=
</p>
   </td>
   <td width=3D"38%" colspan=3D2 valign=3Dtop style=3D'width:38.06%;border:=
solid windowtext 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:10.5pt'>
   <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
   tab-stops:.5in'><b><span lang=3DEN-GB>Study&nbsp;2</span></b><b><span
   lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></b>=
</p>
   </td>
  </tr>
  <tr style=3D'mso-yfti-irow:1;height:28.25pt'>
   <td width=3D"20%" valign=3Dbottom style=3D'width:20.18%;border-top:none;
   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid=
 windowtext 1.0pt;
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windo=
wtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   28.25pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso-fareast-language:EN-G=
B'>Treatment
   difference<sup>a</sup><o:p></o:p></span></b></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso-fareast-language:EN-G=
B'>(95%&nbsp;CI)<o:p></o:p></span></b></p>
   </td>
   <td width=3D"14%" valign=3Dbottom style=3D'width:14.64%;border:solid win=
dowtext 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:28.25pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   tab-stops:.5in'><b><i><span lang=3DEN-GB>P </span></i><span lang=3DEN-GB
   style=3D'mso-bidi-font-style:italic'>value</span></b><b><span lang=3DEN-=
GB
   style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></b></p>
   </td>
   <td width=3D"20%" valign=3Dbottom style=3D'width:20.18%;border-top:none;
   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid=
 windowtext 1.0pt;
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windo=
wtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   28.25pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso-fareast-language:EN-G=
B'>Treatment
   difference<sup>a</sup><o:p></o:p></span></b></p>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   tab-stops:.5in'><b><span lang=3DEN-GB style=3D'mso-fareast-language:EN-G=
B'>(95%&nbsp;CI)<o:p></o:p></span></b></p>
   </td>
   <td width=3D"17%" valign=3Dbottom style=3D'width:17.88%;border-top:none;
   border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid=
 windowtext 1.0pt;
   mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid windo=
wtext .5pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   28.25pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heig=
ht:normal;
   page-break-after:avoid;tab-stops:.5in'><b><i><span lang=3DEN-GB>P </span=
></i><span
   lang=3DEN-GB style=3D'mso-bidi-font-style:italic'>value</span></b><b><sp=
an
   lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></b>=
</p>
   </td>
  </tr>
 </thead>
 <tr style=3D'mso-yfti-irow:2;height:10.5pt'>
  <td width=3D"100%" colspan=3D5 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bott=
om-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:10.5pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b><span lang=3DEN-GB>Mean absolute change from baseline =
in
  CFQ-R</span></b><sup><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bol=
d'>b</span></sup><b><span
  lang=3DEN-GB> respiratory domain score (points)</span></b><sup><span
  lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>c</span></sup><b><i><span
  lang=3DEN-GB><o:p></o:p></span></i></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>Through week 24<o:p></o=
:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>8=
.1<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
4.7,
  11.4)<o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>&=
lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>6=
.1<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
&#8209;1.4,
  13.5)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.1092<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:18.85pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>Through week 48</span><=
/p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>8.6</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>(5.3, 11.9)</span><span lang=3DEN-GB
  style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>&=
lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>5=
.1<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
&#8209;1.6,
  11.8)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.1354<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;height:9.95pt'>
  <td width=3D"100%" colspan=3D5 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:9.95pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b><span lang=3DEN-GB>Relative risk of pulmonary exacerba=
tion</span></b><b><span
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></b><=
/p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;height:10.5pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:10.5pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>T=
hrough week
  24<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.5pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB>0.40</span><sup=
><span
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>d</span></sup><span lan=
g=3DEN-GB
  style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.5pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB>0.0016</span><s=
pan
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.5pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>NA<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.5pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>NA<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;height:9.95pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:9.95pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>T=
hrough week
  48</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:9=
.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.46<sup>d</sup><o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:9=
.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0012<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:9=
.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>NA<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:9=
.95pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>NA<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;height:10.5pt'>
  <td width=3D"100%" colspan=3D5 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:10.5pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b><span lang=3DEN-GB>Mean absolute change from baseline =
in
  body weight (kg)</span></b><b><span lang=3DEN-GB style=3D'mso-fareast-lan=
guage:
  EN-GB'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;height:18.85pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB>At&nbsp;week 24</span><span lang=3DEN-GB style=3D'mso-fareas=
t-language:
  EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>2.8</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>(1.8, 3.7)</span><span lang=3DEN-GB
  style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>&lt;&nbsp;0.0001</span><span lang=3DEN=
-GB
  style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>1.9</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
0.9,
  2.9)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.85pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0004<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB>At&nbsp;week 48</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:35.75pt'><span lang=3DEN-GB>2.7</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>(1.3, 4.1)</span><span lang=3DEN-GB
  style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>0=
.0001<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:32.7pt'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'=
>2.8<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
1.3,
  4.2)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0002<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;height:15.5pt'>
  <td width=3D"100%" colspan=3D5 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bott=
om-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:15.5pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-=
GB
  style=3D'mso-fareast-language:EN-GB'>Mean absolute change from baseline i=
n BMI
  (kg/m<sup>2</sup>)<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:12;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB>At week 24</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:35.2pt'><span lang=3DEN-GB>0.94</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:34.05pt'><span lang=3DEN-GB>(0.62, 1.26)</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>&=
lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>0=
.81<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
0.34,
  1.28)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0008<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:13;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB>At week 48</span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>0.93</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>(0.48, 1.38)</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>&=
lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>1=
.09<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
0.51,
  1.67)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0003<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:14;height:15.05pt'>
  <td width=3D"100%" colspan=3D5 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-left-alt:solid windowtext .5pt;mso-border-bott=
om-alt:
  solid windowtext .5pt;mso-border-right-alt:solid windowtext .5pt;padding:
  0in 5.4pt 0in 5.4pt;height:15.05pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-=
GB
  style=3D'mso-fareast-language:EN-GB'>Mean change from baseline in z&#8209=
;scores</span></b><span
  lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:15;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
  lang=3DEN-GB>Weight&#8209;for&#8209;age z&#8209;score at week 48<sup>e</s=
up></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>0.33</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>(0.04, 0.62)</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>0=
.0260<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>0=
.39<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-language:EN-GB'>(=
0.24,
  0.53)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>&lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:16;mso-yfti-lastrow:yes;height:18.3pt'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.12%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:18.3pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;
  tab-stops:.5in'><span lang=3DEN-GB>BMI&#8209;for&#8209;age z&#8209;score =
at week
  48<sup>e</sup></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB>0.33</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB>(0.002, 0.65)</=
span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.64%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.0490<o:p></o:p></span></p>
  </td>
  <td width=3D"20%" valign=3Dtop style=3D'width:20.18%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>0.45<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>(0.26, 0.65)<o:p></o:p></span></p>
  </td>
  <td width=3D"17%" valign=3Dtop style=3D'width:17.88%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
8.3pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fa=
reast-language:
  EN-GB'>&lt;&nbsp;0.0001<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'font-size:9.0pt'>CI: confidence interval; NA: not ana=
lysed
due to low incidence of events <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;page-break=
-after:
avoid'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt'>a</span></sup><span
lang=3DEN-GB style=3D'font-size:9.0pt'><span style=3D'mso-tab-count:1'>=
 </span>Treatment
difference =3D effect of ivacaftor  effect of placebo<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;page-break=
-after:
avoid'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt'>b</span></sup><span
lang=3DEN-GB style=3D'font-size:9.0pt'><span style=3D'mso-tab-count:1'>=
 </span>CFQ-R:
Cystic Fibrosis Questionnaire-Revised is a disease-specific, health-related
quality-of-life measure for CF.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;page-break=
-after:
avoid;tab-stops:.5in'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt'>c</=
span></sup><span
lang=3DEN-GB style=3D'font-size:9.0pt'><span style=3D'mso-tab-count:1'>=
 </span>Study&nbsp;1
data were pooled from CFQ-R for adults/adolescents and CFQ-R for children 1=
2 to
13&nbsp;years of age; Study&nbsp;2 data were obtained from CFQ-R for childr=
en 6
to 11&nbsp;years of age.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;page-break=
-after:
avoid'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt'>d</span></sup><span
lang=3DEN-GB style=3D'font-size:9.0pt'><span style=3D'mso-tab-count:1'>=
 </span>Hazard
ratio for time to first pulmonary exacerbation<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;page-break=
-after:
avoid'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt'>e</span></sup><span
lang=3DEN-GB style=3D'font-size:9.0pt'><span style=3D'mso-tab-count:1'>=
 </span>In
subjects under 20&nbsp;years of age (CDC growth charts)<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Study&nbsp;5: study=
 in
patients with CF with non-G551D gating mutations<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Study&nbsp;5 was a phase&nbsp;3, two&#8209;part, randomised, d=
ouble&#8209;blind,
placebo-controlled, crossover study (part&nbsp;1) followed by a 16&#8209;we=
ek
open&#8209;label extension period (part&nbsp;2) to evaluate the efficacy and
safety of ivacaftor in patients with CF aged 6&nbsp;years and older who hav=
e a <i
style=3D'mso-bidi-font-style:normal'>G970R</i> or non&#8209;<i style=3D'mso=
-bidi-font-style:
normal'>G551D</i> gating mutation in the <i style=3D'mso-bidi-font-style:no=
rmal'>CFTR</i>
gene <span style=3D'mso-bidi-font-weight:bold'>(<i style=3D'mso-bidi-font-s=
tyle:
normal'>G178R, S549N, S549R, G551S, G1244E, S1251N, S1255P</i> or<i
style=3D'mso-bidi-font-style:normal'> G1349D</i>)</span>.<s><o:p></o:p></s>=
</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>In par=
t&nbsp;1, patients
were randomised 1:1 to receive either 150&nbsp;mg of ivacaftor or placebo e=
very
12&nbsp;hours with fat-containing food for 8&nbsp;weeks in addition to their
prescribed CF therapies and crossed over to the other treatment for the sec=
ond
8&nbsp;weeks after a 4- to 8&#8209;week washout period. The use of inhaled
hypertonic saline was not permitted. In part 2, all patients received ivaca=
ftor
as indicated in part 1 for 16 additional weeks. The duration of continuous
ivacaftor treatment was 24<span style=3D'mso-bidi-font-weight:bold'>&nbsp;<=
/span>weeks
for patients randomised to the part 1 placebo/ivacaftor treatment sequence =
and
16 weeks for patients randomised to part 1 ivacaftor/placebo treatment
sequence.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Thirty=
-nine
patients (mean age 23&nbsp;years) with baseline FEV<sub>1</sub> </span><span
style=3D'font-family:SimSun;mso-ascii-font-family:"Times New Roman";mso-han=
si-font-family:
"Times New Roman"'>&#8805;</span><span lang=3DEN-GB style=3D'mso-bidi-font-=
weight:
bold'>&nbsp;</span><span lang=3DEN-GB>40% predicted (mean FEV<sub>1</sub> 7=
8%
predicted [range: 43% to 119%]) were enrolled. Sixty&#8209;two percent (24/=
39)
of them carried the <i style=3D'mso-bidi-font-style:normal'>F508del</i>-<i
style=3D'mso-bidi-font-style:normal'>CFTR</i> mutation in the second allele=
. A
total of 36 patients continued into part 2 (18 per treatment sequence).</sp=
an></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold'><o:p><span style=3D'text-decoration:non=
e'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold'>In part 1 of study&nbsp;5, the mean FEV=
<sub>1</sub>
percent predicted at baseline in placebo-treated patients was 79.3% while in
ivacaftor&#8209;treated patients this value was 76.4%. The mean overall pos=
t&#8209;baseline
value was 76.0% and 83.7%, respectively. <span style=3D'mso-bidi-font-style=
:italic'>The
mean absolute change from baseline through week&nbsp;8 in percent predicted=
 FEV<sub>1</sub>
(primary efficacy endpoint) was 7.5% in the ivacaftor period and &#8209;3.2=
% in
the placebo period. The observed treatment difference (95% CI) between
ivacaftor and placebo was 10.7% (7.3, 14.1) </span></span><span lang=3DEN-G=
B>(P&nbsp;&lt;&nbsp;0.0001).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The ef=
fect of
ivacaftor in the overall population of study&nbsp;5 (including the secondary
endpoints absolute change in BMI<span style=3D'mso-bidi-font-style:italic'>=
 at 8</span>&nbsp;<span
style=3D'mso-bidi-font-style:italic'>weeks of treatment and absolute change=
 in
the respiratory domain score of the CFQ&#8209;R through 8</span>&nbsp;<span
style=3D'mso-bidi-font-style:italic'>weeks of treatment)</span> and by indi=
vidual
mutation (absolute change in sweat chloride and in percent predicted FEV<su=
b>1</sub>
at week&nbsp;8) is shown in Table&nbsp;5.<span style=3D'mso-bidi-font-style=
:italic'>
</span>Based on clinical (percent predicted FEV<sub>1</sub>) and
pharmacodynamic (sweat chloride) responses to ivacaftor, efficacy in patien=
ts
with the <i style=3D'mso-bidi-font-style:normal'>G970R</i> mutation could n=
ot be
established.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:6.0pt;page-break-after:avoid'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Table&nbsp;5: Effe=
ct of
ivacaftor for efficacy variables in the overall population and for specific=
 <i
style=3D'mso-bidi-font-style:normal'>CFTR</i> mutations<o:p></o:p></span></=
b></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D605
 style=3D'width:454.0pt;margin-left:5.35pt;border-collapse:collapse;border:=
none;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:160;mso-padding-alt:
 0in 5.4pt 0in 5.4pt;mso-border-insideh:.5pt solid windowtext;mso-border-in=
sidev:
 .5pt solid windowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D197 colspan=3D2 valign=3Dtop style=3D'width:147.75pt;border:s=
olid windowtext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>Absolute change in percent
  predicted FEV<sub>1</sub></span></b></p>
  </td>
  <td width=3D203 colspan=3D2 valign=3Dtop style=3D'width:152.5pt;border:so=
lid windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;mso-layout-grid-align:none;text-autospace:none'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  8.0pt'>BMI<o:p></o:p></span></b></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid;mso-layout-grid-align:none;text-autospace:none'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  8.0pt'>(kg/m<sup>2</sup>)<o:p></o:p></span></b></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.75pt;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>CFQ-R respiratory domain =
score
  (points)</span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D197 colspan=3D2 valign=3Dtop style=3D'width:147.75pt;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  8.0pt'>Through week&nbsp;8</span></b></p>
  </td>
  <td width=3D203 colspan=3D2 valign=3Dtop style=3D'width:152.5pt;border-to=
p:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  8.0pt'>At week&nbsp;8</span></b></p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-bid=
i-font-size:
  8.0pt'>Through week&nbsp;8</span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D605 colspan=3D5 valign=3Dtop style=3D'width:454.0pt;border:so=
lid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt=
'>All
  patients (N&nbsp;=3D&nbsp;39)<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt=
'>Results
  shown as mean (95% CI) change from baseline ivacaftor vs. placebo-treated
  patients:<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D197 colspan=3D2 valign=3Dtop style=3D'width:147.75pt;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt;mso-bidi-font-weight:bold;
  mso-bidi-font-style:italic'>10.7 (7.3, 14.1)</span></p>
  </td>
  <td width=3D203 colspan=3D2 valign=3Dtop style=3D'width:152.5pt;border-to=
p:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>0.66 (0.34, 0.99)</span><=
/p>
  </td>
  <td width=3D205 valign=3Dtop style=3D'width:153.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-bidi-font-size:8.0pt'>9.6 (4.5, 14.7)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:13.4pt'>
  <td width=3D"100%" colspan=3D5 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><b><span lang=3DEN-GB>Patients grouped under mutation
  types (n)<o:p></o:p></span></b></p>
  <p class=3DMsoNormal style=3D'line-height:normal;mso-layout-grid-align:no=
ne;
  text-autospace:none'><span lang=3DEN-GB>Results shown as mean (minimum,
  maximum) change from baseline for ivacaftor-treated patients <br>
  at week&nbsp;8*:</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;height:13.4pt'>
  <td width=3D"18%" rowspan=3D2 valign=3Dbottom style=3D'width:18.68%;borde=
r:solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:13.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  mso-layout-grid-align:none;text-autospace:none'><b><span lang=3DEN-GB>Mut=
ation
  (n)<o:p></o:p></span></b></p>
  </td>
  <td width=3D"40%" colspan=3D2 valign=3Dtop style=3D'width:40.52%;border-t=
op:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  mso-layout-grid-align:none;text-autospace:none'><b style=3D'mso-bidi-font=
-weight:
  normal'><span lang=3DEN-GB>Absolute change in sweat chloride (mmol/L)<o:p=
></o:p></span></b></p>
  </td>
  <td width=3D"40%" colspan=3D2 valign=3Dtop style=3D'width:40.8%;border-to=
p:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  mso-layout-grid-align:none;text-autospace:none'><b style=3D'mso-bidi-font=
-weight:
  normal'><span lang=3DEN-GB>Absolute change in percent predicted FEV<sub>1=
 </sub>(percentage
  points)<span style=3D'mso-bidi-font-weight:bold'><o:p></o:p></span></span=
></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;height:13.4pt'>
  <td width=3D"40%" colspan=3D2 valign=3Dtop style=3D'width:40.52%;border-t=
op:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  mso-layout-grid-align:none;text-autospace:none'><b style=3D'mso-bidi-font=
-weight:
  normal'><span lang=3DEN-GB>At week&nbsp;8<o:p></o:p></span></b></p>
  </td>
  <td width=3D"40%" colspan=3D2 valign=3Dtop style=3D'width:40.8%;border-to=
p:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
3.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  mso-layout-grid-align:none;text-autospace:none'><b style=3D'mso-bidi-font=
-weight:
  normal'><span lang=3DEN-GB>At week&nbsp;8<span style=3D'mso-bidi-font-wei=
ght:
  bold'><o:p></o:p></span></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;mso-yfti-lastrow:yes;height:88.5pt'>
  <td width=3D"18%" valign=3Dtop style=3D'width:18.68%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:88.5pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  mso-layout-grid-align:none;text-autospace:none'><i style=3D'mso-bidi-font=
-style:
  normal'><span lang=3DPT style=3D'mso-ansi-language:PT'>G1244E</span></i><=
span
  lang=3DPT style=3D'mso-ansi-language:PT'> (5)<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><i
  style=3D'mso-bidi-font-style:normal'><span lang=3DPT style=3D'mso-ansi-la=
nguage:
  PT'>G1349D</span></i><span lang=3DPT style=3D'mso-ansi-language:PT'> (2)<=
o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><i
  style=3D'mso-bidi-font-style:normal'><span lang=3DPT style=3D'mso-ansi-la=
nguage:
  PT'>G178R</span></i><span lang=3DPT style=3D'mso-ansi-language:PT'> (5)<o=
:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><i
  style=3D'mso-bidi-font-style:normal'><span lang=3DPT style=3D'mso-ansi-la=
nguage:
  PT'>G551S</span></i><span lang=3DPT style=3D'mso-ansi-language:PT'> (2)<o=
:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><i
  style=3D'mso-bidi-font-style:normal'><span lang=3DPT style=3D'mso-ansi-la=
nguage:
  PT'>G970R<sup>#</sup></span></i><span lang=3DPT style=3D'mso-ansi-languag=
e:PT'>
  (4)<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><i><span
  lang=3DEN-GB>S1251N </span></i><span lang=3DEN-GB>(8)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><i><span
  lang=3DEN-GB>S1255P</span></i><span lang=3DEN-GB> (2)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><i><span
  lang=3DEN-GB>S549N</span></i><span lang=3DEN-GB> (6)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  mso-layout-grid-align:none;text-autospace:none'><i><span lang=3DEN-GB>S54=
9R</span></i><span
  lang=3DEN-GB> (4)<b><o:p></o:p></b></span></p>
  </td>
  <td width=3D"40%" colspan=3D2 valign=3Dtop style=3D'width:40.52%;border-t=
op:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:8=
8.5pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>-55 (-75, -34)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>-80 (-82, -79)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>-53 (-65, -35)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>-68<sup><span style=3D'position:relative;top:-3.0pt;mso-text=
-raise:
  3.0pt'></span></sup></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>-6 (-16, -2)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>-54 (-84, -7)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>-78 (-82, -74)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>-74 (-93, -53)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>-61<span style=3D'position:relative;top:-3.0pt;mso-text-rais=
e:3.0pt'></span><span
  style=3D'mso-spacerun:yes'></span>(-71, -54)</span></p>
  </td>
  <td width=3D"40%" colspan=3D2 valign=3Dtop style=3D'width:40.8%;border-to=
p:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:8=
8.5pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>8 (-1, 18)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>20 (3, 36)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>8 (-1, 18)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>3<sup><span style=3D'position:relative;top:-3.0pt;mso-text-r=
aise:
  3.0pt'></span></sup></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>3 (-1, 5)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>9 (-20, 21)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>3 (-1, 8)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>11 (-2, 20)</span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>5 (-3, 13)<b style=3D'mso-bidi-font-weight:normal'><o:p></o:=
p></b></span></p>
  </td>
 </tr>
 <![if !supportMisalignedColumns]>
 <tr height=3D0>
  <td width=3D113 style=3D'border:none'></td>
  <td width=3D123 style=3D'border:none'></td>
  <td width=3D123 style=3D'border:none'></td>
  <td width=3D123 style=3D'border:none'></td>
  <td width=3D124 style=3D'border:none'></td>
 </tr>
 <![endif]>
</table>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;page-break=
-after:
avoid'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt'>*</span></sup><span
lang=3DEN-GB style=3D'font-size:9.0pt'><span style=3D'mso-tab-count:1'>=
 </span>Statistical
testing was not performed due to small numbers for individual mutations.<o:=
p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
page-break-after:avoid'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt'>=
</span></sup><span
lang=3DEN-GB style=3D'font-size:9.0pt'><span style=3D'mso-tab-count:1'>=
 </span>Reflects
results from the one patient with the <i style=3D'mso-bidi-font-style:norma=
l'>G551S</i>
mutation with data at the 8-week time point.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid'><sup><s=
pan
lang=3DEN-GB style=3D'font-size:9.0pt'></span></sup><span lang=3DEN-GB
style=3D'font-size:9.0pt'><span style=3D'mso-tab-count:1'> </span>n&nbsp=
;=3D&nbsp;3
for the analysis of absolute change in sweat chloride.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid'><sup><s=
pan
lang=3DEN-GB style=3D'font-size:9.0pt'>#<span style=3D'mso-tab-count:1'>=
 </span></span></sup><span
lang=3DEN-GB style=3D'font-size:9.0pt'>Causes a splicing defect resulting in
little-to-no CFTR protein at the cell surface<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>In part 2 of study&nbsp;5, the mean=
 (SD)
absolute change in percent predicted FEV<sub>1</sub> following 16 weeks
(patients randomised to the ivacaftor/placebo treatment sequence in part 1)=
 of continuous
ivacaftor treatment was 10.4% (13.2%). At the follow&#8209;up visit 4&nbsp;=
weeks
after ivacaftor dosing had ended, the mean (SD) absolute change in percent
predicted FEV<sub>1 </sub>from<sub> </sub>part 2 week 16 was &#8209;5.9%
(9.4%). For patients randomised to the placebo/ivacaftor treatment sequence=
 in
part 1 there was a further mean (SD) change of 3.3% (9.3%) in percent predi=
cted
FEV<sub>1</sub> after the additional 16 weeks of treatment with ivacaftor. =
At
the follow up visit 4&nbsp;weeks after ivacaftor dosing had ended, the mean
(SD) absolute change in percent predicted FEV<sub>1</sub> from part 2 week =
16
was &#8209;7.4% (5.5%).</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB>Study&nbsp;3:
study in patients with CF with the F508del mutation in the CFTR gene<o:p></=
o:p></span></i></p>

<p class=3DMsoNormal style=3D'mso-pagination:widow-orphan lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><span lang=3DEN-GB>Study&nbsp;3 (part&nbsp;A) was a=
 16&#8209;week,
4:1 randomised, double&#8209;blind, placebo&#8209;controlled, parallel&#820=
9;group
phase&nbsp;2 study of ivacaftor (150&nbsp;mg every 12&nbsp;hours) in
140&nbsp;patients with CF age 12&nbsp;years and older who were homozygous f=
or
the <i>F508del</i> mutation in the <i>CFTR</i> gene and who had FEV<sub>1</=
sub>
&#8805;&nbsp;40% predicted.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The me=
an
absolute change from baseline through week&nbsp;16 in percent predicted FEV=
<sub>1</sub>
(primary efficacy endpoint) was 1.5&nbsp;percentage points in the ivacaftor
group and &#8209;0.2&nbsp;percentage points in the placebo group. The estim=
ated
treatment difference for ivacaftor versus placebo was 1.7&nbsp;percentage
points (95% CI &#8209;0.6, 4.1); this difference was not statistically
significant (P&nbsp;=3D&nbsp;0.15).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho"'><o:p><span style=3D'text-deco=
ration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-fareas=
t-font-family:
"MS Mincho"'>Study&nbsp;4: open-label extension study<o:p></o:p></span></i>=
</p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-fareas=
t-font-family:
"MS Mincho"'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>In study&nbsp;4, patients who completed treatment in studies&nbsp;1 and=
 2
with placebo were switched to ivacaftor while patients on ivacaftor continu=
ed
to receive it for a minimum of 96&nbsp;weeks, i.e., the length of treatment
with ivacaftor was at least 96&nbsp;weeks for patients in the placebo/ivaca=
ftor
group and at least 144&nbsp;weeks for patients in the ivacaftor/ivacaftor
group.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>One h=
undred
and forty&#8209;four (144) patients from study&nbsp;1 were rolled over in
study&nbsp;4, 67 in the placebo/ivacaftor group and 77 in the
ivacaftor/ivacaftor group. Forty&#8209;eight (48)&nbsp;patients from
study&nbsp;2 were rolled over in study&nbsp;4, 22 in the placebo/ivacaftor
group and 26 in the ivacaftor/ivacaftor group.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Table<=
/span><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>&nbsp;</span><span lang=3DEN-GB>6 shows the results of the mean (SD) ab=
solute
change in percent predicted FEV<sub>1</sub> for both groups of patients. For
patients in the placebo/ivacaftor group baseline percent predicted FEV<sub>=
1</sub>
is that of study&nbsp;4 while for patients in the ivacaftor/ivacaftor group=
 the
baseline value is that of studies</span><span lang=3DEN-GB style=3D'mso-far=
east-font-family:
"MS Mincho";mso-fareast-language:JA'>&nbsp;</span><span lang=3DEN-GB>1 and =
2.</span><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-fareast-font-family:"M=
S Mincho";
mso-fareast-language:JA'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:6.0pt;line-height:normal;page-b=
reak-after:
avoid'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Table&nb=
sp;6:
Effect of ivacaftor on percent predicted FEV</span></b><sub><span lang=3DEN=
-GB>1</span></sub><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB> in study&nbsp;4<o=
:p></o:p></span></b></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'margin-left:5.4pt;border-collapse:collapse;border:none;mso-border=
-alt:
 solid windowtext .5pt;mso-yfti-tbllook:160;mso-padding-alt:0in 5.4pt 0in 5=
.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D"24%" rowspan=3D2 valign=3Dbottom style=3D'width:24.72%;borde=
r:solid windowtext 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Original study a=
nd
  treatment group</span></b><span lang=3DEN-GB style=3D'mso-fareast-font-fa=
mily:
  "MS Mincho";mso-fareast-language:JA'><o:p></o:p></span></p>
  </td>
  <td width=3D"27%" rowspan=3D2 valign=3Dbottom style=3D'width:27.72%;borde=
r:solid windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>Duration of ivacaftor treatment (weeks)</span></b><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-lan=
guage:
  JA'><o:p></o:p></span></p>
  </td>
  <td width=3D"47%" colspan=3D2 valign=3Dtop style=3D'width:47.56%;border:s=
olid windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB>Absolute change from baseline in percent predicted FEV<sub>1=
 </sub>(percentage
  points)</span></b><span lang=3DEN-GB style=3D'mso-fareast-font-family:"MS=
 Mincho";
  mso-fareast-language:JA'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.86%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>N<o:p></o:p></sp=
an></b></p>
  </td>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-=
GB>Mean
  (SD)<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D"100%" colspan=3D4 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB>Study&nbsp;1<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D"24%" rowspan=3D2 valign=3Dtop style=3D'width:24.72%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Ivacaftor<o:p></=
o:p></span></b></p>
  </td>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>48<sup>*</sup></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.86%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>77</span></p>
  </td>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>9.4 (8.3)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>144</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.86%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>72</span></p>
  </td>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>9.4 (10.8)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5'>
  <td width=3D"24%" rowspan=3D2 valign=3Dtop style=3D'width:24.72%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Placebo<o:p></o:=
p></span></b></p>
  </td>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>0<sup>*</sup></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.86%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>67</span></p>
  </td>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>&#8209;1.2 (7.8)<sup><span style=3D'po=
sition:
  relative;top:-3.0pt;mso-text-raise:3.0pt'></span></sup></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>96</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.86%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>55</span></p>
  </td>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>9.5 (11.2)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7'>
  <td width=3D"100%" colspan=3D4 valign=3Dtop style=3D'width:100.0%;border:=
solid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><b style=3D'mso-bidi-fo=
nt-weight:
  normal'><span lang=3DEN-GB>Study&nbsp;2<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8'>
  <td width=3D"24%" rowspan=3D2 valign=3Dtop style=3D'width:24.72%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Ivacaftor<o:p></=
o:p></span></b></p>
  </td>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>48<sup>*</sup></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.86%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>26</span></p>
  </td>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>10.2 (15.7)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>144</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.86%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>25</span></p>
  </td>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>10.3 (12.4)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10'>
  <td width=3D"24%" rowspan=3D2 valign=3Dtop style=3D'width:24.72%;border:s=
olid windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Placebo<o:p></o:=
p></span></b></p>
  </td>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>0<sup>*</sup></span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.86%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>22</span></p>
  </td>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>&#8209;0.6 (10.1)<sup><span
  style=3D'position:relative;top:-3.0pt;mso-text-raise:3.0pt'></span></sup=
></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;mso-yfti-lastrow:yes'>
  <td width=3D"27%" valign=3Dtop style=3D'width:27.72%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>96</span></p>
  </td>
  <td width=3D"14%" valign=3Dtop style=3D'width:14.86%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB>21</span></p>
  </td>
  <td width=3D"32%" valign=3Dtop style=3D'width:32.7%;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  tab-stops:.5in'><span lang=3DEN-GB>10.5 (11.5)</span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in'><sup><span
lang=3DEN-GB style=3D'font-size:9.0pt'>*</span></sup><span lang=3DEN-GB
style=3D'font-size:9.0pt'><span style=3D'mso-tab-count:1'> </span>Treat=
ment
occurred during blinded, controlled, 48-week phase&nbsp;3 study.<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:.2in;text-indent:-.2in;line-heigh=
t:normal'><sup><span
lang=3DEN-GB style=3D'font-size:9.0pt'></span></sup><span lang=3DEN-GB
style=3D'font-size:9.0pt'><span style=3D'mso-tab-count:1'> </span>Chang=
e from
prior study baseline after 48&nbsp;weeks of placebo treatment.</span><span
lang=3DEN-GB style=3D'font-size:9.0pt;mso-fareast-font-family:"MS Mincho";
mso-fareast-language:JA'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>When t=
he mean
(SD) absolute change in percent predicted FEV<sub>1</sub> is compared from
study&nbsp;4 baseline for patients in the ivacaftor/ivacaftor group (n</spa=
n><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>&nbsp;=3D&nbsp;</span><span lang=3DEN-GB>72) who rolled over from study=
&nbsp;1,
the mean (SD) absolute change in percent predicted FEV<sub>1</sub> was 0.0%
(9.05), while for patients in the ivacaftor/ivacaftor group (n</span><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>&nbsp;=3D&nbsp;</span><span lang=3DEN-GB>25) who rolled over from study=
&nbsp;2
this figure was 0.6% (9.1). This shows that patients in the ivacaftor/ivaca=
ftor
group maintained the improvement seen at </span><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>week<=
/span><span
lang=3DEN-GB>&nbsp;48 of the initial study (</span><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>day</=
span><span
lang=3DEN-GB>&nbsp;0 through </span><span lang=3DEN-GB style=3D'mso-fareast=
-font-family:
"MS Mincho";mso-fareast-language:JA'>week</span><span lang=3DEN-GB>&nbsp;48=
) in
percent predicted FEV<sub>1</sub> through </span><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>week<=
/span><span
lang=3DEN-GB>&nbsp;144. There were no additional improvements in study&nbsp=
;4 (</span><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>week</span><span lang=3DEN-GB>&nbsp;48 through </span><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>week<=
/span><span
lang=3DEN-GB>&nbsp;144).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>For patients in the placebo/ivacaft=
or group
from study&nbsp;1, the annualised rate of pulmonary exacerbations was highe=
r in
the initial study when patients were on placebo (1.34&nbsp;events/year) than
during the subsequent study&nbsp;4 when patients rolled over to ivacaftor
(0.48&nbsp;events/year across </span><span lang=3DEN-GB style=3D'mso-fareas=
t-font-family:
"MS Mincho";mso-fareast-language:JA'>day</span><span lang=3DEN-GB>&nbsp;1 t=
o </span><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>week</span><span lang=3DEN-GB>&nbsp;48, and 0.67&nbsp;events/year acros=
s </span><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>weeks</span><span lang=3DEN-GB>&nbsp;48 to 96). For patients in the
ivacaftor/ivacaftor group from study&nbsp;1, the annualised rate of pulmona=
ry
exacerbations was 0.57&nbsp;events/year across </span><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>day</=
span><span
lang=3DEN-GB>&nbsp;1 to </span><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>week</span><span lang=3DEN-GB>&nbsp;48=
 when
patients were on ivacaftor. When they rolled over into study&nbsp;4, the ra=
te
of annualised pulmonary exacerbations was 0.91&nbsp;events/year across </sp=
an><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>day</span><span lang=3DEN-GB>&nbsp;1 to </span><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>week<=
/span><span
lang=3DEN-GB>&nbsp;48 and 0.77&nbsp;events/year across </span><span lang=3D=
EN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>weeks=
</span><span
lang=3DEN-GB>&nbsp;48 to 96.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>For pa=
tients who
rolled over from study&nbsp;2 the number of events was, overall, low.</span=
></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span style=3D'mso-ansi-language:EN-US'>Study&nbsp;6: study in pati=
ents
with CF with an R117H mutation in the CFTR gene<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></i=
></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span style=3D'mso-an=
si-language:
EN-US'>Study&nbsp;6 evaluated 69&nbsp;patients who were 6&nbsp;years of age=
 or
older; 53 (76.8%) patients had the <i style=3D'mso-bidi-font-style:normal'>=
F508del</i>
mutation in the second allele. The confirmed <i>R117H </i>poly&#8209;T vari=
ant
was <i>5T </i><span style=3D'mso-bidi-font-style:italic'>in 38&nbsp;patient=
s<i> </i></span>and
<i>7T </i><span style=3D'mso-bidi-font-style:italic'>in 16&nbsp;patients</s=
pan>.
At baseline, mean predicted FEV<sub>1</sub> was 73% (range: 32.5% to 105.5%)
and mean age was 31&nbsp;years (range: 6 to 68&nbsp;years). The mean absolu=
te
change from baseline through week&nbsp;24 in percent predicted FEV<sub>1</s=
ub>
(primary efficacy endpoint) was 2.57&nbsp;percentage points in the ivacaftor
group and 0.46&nbsp;percentage points in the placebo group. The estimated
treatment difference for ivacaftor versus placebo was 2.1&nbsp;percentage
points (95% CI &#8209;1.1, 5.4).<o:p></o:p></span></p>

<p class=3DMsoNormal><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DMsoNormal><span style=3D'mso-ansi-language:EN-US;mso-bidi-font-w=
eight:
bold'>A pre&#8209;planned subgroup analysis was conducted in patients 18&nb=
sp;years
and older (26&nbsp;patients on placebo and 24 on ivacaftor). Treatment with
ivacaftor resulted in a mean absolute change in percent predicted FEV<sub>1=
</sub>
through week&nbsp;24 of 4.5&nbsp;percentage points in the ivacaftor group v=
ersus
&#8209;0.46&nbsp;percentage points in the placebo group. The estimated
treatment difference for ivacaftor versus placebo was 5.0 percentage points
(95% CI 1.1, 8.8).<o:p></o:p></span></p>

<p class=3DMsoNormal><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DMsoNormal><span style=3D'mso-ansi-language:EN-US'>In a subgroup =
analysis
in patients with a confirmed <i>R117H&#8209;5T </i><span style=3D'mso-bidi-=
font-style:
italic'>genetic variant, </span>the difference in the mean absolute change =
from
baseline through week</span><span lang=3DEN-GB>&nbsp;</span><span
style=3D'mso-ansi-language:EN-US'>24 in percent predicted FEV<sub>1</sub> b=
etween
ivacaftor and placebo was 5.3% (95% CI 1.3, 9.3). In patients with a confir=
med <i>R117H&#8209;7T
</i><span style=3D'mso-bidi-font-style:italic'>genetic variant, </span>the
treatment difference between ivacaftor and placebo was 0.2% (95% CI &#8209;=
8.1,
8.5).<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'=
>For
secondary efficacy variables, no treatment differences were observed for
ivacaftor versus placebo in absolute change from baseline in BMI at week 24=
 or
time to first pulmonary exacerbation. Treatment differences were observed in
absolute change in CFQ&#8209;R respiratory domain score through week 24
(treatment difference of ivacaftor versus placebo was 8.4 [95% CI 2.2, 14.6]
points) and for the mean change from baseline in sweat chloride (see
Pharmacodynamic effects).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><i style=3D'mso-bidi-font=
-style:
normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-fareas=
t-font-family:
"MS Mincho"'>Study&nbsp;7: study in paediatric patients </span><span
lang=3DEN-GB>with CF </span></i><i style=3D'mso-bidi-font-style:normal'><sp=
an
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho"'>aged&nbsp;2 to l=
ess than
6</span><span lang=3DEN-GB>&nbsp;years with G551D or another gating mutatio=
n<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-fareas=
t-font-family:
"MS Mincho"'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>The pharmacokinetic profile, safety and efficacy of ivacaftor =
in
34&nbsp;patients aged&nbsp;2 to less than 6&nbsp;years with CF who had a <i
style=3D'mso-bidi-font-style:normal'>G551D</i>, <i><span style=3D'mso-bidi-=
font-weight:
bold'>G1244E</span></i><span style=3D'mso-bidi-font-weight:bold;mso-bidi-fo=
nt-style:
italic'>, <i>G1349D</i>,<i> G178R</i>,<i> G551S</i>,<i> S1251N</i>,<i> S125=
5P</i>,<i>
S549N</i> </span><span style=3D'mso-bidi-font-weight:bold'>or<i> S549R</i><=
/span><i
style=3D'mso-bidi-font-style:normal'> </i>mutation in the <i style=3D'mso-b=
idi-font-style:
normal'>CFTR</i> gene were assessed in a 24&#8209;week uncontrolled study w=
ith
ivacaftor (<span style=3D'mso-bidi-font-weight:bold'>patients weighing less=
 than
14&nbsp;kg received ivacaftor 50&nbsp;mg and patients weighing 14&nbsp;kg or
more received ivacaftor 75&nbsp;mg). Ivacaftor was administered orally ever=
y 12
hours with fat&#8209;containing food in addition to their prescribed CF
therapies.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Patien=
ts in
study&nbsp;7 were aged 2 to less than 6&nbsp;years (mean age 3&nbsp;years).
Twenty&#8209;six patients out of the 34&nbsp;enrolled (76.5%) had a <i
style=3D'mso-bidi-font-style:normal'>CFTR</i> genotype <i style=3D'mso-bidi=
-font-style:
normal'>G551D/F508del</i> with only 2&nbsp;patients with a non&#8209;<i
style=3D'mso-bidi-font-style:normal'>G551D</i> mutation (<i style=3D'mso-bi=
di-font-style:
normal'>S549N</i>). The mean (SD) sweat chloride at baseline (n&nbsp;=3D&nb=
sp;25)
was 97.88&nbsp;mmol/L (14.00).<span style=3D'mso-bidi-font-weight:bold'> Th=
e</span>
mean (SD) faecal elastase&#8209;1 value at <span style=3D'mso-bidi-font-wei=
ght:
bold'>baseline (n&nbsp;=3D&nbsp;27) was 28</span>&nbsp;g/g (95).<span
style=3D'mso-bidi-font-weight:bold'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The pr=
imary
endpoint of safety was evaluated through week&nbsp;24 (see section 4.8).
Secondary and exploratory efficacy endpoints evaluated were absolute change
from baseline in sweat chloride through 24&nbsp;weeks of treatment, absolute
change from baseline in weight, body mass index (BMI) and stature (supporte=
d by
weight, BMI and stature z-scores) at 24&nbsp;weeks of treatment, and measur=
es
of pancreatic function such as faecal elastase&#8209;1. <span style=3D'mso-=
bidi-font-weight:
bold'>Data on percent predicted FEV<sub>1</sub> (exploratory endpoint) were
available for 3&nbsp;patients in the ivacaftor 50&nbsp;mg group and
17&nbsp;patients in the 75&nbsp;mg dosing group.<o:p></o:p></span></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal'><s><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></s></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The me=
an (SD)
overall (both ivacaftor dosing groups combined) absolute change from baseli=
ne
in BMI at week<span style=3D'mso-bidi-font-weight:bold'>&nbsp;</span>24 was=
 0.32<span
style=3D'mso-bidi-font-weight:bold'>&nbsp;</span>kg/m<sup>2</sup> (0.54) an=
d the
mean (SD) overall change in BMI&#8209;for&#8209;age z&#8209;score was 0.37
(0.42). The mean (SD) overall change in stature-for-age z-score was &#8209;=
0.01
(0.33). The mean (SD) overall change from baseline in faecal elastase&#8209=
;1
(n&nbsp;=3D&nbsp;27) was 99.8<span style=3D'mso-bidi-font-weight:bold'>&nbs=
p;</span>g/g
(138.4). Six patients with initial levels below 200&nbsp;g/g achieved, at =
week&nbsp;24,
a level of &#8805;&nbsp;200&nbsp;g/g. The mean (SD) overall change in perc=
ent
predicted FEV<sub>1 </sub>from baseline at week<span style=3D'mso-bidi-font=
-weight:
bold'>&nbsp;</span>24 (exploratory endpoint) was 1.8 (17.81).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-fareas=
t-font-family:
"MS Mincho"'>Study&nbsp;8: study in paediatric patients </span><span
lang=3DEN-GB>with CF </span></i><i style=3D'mso-bidi-font-style:normal'><sp=
an
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho"'>aged less than
24&nbsp;months<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB style=3D'mso-fareas=
t-font-family:
"MS Mincho"'><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>The pharmacokinetic profile, safety, and efficacy of ivacaftor=
 in
patients with CF aged 6&nbsp;months to less than 24&nbsp;months were assess=
ed
in a completed cohort of patients in an on-going 24&#8209;week, open&#8209;=
label,
phase&nbsp;3 clinical study in patients aged less than 24&nbsp;months (stud=
y&nbsp;8).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Part B=
 of study&nbsp;8
enrolled 19&nbsp;patients aged 12&nbsp;months to less than 24&nbsp;months (=
mean
age 15.2&nbsp;months at baseline), with 18&nbsp;patients completing the 24&=
#8209;week
treatment period, 11&nbsp;patients aged 6&nbsp;months to less than
12&nbsp;months (mean age 9.0&nbsp;months at baseline) with all 11&nbsp;pati=
ents
completing the 24&#8209;week treatment period, and 6 patients aged 4 months=
 to
less than 6 months (mean age 4.5 months at baseline) with all 6 patients
completing the 24&#8209;week treatment period. Patients received ivacaftor =
25&nbsp;mg,
50&nbsp;mg or 75&nbsp;mg according to their age and weight at each study vi=
sit
(see section 4.2). Ivacaftor was administered orally every 12&nbsp;hours wi=
th
fat</span><span lang=3DEN-GB style=3D'font-family:"MS Mincho";mso-bidi-font=
-family:
"MS Mincho"'>&#8209;</span><span lang=3DEN-GB>containing food. Patients con=
tinued
on their prescribed standard&#8209;of&#8209;care CF therapies.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>In par=
t&nbsp;B
of study&nbsp;8 the primary endpoint of safety was evaluated through
24&nbsp;weeks (see section&nbsp;4.8). Secondary endpoints were evaluation of
pharmacokinetics and the absolute change from baseline in sweat chloride
through 24&nbsp;weeks of treatment (see Pharmacodynamic effects). Tertiary
endpoints included efficacy measures such as faecal elastase&#8209;1 and gr=
owth
parameters.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><span lang=3DEN-GB>For patients aged 4&nbsp;months =
to
less than 24&nbsp;months, with both baseline and week&nbsp;24 values availa=
ble,
m<span style=3D'mso-bidi-font-weight:bold'>ean (SD) weight&#8209;for&#8209;=
age,
length&#8209;for&#8209;age, and weight&#8209;for&#8209;length z&#8209;scores
are provided in Table&nbsp;7.</span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:0in;margin-bottom=
:6.0pt;
margin-left:40.5pt;text-indent:-40.5pt;line-height:normal;page-break-after:
avoid;tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=
=3DEN-GB>Table&nbsp;7:
Effect of ivacaftor on growth parameters in patients aged 4&nbsp;months to =
less
than 24&nbsp;months with baseline and week&nbsp;24 values<span
style=3D'color:black;mso-themecolor:text1'><o:p></o:p></span></span></b></p>

<table class=3DTableGrid1 border=3D1 cellspacing=3D0 cellpadding=3D0 width=
=3D601
 style=3D'border-collapse:collapse;mso-table-layout-alt:fixed;border:none;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:
 0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D169 rowspan=3D2 style=3D'width:126.9pt;border:solid windowtex=
t 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-far=
east-font-family:
  Calibri;mso-fareast-theme-font:minor-latin'>Parameter<o:p></o:p></span></=
b></p>
  </td>
  <td width=3D72 rowspan=3D2 valign=3Dtop style=3D'width:.75in;border:solid=
 windowtext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>Number of patients<o:p></o:p></span></b></p>
  </td>
  <td width=3D168 colspan=3D2 style=3D'width:1.75in;border:solid windowtext=
 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>Baseline<o:p></o:p></span></b></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D192 colspan=3D2 style=3D'width:2.0in;border:solid windowtext =
1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>Absolute change at week&nbsp;24<o:p></o:p></span></b></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'><o:p>&nbsp;</o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1'>
  <td width=3D78 valign=3Dtop style=3D'width:58.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-far=
east-font-family:
  Calibri;mso-fareast-theme-font:minor-latin'>Mean<o:p></o:p></span></b></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-far=
east-font-family:
  Calibri;mso-fareast-theme-font:minor-latin'>(SD)</span></b><span lang=3DE=
N-GB
  style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-lat=
in'><o:p></o:p></span></p>
  </td>
  <td width=3D90 valign=3Dtop style=3D'width:67.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-far=
east-font-family:
  Calibri;mso-fareast-theme-font:minor-latin'>Median<o:p></o:p></span></b><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-far=
east-font-family:
  Calibri;mso-fareast-theme-font:minor-latin'>(min, max)</span></b><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'><o:p></o:p></span></p>
  </td>
  <td width=3D96 valign=3Dtop style=3D'width:1.0in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-far=
east-font-family:
  Calibri;mso-fareast-theme-font:minor-latin'>Mean<o:p></o:p></span></b></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-far=
east-font-family:
  Calibri;mso-fareast-theme-font:minor-latin'>(SD)</span></b><span lang=3DE=
N-GB
  style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-lat=
in'><o:p></o:p></span></p>
  </td>
  <td width=3D96 valign=3Dtop style=3D'width:1.0in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-far=
east-font-family:
  Calibri;mso-fareast-theme-font:minor-latin'>Median<o:p></o:p></span></b><=
/p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-far=
east-font-family:
  Calibri;mso-fareast-theme-font:minor-latin'>(min, max)</span></b><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'><o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2'>
  <td width=3D169 valign=3Dtop style=3D'width:126.9pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
  style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-lat=
in'>Weightfor&#8209;age
  z&#8209;score<o:p></o:p></span></p>
  </td>
  <td width=3D72 valign=3Dtop style=3D'width:.75in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>35<o:p></o:p></span></p>
  </td>
  <td width=3D78 valign=3Dtop style=3D'width:58.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>0.17 (0.85)<o:p></o:p></span></p>
  </td>
  <td width=3D90 valign=3Dtop style=3D'width:67.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>0.20<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>[-1.92, 1.79]<o:p></o:p></span></p>
  </td>
  <td width=3D96 valign=3Dtop style=3D'width:1.0in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>0.33<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>(0.53)<o:p></o:p></span></p>
  </td>
  <td width=3D96 valign=3Dtop style=3D'width:1.0in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>0.26<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>[-0.54, 1.63]<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3'>
  <td width=3D169 valign=3Dtop style=3D'width:126.9pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
  style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-lat=
in'>Length&#8209;for&#8209;age
  z&#8209;score<o:p></o:p></span></p>
  </td>
  <td width=3D72 valign=3Dtop style=3D'width:.75in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>34<o:p></o:p></span></p>
  </td>
  <td width=3D78 valign=3Dtop style=3D'width:58.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>0.06 (1.03) <o:p></o:p></span></p>
  </td>
  <td width=3D90 valign=3Dtop style=3D'width:67.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>0.12<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>[-1.99, 2.79]<o:p></o:p></span></p>
  </td>
  <td width=3D96 valign=3Dtop style=3D'width:1.0in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>0.32<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>(0.92)<o:p></o:p></span></p>
  </td>
  <td width=3D96 valign=3Dtop style=3D'width:1.0in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>0.47<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>[-1.81, 3.38]<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;mso-yfti-lastrow:yes'>
  <td width=3D169 valign=3Dtop style=3D'width:126.9pt;border:solid windowte=
xt 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
  style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-lat=
in'>Weight&#8209;for&#8209;length
  z&#8209;score<o:p></o:p></span></p>
  </td>
  <td width=3D72 valign=3Dtop style=3D'width:.75in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>34<o:p></o:p></span></p>
  </td>
  <td width=3D78 valign=3Dtop style=3D'width:58.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin;color:black;mso-themecolor:text1'>0.24 (1.01)</span><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'><o:p></o:p></span></p>
  </td>
  <td width=3D90 valign=3Dtop style=3D'width:67.5pt;border-top:none;border-=
left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin;color:black;mso-themecolor:text1'>0.26<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin;color:black;mso-themecolor:text1'>[-1.72, 2.16]<o:p></o:p></s=
pan></p>
  </td>
  <td width=3D96 valign=3Dtop style=3D'width:1.0in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin;color:black;mso-themecolor:text1'>0.24<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin;color:black;mso-themecolor:text1'>(0.98)</span><span lang=3DE=
N-GB
  style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-font:minor-lat=
in'><o:p></o:p></span></p>
  </td>
  <td width=3D96 valign=3Dtop style=3D'width:1.0in;border-top:none;border-l=
eft:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin;color:black;mso-themecolor:text1'>0.29<o:p></o:p></span></p>
  <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-heigh=
t:normal'><span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin;color:black;mso-themecolor:text1'>[-2.04, 2.22]<o:p></o:p></s=
pan></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>In pat=
ients aged
4&nbsp;months to less than 24&nbsp;months, with both baseline and week&nbsp=
;24
values available, 18 patients were pancreatic insufficient at baseline (def=
ined
as faecal elastase-1 &lt;&nbsp;200&nbsp;g/g) with mean (SD) faecal elastas=
e&#8209;1
values at baseline and week&nbsp;24 of 25.5&nbsp;g/g (27.6) and 253.6&nbsp=
;g/g
(128.3), respectively (mean [SD] absolute change 228.41&nbsp;g/g [128.3]).
Results were consistent in the 12&nbsp;months to less than 24&nbsp;months,
6&nbsp;months to less than 12&nbsp;months, and 4 months to less than 6 mont=
hs
age cohorts.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB>Pae=
diatric
population<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The Eu=
ropean
Medicines Agency has deferred the obligation to submit the results of studi=
es
with Kalydeco in one or more subsets of the paediatric population in cystic
fibrosis (see section&nbsp;4.2 for information on paediatric use).</span></=
p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h2 style=3D'margin:0in'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-b=
idi-font-size:
12.0pt'>5.2<span style=3D'mso-tab-count:1'> </span>Pharmacokinetic
properties</span><span lang=3DEN-GB style=3D'font-weight:normal;mso-bidi-fo=
nt-weight:
bold'><o:p></o:p></span></h2>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-fareast-font-family:"MS Mincho";mso-ansi-language:EN-US;mso-fa=
reast-language:
JA'>The pharmacokinetics of ivacaftor are similar between healthy adult
volunteers and patients with CF.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-fareas=
t-font-family:
"MS Mincho";mso-ansi-language:EN-US;mso-fareast-language:JA'><o:p>&nbsp;</o=
:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-fareas=
t-font-family:
"MS Mincho";mso-ansi-language:EN-US;mso-fareast-language:JA'>After oral
administration of a single 150&nbsp;mg dose to healthy volunteers in a fed
state, the mean (&nbsp;SD) for AUC and C<sub>max</sub> were 10600
(5260)&nbsp;ng*hr/mL and 768 (233)&nbsp;ng/mL, respectively. After every 12=
&#8209;hour
dosing, steady-state plasma concentrations of ivacaftor were reached by day=
s&nbsp;3
to 5, with an accumulation ratio ranging from 2.2 to 2.9.<o:p></o:p></span>=
</p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Absorption<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Following multiple oral dose administrations of ivacaftor, the
exposure of ivacaftor generally increased with dose from 25&nbsp;mg every
12&nbsp;hours to 450&nbsp;mg every 12&nbsp;hours. When given with
fat-containing food the exposure of ivacaftor increased approximately 2.5- =
to 4&#8209;fold.
Therefore, ivacaftor should be administered with fat&#8209;containing food.=
 The
median (range) t<sub>max </sub>is approximately 4.0&nbsp;(3.0; 6.0)&nbsp;ho=
urs
in the fed state.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold'>Ivacaftor granules (2 x 75</span><span
lang=3DEN-GB>&nbsp;<span style=3D'mso-bidi-font-weight:bold'>mg sachets) had
similar bioavailability as the 150</span>&nbsp;<span style=3D'mso-bidi-font=
-weight:
bold'>mg tablet when given with fat-containing food to healthy adult subjec=
ts.
The geometric least squares mean ratio (90% CI) for the granules relative to
tablets was 0.951 (0.839, 1.08) for AUC<sub>0-&#8734;</sub> and 0.918 (0.75=
0,
1.12) for C<sub>max</sub>. The effect of food on ivacaftor absorption is
similar for both formulations, i.e., tablets and granules.<o:p></o:p></span=
></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-pag=
ination:
widow-orphan no-line-numbers;page-break-after:avoid;mso-list:skip'><u><span
lang=3DEN-GB>Distribution<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-pag=
ination:
widow-orphan no-line-numbers;page-break-after:avoid;mso-list:skip'><u><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Ivacaftor is approximately 99% bound to plasma proteins, prima=
rily
to alpha 1&#8209;acid glycoprotein and albumin. Ivacaftor does not bind to
human red blood cells. After oral administration of ivacaftor 150&nbsp;mg e=
very
12&nbsp;hours for 7&nbsp;days in healthy volunteers in a fed state, the mea=
n (&nbsp;SD)
apparent volume of distribution was 353 L (122)&nbsp;.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Biotransformation<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><u><span lang=3DEN-GB><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Ivacaftor is extensively metabolised in humans. <i style=3D'ms=
o-bidi-font-style:
normal'>In&nbsp;vitro</i> and <i style=3D'mso-bidi-font-style:normal'>in&nb=
sp;vivo</i>
data indicate that ivacaftor is primarily metabolised by CYP3A. M1 and M6 a=
re
the two major metabolites of ivacaftor in humans. M1 has approximately one&=
#8209;sixth
the potency of ivacaftor and is considered pharmacologically active. M6 has
less than one&#8209;fiftieth the potency of ivacaftor and is not considered
pharmacologically active.<i style=3D'mso-bidi-font-style:normal'><o:p></o:p=
></i></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-pag=
ination:
widow-orphan no-line-numbers;mso-list:skip'><u><span style=3D'mso-ansi-lang=
uage:
EN-US'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span>=
</u></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The ef=
fect of
the CYP3A4*22 heterozygous genotype on ivacaftor exposure is consistent with
the effect of co-administration of a weak CYP3A4 inhibitor, which is not cl=
inically
relevant. No dose adjustment of ivacaftor is considered necessary. The effe=
ct
of CYP3A4*22 homozygous genotype patients is expected to be stronger. Howev=
er,
no data are available for such patients.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-pag=
ination:
widow-orphan no-line-numbers;mso-list:skip'><u><span style=3D'mso-ansi-lang=
uage:
EN-US'><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p></span>=
</u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-list:skip'><u><span lang=3DEN-GB>Elimination<o:p=
></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-list:skip'><u><span lang=3DEN-GB><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Following oral administration in healthy volunteers, the major=
ity of
ivacaftor (87.8%) was eliminated in the faeces after metabolic conversion. =
The
major metabolites M1 and M6 accounted for approximately 65% of the total do=
se
eliminated with 22% as M1 and 43% as M6. There was negligible urinary excre=
tion
of ivacaftor as unchanged parent. The apparent terminal half&#8209;life was
approximately 12&nbsp;hours following a single dose in the fed state. The
apparent clearance (CL/F) of ivacaftor was similar for healthy subjects and
patients with CF. The mean (SD) CL/F for a single 150&nbsp;mg dose was 17.3
(8.4)&nbsp;L/hr in healthy subjects.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB>Linearity/non&#8209;linearity<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><u=
><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>The pharmacokinetics of ivacaftor are generally linear with re=
spect
to time or dose ranging from 25&nbsp;mg to 250&nbsp;mg.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><u><span lang=3DEN-GB>Special populations<o:p></o:p=
></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><u><span lang=3DEN-GB><o:p><span style=3D'text-deco=
ration:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB>Hepatic
impairment<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><i style=3D'mso-bidi-font-style:normal'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Following a single dose of 150&nbsp;mg of ivacaftor, adult sub=
jects
with moderately impaired hepatic function (Child-Pugh Class B, score 7 to 9)
had similar ivacaftor C<sub>max</sub> (mean [&nbsp;SD] of 735
[331]&nbsp;ng/mL) but an approximately two-fold increase in ivacaftor AUC<s=
ub>0-</sub></span><sub><span
style=3D'font-family:SimSun;mso-ascii-font-family:"Times New Roman";mso-han=
si-font-family:
"Times New Roman"'>&#8734;</span></sub><span lang=3DEN-GB> (mean [&nbsp;SD=
] of 16800
[6140]&nbsp;ng*hr/mL) compared with healthy subjects matched for demographi=
cs.
Simulations for predicting the steady-state exposure of ivacaftor showed th=
at
by reducing the dosage from 150&nbsp;mg&nbsp;q12h to 150&nbsp;mg once daily,
adults with moderate hepatic impairment would have comparable steady-state =
C<sub>min</sub>
values as those obtained with a dose of 150&nbsp;mg&nbsp;q12h in adults wit=
hout
hepatic impairment. Based on these results, a modified regimen of Kalydeco
monotherapy is recommended for patients with moderate hepatic impairment (s=
ee
section 4.2)</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>The im=
pact of
severe hepatic impairment (Child Pugh Class C, score 10 to15) on the
pharmacokinetics of ivacaftor have not been studied. The magnitude of incre=
ase
in exposure in these patients is unknown but is expected to be higher than =
that
observed in patients with moderate hepatic impairment. The use of Kalydeco =
in
patients with severe hepatic impairment is therefore not recommended unless=
 the
benefits outweigh the risks (see section&nbsp;4.2 and section 4.4).</span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>No dose
adjustment is considered necessary for patients with mild hepatic impairmen=
t.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Renal impairment<o:=
p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Pharmacokinetic studies have not been performed with ivacaftor=
 in
patients with renal impairment. In a human pharmacokinetic study, there was
minimal elimination of ivacaftor and its metabolites in urine (only 6.6% of
total radioactivity was recovered in the urine). There was negligible urina=
ry
excretion of ivacaftor as unchanged parent (less than 0.01% following a sin=
gle
oral dose of 500&nbsp;mg). </span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>No dose
adjustments are recommended for mild and moderate renal impairment. However,
caution is recommended when administering ivacaftor to patients with severe
renal impairment (creatinine clearance less than or equal to 30&nbsp;mL/min=
) or
end-stage renal disease (see sections&nbsp;4.2 and 4.4).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Race<o:p></o:p></sp=
an></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Race had no clinically meaningful effect on the PK of ivacafto=
r in
white (n<span style=3D'mso-bidi-font-style:italic'>&nbsp;=3D&nbsp;</span>37=
9) and
non-white (n<span style=3D'mso-bidi-font-style:italic'>&nbsp;=3D&nbsp;</spa=
n>29) patients
based on a population PK analysis.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Gender<o:p></o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>The pharmacokinetic parameters of ivacaftor are similar in mal=
es and
females.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Elderly<o:p></o:p><=
/span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Clinical studies of ivacaftor as monotherapy did not include
sufficient numbers of patients aged 65&nbsp;years and older to determine
whether pharmacokinetic parameters are similar or not to those in younger
adults.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB>Paediatric populati=
on<o:p></o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Predicted ivacaftor exposure based on observed ivacaftor
concentrations in phase&nbsp;2 and 3 studies as determined using population=
 PK
analysis is presented by age group in Table<span style=3D'mso-bidi-font-wei=
ght:
bold'>&nbsp;8</span>. </span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:6.0pt;line-height:normal'><b><s=
pan
lang=3DEN-GB>Table&nbsp;8: Mean (SD) ivacaftor exposure by age group<o:p></=
o:p></span></b></p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0 wi=
dth=3D"99%"
 style=3D'width:99.66%;margin-left:5.45pt;border-collapse:collapse;border:n=
one;
 mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:160;mso-padding-alt:
 0in 0in 0in 0in;mso-border-insideh:.5pt solid windowtext;mso-border-inside=
v:
 .5pt solid windowtext'>
 <thead>
  <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:13.7pt'>
   <td width=3D"56%" style=3D'width:56.74%;border:solid windowtext 1.0pt;
   mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:
   13.7pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b
   style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Age group<o:p><=
/o:p></span></b></p>
   </td>
   <td width=3D"15%" style=3D'width:15.24%;border:solid windowtext 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:13.7pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b
   style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Dose<o:p></o:p>=
</span></b></p>
   </td>
   <td width=3D"12%" style=3D'width:12.34%;border:solid windowtext 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:13.7pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b
   style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>C<sub>min, ss</=
sub>
   (ng/mL)<o:p></o:p></span></b></p>
   </td>
   <td width=3D"15%" style=3D'width:15.68%;border:solid windowtext 1.0pt;
   border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-al=
t:
   solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:13.7pt'>
   <p class=3DMsoNormal align=3Dcenter style=3D'text-align:center'><b
   style=3D'mso-bidi-font-weight:normal'><span lang=3DPT style=3D'mso-ansi-=
language:
   PT'>AUC</span><sub><span lang=3DEN-GB>&#964;</span></sub></b><b
   style=3D'mso-bidi-font-weight:normal'><sub><span lang=3DPT style=3D'mso-=
ansi-language:
   PT'>,ss</span></sub></b><b style=3D'mso-bidi-font-weight:normal'><span
   lang=3DPT style=3D'mso-ansi-language:PT'> (ng*h/mL)<sub><o:p></o:p></sub=
></span></b></p>
   </td>
  </tr>
 </thead>
 <tr style=3D'mso-yfti-irow:1;height:15.15pt'>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>4 months to less than 6 months (<=
/span><span
  style=3D'font-family:SimSun;mso-ascii-font-family:"Times New Roman";mso-h=
ansi-font-family:
  "Times New Roman"'>&#8805;</span><span lang=3DEN-GB>5 kg)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.24%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>25 mg q12h</span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.34%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>371 (183)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>6480 (2520)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:15.15pt'>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>6&nbsp;months to less than 12&nbs=
p;months
  (5&nbsp;kg to &lt;&nbsp;7&nbsp;kg)&nbsp;<sup>*</sup></span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.24%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>25&nbsp;mg q12h</span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.34%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>336</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>5410</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:15.15pt'>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>6&nbsp;months to less than 12&nbs=
p;months
  (7&nbsp;kg to &lt;&nbsp;14&nbsp;kg)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.24%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>50&nbsp;mg q12h</span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.34%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>508 (252)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>9140 (4200)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:15.15pt'>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>12&nbsp;months to less than
  24&nbsp;months (7&nbsp;kg to &lt;&nbsp;14&nbsp;kg)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.24%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>50&nbsp;mg&nbsp;q12h</span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.34%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>440 (212)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>9050 (3050)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;height:15.15pt'>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>12&nbsp;months to less than
  24&nbsp;months (</span><span style=3D'font-family:SimSun;mso-ascii-font-f=
amily:
  "Times New Roman";mso-hansi-font-family:"Times New Roman"'>&#8805;</span>=
<span
  lang=3DEN-GB>&nbsp;14&nbsp;kg to &lt;&nbsp;25&nbsp;kg)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.24%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>75&nbsp;mg&nbsp;q12h</span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.34%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>451 (125)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>9600 (1800)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;height:15.15pt'>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>2- to 5-year-olds (&lt;&nbsp;14&n=
bsp;kg)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.24%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>50&nbsp;mg&nbsp;q12h</span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.34%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>577 (317)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>10500 (4260)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:7;height:15.15pt'>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>2- to 5-year-olds (&#8805;&nbsp;1=
4&nbsp;kg
  to &lt;<span style=3D'mso-bidi-font-weight:bold'>&nbsp;</span>25&nbsp;kg)=
</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.24%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>75&nbsp;mg&nbsp;q12h</span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.34%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>629 (296)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>11300 (3820)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:8;height:15.15pt'>
  <td width=3D"56%" style=3D'width:56.74%;border:solid windowtext 1.0pt;bor=
der-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>6- to 11-year-olds&nbsp;<sup></s=
up> (&#8805;<span
  style=3D'mso-bidi-font-weight:bold'>&nbsp;</span>14&nbsp;kg to &lt;<span
  style=3D'mso-bidi-font-weight:bold'>&nbsp;</span>25&nbsp;kg)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.24%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>75&nbsp;mg&nbsp;q12h</span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.34%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>641 (329)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>10760 (4470)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:9;height:15.15pt'>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>6- to 11-year-olds&nbsp;<sup></s=
up> (&#8805;&nbsp;25&nbsp;kg)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.24%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>150&nbsp;mg&nbsp;q12h</span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.34%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>958 (546)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>15300 (7340)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:10;height:15.15pt'>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>12- to 17-year-olds</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.24%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>150&nbsp;mg&nbsp;q12h</span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.34%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>564 (242)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>9240 (3420)</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:11;mso-yfti-lastrow:yes;height:15.15pt'>
  <td width=3D"56%" valign=3Dtop style=3D'width:56.74%;border:solid windowt=
ext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>Adults (&#8805;&nbsp;18&nbsp;year=
s old)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.24%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>150&nbsp;mg&nbsp;q12h</span></p>
  </td>
  <td width=3D"12%" valign=3Dtop style=3D'width:12.34%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>701 (317)</span></p>
  </td>
  <td width=3D"15%" valign=3Dtop style=3D'width:15.68%;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.15pt'>
  <p class=3DMsoNormal><span lang=3DEN-GB>10700 (4100)</span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-left:13.5pt;text-indent:-13.5pt;page-b=
reak-after:
avoid;tab-stops:.5in'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt'>*</=
span></sup><sup><span
style=3D'mso-ansi-language:EN-US'><span style=3D'mso-tab-count:1'> </=
span></span></sup><span
style=3D'font-size:9.0pt;mso-ansi-language:EN-US'>Values based on data from=
 a
single patient; standard deviation not reported.</span><span lang=3DEN-GB
style=3D'font-size:9.0pt'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:13.5pt;text-indent:-13.5pt;page-b=
reak-after:
avoid;tab-stops:.5in'><sup><span lang=3DEN-GB style=3D'font-size:9.0pt;posi=
tion:
relative;top:-3.0pt;mso-text-raise:3.0pt'></span></sup><span lang=3DEN-GB
style=3D'font-size:9.0pt'><span style=3D'mso-tab-count:1'> </span><span
style=3D'mso-bidi-font-weight:bold'>Exposures in 6&#8209; to 11&#8209;year&=
#8209;olds
are predictions based on simulations from the population PK model using data
obtained for this age group.<o:p></o:p></span></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:2'><b><span lang=3DEN-GB>5.3<span
style=3D'mso-tab-count:1'> </span>Preclinical safety data</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>No=
n-clinical
data reveal no special hazard for humans based on conventional studies of
safety pharmacology, repeated dose toxicity, genotoxicity, and carcinogenic
potential.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><u><span lang=3DEN-GB=
>Pregnancy
and fertility<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><i style=3D'mso-bidi-=
font-style:
normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Iv=
acaftor
was associated with slight decreases of the seminal vesicle weights, a decr=
ease
of overall fertility index and number of pregnancies in females mated with
treated males and significant reductions in number of corpora lutea and
implantation sites with subsequent reductions in the average litter size and
average number of viable embryos per litter in treated females. The No&#820=
9;Observed&#8209;Adverse&#8209;Effect&#8209;Level
(NOAEL) for fertility findings provides an exposure level of approximately =
4&nbsp;times
the systemic exposure of ivacaftor and its metabolites when administered as=
 ivacaftor
monotherapy in adult humans at the maximum recommended human dose (MRHD). P=
lacental
transfer of ivacaftor was observed in pregnant rats and rabbits.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><u><span lang=3DEN-GB=
>Peri&#8209;
and post&#8209;natal development<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><u><span lang=3DEN-GB=
><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Iv=
acaftor
decreased survival and lactation indices and caused a reduction in pup body
weights. The NOAEL for viability and growth in the offspring provides an
exposure level approximately 3&nbsp;times the systemic exposure of ivacaftor
and its metabolites when administered as ivacaftor monotherapy in adult hum=
ans
at the MRHD. </span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><u><span lang=3DEN-GB=
>Juvenile
animal studies<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><u><span lang=3DEN-GB=
><o:p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Fi=
ndings of
cataracts were observed in juvenile rats dosed from postnatal day&nbsp;7 th=
rough
35 at ivacaftor exposure levels of 0.22&nbsp;times the MRHD based on system=
ic
exposure of ivacaftor and its metabolites when administered as ivacaftor
monotherapy. This finding has not been observed in foetuses derived from rat
dams treated with ivacaftor on gestation days&nbsp;7 to 17, in rat pups exp=
osed
to ivacaftor through milk ingestion up to postnatal day&nbsp;20, in 7&#8209=
;week
old rats, nor in 3.5 to 5&#8209;month old dogs treated with ivacaftor. The
potential relevance of these findings in humans is unknown.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>6.<span style=3D'mso-tab-count:1'> </span=
>PHARMACEUTICAL
PARTICULARS</span><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:=
"Times New Roman",serif;
font-weight:normal;mso-bidi-font-weight:bold'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><b><span lang=3DEN-GB>6.1<span style=3D'mso-tab-cou=
nt:1'> </span>List
of excipients</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-style:ita=
lic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Silica, colloidal anhydrous</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Croscarmellose sodium</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Hypromellose acetate succinate</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Lactose monohydrate</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DIT style=3D'mso-ansi-language:IT'>Magnesium stearate<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DIT style=3D'mso-ansi-language:IT'>Mannitol<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DIT style=3D'mso-ansi-language:IT'>Sucralose<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DIT style=3D'mso-ansi-language:IT'>Sodium laurilsulfate (E487)<i
style=3D'mso-bidi-font-style:normal'><o:p></o:p></i></span></p>

<p class=3DMsoNormal><span lang=3DIT style=3D'mso-ansi-language:IT'><o:p>&n=
bsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:2'><b><span lang=3DEN-GB>6.2<span
style=3D'mso-tab-count:1'> </span>Incompatibilities</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:1'><span lang=3DEN-GB><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Not applicable.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<h2 style=3D'margin:0in'><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-b=
idi-font-size:
12.0pt'>6.3<span style=3D'mso-tab-count:1'> </span>Shelf life</span><=
/h2>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;tab-stops:28.35pt 35.55pt'><span lang=3DEN-GB>3&nbsp=
;years.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;tab-stops:28.35pt 35.55pt'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Once mixed, the mixture has been shown to be stable for one ho=
ur.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2'><b><span lang=3DEN-GB>6.4<span style=3D'mso-tab-count:=
1'> </span>Special
precautions for storage<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:1'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>This medicinal product does not require any special storage
conditions.</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:2'><b><span lang=3DEN-GB>6.5<span
style=3D'mso-tab-count:1'> </span>Nature and contents of container<o:p>=
</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbs=
p;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tex=
t-autospace:
none'><span lang=3DEN-GB>The granules are packed in a Biaxially Oriented
Polyethylene Terephthalate/Polyethylene/Foil/Polyethylene (BOPET/PE/Foil/PE)
sachet.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;text-autospace:none'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:22.5pt'><span
lang=3DEN-GB>Pack size of 56 sachets (contains 4 individual wallets with 14
sachets per wallet)</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2'><b><span lang=3DEN-GB>6.6<span style=3D'mso-tab-count:=
1'> </span>Special
precautions for disposal and other handling</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
0in'><span lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fa=
reast-language:
JA'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
0in'><span lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fa=
reast-language:
JA'>Any unused medicinal product or waste material should be disposed of in
accordance with local requirements.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>7.<span style=3D'mso-tab-count:1'> </span=
>MARKETING
AUTHORISATION HOLDER</span><span lang=3DEN-GB style=3D'font-size:11.0pt;fon=
t-family:
"Times New Roman",serif'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Vertex Pharmaceuticals (Ireland) Limit=
ed<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>28-32 Pembroke Street Upper<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Dublin 2, D02 EK84<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Ireland</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB><o=
:p>&nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>8.<span style=3D'mso-tab-count:1'> </span=
>MARKETING
AUTHORISATION NUMBER(S)</span><span lang=3DEN-GB style=3D'font-size:11.0pt;
font-family:"Times New Roman",serif;font-weight:normal;mso-bidi-font-weight:
bold'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB>EU/1/12/782/003</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB>EU/1/12/782/004</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB>EU/1/12/782/006</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>9.<span style=3D'mso-tab-count:1'> </span=
>DATE
OF FIRST AUTHORISATION/RENEWAL OF THE AUTHORISATION</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'><o:p></o:p><=
/span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB>Date of first authorisation: 23 =
July
2012</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB>Date of latest renewal: 28 April=
 2017</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<h1 style=3D'margin:0in;line-height:normal'><span lang=3DEN-GB style=3D'fon=
t-size:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>10.<span style=3D'mso-tab-count:1'> </span>=
DATE
OF REVISION OF THE TEXT</span><span lang=3DEN-GB style=3D'font-size:11.0pt;
font-family:"Times New Roman",serif;font-weight:normal;mso-bidi-font-weight:
bold'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-pag=
ination:
widow-orphan no-line-numbers;mso-list:skip'><span lang=3DEN-GB><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-pag=
ination:
widow-orphan no-line-numbers;mso-list:skip'><span lang=3DEN-GB>Detailed
information on this medicinal product is available on the website of the
European Medicines Agency <u>http://www.ema.europa.eu.<o:p></o:p></u></span=
></p>

<u><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roma=
n",serif;
mso-fareast-font-family:SimSun;mso-ansi-language:EN-GB;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span></u>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><u><span
lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp;</span></o:p><=
/span></u></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'><o:p>&nbsp;</o:p></span></p>

<p class=3DNo-numheading3Agency align=3Dcenter style=3D'margin:0in;text-ali=
gn:center;
page-break-after:auto'><span lang=3DEN-GB style=3D'font-family:"Times New R=
oman",serif;
text-transform:uppercase'>Annex II<o:p></o:p></span></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal'><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:9.0pt;font-family=
:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>A.<span style=3D'm=
so-tab-count:
1'> </span>MANUFACTURER(S) RESPONSIBLE FOR BATCH RELEASE <o:p></o:p></=
span></b></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal'><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:9.0pt;font-family=
:"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>B.<span style=3D'm=
so-tab-count:
1'> </span>CONDITIONS OR RESTRICTIONS REGARDING SUPPLY AND USE<o:p></o=
:p></span></b></p>

<p class=3DTitleB style=3D'mso-outline-level:body-text'><span lang=3DEN-GB
style=3D'text-transform:none'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>C.<span style=3D'm=
so-tab-count:
1'> </span>OTHER CONDITIONS AND REQUIREMENTS OF THE MARKETING AUTHORIS=
ATION<o:p></o:p></span></b></p>

<p class=3DTitleB style=3D'mso-outline-level:body-text'><span lang=3DEN-GB
style=3D'text-transform:none;font-weight:normal;mso-bidi-font-weight:bold'>=
<o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>D.<span style=3D'm=
so-tab-count:
1'> </span>CONDITIONS OR RESTRICTIONS WITH REGARD TO THE SAFE AND
EFFECTIVE USE OF THE MEDICINAL PRODUCT<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt'><sp=
an
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<b><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roma=
n Bold";
mso-fareast-font-family:Verdana;mso-bidi-font-family:"Times New Roman";
text-transform:uppercase;mso-font-kerning:16.0pt;mso-ansi-language:EN-GB;
mso-fareast-language:EN-GB;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'page-break-before:always'>
</span></b>

<p class=3DTitleB><span lang=3DEN-GB>A.<span style=3D'mso-tab-count:1'>=
 </span>MANUFACTURER(S)
RESPONSIBLE FOR BATCH RELEASE</span></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal'><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB>Nam=
e and
address of the manufacturer(s) responsible for batch release<o:p></o:p></sp=
an></u></p>

<p class=3DMsoNormal style=3D'line-height:normal'><u><span lang=3DEN-GB><o:=
p><span
 style=3D'text-decoration:none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal><span lang=3DEN-GB>Almac Pharma Services (Ireland) Lim=
ited</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>Finnabair Industrial Estate</span><=
/p>

<p class=3DMsoNormal><span lang=3DEN-GB>Dundalk</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>Co. Louth</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>A91 P9KD</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB>Ireland</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Almac =
Pharma
Services Ltd.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Seagoe
Industrial Estate</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Craiga=
von</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Co. Ar=
magh BT63
5UA</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>United=
 Kingdom</span></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal'><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal'><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'=
>The
printed package leaflet of the medicinal product must state the name and
address of the manufacturer responsible for the release of the concerned ba=
tch.<o:p></o:p></span></p>

<p class=3DNormalAgency><span lang=3DEN-GB style=3D'font-size:11.0pt;font-f=
amily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DNormalAgency><span lang=3DEN-GB style=3D'font-size:11.0pt;font-f=
amily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleB style=3D'mso-outline-level:2'><span lang=3DEN-GB>B.<span
style=3D'mso-tab-count:1'> </span>CONDITIONS OR RESTRICTIONS REGARDING
SUPPLY AND USE</span><span lang=3DEN-GB style=3D'text-transform:none'><o:p>=
</o:p></span></p>

<p class=3DNormalAgency><span lang=3DEN-GB style=3D'font-size:11.0pt;font-f=
amily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DNormalAgency><span lang=3DEN-GB style=3D'font-size:11.0pt;font-f=
amily:
"Times New Roman",serif'>Medicinal product subject to restricted medical
prescription (see Annex I: Summary of Product Characteristics, section 4.2)=
.<o:p></o:p></span></p>

<p class=3DNormalAgency><span lang=3DEN-GB style=3D'font-size:11.0pt;font-f=
amily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleB style=3D'mso-outline-level:2'><span lang=3DEN-GB>C. <span
style=3D'mso-tab-count:1'> </span>Other conditions and requirements of =
the
Marketing Authorisation</span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;line-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l59 level1 lfo1=
1;
tab-stops:list .25in'><![if !supportLists]><span lang=3DEN-GB style=3D'font=
-family:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB>Periodic safety update reports (PSURs)<o:p></o:p></span></b></=
p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;line-height:normal;mso-p=
agination:
widow-orphan no-line-numbers;tab-stops:0in 28.35pt'><span lang=3DEN-GB><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.85pt;line-height:normal;mso-p=
agination:
widow-orphan no-line-numbers;tab-stops:0in 28.35pt'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>The requirements for submission of PSU=
Rs for
this medicinal product are set out in the list of Union reference dates (EU=
RD
list) provided for under Article 107c(7) of Directive 2001/83/EC and any
subsequent updates published on the European medicines web-portal.<o:p></o:=
p></span></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal'><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DNormalAgency><span lang=3DEN-GB style=3D'font-size:11.0pt;font-f=
amily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleB style=3D'mso-outline-level:2'><span lang=3DEN-GB>D.<span
style=3D'mso-tab-count:1'> </span>Conditions or restrictions with rega=
rd to
the safe and effective use of the medicinal product</span></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal'><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DNormalAgency style=3D'margin-left:.25in;text-indent:-.25in;mso-l=
ist:
l63 level1 lfo12'><![if !supportLists]><span lang=3DEN-GB style=3D'font-siz=
e:11.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'=
>Risk management
plan (RMP)</span></b><span lang=3DEN-GB style=3D'font-size:11.0pt;font-fami=
ly:"Times New Roman",serif'><o:p></o:p></span></p>

<p class=3DNormalAgency><u><span lang=3DEN-GB style=3D'font-size:11.0pt;fon=
t-family:
"Times New Roman",serif'><o:p><span style=3D'text-decoration:none'>&nbsp;</=
span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-right:28.35pt;line-height:normal;mso-p=
agination:
widow-orphan no-line-numbers;tab-stops:0in 28.35pt'><span lang=3DEN-GB>The =
marketing
authorisation holder (MAH) shall perform the required pharmacovigilance
activities and interventions detailed in the agreed RMP presented in Module
1.8.2 of the marketing authorisation and any agreed subsequent updates of t=
he
RMP.</span></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal'><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.05pt;line-height:normal;mso-pa=
gination:
widow-orphan no-line-numbers'><span lang=3DEN-GB style=3D'mso-bidi-font-sty=
le:italic'>An
updated RMP should be submitted:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;line-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l14 level1 lfo1=
0;
tab-stops:list .25in'><![if !supportLists]><span lang=3DEN-GB style=3D'font=
-family:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-bidi-=
font-style:
italic'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-st=
yle:
italic'>At the request of the European Medicines Agency;<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.05pt;margin-bot=
tom:
0in;margin-left:.25in;margin-bottom:.0001pt;text-indent:-.25in;line-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l14 level1 lfo1=
0;
tab-stops:list .25in'><![if !supportLists]><span lang=3DEN-GB style=3D'font=
-family:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-bidi-=
font-style:
italic'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-st=
yle:
italic'>Whenever the risk management system is modified, especially as the
result of new information being received that may lead to a significant cha=
nge
to the benefit/risk profile or as the result of an important (pharmacovigil=
ance
or risk minimisation) milestone being reached.<o:p></o:p></span></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal'><s=
pan
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DNormalAgency style=3D'margin-left:.25in;text-indent:-.25in;mso-l=
ist:
l56 level1 lfo2'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size=
:11.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'=
>Obligation
to conduct post-authorisation measures<o:p></o:p></span></b></p>

<p class=3DNormalAgency><span lang=3DEN-GB style=3D'font-family:"Times New =
Roman",serif;
layout-grid-mode:line'><o:p>&nbsp;</o:p></span></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal;pag=
e-break-after:
avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New =
Roman",serif;
layout-grid-mode:line'>The MAH shall complete, within the stated timeframe,=
 the
below measures:<o:p></o:p></span></p>

<p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal;pag=
e-break-after:
avoid'><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New =
Roman",serif;
layout-grid-mode:line'><o:p>&nbsp;</o:p></span></p>

<table class=3DTableGrid1 border=3D1 cellspacing=3D0 cellpadding=3D0 style=
=3D'border-collapse:
 collapse;border:none;mso-border-alt:solid windowtext .5pt;mso-yfti-tbllook:
 480;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes'>
  <td width=3D360 valign=3Dtop style=3D'width:3.75in;border:solid windowtex=
t 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",seri=
f;
  layout-grid-mode:line'>Description</span></b><b style=3D'mso-bidi-font-we=
ight:
  normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times N=
ew Roman",serif'><o:p></o:p></span></b></p>
  </td>
  <td width=3D253 valign=3Dtop style=3D'width:189.65pt;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DBodytextAgency style=3D'margin-bottom:0in;line-height:normal;
  page-break-after:avoid'><b style=3D'mso-bidi-font-weight:normal'><span
  lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",seri=
f;
  layout-grid-mode:line'>Due date</span></b><b style=3D'mso-bidi-font-weigh=
t:
  normal'><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times N=
ew Roman",serif'><o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;mso-yfti-lastrow:yes'>
  <td width=3D360 valign=3Dtop style=3D'width:3.75in;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>Long-term effectiveness study to compare disease progression
  among children with CF who have a specified CFTR gating mutation and are =
aged
  2 through 5 years at the time of Kalydeco treatment initiation versus dis=
ease
  progression among concurrent matched cohort of children with CF who have
  never received Kalydeco treatment.<o:p></o:p></span></p>
  </td>
  <td width=3D253 valign=3Dtop style=3D'width:189.65pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DSV style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-font=
:minor-latin;
  mso-ansi-language:SV'>Interim analysis 1: December 2017<o:p></o:p></span>=
</p>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DSV style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-font=
:minor-latin;
  mso-ansi-language:SV'><o:p>&nbsp;</o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DSV style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-font=
:minor-latin;
  mso-ansi-language:SV'>Interim analysis 2: December 2019<o:p></o:p></span>=
</p>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DSV style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-font=
:minor-latin;
  mso-ansi-language:SV'><o:p>&nbsp;</o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>Interim analysis 3: December 2021<o:p></o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'><o:p>&nbsp;</o:p></span></p>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB style=3D'mso-fareast-font-family:Calibri;mso-fareast-theme-f=
ont:
  minor-latin'>Final report: December 2023<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DNormalAgency><span lang=3DEN-GB style=3D'font-size:11.0pt;font-f=
amily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:"Times New Roman";mso-ansi-language:EN-GB;mso-farea=
st-language:
EN-GB;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DNormalAgency><span lang=3DEN-GB style=3D'font-size:11.0pt;font-f=
amily:
"Times New Roman",serif'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-right:28.3pt;text-align=
:center;
line-height:normal;mso-pagination:widow-orphan no-line-numbers'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:28.3pt;line-height:normal;mso-pa=
gination:
widow-orphan no-line-numbers'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span=
></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB>ANNEX III<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><b><span lang=3DEN-GB><o:p>&nb=
sp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2'><b><span
lang=3DEN-GB>LABELLING AND PACKAGE LEAFLET<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><b><span lang=3DEN-GB><o:p>&nb=
sp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:SimSun;mso-ansi-language:EN-GB;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DTitleA><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleA><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleA><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleA><span lang=3DEN-GB>A. LABELLING</span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:SimSun;color:black;mso-color-alt:windowtext;mso-ans=
i-language:
EN-GB;mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'mso-special-character:line-break;page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
background:white'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>PARTICULARS TO APP=
EAR ON
THE OUTER PACKAGING<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;border:none;mso-border-alt=
:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'text-transform:uppercase'>Outer carton</span><span lang=3DEN-GB> F=
OR
BLISTER  56-TABLET PACK</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-cou=
nt:1'> </span>NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 150&nbsp;mg film&#8209;coated t=
ablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>ivacaftor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-cou=
nt:1'> </span>STATEMENT
OF ACTIVE SUBSTANCE(S)<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Each tablet contains 150&nbsp;mg of ivac=
aftor.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleA align=3Dleft style=3D'margin-left:.5in;text-align:left;te=
xt-indent:
-.5in;mso-outline-level:body-text;tab-stops:.5in'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Contains lactose.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'background:lightgrey;mso-highli=
ght:
lightgrey'>See leaflet for further information.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>56 tablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Read
the package leaflet before use.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Oral use </span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><b><span style=3D'mso-ansi-language:EN-US'>Instru=
ctions
for use<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span style=3D'mso-ansi-language:EN-US'>Take with
fat-containing food.</span> </p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB>Do not break, chew or dissolve=
 the
tablets.</span><span style=3D'mso-ansi-language:EN-US'><o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span style=3D'mso-ansi-language:EN-US;mso-no-pro=
of:
yes'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>6.<span style=3D'mso-tab-cou=
nt:1'> </span>SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REAC=
H OF
CHILDREN</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1;tab-stops:.=
5in'><span
lang=3DEN-GB>Keep out of the sight and reach of children.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>7.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:37.45pt'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>8.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;tab-stop=
s:
.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>EXP</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>9.<span
style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE CONDITIONS</span>=
</b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>10.<span style=3D'mso-tab-count:1'> </span>SPECIAL PRECA=
UTIONS
FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM S=
UCH
MEDICINAL PRODUCTS, IF APPROPRIATE<span style=3D'mso-bidi-font-weight:bold'=
><o:p></o:p></span></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>11.<span style=3D'mso-tab-co=
unt:
1'> </span>NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Vertex
Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>28-32
Pembroke Street Upper<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Dublin 2,
D02 EK84<o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'>Ireland<o:p></o:p></span>=
</p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>12.<span style=3D'mso-tab-co=
unt:
1'> </span>MARKETING AUTHORISATION NUMBER(S)</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1;tab-stops:.=
5in'><span
lang=3DEN-GB>EU/1/12/782/002</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>13.<span style=3D'mso-tab-co=
unt:
1'> </span>BATCH NUMBER</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><i><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>14.<span style=3D'mso-tab-co=
unt:
1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
2.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>15.<span style=3D'mso-tab-co=
unt:
1'> </span>INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-bidi-font-size:12.0pt'>16.<span style=3D'mso-tab-count:1'>=
 </span>INFORMATION
IN BRAILLE</span><span lang=3DEN-GB style=3D'font-size:11.0pt'><o:p></o:p><=
/span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'background:#CCCCCC'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Kalydeco
150&nbsp;mg tablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-bidi-font-size:12.0pt'>17.<span style=3D'mso-tab-count:1'>=
 </span>UNIQUE
IDENTIFIER  2D BARCODE</span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in;mso-layout-grid-align:none;text-autospace:none'><span
style=3D'background:lightgrey;mso-highlight:lightgrey;mso-ansi-language:EN-=
US'>2D
barcode carrying the unique identifier included.</span><span style=3D'mso-f=
areast-font-family:
TimesNewRomanPSMT;mso-ansi-language:EN-US;mso-fareast-language:DE'><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-bidi-font-size:12.0pt'>18.<span style=3D'mso-tab-count:1'>=
 </span>UNIQUE
IDENTIFIER  HUMAN READABLE DATA</span><span lang=3DEN-GB style=3D'font-siz=
e:11.0pt'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in;mso-layout-grid-align:none;text-autospace:none'><span
style=3D'mso-fareast-font-family:TimesNewRomanPSMT;mso-ansi-language:EN-US;
mso-fareast-language:DE'>PC<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in;mso-layout-grid-align:none;text-autospace:none'><span
style=3D'mso-fareast-font-family:TimesNewRomanPSMT;mso-ansi-language:EN-US;
mso-fareast-language:DE'>SN<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-fareast-font-family:TimesNewRomanPSMT;color:black;mso-ansi-lan=
guage:
EN-US;mso-fareast-language:DE'>NN</span><span style=3D'mso-ansi-language:EN=
-US;
mso-bidi-font-weight:bold'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<b><span style=3D'font-size:11.0pt;mso-bidi-font-size:16.0pt;font-family:"T=
imes New Roman",serif;
mso-fareast-font-family:SimSun;mso-bidi-font-family:Arial;mso-font-kerning:
16.0pt;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'><br clear=3Dall style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR ST=
RIPS</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;
font-weight:normal'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b><span
lang=3DEN-GB>BLISTERS  56&#8209;TABLET PACK<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-cou=
nt:1'> </span>NAME
OF THE MEDICINAL PRODUCT<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><i><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 150&nbsp;mg tablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>ivacaftor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-cou=
nt:1'> </span>NAME
OF THE MARKETING AUTHORISATION HOLDER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Vertex
Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 2.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 2.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>EXPIRY
DATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>EXP</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>BATCH
NUMBER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<b><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:16.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:SimSun;mso-bidi=
-font-family:
Arial;mso-font-kerning:16.0pt;mso-ansi-language:EN-GB;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'page-break-before:a=
lways'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'margin:0in;line-height:normal;border:none;mso-border-alt:solid=
 windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New =
Roman",serif'>PARTICULARS
TO APPEAR ON THE OUTER PACKAGING</span><span lang=3DEN-GB style=3D'font-siz=
e:11.0pt;
font-family:"Times New Roman",serif;font-weight:normal;mso-bidi-font-weight:
bold'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;border:none;mso-border-alt=
:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'text-transform:uppercase'>Outer carton</span><span lang=3DEN-GB> F=
OR
BLISTER CARD  28&#8209;TABLET PACK </span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-cou=
nt:1'> </span>NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 150&nbsp;mg film&#8209;coated t=
ablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>ivacaftor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-cou=
nt:1'> </span>STATEMENT
OF ACTIVE SUBSTANCE(S)<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Each tablet contains 150&nbsp;mg of ivac=
aftor.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Contains lactose.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'background:lightgrey;mso-highli=
ght:
lightgrey'>See leaflet for further information.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>28&nbsp;tablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Read
the package leaflet before use.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Oral use </span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><b><span style=3D'mso-ansi-language:EN-US'>Instru=
ctions
for use<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB>Always take this medicine exac=
tly as
your doctor has told you to.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span style=3D'mso-ansi-language:EN-US'>Take with
fat-containing food.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB>Do not break, chew or dissolve=
 the
tablets.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US;mso-no-proof:yes'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US;mso-no-proof:yes'>In=
sert
tab below to close<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US;mso-no-proof:yes'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US;mso-no-proof:yes'>Op=
en<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US;mso-no-proof:yes'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>6.<span style=3D'mso-tab-cou=
nt:1'> </span>SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REAC=
H OF
CHILDREN</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1;tab-stops:.=
5in'><span
lang=3DEN-GB>Keep out of the sight and reach of children.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>7.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>8.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;tab-stop=
s:
.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>EXP</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan lines-together no-line-numbers;page-break-after:
avoid;mso-outline-level:2;tab-stops:.5in;border:none;mso-border-alt:solid w=
indowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
9.<span
style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE CONDITIONS</span>=
</b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>10.<span style=3D'mso-tab-co=
unt:
1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODU=
CTS
OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>11.<span style=3D'mso-tab-co=
unt:
1'> </span>NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Vertex
Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>28-32
Pembroke Street Upper<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Dublin 2,
D02 EK84<o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'>Ireland<o:p></o:p></span>=
</p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>12.<span style=3D'mso-tab-co=
unt:
1'> </span>MARKETING AUTHORISATION NUMBER(S)</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>EU/1/12/782/005</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>13.<span style=3D'mso-tab-co=
unt:
1'> </span>BATCH NUMBER</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><i><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>14.<span style=3D'mso-tab-co=
unt:
1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
2.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>15.<span style=3D'mso-tab-co=
unt:
1'> </span>INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;color:black;mso-themecolor:text1'>16.<span style=3D'mso-tab-count:1'=
> </span>INFORMATION
IN BRAILLE<o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'background:#CCCCCC'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Kalydeco
150&nbsp;mg tablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt'>17.<span style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER =
 2D
BARCODE<o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1;background:lightgrey;mso-highligh=
t:
lightgrey'>2D barcode carrying the unique identifier included.</span><span
lang=3DEN-GB style=3D'color:black;mso-themecolor:text1'><o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'color:black;mso-themecolor:text1;mso-ansi-language:EN-US;mso-bidi-=
font-weight:
bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'color:black;mso-themecolor:text1;mso-ansi-language:EN-US;mso-bidi-=
font-weight:
bold'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;color:black;mso-themecolor:text1'>18.<span style=3D'mso-tab-count:1'=
> </span>UNIQUE
IDENTIFIER  HUMAN READABLE DATA<o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'color:black;mso-themecolor:text1;mso-ansi-language:EN-US;mso-bidi-=
font-weight:
bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'>PC<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'>SN<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>NN</span></p>

<b><span style=3D'font-size:11.0pt;mso-bidi-font-size:16.0pt;font-family:"T=
imes New Roman",serif;
mso-fareast-font-family:SimSun;mso-bidi-font-family:Arial;mso-font-kerning:
16.0pt;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'><br clear=3Dall style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'margin:0in;line-height:normal;tab-stops:.5in;border:none;mso-b=
order-alt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<span
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;
color:black;mso-themecolor:text1;text-transform:uppercase'>PARTICULARS TO
APPEAR ON THE IMMEDIATE PACKAGING</span><span lang=3DEN-GB style=3D'font-si=
ze:11.0pt;
font-family:"Times New Roman",serif;color:black;mso-themecolor:text1;
font-weight:normal;mso-bidi-font-weight:bold'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'color:bla=
ck;
mso-themecolor:text1'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;border:none;mso-border-alt=
:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'color:black;mso-themecolor:text1;text-transform:uppercase'>BLISTER=
</span><span
lang=3DEN-GB style=3D'color:black;mso-themecolor:text1'> CARD  28-TABLET P=
ACK </span></b><span
lang=3DEN-GB style=3D'color:black;mso-themecolor:text1'><o:p></o:p></span><=
/p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></=
span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB style=3D'color:black;mso-the=
mecolor:
text1'>1.<span style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICI=
NAL
PRODUCT</span></b><span lang=3DEN-GB style=3D'color:black;mso-themecolor:te=
xt1'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'color:black;mso-themecolor:text=
1'>Kalydeco
150&nbsp;mg film&#8209;coated tablets<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'color:black;mso-themecolor:text=
1'>ivacaftor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB style=3D'color:black;mso-the=
mecolor:
text1'>2.<span style=3D'mso-tab-count:1'> </span>STATEMENT OF ACTIVE
SUBSTANCE(S)<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1;mso-bidi-font-style:italic'><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'color:black;mso-themecolor:text=
1'>Each
Kalydeco tablet contains 150&nbsp;mg of ivacaftor.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleA align=3Dleft style=3D'margin-left:.5in;text-align:left;te=
xt-indent:
-.5in;mso-outline-level:body-text;tab-stops:.5in'><span lang=3DEN-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB style=3D'color:black;mso-the=
mecolor:
text1'>3.<span style=3D'mso-tab-count:1'> </span>LIST OF EXCIPIENTS=
</span></b><span
lang=3DEN-GB style=3D'color:black;mso-themecolor:text1'><o:p></o:p></span><=
/p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'color:black;mso-themecolor:text=
1'>Contains
lactose.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'color:black;mso-themecolor:text=
1'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'color:black;mso-themecolor:text=
1;
background:lightgrey;mso-highlight:lightgrey'>See leaflet for further
information.</span><span lang=3DEN-GB style=3D'color:black;mso-themecolor:t=
ext1'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB style=3D'color:black;mso-the=
mecolor:
text1'>4.<span style=3D'mso-tab-count:1'> </span>PHARMACEUTICAL FOR=
M AND
CONTENTS</span></b><span lang=3DEN-GB style=3D'color:black;mso-themecolor:t=
ext1'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'color:black;mso-themecolor:text=
1'>7&nbsp;tablets<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB style=3D'color:black;mso-the=
mecolor:
text1'>5.<span style=3D'mso-tab-count:1'> </span>METHOD AND ROUTE(S=
) OF
ADMINISTRATION</span></b><span lang=3DEN-GB style=3D'color:black;mso-themec=
olor:
text1'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'color:black;mso-themecolor:text1'>Read the package leaflet before =
use.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Oral use </span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><b><span style=3D'mso-ansi-language:EN-US'>Instru=
ctions
for use<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB>Always take this medicine exac=
tly as
your doctor has told you to.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span style=3D'mso-ansi-language:EN-US'>Take with
fat-containing food.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB>Do not break, chew or dissolve=
 the
tablets.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-outline-level:1;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-weight:
bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:=
bold'>Mon.
Tue. Wed. Thu. Fri. Sat. Sun.</span><span style=3D'mso-ansi-language:EN-US;
mso-no-proof:yes'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>6.<span style=3D'mso-tab-cou=
nt:1'> </span>SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REAC=
H OF
CHILDREN</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1;tab-stops:.=
5in'><span
lang=3DEN-GB>Keep out of the sight and reach of children.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>7.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>8.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;tab-stop=
s:
.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>EXP</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>9.<span
style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE CONDITIONS</span>=
</b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>10.<span style=3D'mso-tab-co=
unt:
1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODU=
CTS
OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>11.<span style=3D'mso-tab-co=
unt:
1'> </span>NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Vertex
Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-bidi-font-style:italic'>28-32 Pembroke Street Upper<o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-bidi-font-style:italic'>Dublin 2, D02 EK84<o:p></o:p></span><=
/p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey;mso-bidi=
-font-style:
italic'>Ireland</span><span lang=3DEN-GB style=3D'mso-bidi-font-style:itali=
c'><o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>12.<span style=3D'mso-tab-co=
unt:
1'> </span>MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>EU/1/12/782/005</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>13.<span style=3D'mso-tab-co=
unt:
1'> </span>BATCH NUMBER</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><i><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>14.<span style=3D'mso-tab-co=
unt:
1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
2.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>15.<span style=3D'mso-tab-co=
unt:
1'> </span>INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt'>16.<span style=3D'mso-tab-count:1'> </span>INFORMATION IN BRA=
ILLE<o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'background:#CCCCCC'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt'>17.<span style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER =
 2D
BARCODE<o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt'>18.<span style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER 
HUMAN READABLE DATA<o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<span style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;mso-far=
east-font-family:
SimSun;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'><br clear=3Dall style=3D'page-break-before:always'>
</span>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;border:none;mso-border-alt=
:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB>MINIMUM PARTICULARS TO APPEAR ON BLISTERS OR STR=
IPS<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b><span
lang=3DEN-GB>BLISTERS  28-TABLET PACK<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;tab-stops:.5in;border:none;mso-border-alt:solid windowt=
ext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><i><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB>Kalydeco
150&nbsp;mg tablets</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB>ivacaftor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;tab-stops:.5in;border:none;mso-border-alt:solid windowt=
ext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
2.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MARKETING AUTHORISATI=
ON
HOLDER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB>Vertex</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 2.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;tab-stops:.5in;border:none;mso-border-alt:solid windowt=
ext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 2.0pt 4.0pt'><b><span lang=3DEN-GB>=
3.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p></o:p></span></b>=
</p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB>EXP</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;tab-stops:.5in;border:none;mso-border-alt:solid windowt=
ext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
4.<span
style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p></o:p></span></b=
></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;tab-stops:.5in;border:none;mso-border-alt:solid windowt=
ext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
5.<span
style=3D'mso-tab-count:1'> </span>OTHER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<b><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roma=
n",serif;
mso-fareast-font-family:SimSun;mso-font-kerning:16.0pt;mso-ansi-language:EN=
-GB;
mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'mso-column-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'margin:0in;line-height:normal;border:none;mso-border-alt:solid=
 windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'>PARTICULARS =
TO
APPEAR ON THE OUTER PACKAGING</span><span lang=3DEN-GB style=3D'font-size:1=
1.0pt;
font-family:"Times New Roman",serif;font-weight:normal'><o:p></o:p></span><=
/h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;border:none;mso-border-alt=
:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'text-transform:uppercase'>Outer carton</span><span lang=3DEN-GB> F=
OR
BOTTLE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 0in 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-count=
:1'> </span>NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 150&nbsp;mg film&#8209;coated t=
ablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>ivacaftor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-cou=
nt:1'> </span>STATEMENT
OF ACTIVE SUBSTANCE(S)<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Each tablet contains 150&nbsp;mg of ivac=
aftor.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Contains lactose.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'background:lightgrey;mso-highli=
ght:
lightgrey'>See leaflet for further information.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>56&nbsp;tablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Read
the package leaflet before use.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Oral use</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><b><span style=3D'mso-ansi-language:EN-US'>Instru=
ctions
for use<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><b><span style=3D'mso-ansi-language:EN-US'><o:p>&=
nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span style=3D'mso-ansi-language:EN-US'>Take with
fat-containing food.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB>Do not break, chew or dissolve=
 the
tablets.</span><span style=3D'mso-ansi-language:EN-US'><o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;mso-layout-grid-=
align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>6.<span style=3D'mso-tab-cou=
nt:1'> </span>SPECIAL
WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED OUT OF THE SIGHT AND REAC=
H OF
CHILDREN</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1;tab-stops:.=
5in'><span
lang=3DEN-GB>Keep out of the sight and reach of children.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>7.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:37.45pt'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>8.<span style=3D'mso-tab-cou=
nt:1'> </span>EXPIRY
DATE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB>EXP</span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>9.<span style=3D'mso-tab-cou=
nt:1'> </span>SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>10.<span
style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF
UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL
PRODUCTS, IF APPROPRIATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>11.<span style=3D'mso-tab-co=
unt:
1'> </span>NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Vertex
Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>28-32
Pembroke Street Upper<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Dublin 2,
D02 EK84<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB style=3D'ms=
o-bidi-font-style:
italic'>Ireland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>12.<span style=3D'mso-tab-co=
unt:
1'> </span>MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><span
lang=3DEN-GB>EU/1/12/782/001</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>13.<span style=3D'mso-tab-co=
unt:
1'> </span>BATCH NUMBER</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><i><span lang=3DEN-GB><o:p>&nb=
sp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB>Lot</span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>14.<span style=3D'mso-tab-co=
unt:
1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
2.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>15.<span style=3D'mso-tab-co=
unt:
1'> </span>INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt'>16.<span style=3D'mso-tab-count:1'> </span>INFORMATION IN BRA=
ILLE<o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB style=3D'ba=
ckground:
#CCCCCC'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 150&nbsp;mg tablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt'>17.<span style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER =
 2D
BARCODE<o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span style=3D'mso-ansi-langua=
ge:
EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in;mso-layout-grid-align:none;text-autospace:none'><span
style=3D'background:lightgrey;mso-highlight:lightgrey;mso-ansi-language:EN-=
US'>2D
barcode carrying the unique identifier included.</span><span style=3D'mso-f=
areast-font-family:
TimesNewRomanPSMT;mso-ansi-language:EN-US;mso-fareast-language:DE'><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span style=3D'mso-ansi-langua=
ge:
EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span style=3D'mso-ansi-langua=
ge:
EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt'>18.<span style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER 
HUMAN READABLE DATA<o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span style=3D'mso-ansi-langua=
ge:
EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in;mso-layout-grid-align:none;text-autospace:none'><span
style=3D'mso-fareast-font-family:TimesNewRomanPSMT;mso-ansi-language:EN-US;
mso-fareast-language:DE'>PC<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in;mso-layout-grid-align:none;text-autospace:none'><span
style=3D'mso-fareast-font-family:TimesNewRomanPSMT;mso-ansi-language:EN-US;
mso-fareast-language:DE'>SN<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span style=3D'mso-fareast-fon=
t-family:
TimesNewRomanPSMT;color:black;mso-ansi-language:EN-US;mso-fareast-language:
DE'>NN</span><span style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bo=
ld'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<b><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roma=
n",serif;
mso-fareast-font-family:SimSun;mso-font-kerning:16.0pt;mso-ansi-language:EN=
-GB;
mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'margin:0in;line-height:normal;border:none;mso-border-alt:solid=
 windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New =
Roman",serif;
mso-bidi-font-family:Arial'>PARTICULARS TO APPEAR ON THE IMMEDIATE PACKAGIN=
G</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;
font-weight:normal;mso-bidi-font-weight:bold'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>BOTTLE LABEL</span></b><span lang=3DEN-GB style=3D'mso-bidi-fo=
nt-weight:
bold'><o:p></o:p></span></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>1.<span style=3D'mso-tab-count:1'> </span>NAME OF THE
MEDICINAL PRODUCT</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 150&nbsp;mg film&#8209;coated t=
ablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>ivacaftor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>2.<span style=3D'mso-tab-count:1'> </span>STATEMENT OF=
 ACTIVE
SUBSTANCE(S)<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Each tablet contains 150&nbsp;mg of ivac=
aftor.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>3.<span style=3D'mso-tab-count:1'> </span>LIST OF EXCI=
PIENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Contains <span style=3D'mso-bidi-font-we=
ight:
bold'>lactose</span>.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'background:lightgrey;mso-highli=
ght:
lightgrey'>See leaflet for further information.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>4.<span style=3D'mso-tab-count:1'> </span>PHARMACEUTIC=
AL FORM
AND CONTENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>56&nbsp;tablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>5.<span style=3D'mso-tab-count:1'> </span>METHOD AND R=
OUTE(S)
OF ADMINISTRATION</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB>Read the pa=
ckage
leaflet before use.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal'><span
lang=3DEN-GB>Oral use</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-layout-grid-align:none;
text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;border:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>6.<span style=3D'm=
so-tab-count:
1'> </span>SPECIAL WARNING THAT THE MEDICINAL PRODUCT MUST BE STORED =
OUT
OF THE SIGHT AND REACH OF CHILDREN</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1'><span
lang=3DEN-GB>Keep out of the sight and reach of children.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;border:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>7.<span style=3D'm=
so-tab-count:
1'> </span>OTHER SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;border:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>8.<span style=3D'm=
so-tab-count:
1'> </span>EXPIRY DATE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB>EXP</span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>9.<span style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE
CONDITIONS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in'><span lan=
g=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:n=
ormal'><span
lang=3DEN-GB>10.<span style=3D'mso-tab-count:1'> </span>SPECIAL PRECA=
UTIONS
FOR DISPOSAL OF UNUSED MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM S=
UCH
MEDICINAL PRODUCTS, IF APPROPRIATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>11.<span style=3D'mso-tab-count:1'> </span>NAME AND ADDR=
ESS OF
THE MARKETING AUTHORISATION HOLDER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Vertex
Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-bidi-font-style:italic'>28-32 Pembroke Street Upper<o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-bidi-font-style:italic'>Dublin 2, D02 EK84<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'background:lightgrey;mso-highlight:lightgrey;mso-bidi-font-style:i=
talic'>Ireland</span><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>12.<span style=3D'mso-tab-count:1'> </span>MARKETING
AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:1;tab-stops:.=
5in'><span
lang=3DEN-GB>EU/1/12/782/001</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>13.<span style=3D'mso-tab-count:1'> </span>BATCH NUMBER<=
/span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>14.<span style=3D'mso-tab-count:1'> </span>GENERAL
CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
2.0pt 4.0pt 1.0pt 4.0pt'><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB>15.<span style=3D'mso-tab-count:1'> </span>INSTRUCTIONS =
ON USE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt'>16.<span style=3D'mso-tab-count:1'> </span>INFORMATION IN BRA=
ILLE<o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt'>17.<span style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER =
 2D
BARCODE<span style=3D'color:green'><o:p></o:p></span></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt'>18.<span style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER 
HUMAN READABLE DATA<span style=3D'color:green'><o:p></o:p></span></span></h=
2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:SimSun;mso-ansi-language:EN-GB;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><b><span
lang=3DEN-GB style=3D'mso-font-kerning:16.0pt'><o:p>&nbsp;</o:p></span></b>=
</p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;mso-bidi-font-size:16.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-family:Arial'>PARTICULARS TO APPEAR ON THE OUTER PACKAGING</s=
pan><span
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;
font-weight:normal;mso-bidi-font-weight:bold'><o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'line-height:normal;border:none;mso-border-alt=
:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'text-transform:uppercase'>Outer carton</span><span lang=3DEN-GB> F=
OR
SACHET</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-cou=
nt:1'> </span>NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 25&nbsp;mg granules in sachet</=
span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>ivacaftor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:0in 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
0in 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-count=
:1'> </span>STATEMENT
OF ACTIVE SUBSTANCE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><i><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:none;tab-stops:.5in'><span lang=3DEN-GB>Each sachet of granu=
les
contains 25&nbsp;mg of ivacaftor.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Contains lactose.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'background:lightgrey;mso-highli=
ght:
lightgrey'>See leaflet for further information.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'background:lightgrey;mso-highlight:lightgrey;
mso-ansi-language:EN-US'>Granules in sachet</span><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>56&nbsp;sachets<o:p=
></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>4 individual wallet=
s with
14&nbsp;sachets per wallet</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:249.85pt'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Read
the package leaflet before use.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>Oral use<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB=
>Instructions
for use<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB>Mix the entire content of a sachet with
5&nbsp;mL of age&#8209;appropriate soft food or liquid that is at or below =
room
temperature and consume it completely.</span><span style=3D'mso-ansi-langua=
ge:
EN-US;mso-bidi-font-weight:bold'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Use
within one hour after mixing, just before or after a fat&#8209;containing m=
eal
or snack.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Lift
here to open</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>6.<span
style=3D'mso-tab-count:1'> </span>SPECIAL WARNING THAT THE MEDICINAL
PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;tab-stop=
s:
.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Keep out of the sight and reach of child=
ren.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>7.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:37.45pt'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>8.<span style=3D'mso-tab-cou=
nt:1'> </span>EXPIRY
DATE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>EXP</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>9.<span style=3D'mso-tab-cou=
nt:1'> </span>SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>10.<span style=3D'mso-tab-co=
unt:
1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODU=
CTS
OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>11.<span style=3D'mso-tab-co=
unt:
1'> </span>NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Vertex
Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>28-32
Pembroke Street Upper<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Dublin 2,
D02 EK84<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic'>Ire=
land</span><span
style=3D'mso-ansi-language:EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>12.<span style=3D'mso-tab-co=
unt:
1'> </span>MARKETING AUTHORISATION NUMBER(S)</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>EU/1/12/782/006</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>13.<span style=3D'mso-tab-co=
unt:
1'> </span>BATCH NUMBER</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>14.<span style=3D'mso-tab-co=
unt:
1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</span></b><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p></o:p></span>=
</b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
2.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>15.<span style=3D'mso-tab-co=
unt:
1'> </span>INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-bidi-font-weight:normal'>16.<span style=3D'mso-tab-count:1'>=
 </span>INFORMATION
IN BRAILLE</span><span lang=3DEN-GB style=3D'font-size:11.0pt'><o:p></o:p><=
/span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'background:#CCCCCC'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 25&nbsp;mg granules</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
page-break-after:avoid;mso-outline-level:2;tab-stops:.5in;border:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-farea=
st-language:
EN-GB'>17.<span style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER =
 2D
BARCODE<span style=3D'mso-bidi-font-weight:bold'><o:p></o:p></span></span><=
/b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in;mso-layout-grid-align:none;text-autospace:none'><span
style=3D'mso-fareast-font-family:TimesNewRomanPSMT;background:lightgrey;
mso-highlight:lightgrey;mso-ansi-language:EN-US;mso-fareast-language:DE'>2D
barcode carrying the unique identifier included.</span><span style=3D'mso-f=
areast-font-family:
TimesNewRomanPSMT;mso-ansi-language:EN-US;mso-fareast-language:DE'><o:p></o=
:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
page-break-after:avoid;mso-outline-level:2;tab-stops:.5in;border:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-farea=
st-language:
EN-GB'>18.<span style=3D'mso-tab-count:1'> </span>UNIQUE IDENTIFIER =
 HUMAN
READABLE DATA<span style=3D'mso-bidi-font-weight:bold'><o:p></o:p></span></=
span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in;mso-layout-grid-align:none;text-autospace:none'><span
style=3D'mso-fareast-font-family:TimesNewRomanPSMT;mso-ansi-language:EN-US;
mso-fareast-language:DE'>PC<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in;mso-layout-grid-align:none;text-autospace:none'><span
style=3D'mso-fareast-font-family:TimesNewRomanPSMT;mso-ansi-language:EN-US;
mso-fareast-language:DE'>SN<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US;mso-fareast-language=
:DE'>NN<o:p></o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:SimSun;mso-font=
-kerning:
16.0pt;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'><br clear=3Dall style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;font-family:"Times New Roman",serif'>PARTICULARS TO APPEAR ON THE
INTERMEDIATE PACKAGING<o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;border:none;mso-border-alt=
:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'text-transform:uppercase'>WALLET</span><span lang=3DEN-GB> FOR SAC=
HET</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-cou=
nt:1'> </span>NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 25&nbsp;mg granules in sachet</=
span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>ivacaftor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-cou=
nt:1'> </span>STATEMENT
OF ACTIVE SUBSTANCE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><i><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:none;tab-stops:.5in'><span lang=3DEN-GB>Each sachet of granu=
les
contains 25&nbsp;mg of ivacaftor.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Contains lactose.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'background:lightgrey;mso-highli=
ght:
lightgrey'>See leaflet for further information.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'background:lightgrey;mso-highlight:lightgrey;
mso-ansi-language:EN-US'>Granules in sachet</span><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>14&nbsp;sachets</sp=
an></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Read
the package leaflet before use.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>Oral use<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB=
>Instructions
for use<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Mix the entire content of a sachet with 5&nbsp;mL of age-appro=
priate
soft food or liquid that is at or below room temperature and consume it
completely. </span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Use within one hour after mixing, just before or after a
fat-containing meal or snack.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Use all 7&nbsp;days doses before starting a new wallet.</span=
></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'=
>Morning<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'=
>Evening<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'=
><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'=
>Mon. Tue.
Wed. Thu. Fri. Sat. Sun.<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>6.<span
style=3D'mso-tab-count:1'> </span>SPECIAL WARNING THAT THE MEDICINAL
PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in'><span lan=
g=3DEN-GB>Keep
out of the sight and reach of children.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;border:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b><span
lang=3DEN-GB>7.<span style=3D'mso-tab-count:1'> </span>OTHER SPECIAL
WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:28.35pt 37.45pt'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;border:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b><span
lang=3DEN-GB>8.<span style=3D'mso-tab-count:1'> </span>EXPIRY DATE</s=
pan></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-=
alt:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>9.<span style=3D'mso-tab-cou=
nt:1'> </span>SPECIAL
STORAGE CONDITIONS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>10.<span style=3D'mso-tab-co=
unt:
1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODU=
CTS
OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in'><span lan=
g=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in'><span lan=
g=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>11.<span style=3D'mso-tab-co=
unt:
1'> </span>NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal'><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'>Vertex Pharmaceuticals (I=
reland)
Limited</span><span style=3D'mso-fareast-font-family:"MS Mincho";background=
:lightgrey;
mso-highlight:lightgrey;mso-ansi-language:EN-US;mso-fareast-language:JA;
mso-bidi-font-weight:bold'><o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-bidi-font-style:italic'>28-32 Pembroke Street Upper<o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-bidi-font-style:italic'>Dublin 2, D02 EK84<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal'><span
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey;mso-bidi=
-font-style:
italic'>Ireland</span><span style=3D'mso-ansi-language:EN-US'><o:p></o:p></=
span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>12.<span style=3D'mso-tab-co=
unt:
1'> </span>MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB style=3D'ms=
o-bidi-font-family:
Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB>EU/1/12/782=
/006</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers'><span lang=3DEN-GB><o:p>&nbsp;=
</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>13.<span style=3D'mso-tab-co=
unt:
1'> </span>BATCH NUMBER</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>14.<span style=3D'mso-tab-co=
unt:
1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;tab-stops:.5in;border:none;mso-border-alt:solid windowt=
ext .5pt;
padding:0in;mso-padding-alt:2.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
15.<span
style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin:0in;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-weight:normal'>16.<span style=3D'ms=
o-tab-count:
1'> </span>INFORMATION IN BRAILLE</span><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin:0in;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-weight:normal'>17.<span style=3D'ms=
o-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span><span lang=3DEN-GB
style=3D'font-size:11.0pt;color:green'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin:0in;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-weight:normal'>18.<span style=3D'ms=
o-tab-count:
1'> </span>UNIQUE IDENTIFIER  HUMAN READABLE DATA</span><span
lang=3DEN-GB style=3D'font-size:11.0pt;color:green'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:SimSun;mso-font=
-kerning:
16.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'><br clear=3Dall style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5p=
t;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;mso-bidi-font=
-weight:
normal'>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS<o:=
p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;border:no=
ne;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;border:no=
ne;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b><span
lang=3DEN-GB>SACHETS<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-cou=
nt:1'> </span>NAME
OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION<o:p></o:p></span></=
b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 25&nbsp;mg granules</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>ivacaftor</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Oral use</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><i><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><i><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-cou=
nt:1'> </span>METHOD
OF ADMINISTRATION<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 2.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 2.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>EXPIRY
DATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>EXP</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>BATCH
NUMBER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>6.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>Vertex Pharmaceutic=
als (Ireland)
Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<b><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roma=
n",serif;
mso-fareast-font-family:SimSun;mso-font-kerning:16.0pt;mso-ansi-language:EN=
-GB;
mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'margin:0in;line-height:normal;border:none;mso-border-alt:solid=
 windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB><sp=
an
style=3D'mso-spacerun:yes'></span></span><span lang=3DEN-GB style=3D'font-=
size:11.0pt;
font-family:"Times New Roman",serif'>PARTICULARS TO APPEAR ON THE OUTER
PACKAGING<o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;border:none;mso-border-alt=
:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'text-transform:uppercase'>Outer carton</span><span lang=3DEN-GB> F=
OR
SACHET</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-cou=
nt:1'> </span>NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Kalyde=
co
50&nbsp;mg granules in sachet</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>ivacaf=
tor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:0in 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
0in 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-count=
:1'> </span>STATEMENT
OF ACTIVE SUBSTANCE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><i><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none'><span
lang=3DEN-GB>Each sachet of granules contains 50&nbsp;mg of ivacaftor.</spa=
n></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Contai=
ns
lactose.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'background:lightgrey;mso-highlight:lightgrey'>See leaflet for furt=
her
information.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'background=
:lightgrey;
mso-highlight:lightgrey;mso-ansi-language:EN-US'>Granules in sachet</span><=
span
style=3D'mso-ansi-language:EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'>56 sachets<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'>4 individual wallets with 14 sachets per wallet</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:249.85pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Read the package leaflet before use.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'>Oral use</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><b><span
style=3D'mso-ansi-language:EN-US'>Instructions for use<o:p></o:p></span></b=
></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Mix the entire content of a sachet with 5&nbsp;mL of age-appro=
priate
soft food or liquid that is at or below room temperature and consume it
completely.</span><span style=3D'mso-ansi-language:EN-US;mso-bidi-font-weig=
ht:
bold'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Use within one hour after mixing, just before or after a fat&#=
8209;containing
meal or snack.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Lift here to open</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.1pt;text-indent:-28.1pt;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
6.<span
style=3D'mso-tab-count:1'> </span>SPECIAL WARNING THAT THE MEDICINAL P=
RODUCT
MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Keep o=
ut of the
sight and reach of children.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>7.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.1pt;text-indent:-28.1pt;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
8.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>EXP</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
9.<span
style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE CONDITIONS</span></=
b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
10.<span
style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF U=
NUSED
MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS,=
 IF
APPROPRIATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal'><b><span lang=3DEN-GB><o:=
p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b><span lang=3DEN-GB><o:=
p>&nbsp;</o:p></span></b></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
11.<span
style=3D'mso-tab-count:1'> </span>NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Vertex
Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>28-32
Pembroke Street Upper<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Dublin 2,
D02 EK84<o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB style=3D=
'mso-bidi-font-style:
italic'>Ireland<o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span style=3D'mso-ansi-lan=
guage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span style=3D'mso-ansi-lan=
guage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
12.<span
style=3D'mso-tab-count:1'> </span>MARKETING AUTHORISATION NUMBER(S) </s=
pan></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>EU/1/12/782/003</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
13.<span
style=3D'mso-tab-count:1'> </span>BATCH NUMBER</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
14.<span
style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</sp=
an></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:2.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
15.<span
style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'font-size:10.0pt'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin:0in;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-weight:normal'>16.<span style=3D'ms=
o-tab-count:
1'> </span>INFORMATION IN BRAILLE</span><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'background:#CCCCCC'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Kalyde=
co
50&nbsp;mg granules</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin:0in;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-weight:normal'>17.<span style=3D'ms=
o-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span style=3D'mso-fareast-font-family:TimesNewRo=
manPSMT;
background:lightgrey;mso-highlight:lightgrey;mso-ansi-language:EN-US;
mso-fareast-language:DE'>2D barcode carrying the unique identifier included=
.</span><span
style=3D'mso-fareast-font-family:TimesNewRomanPSMT;mso-ansi-language:EN-US;
mso-fareast-language:DE'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin:0in;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-weight:normal'>18.<span style=3D'ms=
o-tab-count:
1'> </span>UNIQUE IDENTIFIER  HUMAN READABLE DATA</span><span
lang=3DEN-GB style=3D'font-size:11.0pt'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span style=3D'mso-fareast-font-family:TimesNewRo=
manPSMT;
mso-ansi-language:EN-US;mso-fareast-language:DE'>PC<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span style=3D'mso-fareast-font-family:TimesNewRo=
manPSMT;
mso-ansi-language:EN-US;mso-fareast-language:DE'>SN<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US;mso-fareast-language:DE'>NN<o:p></o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span style=3D'font-size:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:SimSun;mso-font=
-kerning:
16.0pt;mso-ansi-language:EN-US;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'><br clear=3Dall style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;font-family:"Times New Roman",serif'>PARTICULARS TO APPEAR ON THE
INTERMEDIATE PACKAGING<o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;border:none;mso-border-alt=
:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'text-transform:uppercase'>WALLET</span><span lang=3DEN-GB> FOR SAC=
HET</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-cou=
nt:1'> </span>NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 50&nbsp;mg granules in sachet</=
span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>ivacaftor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-cou=
nt:1'> </span>STATEMENT
OF ACTIVE SUBSTANCE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><i><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:none;tab-stops:.5in'><span lang=3DEN-GB>Each sachet of granu=
les
contains 50&nbsp;mg of ivacaftor.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Contains lactose.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'background:lightgrey;mso-highli=
ght:
lightgrey'>See leaflet for further information.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'background:lightgrey;mso-highlight:lightgrey;
mso-ansi-language:EN-US'>Granules in sachet</span><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>14 sachets</span></=
p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Read
the package leaflet before use.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>Oral use</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><b><span style=3D'mso-ansi-language:EN-US'>Instructions for=
 use<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB>Mix the entire content of a sachet with
5&nbsp;mL of age-appropriate soft food or liquid that is at or below room
temperature and consume it completely. </span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Use
within one hour after mixing, just before or after a fat-containing meal or
snack.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Use
all 7&nbsp;days doses before starting a new wallet.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Morning<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Evening<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Mon. Tue. Wed. Thu. Fri. S=
at. Sun.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>6.<span
style=3D'mso-tab-count:1'> </span>SPECIAL WARNING THAT THE MEDICINAL
PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;tab-stop=
s:
.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB>Keep out of the sight and reach of children.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>7.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:37.45pt'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>8.<span style=3D'mso-tab-cou=
nt:1'> </span>EXPIRY
DATE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>9.<span
style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE CONDITIONS</span>=
</b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>10.<span style=3D'mso-tab-co=
unt:
1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODU=
CTS
OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>11.<span style=3D'mso-tab-co=
unt:
1'> </span>NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Vertex
Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-bidi-font-style:italic'>28-32 Pembroke Street Upper<o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-bidi-font-style:italic'>Dublin 2, D02 EK84<o:p></o:p></span><=
/p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey;mso-bidi=
-font-style:
italic'>Ireland</span><span lang=3DEN-GB style=3D'mso-bidi-font-style:itali=
c'><o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>12.<span style=3D'mso-tab-co=
unt:
1'> </span>MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>EU/1/12/782/003</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>13.<span style=3D'mso-tab-co=
unt:
1'> </span>BATCH NUMBER</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>14.<span style=3D'mso-tab-co=
unt:
1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
2.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>15.<span style=3D'mso-tab-co=
unt:
1'> </span>INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-bidi-font-weight:normal'>16.<span style=3D'mso-tab-count:1'>=
 </span>INFORMATION
IN BRAILLE</span><span lang=3DEN-GB style=3D'font-size:11.0pt'><o:p></o:p><=
/span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-bidi-font-weight:normal'>17.<span style=3D'mso-tab-count:1'>=
 </span>UNIQUE
IDENTIFIER  2D BARCODE</span><span lang=3DEN-GB style=3D'font-size:11.0pt;
color:green'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-bidi-font-weight:normal'>18.<span style=3D'mso-tab-count:1'>=
 </span>UNIQUE
IDENTIFIER  HUMAN READABLE DATA</span><span lang=3DEN-GB style=3D'font-siz=
e:11.0pt;
color:green'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:SimSun;mso-font=
-kerning:
16.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'><br clear=3Dall style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'margin:0in;line-height:normal;border:none;mso-border-alt:solid=
 windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;mso-bidi-font=
-weight:
normal'>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIATE PACKAGING UNITS<o:=
p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b><span
lang=3DEN-GB>SACHETS<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
1.<span
style=3D'mso-tab-count:1'> </span>NAME OF THE MEDICINAL PRODUCT AND
ROUTE(S) OF ADMINISTRATION<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Kalyde=
co
50&nbsp;mg granules</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>ivacaf=
tor</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Oral u=
se</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><i><span lang=3DEN-GB><o:=
p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal'><i><span lang=3DEN-GB><o:=
p>&nbsp;</o:p></span></i></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
2.<span
style=3D'mso-tab-count:1'> </span>METHOD OF ADMINISTRATION<o:p></o:p>=
</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 2.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 2.0pt 4.0pt'><b><span lang=3DEN-GB>=
3.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE<o:p></o:p></span></b></=
p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>EXP</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
4.<span
style=3D'mso-tab-count:1'> </span>BATCH NUMBER<o:p></o:p></span></b><=
/p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
5.<span
style=3D'mso-tab-count:1'> </span>CONTENTS BY WEIGHT, BY VOLUME OR BY=
 UNIT<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
6.<span
style=3D'mso-tab-count:1'> </span>OTHER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'>Vertex Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<b><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roma=
n",serif;
mso-fareast-font-family:SimSun;mso-font-kerning:16.0pt;mso-ansi-language:EN=
-GB;
mso-fareast-language:EN-US;mso-bidi-language:AR-SA'><br clear=3Dall
style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'margin:0in;line-height:normal;border:none;mso-border-alt:solid=
 windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;font-family:"Times New Roman",serif'>PARTICULARS =
TO
APPEAR ON THE OUTER PACKAGING<o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;border:none;mso-border-alt=
:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'text-transform:uppercase'>Outer carton</span><span lang=3DEN-GB> F=
OR
SACHET</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 0in 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-count=
:1'> </span>NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Kalyde=
co
75&nbsp;mg granules in sachet</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>ivacaf=
tor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:0in 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
0in 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-count=
:1'> </span>STATEMENT
OF ACTIVE SUBSTANCE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><i><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none'><span
lang=3DEN-GB>Each sachet of granules contains 75&nbsp;mg of ivacaftor.</spa=
n></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Contai=
ns
lactose.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'background:lightgrey;mso-highlight:lightgrey'>See leaflet for furt=
her
information.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'background=
:lightgrey;
mso-highlight:lightgrey;mso-ansi-language:EN-US'>Granules in sachet</span><=
span
style=3D'mso-ansi-language:EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'>56 sachets<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'>4 individual wallets with 14 sachets per wallet</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Read the package leaflet before use.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'>Oral use</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><b><span
style=3D'mso-ansi-language:EN-US'>Instructions for use<o:p></o:p></span></b=
></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Mix the entire content of a sachet with 5&nbsp;mL of age-appro=
priate
soft food or liquid that is at or below room temperature and consume it
completely.</span><span style=3D'mso-ansi-language:EN-US;mso-bidi-font-weig=
ht:
bold'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Use within one hour after mixing, just before or after a fat&#=
8209;containing
meal or snack.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Lift here to open</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.1pt;text-indent:-28.1pt;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
6.<span
style=3D'mso-tab-count:1'> </span>SPECIAL WARNING THAT THE MEDICINAL P=
RODUCT
MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Keep o=
ut of the
sight and reach of children.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>7.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:28.35pt 37.45pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.1pt;text-indent:-28.1pt;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
8.<span
style=3D'mso-tab-count:1'> </span>EXPIRY DATE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>EXP </span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
9.<span
style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE CONDITIONS</span></=
b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
10.<span
style=3D'mso-tab-count:1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF U=
NUSED
MEDICINAL PRODUCTS OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS,=
 IF
APPROPRIATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal'><b><span lang=3DEN-GB><o:=
p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b><span lang=3DEN-GB><o:=
p>&nbsp;</o:p></span></b></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
11.<span
style=3D'mso-tab-count:1'> </span>NAME AND ADDRESS OF THE MARKETING
AUTHORISATION HOLDER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Vertex
Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>28-32
Pembroke Street Upper<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Dublin 2,
D02 EK84<o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB style=3D=
'mso-bidi-font-style:
italic'>Ireland<o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span style=3D'mso-ansi-lan=
guage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span style=3D'mso-ansi-lan=
guage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
12.<span
style=3D'mso-tab-count:1'> </span>MARKETING AUTHORISATION NUMBER(S) </s=
pan></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>EU/1/12/782/004</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
13.<span
style=3D'mso-tab-count:1'> </span>BATCH NUMBER</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
14.<span
style=3D'mso-tab-count:1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</sp=
an></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
mso-outline-level:2;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:2.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>=
15.<span
style=3D'mso-tab-count:1'> </span>INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><i
style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></=
span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 0in 4.0pt'>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 0in 4.0pt'><b><span lang=3DEN-GB>16.<span style=3D'mso-tab-coun=
t:1'> </span>INFORMATION
IN BRAILLE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB style=3D'background:#CCCCCC'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB>Kalydeco 75&nbsp;mg granules</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin:0in;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-weight:normal'>17.<span style=3D'ms=
o-tab-count:
1'> </span>UNIQUE IDENTIFIER  2D BARCODE</span><span lang=3DEN-GB
style=3D'font-size:11.0pt'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span style=3D'mso-fareast-font-family:TimesNewRo=
manPSMT;
background:lightgrey;mso-highlight:lightgrey;mso-ansi-language:EN-US;
mso-fareast-language:DE'>2D barcode carrying the unique identifier included=
.</span><span
style=3D'mso-fareast-font-family:TimesNewRomanPSMT;mso-ansi-language:EN-US;
mso-fareast-language:DE'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin:0in;border:none;mso-border-alt:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-bidi-font-weight:normal'>18.<span style=3D'ms=
o-tab-count:
1'> </span>UNIQUE IDENTIFIER  HUMAN READABLE DATA</span><span
lang=3DEN-GB style=3D'font-size:11.0pt'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid'><span style=3D'mso-ansi-language:EN-US;mso-bidi-fon=
t-weight:
bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in;mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-far=
east-font-family:
TimesNewRomanPSMT;mso-ansi-language:EN-US;mso-fareast-language:DE'>PC<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in;mso-layout-=
grid-align:
none;text-autospace:none'><span style=3D'mso-fareast-font-family:TimesNewRo=
manPSMT;
mso-ansi-language:EN-US;mso-fareast-language:DE'>SN<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
style=3D'mso-fareast-font-family:TimesNewRomanPSMT;color:black;mso-ansi-lan=
guage:
EN-US;mso-fareast-language:DE'>NN<o:p></o:p></span></p>

<b><span style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;
mso-fareast-font-family:TimesNewRomanPSMT;color:black;mso-font-kerning:16.0=
pt;
mso-ansi-language:EN-US;mso-fareast-language:DE;mso-bidi-language:AR-SA'><br
clear=3Dall style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'border:none;mso-border-alt:solid windowtext .5pt;padding:0in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'font-s=
ize:
11.0pt;font-family:"Times New Roman",serif'>PARTICULARS TO APPEAR ON THE
INTERMEDIATE PACKAGING<o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-28.35pt;line=
-height:
normal;mso-pagination:widow-orphan no-line-numbers;border:none;mso-border-a=
lt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;border:none;mso-border-alt=
:solid windowtext .5pt;
padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB
style=3D'text-transform:uppercase'>WALLET</span><span lang=3DEN-GB> FOR SAC=
HET</span></b></p>

</div>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-cou=
nt:1'> </span>NAME
OF THE MEDICINAL PRODUCT</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 75&nbsp;mg granules in sachet</=
span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>ivacaftor<i><o:p></o:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-cou=
nt:1'> </span>STATEMENT
OF ACTIVE SUBSTANCE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><i><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:none;tab-stops:.5in'><span lang=3DEN-GB>Each sachet of granu=
les
contains 75&nbsp;mg of ivacaftor.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>LIST
OF EXCIPIENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Contains lactose.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'background:lightgrey;mso-highli=
ght:
lightgrey'>See leaflet for further information.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>PHARMACEUTICAL
FORM AND CONTENTS</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'background:lightgrey;mso-highlight:lightgrey;
mso-ansi-language:EN-US'>Granules in sachet</span><span style=3D'mso-ansi-l=
anguage:
EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>14 sachets</span></=
p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>METHOD
AND ROUTE(S) OF ADMINISTRATION</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Read
the package leaflet before use.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>Oral use</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><b><span style=3D'mso-ansi-language:EN-US'>Instructions for=
 use<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
tab-stops:.5in'><span lang=3DEN-GB>Mix the entire content of a sachet with
5&nbsp;mL of age-appropriate soft food or liquid that is at or below room
temperature and consume it completely.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Use
within one hour after mixing, just before or after a fat-containing meal or
snack.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Use
all 7&nbsp;days doses before starting a new wallet.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Morning<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Evening<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'>Mon. Tue. Wed. Thu. Fri. S=
at. Sun.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:3.25in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>6.<span
style=3D'mso-tab-count:1'> </span>SPECIAL WARNING THAT THE MEDICINAL
PRODUCT MUST BE STORED OUT OF THE SIGHT AND REACH OF CHILDREN</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;tab-stop=
s:
3.25in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;tab-stops:=
.5in'><span
lang=3DEN-GB>Keep out of the sight and reach of children.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>7.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER
SPECIAL WARNING(S), IF NECESSARY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:37.45pt'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>8.<span style=3D'mso-tab-cou=
nt:1'> </span>EXPIRY
DATE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;mso-outl=
ine-level:
2;tab-stops:.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:0=
in;
mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>9.<span
style=3D'mso-tab-count:1'> </span>SPECIAL STORAGE CONDITIONS</span>=
</b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>10.<span style=3D'mso-tab-co=
unt:
1'> </span>SPECIAL PRECAUTIONS FOR DISPOSAL OF UNUSED MEDICINAL PRODU=
CTS
OR WASTE MATERIALS DERIVED FROM SUCH MEDICINAL PRODUCTS, IF APPROPRIATE<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>11.<span style=3D'mso-tab-co=
unt:
1'> </span>NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER<o:p=
></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-style:italic=
'>Vertex
Pharmaceuticals (Ireland) Limited<o:p></o:p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-bidi-font-style:italic'>28-32 Pembroke Street Upper<o:p></o:p=
></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'background:lightgrey;mso-h=
ighlight:
lightgrey;mso-bidi-font-style:italic'>Dublin 2, D02 EK84<o:p></o:p></span><=
/p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey;mso-bidi=
-font-style:
italic'>Ireland</span><span lang=3DEN-GB style=3D'mso-bidi-font-style:itali=
c'><o:p></o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin-bottom:0in;text-indent:-.5in'><s=
pan
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>12.<span style=3D'mso-tab-co=
unt:
1'> </span>MARKETING AUTHORISATION NUMBER(S) </span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-family:Verdana'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>EU/1/12/782/004</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>13.<span style=3D'mso-tab-co=
unt:
1'> </span>BATCH NUMBER</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>14.<span style=3D'mso-tab-co=
unt:
1'> </span>GENERAL CLASSIFICATION FOR SUPPLY</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:2.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
2.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>15.<span style=3D'mso-tab-co=
unt:
1'> </span>INSTRUCTIONS ON USE</span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-bidi-font-weight:normal'>16.<span style=3D'mso-tab-count:1'>=
 </span>INFORMATION
IN BRAILLE</span><span lang=3DEN-GB style=3D'font-size:11.0pt'><o:p></o:p><=
/span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p=
>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-bidi-font-weight:normal'>17.<span style=3D'mso-tab-count:1'>=
 </span>UNIQUE
IDENTIFIER  2D BARCODE</span><span lang=3DEN-GB style=3D'font-size:11.0pt'=
><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h2 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;border:none;mso-border-alt:solid windowtext .5pt;padding:
0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'><span lang=3DEN-GB style=3D'fo=
nt-size:
11.0pt;mso-bidi-font-weight:normal'>18.<span style=3D'mso-tab-count:1'>=
 </span>UNIQUE
IDENTIFIER  HUMAN READABLE DATA</span><span lang=3DEN-GB style=3D'font-siz=
e:11.0pt'><o:p></o:p></span></h2>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span
style=3D'mso-ansi-language:EN-US;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:=
p></span></p>

<p class=3DMsoNormal><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'=
><o:p>&nbsp;</o:p></span></p>

<b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'font-s=
ize:11.0pt;
font-family:"Times New Roman",serif;mso-fareast-font-family:SimSun;mso-font=
-kerning:
16.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-US;mso-bidi-language:
AR-SA'><br clear=3Dall style=3D'page-break-before:always'>
</span></b>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<h1 style=3D'margin-top:0in;margin-right:0in;margin-bottom:0in;margin-left:=
.5in;
text-indent:-.5in;line-height:normal;tab-stops:.5in;border:none;mso-border-=
alt:
solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0pt 1.0pt 4.0pt'>=
<span
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",serif;
mso-bidi-font-weight:normal'>MINIMUM PARTICULARS TO APPEAR ON SMALL IMMEDIA=
TE
PACKAGING UNITS<o:p></o:p></span></h1>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;border:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in;border:none;
mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-alt:1.0pt 4.0p=
t 1.0pt 4.0pt'><b><span
lang=3DEN-GB>SACHETS<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>1.<span style=3D'mso-tab-cou=
nt:1'> </span>NAME
OF THE MEDICINAL PRODUCT AND ROUTE(S) OF ADMINISTRATION<o:p></o:p></span></=
b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Kalydeco 75&nbsp;mg granules</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>ivacaftor</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB>Oral use</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><i><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><i><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></i></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>2.<span style=3D'mso-tab-cou=
nt:1'> </span>METHOD
OF ADMINISTRATION<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 2.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 2.0pt 4.0pt'><b><span lang=3DEN-GB>3.<span style=3D'mso-tab-cou=
nt:1'> </span>EXPIRY
DATE<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>EXP</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>4.<span style=3D'mso-tab-cou=
nt:1'> </span>BATCH
NUMBER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB>Lot</span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;tab-stops:.5in'><span lang=3DEN=
-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>5.<span style=3D'mso-tab-cou=
nt:1'> </span>CONTENTS
BY WEIGHT, BY VOLUME OR BY UNIT<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<div style=3D'mso-element:para-border-div;border:solid windowtext 1.0pt;
mso-border-alt:solid windowtext .5pt;padding:1.0pt 4.0pt 1.0pt 4.0pt'>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-pagination:widow-orphan no-line-numbers;mso-outline-level:2;tab-stops:.=
5in;
border:none;mso-border-alt:solid windowtext .5pt;padding:0in;mso-padding-al=
t:
1.0pt 4.0pt 1.0pt 4.0pt'><b><span lang=3DEN-GB>6.<span style=3D'mso-tab-cou=
nt:1'> </span>OTHER<o:p></o:p></span></b></p>

</div>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'>Vertex Pharmaceutic=
als (Ireland)
Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
mso-outline-level:1;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></s=
pan></p>

<u><span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Verdana",sans-=
serif;
mso-fareast-font-family:Verdana;mso-bidi-font-family:Arial;mso-font-kerning:
16.0pt;mso-ansi-language:EN-GB;mso-fareast-language:EN-GB;mso-bidi-language:
AR-SA;mso-bidi-font-weight:bold'><br clear=3Dall style=3D'mso-special-chara=
cter:
line-break;page-break-before:always'>
</span></u>

<p class=3DNo-numheading3Agency style=3D'margin:0in;page-break-after:auto'>=
<span
lang=3DEN-GB style=3D'font-family:"Times New Roman",serif;text-transform:up=
percase'><o:p>&nbsp;</o:p></span></p>

<p class=3DTitleB style=3D'margin-left:0in;text-indent:0in'><span lang=3DEN=
-GB
style=3D'font-weight:normal'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DTitleA><span lang=3DEN-GB>B. PACKAGE LEAFLET</span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></s=
pan></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:SimSun;mso-ansi-language:EN-GB;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'mso-special-charact=
er:line-break;
page-break-before:always'>
</span>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-outline-level:1;tab-stops:.5in'><b><span lang=3DEN-GB>Package leaflet:
Information for the patient</span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-list:skip;tab-stops:.5in;background:white'><span lang=3DEN-GB><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-list:skip'><b><span lang=3DEN-GB>Kalydeco 150&nbsp;mg film-coated table=
ts<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-list:skip'><span lang=3DEN-GB>ivacaftor</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-hyphenate:
none'><b><span lang=3DEN-GB>Read all of this leaflet carefully before you s=
tart
taking this medicine because it contains important information for you.<o:p=
></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-.25in;line-height:no=
rmal;
page-break-after:avoid;mso-list:l50 level1 lfo43;tab-stops:.5in'><![if !sup=
portLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Keep this leaflet. You ma=
y need
to read it again.</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-.25in;line-height:no=
rmal;
mso-list:l50 level1 lfo43;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>If you have any further
questions, ask your doctor or pharmacist.</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-.25in;line-height:no=
rmal;
mso-list:l50 level1 lfo43;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>This medicine has been
prescribed for you only. Do not pass it on to others. It may harm them, eve=
n if
their signs of illness are the same as yours.</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-.25in;line-height:no=
rmal;
mso-list:l50 level1 lfo43;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>If you get any side effec=
ts,
talk to your doctor or pharmacist. This includes any possible side effects =
not
listed in this leaflet. See section 4.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:.5in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip'><b><span lang=3DEN-GB>What is in t=
his
leaflet<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip'><span lang=3DEN-GB style=3D'mso-bi=
di-font-weight:
bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal;page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB>1.<span
style=3D'mso-tab-count:1'> </span>What Kalydeco is and what it is used fo=
r</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal;tab-stops:.5in'><span lang=3DEN-GB>2.<span style=3D'mso-tab-count:1'=
> </span>What
you need to know before you take Kalydeco</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal;tab-stops:.5in'><span lang=3DEN-GB>3.<span style=3D'mso-tab-count:1'=
> </span>How
to take Kalydeco</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal;tab-stops:.5in'><span lang=3DEN-GB>4.<span style=3D'mso-tab-count:1'=
> </span>Possible
side effects</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal;tab-stops:.5in'><span lang=3DEN-GB>5.<span style=3D'mso-tab-count:1'=
> </span>How
to store Kalydeco</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal;tab-stops:.5in'><span lang=3DEN-GB>6.<span style=3D'mso-tab-count:1'=
> </span>Contents
of the pack and other information</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:no=
rmal;
page-break-after:avoid;mso-list:l32 level1 lfo1;tab-stops:.5in'><![if !supp=
ortLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'><span
style=3D'mso-list:Ignore'>1.<span style=3D'font:7.0pt "Times New Roman"'>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
lang=3DEN-GB>What Kalydeco is and what it is used for<span style=3D'mso-bid=
i-font-weight:
bold'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB>Ka=
lydeco
contains the active ingredient ivacaftor. Ivacaftor acts at the level of th=
e cystic
fibrosis transmembrane conductance regulator (CFTR), a protein that forms a
channel at the cell surface that allows the movement of particles such as
chloride in and out of the cell. Due to mutations in the <i style=3D'mso-bi=
di-font-style:
normal'>CFTR</i> gene (see below), chloride movement is reduced in those wi=
th
cystic fibrosis (CF). Ivacaftor helps certain abnormal CFTR proteins open m=
ore
often to improve chloride movement in and out of the cell.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><a name=3D"_Hlk462393=
56"><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>Kalydeco ta=
blets
are indicated: <o:p></o:p></span></a></p>

<p class=3Dlabeltext style=3D'margin-left:28.35pt;text-indent:-.25in;page-b=
reak-after:
avoid;mso-list:l16 level1 lfo71'><span style=3D'mso-bookmark:_Hlk46239356'>=
<![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:11.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol;mso-ansi-language:EN-GB'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'font-size:11.0pt;
mso-ansi-language:EN-GB'>As monotherapy for patients aged 6&nbsp;years and
older and weighing 25&nbsp;kg or more with cystic fibrosis (CF) who have an=
 <i>R117H</i></span></span><span
style=3D'mso-bookmark:_Hlk46239356'><i style=3D'mso-bidi-font-style:normal'=
><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-size:10.0pt;mso-ansi-l=
anguage:
EN-GB'> </span></i></span><span style=3D'mso-bookmark:_Hlk46239356'><i><span
lang=3DEN-GB style=3D'font-size:11.0pt;mso-ansi-language:EN-GB'>CFTR</span>=
</i></span><span
style=3D'mso-bookmark:_Hlk46239356'><span lang=3DEN-GB style=3D'font-size:1=
1.0pt;
mso-ansi-language:EN-GB'> mutation or one of the following gating mutations=
 in
the <i>CFTR</i> gene: <i style=3D'mso-bidi-font-style:normal'>G551D</i>, <i
style=3D'mso-bidi-font-style:normal'>G1244E</i>, <i style=3D'mso-bidi-font-=
style:
normal'>G1349D</i>, <i style=3D'mso-bidi-font-style:normal'>G178R</i>, <i
style=3D'mso-bidi-font-style:normal'>G551S</i>, <i style=3D'mso-bidi-font-s=
tyle:
normal'>S1251N</i>, <i style=3D'mso-bidi-font-style:normal'>S1255P</i>, <i
style=3D'mso-bidi-font-style:normal'>S549N</i> <span style=3D'mso-bidi-font=
-style:
italic'>or</span> <i style=3D'mso-bidi-font-style:normal'>S549R</i>.<o:p></=
o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-li=
st:skip;
tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk46239356'><span lang=3DEN-G=
B><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-.25in;mso-list:l16 level1 lfo71;tab-stops:103.5pt;mso-layout-g=
rid-align:
none;text-autospace:none'><span style=3D'mso-bookmark:_Hlk46239356'><![if !=
supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In combination with tezacaftor/ivacaftor tab=
lets
for patients aged 12&nbsp;years and older with CF who have two <i>F508del <=
/i>mutations
in the <i>CFTR </i>gene (homozygous for the <i>F508del </i>mutation) or who
have an <i>F508del </i>mutation and certain other second mutations
(heterozygous for the <i style=3D'mso-bidi-font-style:normal'>F508del</i>
mutation). If you have been prescribed Kalydeco to be taken with
tezacaftor/ivacaftor, read the tezacaftor/ivacaftor package leaflet. It
contains important information about how to take these two medicines.</span=
></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-st=
ops:
28.35pt 103.5pt;mso-layout-grid-align:none;text-autospace:none'><span
style=3D'mso-bookmark:_Hlk46239356'><span lang=3DEN-GB><o:p>&nbsp;</o:p></s=
pan></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-.25in;mso-list:l16 level1 lfo71'><span style=3D'mso-bookmark:_=
Hlk46239356'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>In combination with ivacaftor/tezacaftor/ele=
xacaftor
tablets for patients aged 12 years and over with CF who are homozygous for =
the <i
style=3D'mso-bidi-font-style:normal'>F508del </i>mutation in the <i>CFTR</i=
> gene
or heterozygous for <i>F508del</i> in the <i>CFTR</i> gene with a minimal
function (MF) mutation. A minimal function mutation is defined as one that
results either in no CFTR protein being produced or a CFTR protein that does
not function, and which is unlikely to respond to ivacaftor alone and
tezacaftor/ivacaftor. If you have been prescribed Kalydeco to be taken with=
 ivacaftor/tezacaftor/elexacaftor,
read the ivacaftor/tezacaftor/elexacaftor package leaflet. It contains
important information about how to take these two medicines.<u><o:p></o:p><=
/u></span></p>

<span style=3D'mso-bookmark:_Hlk46239356'></span>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:0in;text-indent:0in;line-height:n=
ormal;
page-break-after:avoid;mso-list:l42 level1 lfo4;tab-stops:list 28.5pt'><![i=
f !supportLists]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-farea=
st-font-family:
"Times New Roman";text-transform:uppercase'><span style=3D'mso-list:Ignore'=
>2.<span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b style=3D'mso-bidi-font-weight:normal'=
><span
lang=3DEN-GB>What you need to know before you take Kalydeco<span
style=3D'text-transform:uppercase'><o:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><b=
><span
lang=3DEN-GB>Do not take Kalydeco<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><b=
><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>if you are allergic to ivacaftor or any of t=
he
other ingredients of this medicine (listed in section&nbsp;6).</p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>Warnings and precauti=
ons<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></sp=
an></b></p>

<p class=3DMsoListParagraphCxSpFirst style=3D'margin-left:28.35pt;mso-add-s=
pace:
auto;text-indent:-.25in;page-break-after:avoid;mso-list:l16 level1 lfo71'><=
![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Talk to your doctor if you have liver proble=
ms
or have previously had them. Your doctor may need to adjust your dose.</p>

<p class=3DMsoListParagraphCxSpLast style=3D'margin-left:28.35pt;mso-add-sp=
ace:
auto;text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><sp=
an
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Increased liver enzymes in the blood have be=
en
seen in some people receiving Kalydeco (alone or in combination with tezaca=
ftor/ivacaftor
or ivacaftor/tezacaftor/elexacaftor). Tell your doctor right away if you ha=
ve
any of these symptoms, which may be a sign of liver problems:</p>

<p class=3DMsoNormal style=3D'margin-left:42.55pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l64 level3 lfo53;tab-stops:.5in;mso-layout-grid-align:none;
text-autospace:none'><![if !supportLists]><span lang=3DEN-GB style=3D'font-=
family:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-farea=
st-language:
JA'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Pain or discomfort in the upper right
stomach (abdominal) area<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:42.55pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l64 level3 lfo53;tab-stops:.5in;mso-layout-grid-align:none;
text-autospace:none'><![if !supportLists]><span lang=3DEN-GB style=3D'font-=
family:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-farea=
st-language:
JA'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Yellowing of the skin or the white par=
t of
the eyes<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:42.55pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l64 level3 lfo53;tab-stops:.5in;mso-layout-grid-align:none;
text-autospace:none'><![if !supportLists]><span lang=3DEN-GB style=3D'font-=
family:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-farea=
st-language:
JA'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Loss of appetite<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:42.55pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l64 level3 lfo53;tab-stops:.5in;mso-layout-grid-align:none;
text-autospace:none'><![if !supportLists]><span lang=3DEN-GB style=3D'font-=
family:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-farea=
st-language:
JA'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Nausea or vomiting<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:42.55pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l64 level3 lfo53;tab-stops:.5in;mso-layout-grid-align:none;
text-autospace:none'><![if !supportLists]><span lang=3DEN-GB style=3D'font-=
family:
Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-farea=
st-language:
JA'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New R=
oman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Dark urine<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.25in;margin-bottom:.0001pt;line-height:normal;mso-list:skip;
tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Min=
cho";
mso-fareast-language:JA'>Your doctor will do some blood tests to check your
liver before and during treatment, particularly during the first year and
especially if your blood tests showed high liver enzymes in the past.<o:p><=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:.25in;margin-bottom:.0001pt;line-height:normal;mso-list:skip;
tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Min=
cho";
mso-fareast-language:JA'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Talk to your doctor if you have kidney probl=
ems or
have previously had them.</p>

<p class=3DMsoNormal style=3D'margin-left:10.35pt'><span lang=3DEN-GB><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Kalydeco (alone or in combination with
tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexacaftor) is not recommende=
d if
you have undergone an organ transplant.</p>

<p class=3DMsoNormal style=3D'margin-left:10.35pt'><span lang=3DEN-GB><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Talk to your doctor if you are using hormonal
contraception  for example, women using the contraceptive pill. This may m=
ean
you are more likely to get a rash while taking Kalydeco in combination with
ivacaftor/tezacaftor/elexacaftor.</p>

<p class=3DMsoNormal style=3D'margin-left:10.35pt'><span lang=3DEN-GB><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Abnormality of the eye lens (cataract) witho=
ut
any effect on vision has been noted in some children and adolescents treate=
d with
Kalydeco (alone or in combination with tezacaftor/ivacaftor or ivacaftor/te=
zacaftor/elexacaftor).
Your doctor may perform some eye examinations prior to and during treatment=
.</p>

<p class=3DMsoNormal style=3D'margin-left:10.35pt'><span lang=3DEN-GB><o:p>=
&nbsp;</o:p></span></p>

<p class=3DMsoListParagraph style=3D'margin-left:28.35pt;mso-add-space:auto;
text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><span
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]>Kalydeco (alone or in combination with
tezacaftor/ivacaftor or ivacaftor/tezacaftor/elexacaftor) should only be us=
ed
if you have one of the mutations in the <i style=3D'mso-bidi-font-style:nor=
mal'>CFTR</i>
gene indicated in section 1 (What Kalydeco is and what it is used for).</p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b><span lang=3DEN-GB>Children and adolescents<o:p></o=
:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><span lang=3DEN-GB>Do not give this medicine to childr=
en
under 4&nbsp;months of age<span style=3D'mso-bidi-font-weight:bold'> as it =
is not
known if ivacaftor is safe and effective in these children</span>.</span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-weight:bold;mso-no-proof:yes'><o:p>&nbsp;</o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB
style=3D'mso-bidi-font-weight:bold;mso-no-proof:yes'>Do not give this medic=
ine in
combination with tezacaftor/ivacaftor or with ivacaftor/tezacaftor/elexacaf=
tor to
children under 12&nbsp;years of age as it is not known if they are safe and
effective for them.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>Other medicines a=
nd
Kalydeco<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB>Tell your doctor or pharmacist if y=
ou are
using, have recently used or might use any other medicines. Some medicines =
can
affect how Kalydeco works or make side effects more likely. In particular, =
tell
your doctor if you are taking any of the medicines listed below. Your doctor
may decide to adjust your dose or that you need extra check-ups.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoListParagraphCxSpFirst style=3D'margin-left:28.35pt;mso-add-s=
pace:
auto;text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><sp=
an
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'>Ant=
ifungal
medicines</b> (used for the treatment of fungal infections). These include =
fluconazole,
itraconazole, ketoconazole, posaconazole, and voriconazole.</p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-left:28.35pt;mso-add-=
space:
auto;text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><sp=
an
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b>Antibiotic medicines</b> (used for the
treatment of bacterial infections). These include clarithromycin, erythromy=
cin,
rifabutin, rifampicin, and telithromycin .</p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-left:28.35pt;mso-add-=
space:
auto;text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><sp=
an
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b>Epilepsy</b><b style=3D'mso-bidi-font-wei=
ght:
normal'> medicines</b> (used for the treatment of epileptic seizures). These
include carbamazepine, phenobarbital, and phenytoin. </p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-left:28.35pt;mso-add-=
space:
auto;text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><sp=
an
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'>Her=
bal
medicines<span style=3D'mso-bidi-font-weight:bold'>.</span></b> These inclu=
de St.
Johns wort (Hypericum perforatum).</p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-left:28.35pt;mso-add-=
space:
auto;text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><sp=
an
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'>Imm=
unosuppressants</b>
(used after an organ transplantation). These include ciclosporin, everolimu=
s,
sirolimus, and tacrolimus, . </p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-left:28.35pt;mso-add-=
space:
auto;text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><sp=
an
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'>Car=
diac glycosides</b>
(used for the treatment of some heart conditions). These include digoxin.</=
p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-left:28.35pt;mso-add-=
space:
auto;text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><sp=
an
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'>Ant=
icoagulant
medicines</b> (used to prevent blood clots). These include warfarin. </p>

<p class=3DMsoListParagraphCxSpMiddle style=3D'margin-left:28.35pt;mso-add-=
space:
auto;text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><sp=
an
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'>Med=
icines
for diabetes<span style=3D'mso-bidi-font-weight:bold'>.</span></b> These in=
clude glimepiride
and glipizide. </p>

<p class=3DMsoListParagraphCxSpLast style=3D'margin-left:28.35pt;mso-add-sp=
ace:
auto;text-indent:-.25in;mso-list:l16 level1 lfo71'><![if !supportLists]><sp=
an
style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-fa=
mily:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b>Medicines for lowering blood pressure.</b=
> These
include verapamil.</p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b><span lang=3DEN-GB>Kalydeco with food and drink<o:p=
></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";mso-ansi-lang=
uage:
EN-GB;mso-fareast-language:JA'>Avoid food or drink containing grapefruit du=
ring
treatment with Kalydeco as they may increase the side effects of Kalydeco by
increasing the amount of ivacaftor in your body.<o:p></o:p></span></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>Pregnancy and
breast-feeding<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></sp=
an></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip'><span lang=3DEN-GB>If you are pregnant or breast-feeding, =
think
you may be pregnant or are planning to have a baby, ask your doctor for adv=
ice
before taking this medicine. </span><span style=3D'mso-ansi-language:EN-US'=
>It
may be better to avoid using Kalydeco during pregnancy, if possible, and </=
span><span
lang=3DEN-GB>your doctor will help you decide what is best for you and your
child.</span><span style=3D'mso-ansi-language:EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>It is =
unknown
whether ivacaftor is excreted in human milk. If you plan to breast-feed, ask
your doctor for advice before taking Kalydeco.</span><span lang=3DEN-GB
style=3D'font-size:10.5pt;font-family:"TimesNewRoman",serif;mso-bidi-font-f=
amily:
TimesNewRoman;mso-ansi-language:EN-US'> </span><span style=3D'mso-ansi-lang=
uage:
EN-US'>Your doctor will decide whether to recommend that you stop
breast-feeding or for you to stop ivacaftor therapy. Your doctor will take =
into
account the benefit of breast-feeding for the child and the benefit of ther=
apy
for you.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-=
GB>Driving
and using machines<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB>=
<o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><span
lang=3DEN-GB>Kalydeco can make you dizzy. If you feel dizzy, do not drive, =
cycle
or use machines.</span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB style=3D=
'mso-fareast-language:
JA'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-farea=
st-language:
JA'>Important information about the contents of Kalydeco<o:p></o:p></span><=
/b></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-farea=
st-language:
JA'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-farea=
st-language:
JA'>Kalydeco contains lactose. </span></b><span lang=3DEN-GB style=3D'mso-f=
areast-language:
JA'>If you have been told by your doctor that you have an intolerance to so=
me
sugars, contact your doctor before taking this medicine.<o:p></o:p></span><=
/p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB style=3D=
'mso-fareast-language:
JA'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><b style=3D'mso-bidi-font-w=
eight:
normal'><span lang=3DEN-GB style=3D'mso-fareast-language:JA'>Kalydeco</span=
><span
lang=3DEN-GB> contains less than 1&nbsp;mmol sodium</span></b><span lang=3D=
EN-GB>
(23&nbsp;mg) per dose, that is to say essentially sodium&#8209;free.</spa=
n></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB><o:p>&nb=
sp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB><o:p>&nb=
sp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:no=
rmal;
page-break-after:avoid;mso-list:l42 level1 lfo4;tab-stops:list 28.5pt'><![i=
f !supportLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'><span
style=3D'mso-list:Ignore'>3.<span style=3D'font:7.0pt "Times New Roman"'>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>How to take Kalyde=
co<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB>Always take this medicine exactly a=
s your
doctor has told you to. Check with your doctor if you are not sure.</span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB>Your
doctor will determine which medicine and dose is right for you.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB>Kalydeco
dosing recommendations are provided in Table&nbsp;1.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:6.0pt;line-height:normal;mso-pa=
gination:
widow-orphan lines-together;page-break-after:avoid;mso-list:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Table&nbsp;1: Dosi=
ng
recommendations</span></b></p>

<table class=3DMsoTableGrid border=3D1 cellspacing=3D0 cellpadding=3D0 widt=
h=3D626
 style=3D'width:469.6pt;border-collapse:collapse;border:none;mso-border-alt=
:solid windowtext .5pt;
 mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in 5.4pt'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:16.25pt'>
  <td width=3D198 style=3D'width:148.2pt;border:solid windowtext 1.0pt;mso-=
border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:16.25pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b><span style=3D'font-size:11.0pt;mso-bidi-font-=
style:
  italic'><o:p>&nbsp;</o:p></span></b></p>
  </td>
  <td width=3D256 style=3D'width:192.35pt;border:solid windowtext 1.0pt;bor=
der-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windo=
wtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.25pt'>
  <p class=3Dlabeltext align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid'><b><span style=3D'font-size:11.0pt;mso-bidi-font-=
style:
  italic'>Morning<o:p></o:p></span></b></p>
  </td>
  <td width=3D172 style=3D'width:129.05pt;border:solid windowtext 1.0pt;bor=
der-left:
  none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:solid windo=
wtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.25pt'>
  <p class=3Dlabeltext align=3Dcenter style=3D'text-align:center;mso-pagina=
tion:widow-orphan lines-together;
  page-break-after:avoid'><b><span style=3D'font-size:11.0pt;mso-bidi-font-=
style:
  italic'>Evening<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;height:15.3pt'>
  <td width=3D626 colspan=3D3 style=3D'width:469.6pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.3pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b><span style=3D'font-size:11.0pt;mso-bidi-font-=
style:
  italic'>Kalydeco as monotherapy<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:16.25pt'>
  <td width=3D198 style=3D'width:148.2pt;border:solid windowtext 1.0pt;bord=
er-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:16.25pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span style=3D'font-size:11.0pt;mso-bidi-font-sty=
le:
  italic'>6&nbsp;years and older, &#8805;25&nbsp;kg<o:p></o:p></span></p>
  </td>
  <td width=3D256 style=3D'width:192.35pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
6.25pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span style=3D'font-size:11.0pt;mso-bidi-font-sty=
le:
  italic'>One Kalydeco 150&nbsp;mg tablet<o:p></o:p></span></p>
  </td>
  <td width=3D172 style=3D'width:129.05pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
6.25pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span style=3D'font-size:11.0pt;mso-bidi-font-sty=
le:
  italic'>One Kalydeco 150&nbsp;mg tablet<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:15.3pt'>
  <td width=3D626 colspan=3D3 style=3D'width:469.6pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.3pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b><span style=3D'font-size:11.0pt;mso-bidi-font-=
style:
  italic'>Kalydeco in combination with tezacaftor/ivacaftor<o:p></o:p></spa=
n></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:15.3pt'>
  <td width=3D198 style=3D'width:148.2pt;border:solid windowtext 1.0pt;bord=
er-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.3pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span style=3D'font-size:11.0pt'>12&nbsp;years and
  older<span style=3D'mso-bidi-font-style:italic'><o:p></o:p></span></span>=
</p>
  </td>
  <td width=3D256 style=3D'width:192.35pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.3pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span style=3D'font-size:11.0pt;mso-bidi-font-sty=
le:
  italic'>One tezacaftor 100&nbsp;mg/ivacaftor 150&nbsp;mg tablet<o:p></o:p=
></span></p>
  </td>
  <td width=3D172 style=3D'width:129.05pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.3pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><span style=3D'font-size:11.0pt;mso-bidi-font-sty=
le:
  italic'>One Kalydeco 150&nbsp;mg tablet<o:p></o:p></span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;height:15.3pt'>
  <td width=3D626 colspan=3D3 style=3D'width:469.6pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.3pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together;
  page-break-after:avoid'><b><span style=3D'font-size:11.0pt'>Kalydeco in
  combination with ivacaftor/tezacaftor/elexacaftor<span style=3D'mso-bidi-=
font-style:
  italic'><o:p></o:p></span></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:6;mso-yfti-lastrow:yes;height:15.3pt'>
  <td width=3D198 style=3D'width:148.2pt;border:solid windowtext 1.0pt;bord=
er-top:
  none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:solid window=
text .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:15.3pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together'=
><span
  style=3D'font-size:11.0pt'>12&nbsp;years and older<o:p></o:p></span></p>
  </td>
  <td width=3D256 style=3D'width:192.35pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.3pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together'=
><span
  style=3D'font-size:11.0pt;mso-bidi-font-style:italic'>Two ivacaftor 75&nb=
sp;mg/tezacaftor
  50&nbsp;mg/elexacaftor 100&nbsp;mg tablets<o:p></o:p></span></p>
  </td>
  <td width=3D172 style=3D'width:129.05pt;border-top:none;border-left:none;
  border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
5.3pt'>
  <p class=3Dlabeltext style=3D'mso-pagination:widow-orphan lines-together'=
><span
  style=3D'font-size:11.0pt;mso-bidi-font-style:italic'>One Kalydeco 150&nb=
sp;mg
  tablet<o:p></o:p></span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB>Take the tablets morning and evening doses approximately 12&nb=
sp;hours
apart with food that contains fat. </span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB>You must keep using all other medicines you use, unless your d=
octor
tells you to stop using any.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB>If you have liver problems, either moderate or severe, your do=
ctor
may need to reduce the dose of your tablets, because your liver will not cl=
ear
the medicine as fast as in people who have normal liver function.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Use
in children<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB>Other forms of this medicine (granu=
les in
sachet) are more suitable for children under 6&nbsp;years of age; ask your
doctor or pharmacist.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB>This medicine is for oral use. </span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB>Swallow the tablet whole. Do not break, chew or dissolve the
tablets. Take Kalydeco tablets with food that contains fat.</span><span
style=3D'mso-ansi-language:EN-US'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Meals =
or snacks
that contain fat include those prepared with butter or oils or those contai=
ning
eggs. Other fat-containing foods are:</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l38 level1 lfo14;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Cheese, whole milk, whole-milk dairy products, yogurt, chocola=
te<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l38 level1 lfo14;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Meats, oily fish<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l38 level1 lfo14;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Avocados, hummus, soy-based products (tofu)<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l38 level1 lfo14;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Nuts, fat-containing nutritional bars or drinks<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:.5in'><span
lang=3DEN-GB style=3D'font-size:12.0pt;mso-fareast-font-family:"Times New R=
oman";
mso-fareast-language:ES'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>If you take more Kaly=
deco
than you should<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip'><span lang=3DEN-GB>You may experie=
nce
side effects, including those mentioned in section 4 below. If so, contact =
your
doctor or pharmacist to ask for advice. If possible, have your medicine and
this leaflet with you.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-s=
tyle:
italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-=
GB>If
you forget to take Kalydeco<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB>=
<o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Take the missed dose if less than 6 hours have passed since th=
e time
you missed the dose. Otherwise, wait until your next scheduled dose as you
normally would. Do not take a double dose to make up for a forgotten dose.<=
/span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-=
GB>If
you stop taking Kalydeco<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-=
GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB>=
Take
Kalydeco for as long as your doctor recommends. Do not stop unless your doc=
tor
advises you to. If you have any further questions on the use of this medici=
ne,
ask your doctor or pharmacist.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'color:black'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'color:black'><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip;tab-stops:.5in'><a name=3D"_Hlk45322707"><b><span lang=
=3DEN-GB>4.<span
style=3D'mso-tab-count:1'> </span>Possible side effects</span></b><=
/a></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;page-=
break-after:
avoid;mso-list:skip;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk4532270=
7'><span
lang=3DEN-GB>Like all medicines, this medicine can cause side effects, alth=
ough
not everybody gets them.</span></span><span style=3D'mso-bookmark:_Hlk45322=
707'><span
style=3D'mso-ansi-language:EN-US'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;page-=
break-after:
avoid;mso-list:skip;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk4532270=
7'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Serious side effec=
ts <span
style=3D'mso-bidi-font-weight:bold'><o:p></o:p></span></span></b></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;page-=
break-after:
avoid;mso-list:skip;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk4532270=
7'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;page-=
break-after:
avoid;mso-list:skip;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk4532270=
7'><span
lang=3DEN-GB>Stomach (abdominal) ache and increased liver enzymes in the bl=
ood. </span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;page-=
break-after:
avoid;mso-list:skip;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk4532270=
7'><b><span
lang=3DEN-GB>Possible signs of liver problems<o:p></o:p></span></b></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk4532=
2707'><span
lang=3DEN-GB>Increased liver enzymes in the blood are common in patients wi=
th CF.
These may be signs of liver problems: </span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l29 level1 lfo3=
1;
tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><![if !supportLis=
ts]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Pain or discomfort in the=
 upper
right area of the stomach (abdominal) area</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l29 level1 lfo3=
1;
tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><![if !supportLis=
ts]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Yellowing of the skin or =
white
part of the eyes</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l29 level1 lfo3=
1;
tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><![if !supportLis=
ts]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Loss of appetite</span></=
span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l29 level1 lfo3=
1;
tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><![if !supportLis=
ts]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Nausea or vomiting</span>=
</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l29 level1 lfo3=
1;
tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><![if !supportLis=
ts]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Dark urine</span></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><b><span
lang=3DEN-GB>Tell</span></b><b style=3D'mso-bidi-font-weight:normal'><span
lang=3DEN-GB> your doctor straight away</span></b><span lang=3DEN-GB> if yo=
u get
any of these.</span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:_Hlk45322707'><b><span lang=3DEN-GB>Very common</span=
></b><span
lang=3DEN-GB> side effects (may affect more than 1 in 10 people)</span></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l29 level1 lfo3=
1;
tab-stops:.5in'><span style=3D'mso-bookmark:_Hlk45322707'><![if !supportLis=
ts]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Upper respiratory tract
infection (the common cold), including sore throat and nasal congestion</sp=
an></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l29 level1 lfo31;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Headache</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l29 level1 lfo31;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Dizziness</span></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l29 level1 lfo31;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Diarrhoea</span></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l29 level1 lfo31;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Stomach or abdominal pain=
</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l29 level1 lfo31;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol;
mso-no-proof:yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0p=
t "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-no-proof:yes=
'>Changes
in the type of bacteria in mucus<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l29 level1 lfo31;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol;
mso-no-proof:yes'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0p=
t "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-no-proof:yes=
'>Increased
liver enzymes (signs of stress on the liver)<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l29 level1 lfo31;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Rash </span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk45322707'><b><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-bookma=
rk:_Hlk45322707'><b><span
lang=3DEN-GB>Common</span></b><span lang=3DEN-GB> side effects (may affect =
up to 1
in 10 people)</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Runny nose</span></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Ear pain, ear discomfort<=
/span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Ringing in the ears</span=
></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Redness inside the ear</s=
pan></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Inner ear disorder (</spa=
n></span><span
style=3D'mso-bookmark:_Hlk45322707'><span lang=3DEN-GB style=3D'mso-fareast=
-font-family:
"Times New Roman"'>feeling dizzy or spinning</span><span lang=3DEN-GB>)</sp=
an></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Sinus problems (sinus
congestion)</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Redness in the throat</sp=
an></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Breast mass</span></span>=
</p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Feeling sick (nausea)</sp=
an></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Flu</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Low blood sugar (hypoglyc=
aemia)</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Abnormal breathing (short=
ness
of breath or difficulty breathing)</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Wind (flatulence)</span><=
/span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Spots (acne)</span></span=
></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Itchy skin </span></span>=
</p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Increased creatine
phosphokinase (sign of muscle breakdown) seen in blood tests</span></span><=
/p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
style=3D'mso-bookmark:_Hlk45322707'><span lang=3DEN-GB><o:p>&nbsp;</o:p></s=
pan></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span
style=3D'mso-bookmark:_Hlk45322707'><b style=3D'mso-bidi-font-weight:normal=
'><span
lang=3DEN-GB>Uncommon</span></b><span lang=3DEN-GB> side effects (may affec=
t up to
1 in 100 people)</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l66 level1 lfo33;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Ear congestion</span></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l66 level1 lfo33;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Breast inflammation </spa=
n></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l66 level1 lfo33;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Enlargement of the breast=
 in
males</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l66 level1 lfo33;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Nipple changes or pain</s=
pan></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l66 level1 lfo33;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Wheezing</span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l57 level1 lfo32;tab-stops:.5in'><span style=3D'mso-bookmar=
k:
_Hlk45322707'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:10=
.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Increased blood pressure<=
/span></span></p>

<span style=3D'mso-bookmark:_Hlk45322707'></span>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Additiona=
l side
effects in children and adolescents<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbs=
p;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip'><span lang=3DEN-GB>Side effects seen in children and adolescents are
similar to those observed in adults. However, increased liver enzymes in the
blood are more frequently seen in young children.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Reporting
of side effects<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB>If you get any side effects, talk t=
o your
doctor or pharmacist. This includes any possible side effects not listed in
this leaflet. You can also report side effects directly via <span
style=3D'background:lightgrey;mso-highlight:lightgrey'>the national reporti=
ng
system listed in </span><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
style=3D'color:windowtext;background:lightgrey;mso-highlight:lightgrey'>App=
endix
V</span></a>. By reporting side effects you can help provide more informati=
on
on the safety of this medicine.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.5in;text-indent:-.5in;line-heigh=
t:normal;
page-break-after:avoid;mso-list:l70 level1 lfo7;tab-stops:list .5in'><![if =
!supportLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'><span
style=3D'mso-list:Ignore'>5.<span style=3D'font:7.0pt "Times New Roman"'>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp=
;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>How to store Kalyd=
eco<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB>Keep this medicine out of the sight=
 and
reach of children.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB>Do not use this medicine after the expir=
y date
which is stated on the package after EXP. The expiry date refers to the last
day of that month.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>This m=
edicine
does not require any special storage conditions.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB>Do not throw away any medicines via wast=
ewater
or household waste. Ask your pharmacist how to throw away medicines you no
longer use. These measures will help to protect the environment.<i><o:p></o=
:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:75.75pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:75.75pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip'><b><span lang=3DEN-GB>6.<span style=3D'mso-tab-count:1'> </span=
>Contents
of the pack and other information<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>What Kalydeco con=
tains<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p>=
</span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;tab-stops:.5in'><span lang=3DEN-GB>The active substance is ivacaftor.=
 Each
film&#8209;coated tablet contains 150&nbsp;mg of ivacaftor.<i><o:p></o:p></=
i></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in'><span lang=3DEN-GB>The other ingredients are:</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-13.5pt;line-=
height:
normal;mso-list:l52 level1 lfo6;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol;mso-fareast-language:JA'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Tablet core: cellulose microcrystallin=
e, lactose
monohydrate, hypromellose acetate succinate, croscarmellose sodium, sodium
laurilsulfate (E487), silica, colloidal anhydrous, and magnesium stearate.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-13.5pt;line-=
height:
normal;mso-list:l52 level1 lfo6;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol;mso-fareast-language:JA'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Coating:<i> </i>polyvinyl alcohol,
titanium dioxide (E171), macrogol (PEG 3350), talc, indigo carmine aluminium
lake (E132) and carnauba wax.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-13.5pt;line-=
height:
normal;mso-list:l52 level1 lfo6;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp; </spa=
n></span></span><![endif]><span
lang=3DEN-GB>Printing ink: </span><span lang=3DEN-GB style=3D'mso-fareast-f=
ont-family:
"MS Mincho";mso-fareast-language:JA'>shellac, iron oxide black (E172),
propylene glycol (E1520) and ammonia solution, concentrated.</span></p>

<p class=3DMsoListParagraph style=3D'margin-left:0in;mso-add-space:auto'>Se=
e the
end of section 2 - Important information about the contents of Kalydeco.</p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b><span lang=3DEN-GB>What Kalydeco looks like and con=
tents
of the pack<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Kalydeco 150&nbsp;mg film-coated tablets are light blue, capsu=
le&#8209;shaped,
16.5&nbsp;mm x 8.4 mm, and printed with V&nbsp;150 in black ink on one si=
de
and plain on the other.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Kalyde=
co is
available in the following pack sizes:</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l17 level1 lfo35;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Blister card pack contain=
ing 28
film&#8209;coated tablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l17 level1 lfo35;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Blister pack containing 5=
6 film&#8209;coated
tablets</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l17 level1 lfo35;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Bottle containing 56 film=
&#8209;coated
tablets</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p=
>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in;mso-layout-grid-align:none;text-autospace:none'><a name=3D"OLE_LINK2">=
</a><a
name=3D"OLE_LINK3"><span style=3D'mso-bookmark:OLE_LINK2'><b style=3D'mso-b=
idi-font-weight:
normal'><span lang=3DEN-GB>Marketing Authorisation Holder<o:p></o:p></span>=
</b></span></a></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in;mso-layout-grid-align:none;text-autospace:none'><span style=3D'mso-boo=
kmark:
OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><b style=3D'mso-bidi-font=
-weight:
normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></span></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Vertex Pharmaceuticals (Ireland) Limit=
ed<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>28-32 Pembroke Street Upper<o:p></o:p>=
</span></span></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Dublin 2, D02 EK84<o:p></o:p></span></=
span></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Ireland<o:p></o:p></span></span></span=
></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><span
style=3D'mso-bookmark:OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><sp=
an
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'>Tel: +353 (0)1 761 7299<o=
:p></o:p></span></span></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span style=3D'mso-bookmark=
:OLE_LINK3'><span
style=3D'mso-bookmark:OLE_LINK2'><span lang=3DEN-GB style=3D'mso-fareast-fo=
nt-family:
"MS Mincho";mso-fareast-language:JA'><o:p>&nbsp;</o:p></span></span></span>=
</p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><span
style=3D'mso-bookmark:OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Manufacturer<o:p><=
/o:p></span></b></span></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><span
style=3D'mso-bookmark:OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></b></span></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><span lang=3DEN-GB>Almac =
Pharma
Services (Ireland) Limited</span></span></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><span lang=3DEN-GB>Finnab=
air
Industrial Estate</span></span></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><span lang=3DEN-GB>Dundal=
k</span></span></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><span lang=3DEN-GB>Co. Lo=
uth</span></span></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><span lang=3DEN-GB>A91 P9=
KD</span></span></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span style=3D'mso-bo=
okmark:
OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><span lang=3DEN-GB>Irelan=
d</span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><sp=
an
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><sp=
an
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>Almac P=
harma
Services Limited<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><sp=
an
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>Seagoe
Industrial Estate<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><sp=
an
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>Craigav=
on<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><sp=
an
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>County =
Armagh<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><sp=
an
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>BT63 5U=
A<o:p></o:p></span></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
style=3D'mso-bookmark:OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><sp=
an
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>United =
Kingdom</span></span></span><span
style=3D'mso-bookmark:OLE_LINK3'><span style=3D'mso-bookmark:OLE_LINK2'><sp=
an
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA;mso-bidi-font-weight:bold'><o:p></o:p></span></span></span></p>

<span style=3D'mso-bookmark:OLE_LINK2'></span><span style=3D'mso-bookmark:O=
LE_LINK3'></span>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-=
GB>This
leaflet was last revised in</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Other
sources of information<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB>Detailed information on this medici=
ne is
available on the European Medicines Agency website: <a
href=3D"http://www.ema.europa.eu"><span style=3D'color:windowtext'>http://w=
ww.ema.europa.eu</span></a>.
There are also links to other websites about rare diseases and treatments.<=
/span></p>

<span lang=3DEN-GB style=3D'font-size:11.0pt;font-family:"Times New Roman",=
serif;
mso-fareast-font-family:SimSun;mso-ansi-language:EN-GB;mso-fareast-language:
EN-US;mso-bidi-language:AR-SA'><br clear=3Dall style=3D'page-break-before:a=
lways'>
</span>

<p class=3DMsoNormal align=3Dcenter style=3D'margin-right:-.1pt;text-align:=
center;
line-height:normal;mso-list:skip'><b><span lang=3DEN-GB>Package leaflet: In=
formation
for the patient</span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-list:skip;tab-stops:.5in;background:white'><span lang=3DEN-GB><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-list:skip'><b><span lang=3DEN-GB>Kalydeco 25&nbsp;mg granules in sachet=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-list:skip'><b><span lang=3DEN-GB>Kalydeco 50&nbsp;mg granules in sachet=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-list:skip'><b><span lang=3DEN-GB>Kalydeco 75&nbsp;mg granules in sachet=
<o:p></o:p></span></b></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-list:skip;tab-stops:28.35pt center 227.1pt left 308.4pt'><span lang=3DE=
N-GB>ivacaftor</span></p>

<p class=3DMsoNormal align=3Dcenter style=3D'text-align:center;line-height:=
normal;
mso-list:skip'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-hyphenate:
none'><b><span lang=3DEN-GB>Read all of this leaflet carefully before your =
child
starts taking this medicine because it contains important information for y=
our
child.<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-.25in;line-height:no=
rmal;
page-break-after:avoid;mso-list:l53 level1 lfo36;tab-stops:.5in'><![if !sup=
portLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Keep this leaflet. You ma=
y need
to read it again.</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-.25in;line-height:no=
rmal;
mso-list:l53 level1 lfo36;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>If you have any further
questions, ask your childs doctor or pharmacist.</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-.25in;line-height:no=
rmal;
mso-list:l53 level1 lfo36;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>This medicine has been
prescribed for your child only. Do not pass it on to others. It may harm th=
em,
even if their signs of illness are the same as your childs.</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.35pt;margin-bottom:.0001pt;text-indent:-.25in;line-height:no=
rmal;
mso-list:l53 level1 lfo36;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>If your child gets any si=
de
effects, talk to your childs doctor or pharmacist. This includes any possi=
ble
side effects not listed in this leaflet. See section&nbsp;4.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:.5in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip'><b><span lang=3DEN-GB>What is in t=
his
leaflet<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip'><b><span lang=3DEN-GB><o:p>&nbsp;<=
/o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal;page-break-after:avoid'><span lang=3DEN-GB>1.<span style=3D'mso-tab-=
count:
1'> </span>What Kalydeco is and what it is used for</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal'><span lang=3DEN-GB>2.<span style=3D'mso-tab-count:1'> </span>What=
 you
need to know before your child takes Kalydeco</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal'><span lang=3DEN-GB>3.<span style=3D'mso-tab-count:1'> </span>How =
to take
Kalydeco</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal'><span lang=3DEN-GB>4.<span style=3D'mso-tab-count:1'> </span>Poss=
ible
side effects</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal'><span lang=3DEN-GB>5.<span style=3D'mso-tab-count:1'> </span>How =
to store
Kalydeco</span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-1.4pt;margin-bot=
tom:
0in;margin-left:17.85pt;margin-bottom:.0001pt;text-indent:-17.85pt;line-hei=
ght:
normal'><span lang=3DEN-GB>6.<span style=3D'mso-tab-count:1'> </span>Cont=
ents of
the pack and other information</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:no=
rmal;
page-break-after:avoid;mso-list:l25 level1 lfo18;tab-stops:list 28.5pt'><![=
if !supportLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'><span
style=3D'mso-list:Ignore'>1.<span style=3D'font:7.0pt "Times New Roman"'>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>What Kalydeco is a=
nd what
it is used for<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB><o=
:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;page-b=
reak-after:
avoid;mso-layout-grid-align:none;text-autospace:none'><span lang=3DEN-GB>Ka=
lydeco
contains the active ingredient ivacaftor. </span><span style=3D'mso-ansi-la=
nguage:
EN-US'>Ivacaftor acts at the level of the cystic fibrosis transmembrane
conductance regulator (CFTR), a protein that forms a channel at the cell
surface that allows the movement of particles such as chloride in and out of
the cell. Due to mutations in the <i style=3D'mso-bidi-font-style:normal'>C=
FTR </i>gene
(see below), chloride movement is reduced in those with cystic fibrosis (CF=
).
Ivacaftor helps certain abnormal CFTR proteins open more often to improve
chloride movement in and out of the cell.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:none;mso-la=
yout-grid-align:
none;text-autospace:none'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3Dlabeltext><span style=3D'font-size:11.0pt'>Kalydeco granules are
indicated for the treatment of babies and children aged 4&nbsp;months and o=
lder
and weighing 5&nbsp;kg to less than 25&nbsp;kg with cystic fibrosis (CF) who
have an</span><i style=3D'mso-bidi-font-style:normal'><span style=3D'font-s=
ize:
11.0pt;mso-bidi-font-size:10.0pt'> </span></i><i><span style=3D'font-size:1=
1.0pt'>R117H
CFTR</span></i><span style=3D'font-size:11.0pt'> mutation or one of the fol=
lowing
gating mutations in the <i>CFTR</i> gene: <i style=3D'mso-bidi-font-style:n=
ormal'>G551D,
G1244E, G1349D, G178R, G551S, S1251N, S1255P, S549N </i><span style=3D'mso-=
bidi-font-style:
italic'>or</span><i style=3D'mso-bidi-font-style:normal'> S549R</i>.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:no=
rmal;
page-break-after:avoid;mso-list:l61 level1 lfo19;tab-stops:list 28.5pt'><![=
if !supportLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman";text-transf=
orm:
uppercase'><span style=3D'mso-list:Ignore'>2.<span style=3D'font:7.0pt "Tim=
es New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>What you need to k=
now
before your child takes Kalydeco<span style=3D'text-transform:uppercase'><o=
:p></o:p></span></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><b=
><span
lang=3DEN-GB>Do not take Kalydeco<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><b=
><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;page-break-after:avoid;mso-list:l68 level1 lfo5;tab-stops:.5in'><![i=
f !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>if your child is allergic=
 to
ivacaftor or any of the other ingredients of this medicine (listed in
section&nbsp;6).</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>Warnings and precauti=
ons<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></sp=
an></b></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;page-break-after:avoid;mso-outline-level:1;mso-list:l30 level1 lfo47;
tab-stops:.5in'><![if !supportLists]><span lang=3DEN-GB style=3D'font-famil=
y:Symbol;
mso-fareast-font-family:Symbol;mso-bidi-font-family:Symbol;mso-bidi-font-we=
ight:
bold'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New=
 Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-bidi-font-we=
ight:
bold'>Talk to your childs doctor if your child has liver problems or has h=
ad
them previously. Your childs doctor may need to adjust your childs dose.<=
o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-outline-level:1;mso-list:l59 level1 lfo11;tab-stops:.5in'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Increased liver enzymes i=
n the
blood have been seen in some people receiving Kalydeco. Tell your childs
doctor right away if your child has any of these symptoms, which may be a s=
ign
of liver problems:</span></p>

<p class=3DMsoNormal style=3D'margin-left:42.55pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l18 level1 lfo37;tab-stops:list 42.55pt;mso-layout-grid-ali=
gn:
none;text-autospace:none'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol;mso-fareast-language:JA'><span style=3D'mso-lis=
t:
Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Pain or discomfort in the upper right
stomach (abdominal) area<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:42.55pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l18 level1 lfo37;tab-stops:list 42.55pt;mso-layout-grid-ali=
gn:
none;text-autospace:none'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol;mso-fareast-language:JA'><span style=3D'mso-lis=
t:
Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Yellowing of the skin or the white par=
t of
the eyes<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:42.55pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l18 level1 lfo37;tab-stops:list 42.55pt;mso-layout-grid-ali=
gn:
none;text-autospace:none'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol;mso-fareast-language:JA'><span style=3D'mso-lis=
t:
Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Loss of appetite<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:42.55pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l18 level1 lfo37;tab-stops:list 42.55pt;mso-layout-grid-ali=
gn:
none;text-autospace:none'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol;mso-fareast-language:JA'><span style=3D'mso-lis=
t:
Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Nausea or vomiting<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:42.55pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l18 level1 lfo37;tab-stops:list 42.55pt;mso-layout-grid-ali=
gn:
none;text-autospace:none'><![if !supportLists]><span lang=3DEN-GB
style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-family:Symbol;
mso-bidi-font-family:Symbol;mso-fareast-language:JA'><span style=3D'mso-lis=
t:
Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho";mso-fareast-language:JA'>Dark urine<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.25in;line-height:normal;tab-stop=
s:.5in'><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>Your childs doctor will do some blood tests to check your childs live=
r before
and during treatment, particularly during the first year and </span><span
lang=3DEN-GB>especially if blood tests showed high liver enzymes in the pas=
t.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.25in;line-height:normal;mso-outl=
ine-level:
1;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-outline-level:1;mso-list:l59 level1 lfo11;tab-stops:.5in'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Talk to your childs doct=
or if
you have been told your child has kidney problems or has previously had the=
m. </span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-ou=
tline-level:
1;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-outline-level:1;mso-list:l59 level1 lfo11;tab-stops:.5in'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Kalydeco is not recommend=
ed for
patients who have undergone an organ transplant.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-ou=
tline-level:
1;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-outline-level:1;mso-list:l59 level1 lfo11;tab-stops:.5in'><![if =
!supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol;mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Abnormality of the eye le=
ns
(cataract) without any effect on vision has been noted in some children and
adolescents during treatment. <span style=3D'mso-bidi-font-weight:bold;
mso-bidi-font-style:italic'><o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;mso-ou=
tline-level:
1;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-font-family:"MS M=
incho";
mso-fareast-language:JA'>Your childs doctor may perform some eye examinati=
ons
prior to and during treatment with ivacaftor.</span><span lang=3DEN-GB
style=3D'mso-bidi-font-weight:bold;mso-bidi-font-style:italic'><o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b><span lang=3DEN-GB>Children<o:p></o:p></span></b></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'=
>Do not
give this medicine to children under 4&nbsp;months of age as it is not know=
n if
ivacaftor is safe and effective in these children.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB style=3D'mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>Other medicines a=
nd
Kalydeco<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></s=
pan></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB>Tell your childs doctor or pharmac=
ist if
your child is using, has recently used or might use any other medicines. So=
me
medicines can affect how Kalydeco works or make side effects more likely. In
particular, tell your childs doctor if your child is taking any of the
medicines listed below. Your childs doctor may decide to adjust your child=
s dose
or if extra check-ups are needed.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l38 level1 lfo14;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB>Antifungal medicines</span></b><span lang=3DEN-GB style=3D'mso=
-fareast-font-family:
"MS Mincho"'> (used for the treatment of fungal infections). These include =
fluconazole,
itraconazole, ketoconazole, posaconazole, and voriconazole.<o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l38 level1 lfo14;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol;mso-no-proof:yes'><span style=3D'mso-list:Ignore'><span style=3D'fo=
nt:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b><span lang=3DEN-GB style=3D'mso-fareast-f=
ont-family:
"MS Mincho"'>Antibiotic medicines </span></b><span lang=3DEN-GB style=3D'ms=
o-fareast-font-family:
"MS Mincho"'>(used for the treatment of bacterial infections). These includ=
e,
clarithromycin, erythromycin, rifabutin, rifampicin and telithromycin<span
style=3D'mso-no-proof:yes'>.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l38 level1 lfo14;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol;mso-no-proof:yes'><span style=3D'mso-list:Ignore'><span style=3D'fo=
nt:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b><span lang=3DEN-GB style=3D'mso-fareast-f=
ont-family:
"MS Mincho"'>Epilepsy</span></b><b style=3D'mso-bidi-font-weight:normal'><s=
pan
lang=3DEN-GB> medicines</span></b><span lang=3DEN-GB style=3D'mso-fareast-f=
ont-family:
"MS Mincho"'> (used for the treatment of epileptic seizures or fits). These
include carbamazepine, phenobarbital, and phenytoin<span style=3D'mso-no-pr=
oof:
yes'>.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l38 level1 lfo14;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB>Herbal medicines</span></b><span lang=3DEN-GB style=3D'mso-far=
east-font-family:
"MS Mincho"'>. These include St. Johns wort (<i style=3D'mso-bidi-font-sty=
le:
normal'>Hypericum perforatum</i>).<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo15;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB>Immunosuppressants</span></b><span lang=3DEN-GB style=3D'mso-f=
areast-font-family:
"MS Mincho"'> (used after an organ transplantation). These include ciclospo=
rin,
everolimus, sirolimus, and tacrolimus. <o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo15;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol;mso-no-proof:yes'><span style=3D'mso-list:Ignore'><span style=3D'fo=
nt:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB>Cardiac glycosides</span></b><span lang=3DEN-GB style=3D'mso-f=
areast-font-family:
"MS Mincho"'> (used for the treatment of some heart conditions). These incl=
ude digoxin<span
style=3D'mso-no-proof:yes'>.<o:p></o:p></span></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo15;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB>Anticoagulant medicines</span></b><span lang=3DEN-GB style=3D'=
mso-fareast-font-family:
"MS Mincho"'> (used to prevent blood clots). These include warfarin.<o:p></=
o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo15;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB>Medicines for diabetes</span></b><span lang=3DEN-GB style=3D'm=
so-fareast-font-family:
"MS Mincho"'>. These include glimepiride and glipizide.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo15;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b><span lang=3DEN-GB>Medicines for lowering=
 blood
pressure</span></b><span lang=3DEN-GB>. These include verapamil.</span><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho"'><o:p></o:p></spa=
n></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p></=
span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b><span lang=3DEN-GB>Kalydeco with food and drink<o:p=
></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3Dlabeltext style=3D'page-break-after:avoid'><span style=3D'font-s=
ize:11.0pt;
mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>Avoid giving y=
our
child food or drink containing grapefruit during treatment with Kalydeco as
they may increase </span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-f=
areast-font-family:
"MS Mincho";mso-ansi-language:EN-GB;mso-fareast-language:JA'>the side effec=
ts
of Kalydeco by increasing the amount of ivacaftor in </span><span
style=3D'font-size:11.0pt;mso-fareast-font-family:"MS Mincho";mso-fareast-l=
anguage:
JA'>your childs body.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:64.5pt'><span style=3D'mso-ansi-language:EN-US'><o:p>&nbsp;</o:p>=
</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>Driving and using mac=
hines<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><span
lang=3DEN-GB>Kalydeco can make your child dizzy. If your child feels dizzy,=
 it is
advised that your child does not ride his/her bike or do anything else that
needs his/her full attention.</span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><b style=3D'mso-bidi-font-w=
eight:
normal'><span lang=3DEN-GB style=3D'mso-fareast-language:JA'><o:p>&nbsp;</o=
:p></span></b></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-farea=
st-language:
JA'>Important information about the contents of Kalydeco<o:p></o:p></span><=
/b></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-farea=
st-language:
JA'><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-farea=
st-language:
JA'>Kalydeco contains lactose. </span></b><span lang=3DEN-GB>If you have be=
en
told by your childs doctor that your child has an intolerance to some suga=
rs,
contact your childs doctor before your child takes this medicine.</span></=
p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB style=3D=
'mso-fareast-language:
JA'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><b style=3D'mso-bidi-font-w=
eight:
normal'><span lang=3DEN-GB style=3D'mso-fareast-language:JA'>Kalydeco</span=
><span
lang=3DEN-GB> contains less than 1&nbsp;mmol sodium </span></b><span lang=
=3DEN-GB>(23&nbsp;mg)
per dose, that is to say essentially sodium&#8209;free.</span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB><o:p>&nb=
sp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB><o:p>&nb=
sp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.65pt;text-indent:-28.65pt;line=
-height:
normal;page-break-after:avoid;mso-list:l61 level1 lfo19;tab-stops:list 28.5=
pt'><![if !supportLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'><span
style=3D'mso-list:Ignore'>3.<span style=3D'font:7.0pt "Times New Roman"'>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>How to take Kalyde=
co<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB>Always give your child this medicine
exactly as your childs doctor has told you to. Check with your childs doc=
tor
if you are not sure.</span></p>

<p class=3Ds15 style=3D'margin:0in'><span class=3Ds10><o:p>&nbsp;</o:p></sp=
an></p>

<p class=3Ds15 style=3D'margin:0in'><span class=3Ds10><span style=3D'font-s=
ize:11.0pt;
mso-bidi-font-size:12.0pt'>Your childs doctor will determine the correct d=
ose
for your child.</span></span><span style=3D'font-size:11.0pt;mso-ansi-langu=
age:
EN-GB'> </span><span lang=3DEN-GB style=3D'font-size:11.0pt;mso-bidi-font-s=
ize:
12.0pt;mso-ansi-language:EN-GB'>Your child must keep using all other medici=
nes,
unless your childs doctor tells him/her to stop using any.</span><span
class=3Ds10><span style=3D'font-size:11.0pt;mso-bidi-font-size:12.0pt'><o:p=
></o:p></span></span></p>

<p class=3Ds15 style=3D'margin:0in'><span class=3Ds10><span style=3D'font-s=
ize:11.0pt;
mso-bidi-font-size:12.0pt'><o:p>&nbsp;</o:p></span></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB>Kalydeco
dosing recommendations are provided in Table&nbsp;1.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip'><span lang=
=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-bottom:6.0pt;line-height:normal;page-b=
reak-after:
avoid;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Table&nbsp;1:
Dosing recommendations for children aged 4&nbsp;months and older</span></b>=
</p>

<table class=3DMsoNormalTable border=3D1 cellspacing=3D0 cellpadding=3D0
 style=3D'margin-left:5.4pt;border-collapse:collapse;border:none;mso-border=
-alt:
 solid windowtext .5pt;mso-yfti-tbllook:1184;mso-padding-alt:0in 5.4pt 0in =
5.4pt;
 mso-border-insideh:.5pt solid windowtext;mso-border-insidev:.5pt solid win=
dowtext'>
 <tr style=3D'mso-yfti-irow:0;mso-yfti-firstrow:yes;height:11.45pt'>
  <td width=3D124 valign=3Dtop style=3D'width:93.3pt;border:solid windowtex=
t 1.0pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.45pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Age<o:p></o:p></=
span></b></p>
  </td>
  <td width=3D135 valign=3Dtop style=3D'width:101.35pt;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:11.45pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Weight<o:p></o:p=
></span></b></p>
  </td>
  <td width=3D229 valign=3Dtop style=3D'width:171.75pt;border:solid windowt=
ext 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:11.45pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Dose<o:p></o:p><=
/span></b></p>
  </td>
  <td width=3D109 valign=3Dtop style=3D'width:81.95pt;border:solid windowte=
xt 1.0pt;
  border-left:none;mso-border-left-alt:solid windowtext .5pt;mso-border-alt:
  solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:11.45pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<b
  style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Total daily dose=
<o:p></o:p></span></b></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:1;height:10.85pt'>
  <td width=3D124 valign=3Dtop style=3D'width:93.3pt;border:solid windowtex=
t 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:10.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>4 months to less than 6 months</span></p>
  </td>
  <td width=3D135 valign=3Dtop style=3D'width:101.35pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>5 kg or more</span></p>
  </td>
  <td width=3D229 valign=3Dtop style=3D'width:171.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>One sachet of 25&nbsp;mg granules taken orally every 12&nbsp=
;hours
  with fat&#8209;containing food</span></p>
  </td>
  <td width=3D109 valign=3Dtop style=3D'width:81.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>50 mg</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:2;height:10.85pt'>
  <td width=3D124 rowspan=3D4 valign=3Dtop style=3D'width:93.3pt;border:sol=
id windowtext 1.0pt;
  border-top:none;mso-border-top-alt:solid windowtext .5pt;mso-border-alt:s=
olid windowtext .5pt;
  padding:0in 5.4pt 0in 5.4pt;height:10.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>6 months and older</span></p>
  </td>
  <td width=3D135 valign=3Dtop style=3D'width:101.35pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>5&nbsp;kg to less than 7&nbsp;kg</span></p>
  </td>
  <td width=3D229 valign=3Dtop style=3D'width:171.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>One Kalydeco sachet of 25&nbsp;mg granules taken orally every
  12&nbsp;hours with fat&#8209;containing food</span></p>
  </td>
  <td width=3D109 valign=3Dtop style=3D'width:81.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.85pt'>
  <p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'>=
<span
  lang=3DEN-GB>50&nbsp;mg</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:3;height:10.75pt'>
  <td width=3D135 valign=3Dtop style=3D'width:101.35pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.75pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>7&nb=
sp;kg to less
  than 14&nbsp;kg</span></p>
  </td>
  <td width=3D229 valign=3Dtop style=3D'width:171.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.75pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>One =
Kalydeco sachet
  of 50&nbsp;mg granules taken orally every 12 hours with fat-containing fo=
od </span></p>
  </td>
  <td width=3D109 valign=3Dtop style=3D'width:81.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
0.75pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>100&=
nbsp;mg</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:4;height:11.45pt'>
  <td width=3D135 valign=3Dtop style=3D'width:101.35pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.45pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>14&n=
bsp;kg to
  less than 25&nbsp;kg</span></p>
  </td>
  <td width=3D229 valign=3Dtop style=3D'width:171.75pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.45pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>One =
Kalydeco sachet
  of 75&nbsp;mg granules taken orally every 12 hours with fat-containing fo=
od </span></p>
  </td>
  <td width=3D109 valign=3Dtop style=3D'width:81.95pt;border-top:none;borde=
r-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
1.45pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>150&=
nbsp;mg</span></p>
  </td>
 </tr>
 <tr style=3D'mso-yfti-irow:5;mso-yfti-lastrow:yes;height:16.95pt'>
  <td width=3D135 valign=3Dtop style=3D'width:101.35pt;border-top:none;bord=
er-left:
  none;border-bottom:solid windowtext 1.0pt;border-right:solid windowtext 1=
.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
6.95pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>25&n=
bsp;kg or
  more</span></p>
  </td>
  <td width=3D338 colspan=3D2 valign=3Dtop style=3D'width:253.7pt;border-to=
p:none;
  border-left:none;border-bottom:solid windowtext 1.0pt;border-right:solid =
windowtext 1.0pt;
  mso-border-top-alt:solid windowtext .5pt;mso-border-left-alt:solid window=
text .5pt;
  mso-border-alt:solid windowtext .5pt;padding:0in 5.4pt 0in 5.4pt;height:1=
6.95pt'>
  <p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Plea=
se refer
  to Kalydeco tablets Package Leaflet</span></p>
  </td>
 </tr>
</table>

<p class=3DMsoNormal style=3D'line-height:normal;mso-list:skip;tab-stops:.5=
in'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>If your child has =
liver problems</span></b><span
lang=3DEN-GB>, your childs doctor may need to reduce the dose of Kalydeco =
as
your childs liver will not clear the medicine as fast as in children who h=
ave
normal liver function.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l38 level1 lfo14;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB>Moderate liver problems in children 6 months of age or older:<=
/span></b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho"'> the dose may be=
 reduced
to one half of the indicated dose in the table above, that is one sachet on=
ce
daily.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l38 level1 lfo14;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB>Severe liver problems in children 6 months of age or older:</s=
pan></b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho"'> the use is not
recommended but your childs doctor will decide if it is appropriate for yo=
ur
child to use this medicine in which case the dose (as indicated in the table
above) must be reduced to one sachet every other day.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l38 level1 lfo14;tab-stops:.5in'><a name=3D"_Hlk36546718"><=
![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><b style=3D'mso-bidi-font-weight:normal'><sp=
an
lang=3DEN-GB>Liver problems in children between 4 months and 6 months of ag=
e:</span></b></a><span
style=3D'mso-bookmark:_Hlk36546718'><span lang=3DEN-GB style=3D'mso-fareast=
-font-family:
"MS Mincho"'> the use is not recommended but your childs doctor will decid=
e if
it is appropriate for your child to use<a name=3D"_Hlk36546744"> and </a>wh=
at
dose your child should have.<o:p></o:p></span></span></p>

<span style=3D'mso-bookmark:_Hlk36546718'></span>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB>Kalydeco is for oral use.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:0in'><span
lang=3DEN-GB>Each sachet is for single use only.</span><b style=3D'mso-bidi=
-font-weight:
normal'><i style=3D'mso-bidi-font-style:normal'><span lang=3DEN-GB
style=3D'font-size:10.0pt;mso-bidi-font-size:11.0pt'><o:p></o:p></span></i>=
</b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB style=3D'font-size:10.0pt;mso-bidi-font-size:11.0pt'><o:p>&nbs=
p;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:0in 28.35pt'><sp=
an
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA'>Giving Kalydeco to your child:<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo49;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Hold sachet of granules with cut line on top.<o:p></o:p></span=
></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo49;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Shake sachet gently to settle contents.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo49;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Tear or cut sachet open along cut line.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo49;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Mix the entire content of a sachet with 5&nbsp;mL of
age-appropriate soft food or liquid. Food or liquid should be at room
temperature or below. Some examples of age-appropriate soft foods or liquids
include pured fruits or vegetables, yogurt, applesauce, water, milk, </spa=
n><span
lang=3DEN-GB>breast milk, infant formula, </span><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho"'>or juice.<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo49;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Once mixed, give the product to your child immediately. If thi=
s is
not possible, give it within the following hour after mixing. Ensure that t=
he
mixture is completely and immediately consumed.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo49;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>A fat-containing meal or snack should be given to your child j=
ust
before or just after dosing (some examples are provided below).<o:p></o:p><=
/span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;tab-sto=
ps:0in'><b
style=3D'mso-bidi-font-weight:normal'><i style=3D'mso-bidi-font-style:norma=
l'><span
lang=3DEN-GB style=3D'font-size:10.0pt;mso-bidi-font-size:11.0pt'><o:p>&nbs=
p;</o:p></span></i></b></p>

<p class=3DMsoListParagraph style=3D'margin-left:0in;mso-add-space:auto;pag=
e-break-after:
avoid;tab-stops:13.5pt'>Meals or snacks that contain fat include those prep=
ared
with butter or oils or those containing eggs. Other fat-containing foods ar=
e:</p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo49;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Cheese, whole milk, whole-milk dairy products, yogurt, </span>=
<span
lang=3DEN-GB>breast milk, infant formula,</span><span lang=3DEN-GB
style=3D'mso-fareast-font-family:"MS Mincho"'> chocolate<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo49;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Meats, oily fish<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo49;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Avocados, hummus, soy-based products (tofu)<o:p></o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l40 level1 lfo49;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-family:Symbol;mso-fareast-font-family:Symbol;mso=
-bidi-font-family:
Symbol'><span style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times N=
ew Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB style=3D'mso-fareast-font=
-family:
"MS Mincho"'>Nuts, fat-containing nutritional bars or drinks<o:p></o:p></sp=
an></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></sp=
an></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>If your child takes m=
ore
Kalydeco than he/she should<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-outline-level:
1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip'><span lang=3DEN-GB>Your child may
experience side effects, including those mentioned in section&nbsp;4 below.=
 If
so, contact your childs doctor or pharmacist to ask for advice. If possibl=
e,
have your childs medicine and this leaflet with you.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip;tab-stops:.5in'><i><span lang=3DEN-GB><o:p>&nbsp;</o:p></sp=
an></i></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-pag=
ination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1;
mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>If you forget to give y=
our
child Kalydeco<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-pag=
ination:
widow-orphan lines-together;page-break-after:avoid;mso-outline-level:1;
mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></=
p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n lines-together;
page-break-after:avoid'><span lang=3DEN-GB>Give the missed dose if less than
6&nbsp;hours have passed since the time your child missed the dose. Otherwi=
se,
wait until your childs next scheduled dose as you normally would. Do not g=
ive
your child a double dose to make up for a forgotten dose.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-=
GB>If
you stop giving your child Kalydeco<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-=
GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB>=
Give
Kalydeco to your child for as long as your childs doctor recommends. Do no=
t stop
unless your childs doctor advises you to. If you have any further question=
s on
the use of this medicine, ask your childs doctor or pharmacist.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span>=
</p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:no=
rmal;
page-break-after:avoid;mso-list:l61 level1 lfo19;tab-stops:list 28.5pt'><![=
if !supportLists]><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB style=3D'mso-farea=
st-font-family:
"Times New Roman"'><span style=3D'mso-list:Ignore'>4.<span style=3D'font:7.=
0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbs=
p;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>Possible side effe=
cts</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;page-=
break-after:
avoid;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB>Like all medicines, =
this
medicine can cause side effects, although not everybody gets them.</span></=
p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Serious
side effects<span style=3D'mso-bidi-font-weight:bold'><o:p></o:p></span></s=
pan></b></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span lang=3DEN-GB>Stomach (abdominal) ache and increa=
sed
liver enzymes in the blood. </span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;page-=
break-after:
avoid;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>Possible signs of=
 liver
problems<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;mso-pagination:widow-orpha=
n no-line-numbers;
page-break-after:avoid;tab-stops:.5in'><span lang=3DEN-GB>Increased liver e=
nzymes
in the blood are common in patients with CF. These may be signs of liver
problems: </span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l29 level1 lfo3=
1;
tab-stops:.5in'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:=
10.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Pain or discomfort in the=
 upper
right area of the stomach (abdominal) area</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l29 level1 lfo3=
1;
tab-stops:.5in'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:=
10.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Yellowing of the skin or =
white
part of the eyes</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l29 level1 lfo3=
1;
tab-stops:.5in'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:=
10.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Loss of appetite</span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l29 level1 lfo3=
1;
tab-stops:.5in'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:=
10.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Nausea or vomiting</span>=
</p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l29 level1 lfo3=
1;
tab-stops:.5in'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:=
10.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Dark urine</span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span lang=3DEN-GB>Tell your childs doctor straight a=
way if
he/she gets any of these.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-1.45pt;line-height:normal;mso-l=
ist:
skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><b=
><span
lang=3DEN-GB>Very common</span></b><span lang=3DEN-GB> side effects (may af=
fect
more than 1 in 10&nbsp;people)</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;page-break-after:avoid;
mso-list:l11 level1 lfo38;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Upper respiratory tract
infection (the common cold), including sore throat and nasal congestion</sp=
an></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l11 level1 lfo38;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Headache</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l11 level1 lfo38;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Dizziness</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l11 level1 lfo38;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Diarrhoea</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l11 level1 lfo38;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Rash</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-pagination:widow-orphan no-line-numbers;mso-list:l11 level1 lfo3=
8;
tab-stops:.5in'><![if !supportLists]><span lang=3DEN-GB style=3D'font-size:=
10.0pt;
font-family:Symbol;mso-fareast-font-family:Symbol;mso-bidi-font-family:Symb=
ol'><span
style=3D'mso-list:Ignore'><span style=3D'font:7.0pt "Times New Roman"'>&nb=
sp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Changes in the type of ba=
cteria
in mucus</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><b><span lang=3DEN-GB><o:=
p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><b=
><span
lang=3DEN-GB>Common</span></b><span lang=3DEN-GB> side effects (may affect =
up to 1
in 10&nbsp;people)</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l41 level1 lfo39;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Runny nose</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l41 level1 lfo39;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Ear pain, ear discomfort<=
/span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l41 level1 lfo39;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Ringing in the ears</span=
></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l41 level1 lfo39;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Redness inside the ear</s=
pan></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l41 level1 lfo39;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Inner ear disorder (feeli=
ng
dizzy or spinning)</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l41 level1 lfo39;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Sinus congestion</span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l41 level1 lfo39;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Redness in the throat</sp=
an></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l41 level1 lfo39;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Breast mass<b style=3D'ms=
o-bidi-font-weight:
normal'><o:p></o:p></b></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-st=
ops:
.5in'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbs=
p;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;tab-stops:.5in'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Uncommon</span></b=
><span
lang=3DEN-GB> side effects (may affect up to 1 in 100&nbsp;people)</span></=
p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l10 level1 lfo40;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Ear congestion</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l10 level1 lfo40;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Breast inflammation</span=
></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l10 level1 lfo40;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Enlargement of the breast=
 in
males</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l10 level1 lfo40;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Nipple changes or pain</s=
pan></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Additiona=
l side
effects in children and adolescents<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB>Side effects seen in children and adolescents are similar to t=
hose
observed in adults. However, increased liver enzymes in the blood are more
frequently seen in young children.<span style=3D'mso-bidi-font-weight:bold'=
> </span></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Reporting=
 of side
effects<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbs=
p;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB>If your child gets any side effects=
, talk
to your childs doctor or pharmacist. This includes any possible side effec=
ts
not listed in this leaflet. You can also report side effects directly via <=
span
style=3D'background:lightgrey;mso-highlight:lightgrey'>the national reporti=
ng
system listed in </span><a
href=3D"http://www.ema.europa.eu/docs/en_GB/document_library/Template_or_fo=
rm/2013/03/WC500139752.doc"><span
style=3D'color:windowtext;background:lightgrey;mso-highlight:lightgrey'>App=
endix
V</span></a>. By reporting side effects you can help provide more informati=
on
on the safety of this medicine.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:.4in;text-indent:-.4in;line-heigh=
t:normal;
page-break-after:avoid;mso-list:l61 level1 lfo19;tab-stops:list 28.5pt'><![=
if !supportLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'><span
style=3D'mso-list:Ignore'>5.<span style=3D'font:7.0pt "Times New Roman"'>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>How to store Kalyd=
eco<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB>Keep this medicine out of the sight=
 and
reach of children.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB>Do not use this medicine after the expir=
y date
which is stated on the package after EXP. The expiry date refers to the last
day of that month.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>This m=
edicine
does not require any special storage conditions.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><span
lang=3DEN-GB>Once mixed, the mixture has been shown to be stable for one ho=
ur.</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:.5in'><span lang=3DEN-GB>Do not throw away any medicines via wast=
ewater
or household waste. Ask your pharmacist how to throw away medicines you no
longer use. These measures will help to protect the environment.<i><o:p></o=
:p></i></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:75.75pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip;
tab-stops:75.75pt'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-top:0in;margin-right:-.1pt;margin-bott=
om:0in;
margin-left:28.5pt;margin-bottom:.0001pt;text-indent:-28.5pt;line-height:no=
rmal;
page-break-after:avoid;mso-list:l61 level1 lfo19;tab-stops:list 28.5pt'><![=
if !supportLists]><b><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"Times New Roman"'><span
style=3D'mso-list:Ignore'>6.<span style=3D'font:7.0pt "Times New Roman"'>&n=
bsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;
</span></span></span></b><![endif]><b><span lang=3DEN-GB>Contents of the pa=
ck and
other information<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;mso=
-list:
skip;tab-stops:.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>What Kalydeco con=
tains<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-left:.25in;line-height:normal;page-bre=
ak-after:
avoid;tab-stops:.25in'><u><span lang=3DEN-GB><o:p><span style=3D'text-decor=
ation:
 none'>&nbsp;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;page-b=
reak-after:
avoid;tab-stops:.5in'><u><span lang=3DEN-GB>Kalydeco 25&nbsp;mg granules in
sachet:<o:p></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-st=
ops:
.5in'><span lang=3DEN-GB>The active substance is ivacaftor. Each sachet con=
tains
25&nbsp;mg of ivacaftor.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-st=
ops:
.5in'><u><span lang=3DEN-GB><o:p><span style=3D'text-decoration:none'>&nbsp=
;</span></o:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-st=
ops:
.5in'><u><span lang=3DEN-GB>Kalydeco 50&nbsp;mg granules in sachet:<o:p></o=
:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-st=
ops:
.5in'><span lang=3DEN-GB>The active substance is ivacaftor. Each sachet con=
tains
50&nbsp;mg of ivacaftor.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-st=
ops:
.5in'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-st=
ops:
.5in'><u><span lang=3DEN-GB>Kalydeco 75&nbsp;mg granules in sachet:<o:p></o=
:p></span></u></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;line-height:normal;tab-st=
ops:
.5in'><span lang=3DEN-GB>The active substance is ivacaftor. Each sachet con=
tains
75&nbsp;mg of ivacaftor.</span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;tab-stops:22.5pt'><span
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;tab-stops:22.5pt'><span
lang=3DEN-GB>The other ingredients are: silica, colloidal anhydrous, crosca=
rmellose
sodium, hypromellose acetate succinate, lactose monohydrate, magnesium
stearate, mannitol, sucralose and sodium laurilsulfate </span><span lang=3D=
EN-GB
style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-language:JA'>(E487=
)</span><span
lang=3DEN-GB>.</span></p>

<p class=3DMsoNormal style=3D'margin-left:.25in;tab-stops:.25in 22.5pt'><sp=
an
lang=3DEN-GB><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoListParagraphCxSpFirst style=3D'margin-left:0in;mso-add-space=
:auto'>See
the end of section 2 - Important information about the contents of Kalydeco=
.</p>

<p class=3DMsoListParagraphCxSpLast style=3D'margin-left:0in;mso-add-space:=
auto'><o:p>&nbsp;</o:p></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB>What Kalydeco loo=
ks
like and contents of the pack<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-GB><o:p>&nbsp;</o:p>=
</span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB>Kalydeco 25&nbsp;mg granules in sachet are white to off-white
granules.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Kalyde=
co
50&nbsp;mg granules in sachet are white to off-white granules.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB>Kalyde=
co
75&nbsp;mg granules in sachet are white to off-white granules.</span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><o:p>&=
nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal'><span style=3D'mso-ansi-l=
anguage:
EN-US'>The granules are supplied in sachets.<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-left:28.35pt;text-indent:-.25in;line-h=
eight:
normal;mso-list:l28 level1 lfo42;tab-stops:.5in'><![if !supportLists]><span
lang=3DEN-GB style=3D'font-size:10.0pt;font-family:Symbol;mso-fareast-font-=
family:
Symbol;mso-bidi-font-family:Symbol'><span style=3D'mso-list:Ignore'><span
style=3D'font:7.0pt "Times New Roman"'>&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;&nbsp;=
&nbsp;&nbsp;
</span></span></span><![endif]><span lang=3DEN-GB>Pack size of 56 sachets
(contains 4 individual wallets with 14 sachets per wallet)</span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip;tab-stops:.5in'><i><span lang=3DEN-GB><o:p>&nbsp;</o:p>=
</span></i></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in;mso-layout-grid-align:none;text-autospace:none'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB>Marketing Authorisation Holder<o:p></o:p></span>=
</b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid;tab=
-stops:
.5in;mso-layout-grid-align:none;text-autospace:none'><b style=3D'mso-bidi-f=
ont-weight:
normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Vertex Pharmaceuticals (Ireland) Limit=
ed<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>28-32 Pembroke Street Upper<o:p></o:p>=
</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Dublin 2, D02 EK84<o:p></o:p></span></=
p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Ireland<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB
style=3D'mso-bidi-font-style:italic'>Tel: +353 (0)1 761 7299<o:p></o:p></sp=
an></p>

<p class=3DMsoNormalIndent style=3D'margin:0in'><span lang=3DEN-GB><o:p>&nb=
sp;</o:p></span></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB>Manufacturer<o:p><=
/o:p></span></b></p>

<p class=3DMsoNormalIndent style=3D'margin:0in;page-break-after:avoid'><b
style=3D'mso-bidi-font-weight:normal'><span lang=3DEN-GB><o:p>&nbsp;</o:p><=
/span></b></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Al=
mac Pharma
Services (Ireland) Limited</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Fi=
nnabair
Industrial Estate</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Du=
ndalk</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Co=
. Louth</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>A9=
1 P9KD</span></p>

<p class=3DMsoNormal style=3D'page-break-after:avoid'><span lang=3DEN-GB>Ir=
eland</span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA;mso-bidi-font-weight:bold'><o:p>&nbsp;</o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>Almac P=
harma
Services Limited<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>Seagoe
Industrial Estate<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>Craigav=
on<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>County =
Armagh<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>BT63 5U=
A<o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'background:lightgrey;mso-highlight:lightgrey'>United =
Kingdom</span><span
lang=3DEN-GB style=3D'mso-fareast-font-family:"MS Mincho";mso-fareast-langu=
age:
JA;mso-bidi-font-weight:bold'><o:p></o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-out=
line-level:
1;mso-list:skip;tab-stops:.5in'><span lang=3DEN-GB style=3D'mso-fareast-fon=
t-family:
"MS Mincho";mso-fareast-language:JA;mso-bidi-font-weight:bold'><o:p>&nbsp;<=
/o:p></span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-outline-level:1;mso-list:skip;tab-stops:.5in'><b><span lang=3DEN-=
GB>This
leaflet was last revised in </span></b></p>

<p class=3DMsoNormal style=3D'line-height:normal;page-break-after:avoid'><s=
pan
lang=3DEN-GB style=3D'mso-bidi-font-style:italic'><o:p>&nbsp;</o:p></span><=
/p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB>Other
sources of information<o:p></o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><b style=3D'mso-bidi-font-weight:normal'><span lang=3D=
EN-GB><o:p>&nbsp;</o:p></span></b></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;page-br=
eak-after:
avoid;mso-list:skip'><span lang=3DEN-GB>Detailed information on this medici=
ne is
available on the European Medicines Agency website: <a
href=3D"http://www.ema.europa.eu"><span style=3D'color:windowtext'>http://w=
ww.ema.europa.eu</span></a>.
There are also links to other websites about rare diseases and treatments.<=
/span></p>

<p class=3DMsoNormal style=3D'margin-right:-.1pt;line-height:normal;mso-lis=
t:skip'><a
name=3D"page_total_master4"></a><a name=3D"page_total"></a><span lang=3DEN-=
GB><o:p>&nbsp;</o:p></span></p>

</div>

</body>

</html>

------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/item0001.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><ct:contentTypeSchema ct:_=3D"" m=
a:_=3D"" ma:contentTypeName=3D"Document" ma:contentTypeID=3D"0x010100726F91=
DD1AE57B44B1BCEB7F1056F5D0" ma:contentTypeVersion=3D"6" ma:contentTypeDescr=
iption=3D"Create a new document." ma:contentTypeScope=3D"" ma:versionID=3D"=
80d1dd17cb0c17b7740334051d5d16b2" xmlns:ct=3D"http://schemas.microsoft.com/=
office/2006/metadata/contentType" xmlns:ma=3D"http://schemas.microsoft.com/=
office/2006/metadata/properties/metaAttributes">
<xsd:schema targetNamespace=3D"http://schemas.microsoft.com/office/2006/met=
adata/properties" ma:root=3D"true" ma:fieldsID=3D"c170dc105f61f60cf84b7b3e6=
d807e4f" ns2:_=3D"" ns3:_=3D"" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchem=
a" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:p=3D"http://schemas.=
microsoft.com/office/2006/metadata/properties" xmlns:ns2=3D"a6a35199-84b7-4=
ca5-aa1c-39e9ca4c46ff" xmlns:ns3=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9">
<xsd:import namespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/>
<xsd:import namespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9"/>
<xsd:element name=3D"properties">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"documentManagement">
<xsd:complexType>
<xsd:all>
<xsd:element ref=3D"ns2:MediaServiceMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceFastMetadata" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceAutoKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns2:MediaServiceKeyPoints" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithUsers" minOccurs=3D"0"/>
<xsd:element ref=3D"ns3:SharedWithDetails" minOccurs=3D"0"/>
</xsd:all>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"MediaServiceMetadata" ma:index=3D"8" nillable=3D"true"=
 ma:displayName=3D"MediaServiceMetadata" ma:hidden=3D"true" ma:internalName=
=3D"MediaServiceMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceFastMetadata" ma:index=3D"9" nillable=3D"t=
rue" ma:displayName=3D"MediaServiceFastMetadata" ma:hidden=3D"true" ma:inte=
rnalName=3D"MediaServiceFastMetadata" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceAutoKeyPoints" ma:index=3D"10" nillable=3D=
"true" ma:displayName=3D"MediaServiceAutoKeyPoints" ma:hidden=3D"true" ma:i=
nternalName=3D"MediaServiceAutoKeyPoints" ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note"/>
</xsd:simpleType>
</xsd:element>
<xsd:element name=3D"MediaServiceKeyPoints" ma:index=3D"11" nillable=3D"tru=
e" ma:displayName=3D"KeyPoints" ma:internalName=3D"MediaServiceKeyPoints" m=
a:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"0ac2e3cc-46bd-4320-b2ac-d7f7d167e1a9" elemen=
tFormDefault=3D"qualified" xmlns:xsd=3D"http://www.w3.org/2001/XMLSchema" x=
mlns:xs=3D"http://www.w3.org/2001/XMLSchema" xmlns:dms=3D"http://schemas.mi=
crosoft.com/office/2006/documentManagement/types" xmlns:pc=3D"http://schema=
s.microsoft.com/office/infopath/2007/PartnerControls">
<xsd:import namespace=3D"http://schemas.microsoft.com/office/2006/documentM=
anagement/types"/>
<xsd:import namespace=3D"http://schemas.microsoft.com/office/infopath/2007/=
PartnerControls"/>
<xsd:element name=3D"SharedWithUsers" ma:index=3D"12" nillable=3D"true" ma:=
displayName=3D"Shared With" ma:internalName=3D"SharedWithUsers" ma:readOnly=
=3D"true">
<xsd:complexType>
<xsd:complexContent>
<xsd:extension base=3D"dms:UserMulti">
<xsd:sequence>
<xsd:element name=3D"UserInfo" minOccurs=3D"0" maxOccurs=3D"unbounded">
<xsd:complexType>
<xsd:sequence>
<xsd:element name=3D"DisplayName" type=3D"xsd:string" minOccurs=3D"0"/>
<xsd:element name=3D"AccountId" type=3D"dms:UserId" minOccurs=3D"0" nillabl=
e=3D"true"/>
<xsd:element name=3D"AccountType" type=3D"xsd:string" minOccurs=3D"0"/>
</xsd:sequence>
</xsd:complexType>
</xsd:element>
</xsd:sequence>
</xsd:extension>
</xsd:complexContent>
</xsd:complexType>
</xsd:element>
<xsd:element name=3D"SharedWithDetails" ma:index=3D"13" nillable=3D"true" m=
a:displayName=3D"Shared With Details" ma:internalName=3D"SharedWithDetails"=
 ma:readOnly=3D"true">
<xsd:simpleType>
<xsd:restriction base=3D"dms:Note">
<xsd:maxLength value=3D"255"/>
</xsd:restriction>
</xsd:simpleType>
</xsd:element>
</xsd:schema>
<xsd:schema targetNamespace=3D"http://schemas.openxmlformats.org/package/20=
06/metadata/core-properties" elementFormDefault=3D"qualified" attributeForm=
Default=3D"unqualified" blockDefault=3D"#all" xmlns=3D"http://schemas.openx=
mlformats.org/package/2006/metadata/core-properties" xmlns:xsd=3D"http://ww=
w.w3.org/2001/XMLSchema" xmlns:xsi=3D"http://www.w3.org/2001/XMLSchema-inst=
ance" xmlns:dc=3D"http://purl.org/dc/elements/1.1/" xmlns:dcterms=3D"http:/=
/purl.org/dc/terms/" xmlns:odoc=3D"http://schemas.microsoft.com/internal/ob=
d">
<xsd:import namespace=3D"http://purl.org/dc/elements/1.1/" schemaLocation=
=3D"http://dublincore.org/schemas/xmls/qdc/2003/04/02/dc.xsd"/>
<xsd:import namespace=3D"http://purl.org/dc/terms/" schemaLocation=3D"http:=
//dublincore.org/schemas/xmls/qdc/2003/04/02/dcterms.xsd"/>
<xsd:element name=3D"coreProperties" type=3D"CT_coreProperties"/>
<xsd:complexType name=3D"CT_coreProperties">
<xsd:all>
<xsd:element ref=3D"dc:creator" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dcterms:created" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:identifier" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentType" minOccurs=3D"0" maxOccurs=3D"1" type=3D"x=
sd:string" ma:index=3D"0" ma:displayName=3D"Content Type"/>
<xsd:element ref=3D"dc:title" minOccurs=3D"0" maxOccurs=3D"1" ma:index=3D"4=
" ma:displayName=3D"Title"/>
<xsd:element ref=3D"dc:subject" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element ref=3D"dc:description" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"keywords" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element ref=3D"dc:language" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"category" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string"/>
<xsd:element name=3D"version" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:s=
tring"/>
<xsd:element name=3D"revision" minOccurs=3D"0" maxOccurs=3D"1" type=3D"xsd:=
string">
<xsd:annotation>
<xsd:documentation>
                        This value indicates the number of saves or revisio=
ns. The application is responsible for updating this value after each revis=
ion.
                    </xsd:documentation>
</xsd:annotation>
</xsd:element>
<xsd:element name=3D"lastModifiedBy" minOccurs=3D"0" maxOccurs=3D"1" type=
=3D"xsd:string"/>
<xsd:element ref=3D"dcterms:modified" minOccurs=3D"0" maxOccurs=3D"1"/>
<xsd:element name=3D"contentStatus" minOccurs=3D"0" maxOccurs=3D"1" type=3D=
"xsd:string"/>
</xsd:all>
</xsd:complexType>
</xsd:schema>
<xs:schema targetNamespace=3D"http://schemas.microsoft.com/office/infopath/=
2007/PartnerControls" elementFormDefault=3D"qualified" attributeFormDefault=
=3D"unqualified" xmlns:pc=3D"http://schemas.microsoft.com/office/infopath/2=
007/PartnerControls" xmlns:xs=3D"http://www.w3.org/2001/XMLSchema">
<xs:element name=3D"Person">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:DisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountId" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:AccountType" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"DisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountId" type=3D"xs:string"></xs:element>
<xs:element name=3D"AccountType" type=3D"xs:string"></xs:element>
<xs:element name=3D"BDCAssociatedEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:BDCEntity" minOccurs=3D"0" maxOccurs=3D"unbounded"></=
xs:element>
</xs:sequence>
<xs:attribute ref=3D"pc:EntityNamespace"></xs:attribute>
<xs:attribute ref=3D"pc:EntityName"></xs:attribute>
<xs:attribute ref=3D"pc:SystemInstanceName"></xs:attribute>
<xs:attribute ref=3D"pc:AssociationName"></xs:attribute>
</xs:complexType>
</xs:element>
<xs:attribute name=3D"EntityNamespace" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"EntityName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"SystemInstanceName" type=3D"xs:string"></xs:attribute>
<xs:attribute name=3D"AssociationName" type=3D"xs:string"></xs:attribute>
<xs:element name=3D"BDCEntity">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:EntityDisplayName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityInstanceReference" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId1" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId2" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId3" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId4" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:EntityId5" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"EntityDisplayName" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityInstanceReference" type=3D"xs:string"></xs:elemen=
t>
<xs:element name=3D"EntityId1" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId2" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId3" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId4" type=3D"xs:string"></xs:element>
<xs:element name=3D"EntityId5" type=3D"xs:string"></xs:element>
<xs:element name=3D"Terms">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermInfo" minOccurs=3D"0" maxOccurs=3D"unbounded"></x=
s:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermInfo">
<xs:complexType>
<xs:sequence>
<xs:element ref=3D"pc:TermName" minOccurs=3D"0"></xs:element>
<xs:element ref=3D"pc:TermId" minOccurs=3D"0"></xs:element>
</xs:sequence>
</xs:complexType>
</xs:element>
<xs:element name=3D"TermName" type=3D"xs:string"></xs:element>
<xs:element name=3D"TermId" type=3D"xs:string"></xs:element>
</xs:schema>
</ct:contentTypeSchema>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/props002.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{1103767D-DD73-479D-A943-8ED0FD361D17}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/office/20=
06/metadata/contentType"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.=
com/office/2006/metadata/properties/metaAttributes"/><ds:schemaRef ds:uri=
=3D"http://www.w3.org/2001/XMLSchema"/><ds:schemaRef ds:uri=3D"http://schem=
as.microsoft.com/office/2006/metadata/properties"/><ds:schemaRef ds:uri=3D"=
a6a35199-84b7-4ca5-aa1c-39e9ca4c46ff"/><ds:schemaRef ds:uri=3D"0ac2e3cc-46b=
d-4320-b2ac-d7f7d167e1a9"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft=
.com/office/2006/documentManagement/types"/><ds:schemaRef ds:uri=3D"http://=
schemas.microsoft.com/office/infopath/2007/PartnerControls"/><ds:schemaRef =
ds:uri=3D"http://schemas.openxmlformats.org/package/2006/metadata/core-prop=
erties"/><ds:schemaRef ds:uri=3D"http://purl.org/dc/elements/1.1/"/><ds:sch=
emaRef ds:uri=3D"http://purl.org/dc/terms/"/><ds:schemaRef ds:uri=3D"http:/=
/schemas.microsoft.com/internal/obd"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/item0003.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?><b:Sources Sele=
ctedStyle=3D"\APA.XSL" StyleName=3D"APA" xmlns=3D"http://schemas.openxmlfor=
mats.org/officeDocument/2006/bibliography" xmlns:b=3D"http://schemas.openxm=
lformats.org/officeDocument/2006/bibliography"></b:Sources>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/props004.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{5C0A11BD-03D8-48DB-A8E6-2CB80DB5B28C}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/item0005.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?mso-contentType?><FormTemplates xmlns=3D"http://schemas.microsoft.com/sha=
repoint/v3/contenttype/forms"><Display>DocumentLibraryForm</Display><Edit>D=
ocumentLibraryForm</Edit><New>DocumentLibraryForm</New></FormTemplates>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/props006.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{89212380-2D00-415B-B7C3-7385BCD39C0E}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.microsoft.com/sharepoin=
t/v3/contenttype/forms"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/item0007.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"utf-8"?><p:properties xmlns:p=3D"http://s=
chemas.microsoft.com/office/2006/metadata/properties" xmlns:xsi=3D"http://w=
ww.w3.org/2001/XMLSchema-instance" xmlns:pc=3D"http://schemas.microsoft.com=
/office/infopath/2007/PartnerControls"><documentManagement/></p:properties>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/props008.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{C1BC6594-923B-4AA8-B933-2F588D61A728}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"653cdcb5-02e7-4bda-b933-42425bf6da11"/=
><ds:schemaRef ds:uri=3D"http://purl.org/dc/terms/"/><ds:schemaRef ds:uri=
=3D"http://www.w3.org/XML/1998/namespace"/><ds:schemaRef ds:uri=3D"http://s=
chemas.microsoft.com/office/2006/documentManagement/types"/><ds:schemaRef d=
s:uri=3D"http://purl.org/dc/dcmitype/"/><ds:schemaRef ds:uri=3D"http://purl=
.org/dc/elements/1.1/"/><ds:schemaRef ds:uri=3D"http://schemas.microsoft.co=
m/office/infopath/2007/PartnerControls"/><ds:schemaRef ds:uri=3D"http://sch=
emas.openxmlformats.org/package/2006/metadata/core-properties"/><ds:schemaR=
ef ds:uri=3D"http://schemas.microsoft.com/office/2006/metadata/properties"/=
></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/item0009.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?><b:Sources Sele=
ctedStyle=3D"\APA.XSL" StyleName=3D"APA" xmlns=3D"http://schemas.openxmlfor=
mats.org/officeDocument/2006/bibliography" xmlns:b=3D"http://schemas.openxm=
lformats.org/officeDocument/2006/bibliography"></b:Sources>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/props010.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{43036AA9-D02E-4416-A35A-5B28BB175A0B}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/item0011.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?><b:Sources Sele=
ctedStyle=3D"\APA.XSL" StyleName=3D"APA" xmlns=3D"http://schemas.openxmlfor=
mats.org/officeDocument/2006/bibliography" xmlns:b=3D"http://schemas.openxm=
lformats.org/officeDocument/2006/bibliography"></b:Sources>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/props012.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{2BCF5D4F-3150-4F05-AFC4-846C2FC35F00}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/item0013.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?><b:Sources Sele=
ctedStyle=3D"\APA.XSL" StyleName=3D"APA" xmlns=3D"http://schemas.openxmlfor=
mats.org/officeDocument/2006/bibliography" xmlns:b=3D"http://schemas.openxm=
lformats.org/officeDocument/2006/bibliography"></b:Sources>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/props014.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"no"?>
<ds:datastoreItem ds:itemID=3D"{32C9E0EC-76F8-4486-B054-61EB25C8C5FE}" xmln=
s:ds=3D"http://schemas.openxmlformats.org/officeDocument/2006/customXml"><d=
s:schemaRefs><ds:schemaRef ds:uri=3D"http://schemas.openxmlformats.org/offi=
ceDocument/2006/bibliography"/></ds:schemaRefs></ds:datastoreItem>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/themedata.thmx
Content-Transfer-Encoding: base64
Content-Type: application/vnd.ms-officetheme

UEsDBBQABgAIAAAAIQDp3g+//wAAABwCAAATAAAAW0NvbnRlbnRfVHlwZXNdLnhtbKyRy07DMBBF
90j8g+UtSpyyQAgl6YLHjseifMDImSQWydiyp1X790zSVEKoIBZsLNkz954743K9Hwe1w5icp0qv
8kIrJOsbR12l3zdP2a1WiYEaGDxhpQ+Y9Lq+vCg3h4BJiZpSpXvmcGdMsj2OkHIfkKTS+jgCyzV2
JoD9gA7NdVHcGOuJkTjjyUPX5QO2sB1YPe7l+Zgk4pC0uj82TqxKQwiDs8CS1Oyo+UbJFkIuyrkn
9S6kK4mhzVnCVPkZsOheZTXRNajeIPILjBLDsAyJX89nIBkt5r87nons29ZZbLzdjrKOfDZezE7B
/xRg9T/oE9PMf1t/AgAA//8DAFBLAwQUAAYACAAAACEApdan58AAAAA2AQAACwAAAF9yZWxzLy5y
ZWxzhI/PasMwDIfvhb2D0X1R0sMYJXYvpZBDL6N9AOEof2giG9sb69tPxwYKuwiEpO/3qT3+rov5
4ZTnIBaaqgbD4kM/y2jhdj2/f4LJhaSnJQhbeHCGo3vbtV+8UNGjPM0xG6VItjCVEg+I2U+8Uq5C
ZNHJENJKRds0YiR/p5FxX9cfmJ4Z4DZM0/UWUtc3YK6PqMn/s8MwzJ5PwX+vLOVFBG43lExp5GKh
qC/jU72QqGWq1B7Qtbj51v0BAAD//wMAUEsDBBQABgAIAAAAIQBreZYWgwAAAIoAAAAcAAAAdGhl
bWUvdGhlbWUvdGhlbWVNYW5hZ2VyLnhtbAzMTQrDIBBA4X2hd5DZN2O7KEVissuuu/YAQ5waQceg
0p/b1+XjgzfO3xTVm0sNWSycBw2KZc0uiLfwfCynG6jaSBzFLGzhxxXm6XgYybSNE99JyHNRfSPV
kIWttd0g1rUr1SHvLN1euSRqPYtHV+jT9yniResrJgoCOP0BAAD//wMAUEsDBBQABgAIAAAAIQAw
3UMpqAYAAKQbAAAWAAAAdGhlbWUvdGhlbWUvdGhlbWUxLnhtbOxZT2/bNhS/D9h3IHRvYyd2Ggd1
itixmy1NG8Ruhx5piZbYUKJA0kl9G9rjgAHDumGHFdhth2FbgRbYpfs02TpsHdCvsEdSksVYXpI2
2IqtPiQS+eP7/x4fqavX7scMHRIhKU/aXv1yzUMk8XlAk7Dt3R72L615SCqcBJjxhLS9KZHetY33
37uK11VEYoJgfSLXcduLlErXl5akD8NYXuYpSWBuzEWMFbyKcCkQ+AjoxmxpuVZbXYoxTTyU4BjI
3hqPqU/QUJP0NnLiPQaviZJ6wGdioEkTZ4XBBgd1jZBT2WUCHWLW9oBPwI+G5L7yEMNSwUTbq5mf
t7RxdQmvZ4uYWrC2tK5vftm6bEFwsGx4inBUMK33G60rWwV9A2BqHtfr9bq9ekHPALDvg6ZWljLN
Rn+t3slplkD2cZ52t9asNVx8if7KnMytTqfTbGWyWKIGZB8bc/i12mpjc9nBG5DFN+fwjc5mt7vq
4A3I4lfn8P0rrdWGizegiNHkYA6tHdrvZ9QLyJiz7Ur4GsDXahl8hoJoKKJLsxjzRC2KtRjf46IP
AA1kWNEEqWlKxtiHKO7ieCQo1gzwOsGlGTvky7khzQtJX9BUtb0PUwwZMaP36vn3r54/RccPnh0/
+On44cPjBz9aQs6qbZyE5VUvv/3sz8cfoz+efvPy0RfVeFnG//rDJ7/8/Hk1ENJnJs6LL5/89uzJ
i68+/f27RxXwTYFHZfiQxkSim+QI7fMYFDNWcSUnI3G+FcMI0/KKzSSUOMGaSwX9nooc9M0pZpl3
HDk6xLXgHQHlowp4fXLPEXgQiYmiFZx3otgB7nLOOlxUWmFH8yqZeThJwmrmYlLG7WN8WMW7ixPH
v71JCnUzD0tH8W5EHDH3GE4UDklCFNJz/ICQCu3uUurYdZf6gks+VuguRR1MK00ypCMnmmaLtmkM
fplW6Qz+dmyzewd1OKvSeoscukjICswqhB8S5pjxOp4oHFeRHOKYlQ1+A6uoSsjBVPhlXE8q8HRI
GEe9gEhZteaWAH1LTt/BULEq3b7LprGLFIoeVNG8gTkvI7f4QTfCcVqFHdAkKmM/kAcQohjtcVUF
3+Vuhuh38ANOFrr7DiWOu0+vBrdp6Ig0CxA9MxEVvrxOuBO/gykbY2JKDRR1p1bHNPm7ws0oVG7L
4eIKN5TKF18/rpD7bS3Zm7B7VeXM9olCvQh3sjx3uQjo21+dt/Ak2SOQEPNb1Lvi/K44e//54rwo
ny++JM+qMBRo3YvYRtu03fHCrntMGRuoKSM3pGm8Jew9QR8G9Tpz4iTFKSyN4FFnMjBwcKHAZg0S
XH1EVTSIcApNe93TREKZkQ4lSrmEw6IZrqSt8dD4K3vUbOpDiK0cEqtdHtjhFT2cnzUKMkaq0Bxo
c0YrmsBZma1cyYiCbq/DrK6FOjO3uhHNFEWHW6GyNrE5lIPJC9VgsLAmNDUIWiGw8iqc+TVrOOxg
RgJtd+uj3C3GCxfpIhnhgGQ+0nrP+6hunJTHypwiWg8bDPrgeIrVStxamuwbcDuLk8rsGgvY5d57
Ey/lETzzElA7mY4sKScnS9BR22s1l5se8nHa9sZwTobHOAWvS91HYhbCZZOvhA37U5PZZPnMm61c
MTcJ6nD1Ye0+p7BTB1Ih1RaWkQ0NM5WFAEs0Jyv/chPMelEKVFSjs0mxsgbB8K9JAXZ0XUvGY+Kr
srNLI9p29jUrpXyiiBhEwREasYnYx+B+HaqgT0AlXHeYiqBf4G5OW9tMucU5S7ryjZjB2XHM0ghn
5VanaJ7JFm4KUiGDeSuJB7pVym6UO78qJuUvSJVyGP/PVNH7Cdw+rATaAz5cDQuMdKa0PS5UxKEK
pRH1+wIaB1M7IFrgfhemIajggtr8F+RQ/7c5Z2mYtIZDpNqnIRIU9iMVCUL2oCyZ6DuFWD3buyxJ
lhEyEVUSV6ZW7BE5JGyoa+Cq3ts9FEGom2qSlQGDOxl/7nuWQaNQNznlfHMqWbH32hz4pzsfm8yg
lFuHTUOT278QsWgPZruqXW+W53tvWRE9MWuzGnlWALPSVtDK0v41RTjnVmsr1pzGy81cOPDivMYw
WDREKdwhIf0H9j8qfGa/dugNdcj3obYi+HihiUHYQFRfso0H0gXSDo6gcbKDNpg0KWvarHXSVss3
6wvudAu+J4ytJTuLv89p7KI5c9k5uXiRxs4s7Njaji00NXj2ZIrC0Dg/yBjHmM9k5S9ZfHQPHL0F
3wwmTEkTTPCdSmDooQcmDyD5LUezdOMvAAAA//8DAFBLAwQUAAYACAAAACEADdGQn7YAAAAbAQAA
JwAAAHRoZW1lL3RoZW1lL19yZWxzL3RoZW1lTWFuYWdlci54bWwucmVsc4SPTQrCMBSE94J3CG9v
07oQkSbdiNCt1AOE5DUNNj8kUeztDa4sCC6HYb6ZabuXnckTYzLeMWiqGgg66ZVxmsFtuOyOQFIW
TonZO2SwYIKObzftFWeRSyhNJiRSKC4xmHIOJ0qTnNCKVPmArjijj1bkIqOmQci70Ej3dX2g8ZsB
fMUkvWIQe9UAGZZQmv+z/TgaiWcvHxZd/lFBc9mFBSiixszgI5uqTATKW7q6xN8AAAD//wMAUEsB
Ai0AFAAGAAgAAAAhAOneD7//AAAAHAIAABMAAAAAAAAAAAAAAAAAAAAAAFtDb250ZW50X1R5cGVz
XS54bWxQSwECLQAUAAYACAAAACEApdan58AAAAA2AQAACwAAAAAAAAAAAAAAAAAwAQAAX3JlbHMv
LnJlbHNQSwECLQAUAAYACAAAACEAa3mWFoMAAACKAAAAHAAAAAAAAAAAAAAAAAAZAgAAdGhlbWUv
dGhlbWUvdGhlbWVNYW5hZ2VyLnhtbFBLAQItABQABgAIAAAAIQAw3UMpqAYAAKQbAAAWAAAAAAAA
AAAAAAAAANYCAAB0aGVtZS90aGVtZS90aGVtZTEueG1sUEsBAi0AFAAGAAgAAAAhAA3RkJ+2AAAA
GwEAACcAAAAAAAAAAAAAAAAAsgkAAHRoZW1lL3RoZW1lL19yZWxzL3RoZW1lTWFuYWdlci54bWwu
cmVsc1BLBQYAAAAABQAFAF0BAACtCgAAAAA=

------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/colorschememapping.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml

<?xml version=3D"1.0" encoding=3D"UTF-8" standalone=3D"yes"?>
<a:clrMap xmlns:a=3D"http://schemas.openxmlformats.org/drawingml/2006/main"=
 bg1=3D"lt1" tx1=3D"dk1" bg2=3D"lt2" tx2=3D"dk2" accent1=3D"accent1" accent=
2=3D"accent2" accent3=3D"accent3" accent4=3D"accent4" accent5=3D"accent5" a=
ccent6=3D"accent6" hlink=3D"hlink" folHlink=3D"folHlink"/>
------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/image001.png
Content-Transfer-Encoding: base64
Content-Type: image/png
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------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/header.htm
Content-Transfer-Encoding: quoted-printable
Content-Type: text/html; charset="windows-1252"

<html xmlns:v=3D"urn:schemas-microsoft-com:vml"
xmlns:o=3D"urn:schemas-microsoft-com:office:office"
xmlns:w=3D"urn:schemas-microsoft-com:office:word"
xmlns:m=3D"http://schemas.microsoft.com/office/2004/12/omml"
xmlns=3D"http://www.w3.org/TR/REC-html40">

<head>
<meta http-equiv=3DContent-Type content=3D"text/html; charset=3Dwindows-125=
2">
<meta name=3DProgId content=3DWord.Document>
<meta name=3DGenerator content=3D"Microsoft Word 15">
<meta name=3DOriginator content=3D"Microsoft Word 15">
<link id=3DMain-File rel=3DMain-File href=3D"../Kalydeco_clean.htm">
<![if IE]>
<base href=3D"file:///C:/8467A08E/Kalydeco_clean_files/header.htm"
id=3D"webarch_temp_base_tag">
<![endif]><!--[if gte mso 9]><xml>
 <o:shapedefaults v:ext=3D"edit" spidmax=3D"2049"/>
</xml><![endif]-->
</head>

<body lang=3DEN-US link=3Dblue vlink=3Dpurple>

<div style=3D'mso-element:footnote-separator' id=3Dfs>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><span
style=3D'mso-special-character:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footnote-continuation-separator' id=3Dfcs>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><span
style=3D'mso-special-character:footnote-continuation-separator'><![if !supp=
ortFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-separator' id=3Des>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><span
style=3D'mso-special-character:footnote-separator'><![if !supportFootnotes]>

<hr align=3Dleft size=3D1 width=3D"33%">

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:endnote-continuation-separator' id=3Decs>

<p class=3DMsoNormal style=3D'line-height:normal'><span lang=3DEN-GB><span
style=3D'mso-special-character:footnote-continuation-separator'><![if !supp=
ortFootnotes]>

<hr align=3Dleft size=3D1>

<![endif]></span></span></p>

</div>

<div style=3D'mso-element:footer' id=3Df1>

<p class=3DMsoFooter align=3Dcenter style=3D'margin-right:4.8pt;text-align:=
center;
tab-stops:28.35pt center 3.15in right 415.3pt 446.55pt'><!--[if supportFiel=
ds]><span
lang=3DEN-GB><span style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'></span>EQ <span style=3D'mso-element:field-sepa=
rator'></span></span><![endif]--><!--[if supportFields]><span
lang=3DEN-GB><span style=3D'mso-element:field-end'></span></span><![endif]-=
-><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-begin'></span>PAGE<span style=3D'mso-spacerun:ye=
s'>
</span><span style=3D'mso-element:field-separator'></span></span></span><![=
endif]--><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-no-proof:yes'>2</span></span></span><!--[if supportFields]><sp=
an
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-end'></span></span></span><![endif]--></p>

</div>

<div style=3D'mso-element:footer' id=3Dff1>

<p class=3DMsoFooter align=3Dcenter style=3D'margin-right:4.8pt;text-align:=
center;
tab-stops:28.35pt center 3.15in right 415.3pt 446.55pt'><!--[if supportFiel=
ds]><span
lang=3DEN-GB><span style=3D'mso-element:field-begin'></span><span
style=3D'mso-spacerun:yes'></span>EQ <span style=3D'mso-element:field-sepa=
rator'></span></span><![endif]--><!--[if supportFields]><span
lang=3DEN-GB><span style=3D'mso-element:field-end'></span></span><![endif]-=
-><!--[if supportFields]><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-begin'></span>PAGE<span style=3D'mso-spacerun:ye=
s'>
</span><span style=3D'mso-element:field-separator'></span></span></span><![=
endif]--><span
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-no-proof:yes'>1</span></span></span><!--[if supportFields]><sp=
an
class=3DMsoPageNumber><span lang=3DEN-GB style=3D'font-family:"Arial",sans-=
serif'><span
style=3D'mso-element:field-end'></span></span></span><![endif]--></p>

</div>

</body>

</html>

------=_NextPart_01D74CBE.98D67E10
Content-Location: file:///C:/8467A08E/Kalydeco_clean_files/filelist.xml
Content-Transfer-Encoding: quoted-printable
Content-Type: text/xml; charset="utf-8"

<xml xmlns:o=3D"urn:schemas-microsoft-com:office:office">
 <o:MainFile HRef=3D"../Kalydeco_clean.htm"/>
 <o:File HRef=3D"item0001.xml"/>
 <o:File HRef=3D"props002.xml"/>
 <o:File HRef=3D"item0003.xml"/>
 <o:File HRef=3D"props004.xml"/>
 <o:File HRef=3D"item0005.xml"/>
 <o:File HRef=3D"props006.xml"/>
 <o:File HRef=3D"item0007.xml"/>
 <o:File HRef=3D"props008.xml"/>
 <o:File HRef=3D"item0009.xml"/>
 <o:File HRef=3D"props010.xml"/>
 <o:File HRef=3D"item0011.xml"/>
 <o:File HRef=3D"props012.xml"/>
 <o:File HRef=3D"item0013.xml"/>
 <o:File HRef=3D"props014.xml"/>
 <o:File HRef=3D"themedata.thmx"/>
 <o:File HRef=3D"colorschememapping.xml"/>
 <o:File HRef=3D"image001.png"/>
 <o:File HRef=3D"header.htm"/>
 <o:File HRef=3D"filelist.xml"/>
</xml>
------=_NextPart_01D74CBE.98D67E10--
